• A-Gonzalez N, Bensinger SJ, Hong C, Beceiro S, Bradley MN, Zelcer N, Deniz J, Ramirez C, Diaz M, Gallardo G, Ruiz de Galarreta C, Salazar J, Lopez F, Edwards P, Parks J, Andujar M, Tontonoz P, Castrillo A. Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity 31: 245-258 (2009). *

• Aarnisalo J, Treszl A, Svec P, Marttila J, Oling V, Simell O, Knip M, Korner A, Madacsy L, Vasarhelyi B, Ilonen J, Hermann R. Reduced CD4(+)T cell activation in children with type 1 diabetes carrying the PTPN22/Lyp 620Trp variant. J. Autoimmun. 31: 13-21 (2008).

• Abad E, Tural C, Mirapeix E, Cuxart A. Relationship between ANCA and clinical activity in inflammatory bowel disease: variation in prevalence of ANCA and evidence of heterogeneity. J. Autoimmun. 10: 175-180 (1997). *

• Abbasciano V, Trevisani L, Di Todaro F, Guglielmini C, Marzola A, Sartori S, Salemi A. Primary biliary cirrhosis and autoimmune hepatitis overlap syndrome. An early case. Recenti Prog. Med. 97: 28-31 (2006).

• Abbasi SY, Milhem M, Zaru L. A positive antinuclear antibody test predicts for a poor response to initial steroid therapy in adults with idiopathic thrombocytopenic purpura. Ann. Hematol. 87: 459-462 (2008). *

• Abdel Fattah S, Abdel KhaliK K, el-Shawarby L, Abdel Fattah S, el Shimi S, Soliman M, Hassan H. Some immunological aspects of chronic liver diseases in Egyptian children. J. Egypt. Soc. Parasitol. 21: 343-355 (1991).

• Abe K, Saito H, Takahashi A, Rai T, Takiguchi J, Kanno Y, Monoe K, Ohira H. A case of acute hepatitis associated with Basedow's disease. Nippon Shokakibyo Gakkai Zasshi 104: 52-56 (2007).

• Abe M, Furukawa S, Takayama S, Michitaka K, Minami H, Yamamoto K, Horiike N, Onji M. Drug-induced hepatitis with autoimmune features during minocycline therapy. Intern. Med. 42: 48-52 (2003). *

• Abe M, Onji M, Kawai-Ninomiya K, Michitaka K, Matsuura B, Hiasa Y, Horiike N. Clinicopathologic features of the severe form of acute type 1 autoimmune hepatitis. Clin. Gastroenterol. Hepatol. 5: 255-258 (2007).

• Abedi MR, Hammarstrom L, Broome U, Angelin B, Smith CI, Christensson B. Reduction in serum levels of antimitochondrial (M2) antibodies following immunoglobulin therapy in severe combined immunodeficient (SCID) mice reconstituted with lymphocytes from patients with primary biliary cirrhosis (PBC). Clin. Exp. Immunol. 105: 266-273 (1996). *

• Ablin JN, Boguslavski V, Aloush V, Elkayam O, Paran D, Caspi D, George J. Effect of anti-TNFalpha treatment on circulating endothelial progenitor cells (EPCs) in rheumatoid arthritis. Life Sci. 79: 2364-2369 (2006). *

• Abraham M, Karni A, Dembinsky A, Miller A, Gandhi R, Anderson D, Weiner HL. In vitro induction of regulatory T cells by anti-CD3 antibody in humans. J. Autoimmun. 30: 21-28 (2008). *

• Abreu MT. The pathogenesis of inflammatory bowel disease: translational implications for clinicians. Curr. Gastroenterol. Rep. 4: 481-489 (2002).

• Achkar JP, Barmada MM, Duerr RH. Perinuclear neutrophil antibodies are not markers for genetic susceptibility or indicators of genetic heterogeneity in familial ulcerative colitis. Am. J. Gastroenterol. 97: 2343-2349 (2002). *

• Adamopoulos AB. Inflammatory bowel disease (IBD) and the liver. Annals of Gastroenterology 19: 146-151 (2006). *

• Adams LA, Lindor KD, Angulo P. The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease. Am. J. Gastroenterol. 99: 1316-1320 (2004). *

• Afford SC, Ahmed-Choudhury J, Randhawa S, Russell C, Youster J, Crosby HA, Eliopoulos A, Hubscher SG, Young LS, Adams DH. CD40 activation-induced, Fas-dependent apoptosis and NF-kappaB/AP-1 signaling in human intrahepatic biliary epithelial cells. FASEB J. 15: 2345-2354 (2001). *

• Agache I, Duca L, Anghel M, Pamfil G. Antinuclear antibodies in asthma patients- a special asthma phenotype? Iran. J. Allergy Asthma Immunol. 8: 49-52 (2009).

• Agarwal K, Jones DE, Watt FE, Burt AD, Floreani A, Bassendine MF. Familial primary biliary cirrhosis and autoimmune cholangitis. Dig. Liver Dis. 34: 50-52 (2002).

• Agmon-Levin N, Shapira Y, Selmi C, Barzilai O, Ram M, Szyper-Kravitz M, Sella S, Katz BS, Youinou P, Renaudineau Y, Larida B, Invernizzi P, Gershwin ME, Shoenfeld Y. A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis. J. Autoimmun. Nov 6 [Epub ahead of print] (2009).

• Agoston-Coldea L, Fodor D, Pais R, Rusu ML, Georgiu C. Autoimmune cholangitis in patients with primary Sjogren's syndrome. A case report. Rom. J. Gastroenterol. 11: 321-324 (2002).

• Aguilera O, Pena C, Garcia JM, Larriba MJ, Ordonez-Moran P, Navarro D, Barbachano A, de Silanes IL, Ballestar E, Fraga MF, Esteller M, Gamallo C, Bonilla F, Gonzalez-Sancho JM, Munoz A. The Wnt antagonist DICKKOPF-1 gene is induced by 1alpha,25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells. Carcinogenesis 28: 1877-1884 (2007). *

• Ahmad R, Rasheed Z, Ahsan H. Biochemical and cellular toxicology of peroxynitrite: implications in cell death and autoimmune phenomenon. Immunopharmacol. Immunotoxicol. 31: 388-396 (2009).

• Ahuja A, Shupe J, Dunn R, Kashgarian M, Kehry MR, Shlomchik MJ. Depletion of B cells in murine lupus: efficacy and resistance. J. Immunol. 179: 3351-3361 (2007). *

• Aisenberg J, Legnani PE, Nilubol N, Cobrin GM, Ellozy SH, Hegazi RAF, Yager J, Bodian C, Gorfine SR, Bauer JJ, Plevy SE, Sachar DB. Are pANCA, ASCA, or cytokine gene polymorphisms associated with pouchitis? Long-term follow-up in 102 ulcerative colitis patients. Am. J. Gastroenterol. 99: 432-441 (2004). *

• Aisenberg J, Wagreich J, Shim J, Almer S, Peen E, Heimann T, Gelernt IM, Greenstein A, Rubin P, Harpaz N, et al. Perinuclear anti-neutrophil cytoplasmic antibody and refractory pouchitis. A case-control study. Dig. Dis. Sci. 40: 1866-1872 (1995).

• Aitola P, Miettinen A, Mattila A, Matikainen M, Soppi E. Effect of proctocolectomy on serum antineutrophil cytoplasmic antibodies in patients with chronic ulcerative colitis. J. Clin. Pathol. 48: 645-647 (1995). *

• Akbar SM, Yamamoto K, Miyakawa H, Ninomiya T, Abe M, Hiasa Y, Masumoto T, Horiike N, Onji M. Peripheral blood T-cell responses to pyruvate dehydrogenase complex in primary biliary cirrhosis: role of antigen-presenting dendritic cells. Eur. J. Clin. Invest. 31: 639-646 (2001). *

• Al-Daraji WI, Malak TT, Prescott RJ, Abdellaoui A, Ali MM, Dabash T, Zelger BG, Zelger B. Expression, localisation and functional activation of NFAT-2 in normal human skin, psoriasis, and cultured keratocytes. Int. J. Clin. Exp. Med. 2: 176-192 (2009).

• Al-Hanbali M, Ali D, Bustami M, Abdel-Malek S, Al-Hanbali R, Alhussainy T, Qadan F, Matalka KZ. Epicatechin suppresses IL-6, IL-8 and enhances IL-10 production with NF-kappaB nuclear translocation in whole blood stimulated system. Neuro. Endocrinol. Lett. 30: 131-138 (2009).

• Al-Jabri AA, Al Belushi MS, Nsanze H. Frequency and levels of autoantibodies in healthy adult Omanis. Ann. Saudi Med. 23: 372-375 (2003).

• Alarcon-Segovia D, Fishbein E, Alcala H, Olguin-Palacios E, Estrada-Parra S. The range and specificity of antinuclear antibodies in systemic lupus erythematosus. Clin. Exp. Immunol. 6: 557-571 (1970). *

• Alderson MR, McGowan P, Baldridge JR, Probst P. TLR4 agonists as immunomodulatory agents. J. Endotoxin Res. 12: 313-319 (2006). *

• Aleksic Z, Aleksic A, Mitov V, Jovic M, Zdravkovic D. Amiodaron treatment and thyroid autoimmunity markers. Hell. J. Nucl. Med. 11: 105-109 (2008).

• Alla V, Abraham J, Siddiqui J, Raina D, Wu GY, Chalasani NP, Bonkovsky HL. Autoimmune hepatitis triggered by statins. J. Clin. Gastroenterol. 40: 757-776 (2006)..

• Allende LM, Corell A, Madrono A, Gongora R, Rodriguez-Gallego C, Lopez-Goyanes A, Rosal M, Arnaiz-Villena A. Retinol (vitamin A) is a cofactor in CD3-induced human T-lymphocyte activation. Immunology 90: 388-396 (1997). *

• Allenspach K, Luckschander N, Styner M, Seibold F, Doherr M, Aeschbach D, Gaschen F. Evaluation of assays for perinuclear antineutrophilic cytoplasmic antibodies and antibodies to Saccharomyces cerevisiae in dogs with inflammatory bowel disease. Am. J. Vet. Res. 65: 1279-1283 (2004).

• Alleva DG, Johnson EB, Lio FM, Boehme SA, Conlon PJ, Crowe PD. Regulation of murine macrophage proinflammatory and anti-inflammatory cytokines by ligands for peroxisome proliferator-activated receptor-gamma: counter-regulatory activity by IFN-gamma. J. Leukoc. Biol. 71: 677-685 (2002). *

• Alric L, Thebault S, Selves J, Peron JM, Mejdoubi S, Fortenfant F, Vinel JP. Characterization of overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis according to antimitochondrial antibodies status. Gastroenterol. Clin. Biol. 31: 11-16 (2007). *

• Alsaeid K, Haider MZ, Sharma PN, Ayoub EM. The prevalence of human leukocyte antigen (HLA) DR/DQ/DP alleles in Kuwaiti children with oligoarticular juvenile idiopathic arthritis. Rheumatol. Int. 26: 224-228 (2006). *

• Alsaeid KM, Haider MZ, al-Awadhi AM, Srivastva BS, Ayoub EM. Role of human leukocyte antigen DRB1*0307 and DRB1*0308 in susceptibility to juvenile rheumatoid arthritis. Clin. Exp. Rheumatol. 21: 399-402 (2003).

• Altintas A, Cil T, Pasa S, Danis R, Kilinc I, Ayyildiz O, Muftuoglu E. Clinical significance of elevated antinuclear antibody test in patients with Hodgkin's and Non-Hodgkin's lymphoma: a single center experience. Minerva Med. 99: 7-14 (2008).

• Alvarez F. Clinical and diagnostics aspects in children. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 87-88 (2004). *

• Alvarez Madrid C, Gonzalez Fernandez A, Lisbona Munoz M, Molina Rodriguez MA, Merino Munoz R, Garcia-Consuegra Molina J. Thyroid disorders and childhood rheumatic diseases. An. Pediatr. (Barc.) 70: 53-56 (2009).

• Amadi-Obi A, Yu CR, Liu X, Mahdi RM, Clarke GL, Nussenblatt RB, Gery I, Lee YS, Egwuagu CE. T(H)17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat. Med. 13: 711-718 (2007). *

• Amati L, Caradonna L, Jirillo E, Caccavo D. Immunological disorders in inflammatory bowel disease and immunotherapeutic implications. Ital. J. Gastroenterol. Hepatol. 31: 313-325 (1999).

• Amato L, Mei S, Massi D, Gallerani I, Fabbri P. Cicatricial alopecia; a dermatopathologic and immunopathologic study of 33 patients (pseudopelade of Brocq is not a specific clinico-pathologic entity). Int. J. Dermatol. 41: 8-15 (2002). *

• Amezcua-Guerra LM, Springall R, Marquez-Velasco R, Gomez-Garcia L, Vargas A, Bojalil R. Presence of antibodies against cyclic citrullinated peptides (anti-CCP) in patients with rhupus: a cross-sectional study. Arthritis Res. Ther. 8: R144 (2006). *

• Amicosante M, Berretta F, Dweik R, Saltini C. Role of high-affinity HLA-DP specific CLIP-derived peptides in beryllium binding to the HLA-DPGlu69 berylliosis-associated molecules and presentation to beryllium-sensitized T cells. Immunology 128: e462-e470 (2009). *

• Amre DK, Lu SE, Costea F, Seidman EG. Utility of serological markers in predicting the early occurrence of complications and surgery in pediatric Crohn's disease patients. Am. J. Gastroenterol. 101: 645-652 (2006). *

• Amsaguine-Safir S, Bianchi A, Collet P, Huin-Schohn C, Jeanvoine A, Becuwe P, Kremarik-Bouillaud P, Domenjoud L, Keller JM, Schohn H, Dauca M. Induction of the expression of the peroxisome proliferator-activated receptor alpha (PPARalpha) by clofibrate in jerboa tissues. Microsc. Res. Tech. 61: 185-190 (2003). *

• Anand V, Russell AS, Tsuyuki R, Fedorak R. Perinuclear antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies as serological markers are not specific in the identification of Crohn's disease and ulcerative colitis. Can. J. Gastroenterol. 22: 33-36 (2008). *

• Andersson U, Erlandsson-Harris H, Yang H, Tracey KJ. HMGB1 as a DNA-binding cytokine. J. Leukoc. Biol. 72: 1084-1091 (2002). *

• Andersson U, Harris HE. The role of HMGB1 in the pathogenesis of rheumatic disease. Biochim. Biophys. Acta 1799: 141-148 (2010). *

• Ando T, Jordan P, Wang Y, Itoh M, Joh T, Sasaki M, Elrod JW, Carpenter A, Jennings MH, Minagar A, Alexander JS. MAdCAM-1 expression and regulation in murine colonic endothelial cells in vitro. Inflamm. Bowel Dis. 11: 258-264 (2005). *

• Andreakos E, Sacre S, Foxwell BM, Feldmann M. The Toll-like receptor-nuclear factor kappaB pathway in rheumatoid arthritis. Front. Biosci. 10: 2478-2488 (2005).

• Andreani ML, Frasca G, Brusco G, Borgnino L, Biagi F, Gasbarrini G, Corazza GR. Antineutrophil cytoplasmic antibodies in inflammatory bowel disease: diagnostic tool or research procedure?. Ann. Ital. Med. Int. 11: 254-257 (1996).

• Andreoli L, Rizzini S, Allegri F, Meroni P, Tincani A. Are the current attempts at standardization of antiphospholipid antibodies still useful? Emerging technologies signal a shift in direction. Semin. Thromb. Hemost. 34: 356-360 (2008).

• Aneja RK, Tsung A, Sjodin H, Gefter JV, Delude RL, Billiar TR, Fink MP. Preconditioning with high mobility group box 1 (HMGB1) induces lipopolysaccharide (LPS) tolerance. J. Leukoc. Biol. 84: 1326-1334 (2008). *

• Ang TL, Fock KM, Ng TM, Teo EK, Chua TS, Tan JY. Clinical profile of primary sclerosing cholangitis in Singapore. J. Gastroenterol. Hepatol. 17: 908-913 (2002). *

• Angulo JM, Sigal LH, Espinoza LR. Coexistent minocycline-induced systemic lupus erythematosus and autoimmune hepatitis. Semin. Arthritis Rheum. 28: 187-192 (1998). *

• Angulo P. Use of ursodeoxycholic acid in patients with liver disease. Curr. Gastroenterol. Rep. 4: 37-44 (2002).

• Angulo P, Peter JB, Gershwin ME, DeSotel CK, Shoenfeld Y, Ahmed AE, Lindor KD. Serum autoantibodies in patients with primary sclerosing cholangitis. J. Hepatol. 32: 182-187 (2000). *

• Antonio Olivera M, Zapata L, Kaplan M, Bobadilla J, Corte G, de la Mora G, Uribe M, Cabiedes J, Dehesa M, Kershenobich D. Prevalence of antinuclear antibodies in primary biliary cirrhosis, with negative antimitochondrial antibodies. Rev. Gastroenterol. Mex. 58: 220-222 (1993).

• Aoki A, Kirino Y, Ishigatsubo Y, Senuma A, Nagaoka S. Liver involvement in primary Sjogren's syndrome. Nihon Rinsho Meneki Gakkai Kaishi 27: 397-401 (2004).

• Aoki CA, Roifman CM, Lian ZX, Bowlus CL, Norman GL, Shoenfeld Y, Mackay IR, Gershwin ME. IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J. Autoimmun. 27: 50-53 (2006).

• Arakawa Y, Amaki S, Miyakawa H, Sakai T, Gotou I, Tanaka N, Moriyama M, Iwasaki A, Sugitani M, Arakawa Y. PBC-AIH overlap syndrome with concomitant ITP and Hashimoto's disease with positivity for anti-centromere antibody. J. Gastroenterol. 39: 490-495 (2004). *

• Arcavi M, Orfus G. Prevalence of antinuclear envelope antibodies and their isotypes in sera positive for antinuclear antibodies. Medicina (B. Aires) 66: 327-331 (2006).

• Ardiles LG, Valderrama G, Moya P, Mezzano SA. Incidence and studies on antigenic specificities of antineutrophil-cytoplasmic autoantibodies (ANCA) in poststreptococcal glomerulonephritis. Clin. Nephrol. 47: 1-5 (1997).

• Ardite E, Panes J, Miranda M, Salas A, Elizalde JI, Sans M, Arce Y, Bordas JM, Fernandez-Checa JC, Pique JM. Effects of steroid treatment on activation of nuclear factor kappaB in patients with inflammatory bowel disease. Br. J. Pharmacol. 124: 431-433 (1998). *

• Ardoin SP, Pisetsky DS. Developments in the scientific understanding of lupus. Arthritis Res. Ther. 10: 218 (2008). *

• Argueta JG, Shiota S, Yamaguchi N, Masuhiro Y, Hanazawa S. Induction of Porphyromonas gingivalis GroEL signaling via binding to Toll-like receptors 2 and 4. Oral. Microbiol. Immunol. 21: 245-251 (2006). *

• Aringer M, Steiner G, Graninger WB, Hofler E, Steiner CW, Smolen JS. Effects of short-term infliximab therapy on autoantibodies in systemic lupus erythematosus. Arthritis Rheum. 56: 274-279 (2007). *

• Arkwright PD, Abinun M, Cant AJ. Autoimmunity in human primary immunodeficiency diseases. Blood 99: 2694-2702 (2002). *

• Arnett FC, Hamilton RG, Reveille JD, Bias WB, Harley JB, Reichlin M. Genetic studies of Ro (SS-A) and La (SS-B) autoantibodies in families with systemic lupus erythematosus and primary Sjogren's syndrome. Arthritis Rheum. 32: 413-419 (1989).

• Arnott ID, Landers CJ, Nimmo EJ, Drummond HE, Smith BK, Targan SR, Satsangi J. Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype. Am. J. Gastroenterol. 99: 2376-2384 (2004). *

• Aroeira LS. TCR vaccination in aluminum adjuvant protects against autoimmune encephalomyelitis. Clin. Immunol. 119: 252-260 (2006). *

• Artiko V, Petrovic M, Sobic-Saranovic D, Krajnovic-Jaksic E, Tulic C, Milovanovic J, Djukic V, Rankovic V, Matic S, Antic A, Radoman I, Lausevic Z, Stojkovic M, Pavlovic S, Obradovic V. Detection of gastrointestinal and abdominal infections by 99mTc-antigranulocyte antibodies. Hepatogastroenterology 56: 1053-1058 (2009).

• Ascherio A, Munger KL, Lennette ET, Spiegelman D, Hernan MA, Olek MJ, Hankinson SE, Hunter DJ. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 286: 3083-3088 (2001). *

• Asherson RA, Giampaolo D, Strimling M. A case of adult-onset Satoyoshi syndrome with gastric ulceration and eosinophilic enteritis. Nat. Clin. Pract. Rheumatol. 4: 439-444 (2008).

• Atagunduz P, Appel H, Kuon W, Wu P, Thiel A, Kloetzel PM, Sieper J. HLA-B27-restricted CD8+ T cell response to cartilage-derived self peptides in ankylosing spondylitis. Arthritis Rheum. 52: 892-901 (2005). *

• Atta AM, Sousa CP, Carvalho EM, Sousa-Atta ML. Immunoglobulin E and systemic lupus erythematosus. Braz. J. Med. Biol. Res. 37: 1497-1501 (2004). *

• Atzeni F, Ardizzone S, Sarzi-Puttini P, Colombo E, Maconi G, DE Portu S, Carrabba M, Bianchi Porro G. Autoantibody profile during short-term infliximab treatment for Crohn's disease: a prospective cohort study. Aliment. Pharmacol. Ther. 22: 453-461 (2005). *

• Atzeni F, Turiel M, Capsoni F, Doria A, Meroni P, Sarzi-Puttini P. Autoimmunity and anti-TNF-alpha agents. Ann. N. Y. Acad. Sci. 1051: 559-569 (2005). *

• Audan A, Bruley Des Varannes S, Georgelin T, Sagan C, Cloarec D, Serraz H, Le Bodic L. Primary sclerosing cholangitis and systemic lupus erythematosus. Gastroenterol. Clin. Biol. 19: 123-126 (1995).

• Audrain MA, Sesboue R, Baranger TA, Elliott J, Testa A, Martin JP, Lockwood CM, Esnault VL. Analysis of anti-neutrophil cytoplasmic antibodies (ANCA): frequency and specificity in a sample of 191 homozygous (PiZZ) alpha1-antitrypsin-deficient subjects. Nephrol. Dial. Transplant. 16: 39-44 (2001). *

• Auvin S, Dalle JH, Ganga-Zandzou PS, Ythier H. Is agranulocytosis following infectious mononucleosis caused by autoimmunity? Pediatr. Hematol. Oncol. 20: 611-615 (2003).

• Avalos AM, Kiefer K, Tian J, Christensen S, Shlomchik M, Coyle AJ, Marshak-Rothstein A. RAGE-independent autoreactive B cell activation in response to chromatin and HMGB1/DNA immune complexes. Autoimmunity Dec 17 [Epub ahead of print] (2009).

• Avaniss-Aghajani E, Berzon S, Sarkissian A. Clinical value of multiplexed bead based immunoassays for detection of autoantibodies to nuclear antigens. Clin. Vaccine Immunol. 14: 505-509 (2007). *

• Aviel YB, Tyrrell PN, Schneider R, Dhillon S, Feldman BM, Laxer RM, Saurenmann RK, Spiegel L, Cameron B, Tse SM, Silverman ED. Comparison of patients with juvenile psoriatic arthritis and nonpsoriatic juvenile idiopathic arthritis: how different are they? J. Rheumatol. 36: 2033-2041 (2009).

• Avigan MI, Adamson G, Hoofnagle JH, Jones EA. The in vitro production of antibodies to mitochondrial antigens by peripheral blood mononuclear cells from patients with primary biliary cirrhosis. Hepatology 6: 999-1004 (1986).

• Avouac J, Airo P, Dieude P, Caramaschi P, Tiev K, Diot E, Sibilia J, Cappelli S, Granel B, Vacca A, Wipff J, Meyer O, Kahan A, Matucci-Cerinic M, Allanore Y. Associated autoimmune diseases in systemic sclerosis define a subset of patients with milder disease: results from 2 large cohorts of European Caucasian patients. J. Rheumatol. Jan 28 [Epub ahead of print] (2010).

• Axmann R, Bohm C, Kronke G, Zwerina J, Smolen J, Schett G. Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo. Arthritis Rheum. 60: 2747-2756 (2009). *

• Ayadi W, Karray-Hakim H, Feki L, Khabir A, Boudawara T, Ghorbel A, Daoud J, Frikha M, Hammami A. IgA antibodies against the Epstein-Barr nuclear antigen1 as a valuable biomarker for the diagnosis of nasopharyngeal carcinoma in Tunisian patients. J. Med. Virol. 81: 1412-1421 (2009).

• Ayala de la Cruz Mdel C, Gonzalez Diaz R, Lopez Lara ND. Wegener's granulomatosis. Report of a pediatric case and review of the literature. Rev. Alerg. Mex. 50: 71-75 (2003).

• Aydogan K, Karadogan S, Balaban Adim S, Tunali S. Lupus erythematosus associated with erythema multiforme: report of two cases and review of the literature. J. Eur. Acad. Dermatol. Venereol. 19: 621-627 (2005).

• Babakov VN, Petukhova OA, Turoverova LV, Kropacheva IV, Tentler DG, Bolshakova AV, Podolskaya EP, Magnusson KE, Pinaev GP. RelA/NF-kappaB transcription factor associates with alpha-actinin-4. Exp. Cell Res. 314: 1030-1038 (2008). *

• Badakere SS, Pradhan VD, Almeida AF, Pawar AR. Use of immunofluorescence and confocal laser scanning microscopy in identifying rare cases of anti-neutrophil cytoplasmic antibodies (ANCA) showing dual specificities to myeloperoxidase and proteinase3. J. Fluoresc. 14: 459-463 (2004). *

• Bae Y, Kemper JK, Kemper B. Repression of CAR-mediated transactivation of CYP2B genes by the orphan nuclear receptor, short heterodimer partner (SHP). DNA Cell Biol. 23: 81-91 (2004).

• Bagnari V, Colina M, Ciancio G, Govoni M, Trotta F. Adult-onset Still's disease. Rheumatol. Int. Dec 18 [Epub ahead of print] (2009). *

• Bagnasco M, Grassia L, Pesce G. The management of the patient with unexpected autoantibody positivity. Autoimmun. Rev. 6: 347-353 (2007).

• Baharav E, Mor F, Halpern M, Quintana F, Weinberger A. Tropomyosin-induced arthritis in rats. Clin. Exp. Rheumatol. 25: S86-S92 (2007).

• Bahari A, Aarabi M, Aarabi M, Hedayati M, Jarollahi A, Firouzi F, Aghazadeh R, Zali MR, Hashemi M. Diagnostic value of antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibody in Iranian patients with inflammatory bowel disease. Acta Gastroenterol. Belg. 72: 301-305 (2009).

• Bai L, Feng ZR, Lu HY, Li WG, Yu M, Xu XY. Prevalence of antinuclear and anti-liver-kidney-microsome type-1 antibodies in patients with chronic hepatitis C in China. Chin. Med. J. (Engl.) 122: 5-9 (2009).

• Bai L, Lu HY, Feng ZR, Yu M, Li WG, Gong WB, Zhao NE, Xu XY. Detection and the production mechanism of antinuclear antibodies (ANA) and anti-liver/kidney microsomal tpe 1 antibodies (anti-LKM1) in patients with chronic hepatitis C. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 23: 278-281 (2009).

• Baker VS, Imade GE, Molta NB, Tawde P, Pam SD, Obadofin MO, Sagay SA, Egah DZ, Iya D, Afolabi BB, Baker M, Ford K, Ford R, Roux KH, Keller TC 3rd. Cytokine-associated neutrophil extracellular traps and antinuclear antibodies in Plasmodium falciparum infected children under six years of age. Malar. J. 7: 41 (2008). *

• Bakker-Jonges LE, ter Borg PC, van Buuren HR, Hooijkaas H. A retrospective study on the role of antibodies against soluble liver antigen (anti-SLA antibodies) and other autoantibodies in the diagnostics of autoimmune hepatitis. Ned. Tijdschr. Geneeskd. 150: 490-494 (2006).

• Baksh MF, Balding DJ, Vyse TJ, Whittaker JC. Family-based association analysis with ordered categorical phenotypes, covariates and interactions. Genet. Epidemiol. 31: 1-8 (2007).

• Ballanger F, Allix ML, Rimbert M, Audrain M, Muller JY, Dreno B. Auto-immunity induced by low doses of interferon in melanoma stage I. Ann. Dermatol. Venereol. 133: 543-548 (2006).

• Ballok DA, Sakic B. Purine receptor antagonist modulates serology and affective behaviors in lupus-prone mice: evidence of autoimmune-induced pain? Brain Behav. Immun. 22: 1208-1216 (2008).

• Ballot E, Homberg JC, Johanet C. Antibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis. J. Hepatol. 33: 208-215 (2000). *

• Ballow M, Xiang S, Wang W, Brodsky L. The effects of retinoic acid on immunoglobulin synthesis: role of interleukin 6. J. Clin. Immunol. 16: 171-179 (1996).

• Bamias G, Martin C, Mishina M, Ross WG, Rivera-Nieves J, Marini M, Cominelli F. Proinflammatory effects of TH2 cytokines in a murine model of chronic small intestinal inflammation. Gastroenterology 128: 654-666 (2005). *

• Bandin O, Courvalin JC, Poupon R, Dubel L, Homberg JC, Johanet C. Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis. Hepatology 23: 1020-1024 (1996). *

• Banham AH, Lyne L, Scase TJ, Blacklaws BA. Monoclonal antibodies raised to the human FOXP3 protein can be used effectively for detecting Foxp3(+) T cells in other mammalian species. Vet. Immunol. Immunopathol. 127: 376-381 (2009).

• Bansi DS, Lo S, Chapman RW, Fleming KA. Absence of antineutrophil cytoplasmic antibodies in relatives of UK patients with primary sclerosing cholangitis and ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 8: 111-116 (1996).

• Barahona-Garrido J, Camacho-Escobedo J, Garcia-Martinez CI, Tocay H, Cabiedes J, Yamamoto-Furusho JK. Antinuclear antibodies: a marker associated with steroid dependence in patients with ulcerative colitis. Inflamm. Bowel Dis. 15: 1039-1043 (2009). *

• Barahona-Garrido J, Sarti HM, Barahona-Garrido MK, Hernandez-Calleros J, Coss-Adame E, Garcia-Saenz SM, Yamamoto-Furusho JK. Serological markers in inflammatory bowel disease: a review of their clinical utility. Rev. Gastroenterol. Mex. 74: 230-237 (2009).

• Barksby HE, Lea SR, Preshaw PM, Taylor JJ. The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders. Clin. Exp. Immunol. 149: 217-225 (2007). *

• Barland P. Antibodies to citrullinated peptides: current role in diagnosis, prognosis, and pathogenesis of rheumatoid arthritis. New Developments in Rheumatic Diseases 1: 6-9 (2004). *

• Barreto M, Ferreira RC, Lourenco L, Moraes-Fontes MF, Santos E, Alves M, Carvalho C, Martins B, Andreia R, Viana JF, Vasconcelos C, Mota-Vieira L, Ferreira C, Demengeot J, Vicente AM. Low frequency of CD4+CD25+ Treg in SLE patients: a heritable trait associated with CTLA4 and TGF beta gene variants. BMC Immunol. 10: 5 (2009). *

• Barta Z, Csipo I, Szabo GG, Szegedi G. Seroreactivity against Saccharomyces cerevisiae in patients with Crohn's disease and celiac disease. World J. Gastroenterol. 9: 2308-2312 (2003). *

• Bartsch H, Bachmann M. Sequential use of immunoblots for characterization of autoantibody specificities. Methods Mol. Biol. 536: 293-298 (2009).

• Bartunkova J, Araujo A, Hrusak O, Sediva A. Autoimmunity to polymorphonuclears: functional consequences of the binding of antibodies to membrane and cytoplasmic target antigens of polymorphonuclear leukocytes. J. Clin. Immunol. 17: 455-461 (1997).

• Barzilai O, Ram M, Shoenfeld Y. Viral infection can induce the production of autoantibodies. Curr. Opin. Rheumatol. 19: 636-643 (2007).

• Barzilai O, Sherer Y, Ram M, Izahaky D, Anaya JM, Shoenfeld Y. Epstein-Barr virus and cytomegalovirus in autoimmune diseases. Are they truly notorious? A preliminary report. Ann. N. Y. Acad. Sci. 1108: 567-577 (2007). *

• Baslund B, Gregers J, Nielsen CH. Reduced folate carrier polymorphism determines methotrexate uptake by B cells and CD4+ T cells. Rheumatology (Oxford) 47: 451-453 (2008). *

• Basu D, Lopez I, Kulkarni A, Sellin JH. Impact of race and ethnicity on inflammatory bowel disease. Am. J. Gastroenterol. 100: 2254-2261 (2005). *

• Basu S, Zhuang H, Torigian DA, Rosenbaum J, Chen W, Alavi A. Functional imaging of inflammatory diseases using nuclear medicine techniques. Semin. Nucl. Med. 39: 124-145 (2009).

• Bauer A, Habior A. Measurement of gp210 autoantibodies in sera of patients with primary biliary cirrhosis. J. Clin. Lab. Anal. 21: 227-231 (2007).

• Bave U, Nordmark G, Lovgren T, Ronnelid J, Cajander S, Eloranta ML, Alm GV, Ronnblom L. Activation of the type I interferon system in primary Sjogren's syndrome: a possible etiopathogenic mechanism. Arthritis Rheum. 52: 1185-1195 (2005). *

• Beaven SW, Abreu MT. Biomarkers in inflammatory bowel disease. Curr. Opin. Gastroenterol. 20: 318-327 (2004).

• Becker H, Weber C, Storch S, Federlin K. Relationship between CD5+ B lymphocytes and the activity of systemic autoimmunity. Clin. Immunol. Immunopathol. 56: 219-225 (1990).

• Becker-Merok A, Kalaaji M, Haugbro K, Nikolaisen C, Nilsen K, Rekvig OP, Nossent JC. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis. Arthritis Res. Ther. 8: R162 (2006). *

• Bel Hadj Jrad B, Mahfouth W, Bouaouina N, Gabbouj S, Ahmed SB, Ltaief M, Jalbout M, Chouchane L. A polymorphism in FAS gene promoter associated with increased risk of nasopharyngeal carcinoma and correlated with anti-nuclear autoantibodies induction. Cancer Lett. 233: 21-27 (2006). *

• Ben-Ari Z, Dhillon AP, Sherlock S. Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis. Hepatology 18: 10-15 (1993).

• Benahmed MB, Meresse B, Arnulf B, Barbe U, Mention JJ, Verkarre V, Allez M, Cellier C, Hermine O, Cerf-Bensussan N. Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease. Gastroenterology 132: 994-1008 (2007). *

• Bennink RJ, Hamann J, de Bruin K, Ten Kate FJ, van Deventer SJ, Te Velde AA. Dedicated pinhole SPECT of intestinal neutrophil recruitment in a mouse model of dextran sulfate sodium-induced colitis. J. Nucl. Med. 46: 526-531 (2005). *

• Benucci M, Nenci G, Cappelletti C, Manfredi M. Lupus like syndrome induced by treatment with anti TNFalpha (infliximab): report of three cases. Recenti Prog. Med. 99: 363-366 (2008).

• Benucci M, Saviola G, Baiardi P, Cammelli E, Manfredi M. Anti-nucleosome antibodies as prediction factor of development of autoantibodies during therapy with three different TNFalpha blocking agents in rheumatoid arthritis. Clin. Rheumatol. 27: 91-95 (2008). *

• Berg L, Ronnelid J, Sanjeevi CB, Lampa J, Klareskog L. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8. Arthritis Res. 2: 75-84 (2000). *

• Berg PA, Klein R. Autoimmune hepatitis and overlap syndrome: diagnosis. Schweiz. Rundsch. Med. Prax. 91: 1339-1346 (2002).

• Bergasa NV, Mason A, Floreani A, Heathcote J, Swain MG, Jones DE, Lindor KM, Bassendine MF, Worman HJ. Primary biliary cirrhosis: report of a focus study group. Hepatology 40: 1013-1020 (2004). *

• Berggren MA, Heinlen L, Isaksson A, Nystrom U, Ricksten A. EBNA1 expression in a lung transplant recipient with hypocomplementemic urticarial vasculitis syndrome. J. Med. Virol. 79: 963-969 (2007).

• Bergquist A, Glaumann H, Stal P, Wang GS, Broome U. Biliary dysplasia, cell proliferation and nuclear DNA-fragmentation in primary sclerosing cholangitis with and without cholangiocarcinoma. J. Intern. Med. 249: 69-75 (2001). *

• Berkun Y, Zandman-Goddard G, Barzilai O, Boaz M, Sherer Y, Larida B, Blank M, Anaya JM, Shoenfeld Y. Infectious antibodies in systemic lupus erythematosus patients. Lupus 18: 1129-1135 (2009).

• Bernatsky S, Ramsey-Goldman R, Lachance S, Pineau CA, Clarke AE. Lymphoma in a patient with systemic lupus erythematosus. Nat. Clin. Pract. Rheumatol. 2: 570-574 (2006). *

• Bernstein CN, Pettigrew NM, el-Gabalawy HS, Sargent M, Meu Y, Wilkins J. The differential expression of a novel intestinal epithelial glycoprotein in various forms of inflammatory bowel disease. Am. J. Clin. Pathol. 106: 42-51 (1996).

• Bernstein RM, Neuberger JM, Bunn CC, Callender ME, Hughes GR, Williams R. Diversity of autoantibodies in primary biliary cirrhosis and chronic active hepatitis. Clin. Exp. Immunol. 55: 553-560 (1984). *

• Berry PA, Smith-Laing G. Hepatitis A vaccine associated with autoimmune hepatitis. World J. Gastroenterol. 13: 2238-2239 (2007). *

• Beuers U, Rust C. Chapter 22. Overlap syndromes of autoimmune hepatitis with primary biliary cirrhosis and primary sclerosing cholangitis. In "Liver Immunology: Principles and Practice" (eds. Gershwin ME, Vierling JM, Manns MP), Humana Press Inc., Totowa, NJ, p. 285-291 (2007). *

• Bhan AK, Dienstag JL, Wands JR, Schlossman SF, Reinherz EL. Alterations of T-cell subsets in primary biliary cirrhosis. Clin. Exp. Immunol. 47: 351-358 (1982). *

• Bhanji RA, Eystathioy T, Chan EK, Bloch DB, Fritzler MJ. Clinical and serological features of patients with autoantibodies to GW/P bodies. Clin. Immunol. 125: 247-256 (2007). *

• Bhat M, Guindi M, Heathcote EJ, Hirschfield GM. Transient development of anti-mitochondrial antibodies accompanies autoimmune hepatitis-sclerosing cholangitis overlap. Gut 58: 152-153 (2009).

• Bhatia S, Huber BR, Upton MP, Thompson JA. Inflammatory enteric neuropathy with severe constipation after ipilimumab treatment for melanoma: a case report. J. Immunother. 32: 203-205 (2009).

• Bhatnagar A, Wig JD, Majumdar S. Immunological findings in acute and chronic pancreatitis. ANZ J. Surg. 73: 59-64 (2003). *

• Biagini RE, Parks CG, Smith JP, Sammons DL, Robertson SA. Analytical performance of the AtheNA MultiLyte(R) ANA II assay in sera from lupus patients with multiple positive ANAs. Anal. Bioanal. Chem. 388: 613-618 (2007). *

• Bianchi FB, Muratori L. Primary and secondary autoimmunity in hepatology. Ann. Ital. Med. Int. 15: 56-62 (2000).

• Biancone L, Mandal A, Yang H, Dasgupta T, Paoluzi AO, Marcheggiano A, Paoluzi P, Pallone F, Das KM. Production of immunoglobulin G and G1 antibodies to cytoskeletal protein by lamina propria cells in ulcerative colitis. Gastroenterology 109: 3-12 (1995). *

• Bickel YB, Barnett EV, Pearson CM. Immunofluorescent patterns and specificity of human antinuclear antibodies. Clin. Exp. Immunol. 3: 641-656 (1968). *

• Biecker E, Stieger M, Zimmermann A, Reichen J. Autoimmune hepatitis, cryoglobulinaemia and untreated coeliac disease: a case report. Eur. J. Gastroenterol. Hepatol. 15: 423-427 (2003).

• Billing P, Tahir S, Calfin B, Gagne G, Cobb L, Targan S, Vidrich A. Nuclear localization of the antigen detected by ulcerative colitis-associated perinuclear antineutrophil cytoplasmic antibodies. Am. J. Pathol. 147: 979-987 (1995). *

• Billings PB, Hoch SO, White PJ, Carson DA, Vaughan JH. Antibodies to the Epstein-Barr virus nuclear antigen and to rheumatoid arthritis nuclear antigen identify the same polypeptide. Proc. Natl. Acad. Sci. U.S.A. 80: 7104-7108 (1983). *

• Bilu Martin D, Deng A, Gaspari A, Pearson F. Perinuclear antineutrophil cytoplasmic antibody-associated vasculitis in a patient with Graves' disease treated with methimazole. Skinmed. 5: 302-305 (2006). *

• Binard A, Alassane S, Devauchelle-Pensec V, Berthelot JM, Jousse-Joulin S, Chales G, Le Henaff C, Thorel JB, Hoang S, Youinou P, Saraux A. Outcome of early monoarthritis: a followup study. J. Rheumatol. 34: 2351-2357 (2007).

• Binder SR. Autoantibody detection using multiplex technologies. Lupus 15: 412-421 (2006).

• Biondo M, Field J, Toh BH, Alderuccio F. Prednisolone promotes remission and gastric mucosal regeneration in experimental autoimmune gastritis. J. Pathol. 209: 384-391 (2006). *

• Bioque G, Bouma G, Crusius JB, Koutroubakis I, Kostense PJ, Meuwissen SG, Pena AS. Evidence of genetic heterogeneity in IBD: 1. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 8: 105-110 (1996).

• Bittencourt PL, Farias AQ, Abrantes-Lemos CP, Goncalves LL, Goncalves PL, Magalhaes EP, Carrilho FJ, Laudanna AA, Cancado EL. Prevalence of immune disturbances and chronic liver disease in family members of patients with primary biliary cirrhosis. J. Gastroenterol. Hepatol. 19: 873-878 (2004). *

• Bittencourt PL, Farias AQ, Porta G, Cancado EL, Miura I, Pugliese R, Kalil J, Goldberg AC, Carrilho FJ. Frequency of concurrent autoimmune disorders in patients with autoimmune hepatitis: effect of age, gender, and genetic background. J. Clin. Gastroenterol. 42: 300-305 (2008).

• Bittencourt PL, Goldberg AC, Cancado EL, Porta G, Carrilho FJ, Farias AQ, Palacios SA, Chiarella JM, Abrantes-Lemos CP, Baggio VL, Laudanna AA, Kalil J. Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2. Am. J. Gastroenterol. 94: 1906-1913 (1999). *

• Blenman KR, Duan B, Xu Z, Wan S, Atkinson MA, Flotte TR, Croker BP, Morel L. IL-10 regulation of lupus in the NZM2410 murine model. Lab. Invest. 86: 1136-1148 (2006). *

• Bloch DB, de la Monte SM, Guigaouri P, Filippov A, Bloch KD. Identification and characterization of a leukocyte-specific component of the nuclear body. J. Biol. Chem. 271: 29198-29204 (1996). *

• Bloch DB, Yu JH, Yang WH, Graeme-Cook F, Lindor KD, Viswanathan A, Bloch KD, Nakajima A. The cytoplasmic dot staining pattern is detected in a subgroup of patients with primary biliary cirrhosis. J. Rheumatol. 32: 477-483 (2005).

• Blockmans D, Stevens E, Marien G, Bobbaers H. Clinical spectrum associated with positive ANCA titres in 94 consecutive patients: is there a relation with PR-3 negative c-ANCA and hypergammaglobulinaemia? Ann. Rheum. Dis. 57: 141-145 (1998). *

• Blondin DA, Zhang Z, Shideler KK, Hou H, Fritzler MJ, Mydlarski PR. Prevalence of non-organ-specific autoantibodies in patients with pemphigus vulgaris. J. Cutan. Med. Surg. 13: 82-87 (2009).

• Blumenthal DE. Tired, aching, ANA-positive: does your patient have lupus or fibromyalgia? Cleve. Clin. J. Med. 69: 143-146, 151-152 (2002). *

• Bluthner M, Schafer C, Schneider C, Bautz FA. Identification of major linear epitopes on the sp100 nuclear PBC autoantigen by the gene-fragment phage-display technology. Autoimmunity 29: 33-42 (1999).

• Boasso A, Herbeuval JP, Hardy AW, Anderson SA, Dolan MJ, Fuchs D, Shearer GM. HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. Blood 109: 3351-3359 (2007). *

• Boberg KM, Fausa O, Haaland T, Holter E, Mellbye OJ, Spurkland A, Schrumpf E. Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis. Hepatology 23: 1369-1376 (1996). *

• Boberg KM, Lundin KE, Schrumpf E. Etiology and pathogenesis in primary sclerosing cholangitis. Scand. J. Gastroenterol. Suppl. 204: 47-58 (1994).

• Bobota AC, Megalakaki C, Repousis P, Chalkiopoulou I, Lalaki I, Trafalis DT, Athanassiou AE, Mentzikof CM. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases. J. BUON 11: 485-489 (2006).

• Bocelli-Tyndall C, Bracci L, Spagnoli G, Braccini A, Bouchenaki M, Ceredig R, Pistoia V, Martin I, Tyndall A. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro. Rheumatology (Oxford) 46: 403-408 (2007). *

• Bodano A, Gonzalez A, Ferreiros-Vidal I, Balada E, Ordi J, Carreira P, Gomez-Reino JJ, Conde C. Association of a non-synonymous single-nucleotide polymorphism of DNASEI with SLE susceptibility. Rheumatology (Oxford) 45: 819-823 (2006). *

• Bodger K, Crabtree JE. Helicobacter pylori and gastric inflammation. Br. Med. Bull. 54: 139-150 (1998). *

• Bogdanos D, Vergani D, Mieli-Vergani G. Overlap syndromes from pediatrics to adulthood. J. Gastroenterol. Hepatol. 19: S284-S286 (2004). *

• Bogdanos DP, Baum H, Butler P, Rigopoulou EI, Davies ET, Ma Y, Burroughs AK, Vergani D. Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection. Dig. Liver Dis. 35: 801-805 (2003).

• Bogdanos DP, Baum H, Vergani D. Antimitochondrial and other autoantibodies. Clin. Liver Dis. 7: 759-777, vi (2003).

• Bogdanos DP, Bianchi I, Ma Y, Mitry RR, Mieli-Vergani G, Vergani D. Targets of antibodies to soluble liver antigen in patients with autoimmune hepatitis. Clin. Chem. 50: 682-683 (2004). *

• Bogdanos DP, Invernizzi P, Mackay IR, Vergani D. Autoimmune liver serology: current diagnostic and clinical challenges. World J. Gastroenterol. 14: 3374-3387 (2008). *

• Bogdanos DP, Mieli-Vergani G, Vergani D. Autoantibodies and their antigens in autoimmune hepatitis. Semin. Liver Dis. 29: 241-253 (2009).

• Bogdanos DP, Pares A, Rodes J, Vergani D. Primary biliary cirrhosis specific antinuclear antibodies in patients from Spain. Am. J. Gastroenterol. 99: 763-764 (2004). *

• Bohm I. The apoptosis marker enzyme poly-(ADP-ribose) polymerase (PARP) in systemic lupus erythematosus. Z. Rheumatol. 65: 541-544 (2006).

• Boitard C, Debray-Sachs M, Bach JF. Autoimmune disorders in diabetes. Adv. Nephrol. Necker Hosp. 15: 281-305 (1986).

• Bolstad AI, Jonsson R. Gene therapeutics in Sjogren's syndrome. Expert Opin. Biol. Ther. 5: 763-772 (2005).

• Bonaci-Nikolic B, Andrejevic S, Bukilica M, Urosevic I, Nikolic M. Autoantibodies to mitotic apparatus: association with other autoantibodies and their clinical significance. J. Clin. Immunol. 26: 438-446 (2006). *

• Bonaci-Nikolic B, Andrejevic S, Radlovic N, Davidovic I, Sofronic L, Spuran M, Micev M, Nikolic MM. Serological and clinical comparison of children and adults with anti-endomysial antibodies. J. Clin. Immunol. 27: 163-171 (2007). *

• Bonaci-Nikolic B, Nikolic MM, Andrejevic S, Zoric S, Bukilica M. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides. Arthritis Res. Ther. 7: R1072-R1081 (2005). *

• Bonaguri C, Melegari A, Dall'Aglio P, Ballabio A, Terenziani P, Russo A, Battistelli L, Aloe R, Camisa R, Campaniello G, Sartori E, Monica C. An Italian multicenter study for application of a diagnostic algorithm in autoantibody testing. Ann. N. Y. Acad. Sci. 1173: 124-129 (2009). *

• Bonilla E, Francis L, Allam F, Ogrinc M, Neupane H, Phillips PE, Perl A. Immunofluorescence microscopy is superior to fluorescent beads for detection of antinuclear antibody reactivity in systemic lupus erythematosus patients. Clin. Immunol. 124: 18-21 (2007).

• Borg FA, Isenberg DA. Syndromes and complications of interferon therapy. Curr. Opin. Rheumatol. 19: 61-66 (2007).

• Bossowski A, Stasiak-Barmuta A, Urban M. Relationship between CTLA-4 and CD28 molecule expression on T lymphocytes and stimulating and blocking autoantibodies to the TSH-receptor in children with Graves' disease. Horm. Res. 64: 189-197 (2005).

• Bossowski A, Stasiak-Barmuta A, Urban M, Rinderle C. Analysis of costimulatory molecules (CD28-CTLA-4/B7) expression on chosen mononuclear cells in adolescents with Graves' disease during methimazole therapy. Endokrynol. Diabetol. Chor. Przemiany. Materii. Wieku. Rozw. 10: 93-101 (2004).

• Bossuyt X. Serologic markers in inflammatory bowel disease. Clin. Chem. 52: 171-181 (2006). *

• Bouhnik Y. Diagnostic tools in inflammatory bowel diseases. Rev. Prat. 55: 977-983 (2005).

• Boulenger-Vazel A, Kupfer-Bessaguet I, Gouedard C, Leberre R, Leroy JP, Sonnet E, Desvignes O, Misery L, Sassolas B. Neutrophilic dermatosis associated with propylthiouracil-induced p-ANCA (p-antineutrophil cytoplasmic antibodies). Ann. Dermatol. Venereol. 132: 27-31 (2005).

• Bouma G, Xia B, Crusius JB, Bioque G, Koutroubakis I, Von Blomberg BM, Meuwissen SG, Pena AS. Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD). Clin. Exp. Immunol. 103: 391-396 (1996). *

• Bouwhuis MG, Suciu S, Collette S, Aamdal S, Kruit WH, Bastholt L, Stierner U, Sales F, Patel P, Punt CJ, Hernberg M, Spatz A, Ten Hagen TL, Hansson J, Eggermont AM; for the EORTC Melanoma Group and the Nordic Melanoma Group. Autoimmune antibodies and recurrence-free interval in melanoma patients treated with adjuvant interferon. J. Natl. Cancer Inst. 101: 869-877 (2009). *

• Boyer JF, Balard P, Authier H, Faucon B, Bernad J, Mazieres B, Davignon JL, Cantagrel A, Pipy B, Constantin A. TNF alpha and adalimumab differentially regulate CD36 expression in human monocytes. Arthritis Res. Ther. 9: R22 (2007). *

• Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137: 354-366 (1996). *

• Brant SR. Exposed: the genetic underpinnings of ulcerative colitis relative to Crohn's disease. Gastroenterology 136: 396-399 (2009). *

• Bratland E, Skinningsrud B, Undlien DE, Mozes E, Husebye ES. T cell responses to steroid cytochrome P450 21-hydroxylase in patients with autoimmune primary adrenal insufficiency. J. Clin. Endocrinol. Metab. 94: 5117-5124 (2009).

• Braun A, Gessner JE, Varga-Szabo D, Syed SN, Konrad S, Stegner D, Vogtle T, Schmidt RE, Nieswandt B. STIM1 is essential for Fcgamma receptor activation and autoimmune inflammation. Blood 113: 1097-1104 (2009). *

• Braun A, Sis J, Max R, Mueller K, Fiehn C, Zeier M, Andrassy K. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases. Scand. J. Rheumatol. 36: 291-298 (2007). *

• Braun-Moscovici Y, Schapira D, Balbir-Gurman A, Sevilia R, Nahir AM. Ticlopidine-induced lupus. J. Clin. Rheumatol. 7: 102-105 (2001).

• Bray PF, Luka J, Bray PF, Culp KW, Schlight JP. Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSF, and two pentapeptide sequence identities between EBNA and myelin basic protein. Neurology 42: 1798-1804 (1992).

• Breda L, Nozzi M, De Sanctis S, Chiarelli F. Laboratory tests in the diagnosis and follow-up of pediatric rheumatic diseases: an update. Semin. Arthritis Rheum. Feb 24 [Epub ahead of print] (2009). *

• Brenard R, Geubel AP. Antimitochondrial and antinuclear antibodies in primary biliary cirrhosis: an update in relation to their biochemical characterization and clinical significance. Acta Clin. Belg. 46: 305-312 (1991).

• Brennan MT, Sankar V, Leakan RA, Grisius MM, Collins MT, Fox PC, Baum BJ, Pillemer SR. Sex steroid hormones in primary Sjogren's syndrome. J. Rheumatol. 30: 1267-1271 (2003).

• Brett PM, Yasuda N, Yiannakou JY, Herbst F, Ellis HJ, Vaughan R, Nicholls RJ, Ciclitira PJ. Genetic and immunological markers in pouchitis. Eur. J. Gastroenterol. Hepatol. 8: 951-955 (1996).

• Bridoux F, Kyndt X, Abou-Ayache R, Mougenot B, Baillet S, Bauwens M, Lemaitre V, Goujon JM, Touchard G, Vanhille P. Proximal tubular dysfunction in primary Sjogren's syndrome: a clinicopathological study of 2 cases. Clin. Nephrol. 61: 434-439 (2004).

• Broccolo F, Drago F, Paolino S, Cassina G, Gatto F, Fusetti L, Matteoli B, Zaccaria E, Parodi A, Lusso P, Ceccherini-Nelli L, Malnati MS. Reactivation of human herpesvirus 6 (HHV-6) infection in patients with connective tissue diseases. J. Clin. Virol. 46: 43-46 (2009).

• Brooks CJ, King WJ, Radford DJ, Adu D, McGrath M, Savage CO. IL-1 beta production by human polymorphonuclear leucocytes stimulated by anti-neutrophil cytoplasmic autoantibodies: relevance to systemic vasculitis. Clin. Exp. Immunol. 106: 273-279 (1996). *

• Broome U. Autoimmune hepatitis and overlap syndromes. Falk Symposium 135. Immmunological diseases of liver and gut. Prague (Czech Republic). p. 38-39. September 12 - 13 (2003). *

• Brostoff JM, Rashid S, McCrea D. Primary biliary cirrhosis with a normal alkaline phosphatase: a case report. Cases J. 1: 33 (2008). *

• Brown IS, Lambie DL. Microscopic colitis with giant cells: a clinico-pathological review of 11 cases and comparison with microscopic colitis without giant cells. Pathology 40: 671-675 (2008). *

• Brown RJ, Rother KI, Artman H, Mercurio MG, Wang R, Looney RJ, Cowen EW. Minocycline-induced drug hypersensitivity syndrome followed by multiple autoimmune sequelae. Arch. Dermatol. 145: 63-66 (2009). *

• Brucato A, Brambilla G, Moreo A, Alberti A, Munforti C, Ghirardello A, Doria A, Shinar Y, Livneh A, Adler Y, Shoenfeld Y, Mauri F, Palmieri G, Spodick DH. Long-term outcomes in difficult-to-treat patients with recurrent pericarditis. Am. J. Cardiol. 98: 267-271 (2006). *

• Brucato A, Maestroni S, Cumetti D, Thiella G, Alari G, Brambilla G, Imazio M, Doria A, Palmieri G, Adler Y. Recurrent pericarditis: infectious or autoimmune? Autoimmun. Rev. 8: 44-47 (2008).

• Brunner G, Klinge O. A chronic destructive non-suppurative cholangitis-like disease picture with antinuclear antibodies (immunocholangitis). Dtsch. Med. Wochenschr. 112: 1454-1458 (1987).

• Bueno de Mesquita M, Ferrante M, Henckaerts L, Joossens M, Janssens V, Hlavaty T, Pierik M, Joossens S, Van Schuerbeek N, Van Assche G, Rutgeerts P, Vermeire S, Hoffman I. Clustering of (auto)immune diseases with early-onset and complicated inflammatory bowel disease. Eur. J. Pediatr. 168: 575-583 (2009). *

• Buisson M, Berthelot JM, Le Goff P, Chastel C, Lamour A, Seigneurin JM, Youinou P. Lack of relationship between the Epstein-Barr virus and the antiperinuclear factor/'perinuclear antigen' system in rheumatoid arthritis. J. Autoimmun. 7: 485-495 (1994).

• Bunn CC, Denton CP, Shi-Wen X, Knight C, Black CM. Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis. Br. J. Rheumatol. 37: 15-20 (1998). *

• Burnett R, Ravel G, Descotes J. Clinical and histopathological progression of lesions in lupus-prone (NZB x NZW) F1 mice. Exp. Toxicol. Pathol. 56: 37-44 (2004).

• Burt AD. Spectrum of liver pathology in immune mediated liver diseases. J. Gastroenterol. Hepatol. 19: S353-S355 (2004). *

• Burt RK, Traynor A, Statkute L, Barr WG, Rosa R, Schroeder J, Verda L, Krosnjar N, Quigley K, Yaung K, Villa Bs M, Takahashi M, Jovanovic B, Oyama Y. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA 295: 527-535 (2006). *

• Bush ZM, Lopes MB, Hussaini IM, Jane JA Jr, Laws ER Jr, Vance ML. Immunohistochemistry of COUP-TFI: an adjuvant diagnostic tool for the identification of corticotroph microadenomas. Pituitary Jun 13 [Epub ahead of print] (2009).

• Bustos D, Moret A, Tambutti M, Gogorza S, Testa R, Ascione A, Prigoshin N. Autoantibodies in Argentine women with recurrent pregnancy loss. Am. J. Reprod. Immunol. 55: 201-207 (2006). *

• Caballeria L, Pares A, Rodes J. Treatment of primary biliary cirrhosis. Contributions to Science 1: 79-85 (1999). *

• Cabral DA, Petty RE, Malleson PN, Ensworth S, McCormick AQ, Shroeder ML. Visual prognosis in children with chronic anterior uveitis and arthritis. J. Rheumatol. 21: 2370-2375 (1994).

• Cabral VL, Miszputen SJ, Catapani WR. Anti-neutrophil cytoplasmic antibodies in Brazilian patients with inflammatory bowel disease. Hepatogastroenterology 50: 412-415 (2003).

• Caccavo D, Afeltra A, Guido F, Di Monaco C, Ferri GM, Amoroso A, Vaccaro F, Bonomo L. Two spatially distant epitopes of human lactoferrin. Hybridoma 15: 263-269 (1996).

• Caccavo D, Rigon A, Picardi A, Galluzzo S, Vadacca M, Ferri GM, Amoroso A, Afeltra A. Anti-lactoferrin antibodies in systemic lupus erythematosus: isotypes and clinical correlates. Clin. Rheumatol. 24: 381-387 (2005). *

• Cacciapaglia F, Arcarese L, Rigon A, Vadacca M, Valorani MG, Pozzilli P, Afeltra A. Antinuclear antibodies prevalence in Filipinos migrated to Italy. Eur. Rev. Med. Pharmacol. Sci. 12: 267-270 (2008).

• Caglar E, Ugurlu S, Ozenoglu A, Can G, Kadioglu P, Dobrucali A. Autoantibody frequency in celiac disease. Clinics (Sao Paulo) 64: 1195-1200 (2009). *

• Cai P, Konig R, Boor PJ, Kondraganti S, Kaphalia BS, Khan MF, Ansari GA. Chronic exposure to trichloroethene causes early onset of SLE-like disease in female MRL +/+ mice. Toxicol. Appl. Pharmacol. 228: 68-75 (2008). *

• Caldwell SH, Leung PS, Spivey JR, Prindiville T, de Medina M, Saicheur T, Rowley M, Reddy KR, Coppel R, Jeffers LJ, et al. Antimitochondrial antibodies in kindreds of patients with primary biliary cirrhosis: antimitochondrial antibodies are unique to clinical disease and are absent in asymptomatic family members. Hepatology 16: 899-905 (1992).

• Cale CM, Morton L, Goldblatt D. Cutaneous and other lupus-like symptoms in carriers of X-linked chronic granulomatous disease: incidence and autoimmune serology. Clin. Exp. Immunol. 148: 79-84 (2007). *

• Cales P, Calot M, Voigt JJ, Oksman F, Cassigneul J, Vinel JP, Pascal JP. Familial autoimmune pathology comprising 2 cases of primary biliary cirrhosis. Gastroenterol. Clin. Biol. 7: 777-784 (1983).

• Calista D, Morri M. Lichen planus induced by hepatitis B vaccination: a new case and review of the literature. Int. J. Dermatol. 43: 562-564 (2004).

• Callado MR, Viana VS, Vendramini MB, Leon EP, Bueno C, Velosa AP, Teodoro WR, Yoshinari NH. Autoantibody profile in the experimental model of scleroderma induced by type V human collagen. Immunology 122: 38-46 (2007). *

• Cambridge G, Rampton DS, Stevens TR, McCarthy DA, Kamm M, Leaker B. Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 33: 668-674 (1992). *

• Candore G, Modica MA, Lio D, Colonna-Romano G, Listě F, Grimaldi MP, Russo M, Triolo G, Accardo-Palumbo A, Cuccia MC, Caruso C. Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: a genetically determined defect of C4 influences immunological parameters of healthy carriers of the haplotype. Biomed. Pharmacother. 57: 274-277 (2003).

• Cantaert T, De Rijcke L, Mavragani CP, Wijbrandts CA, Niewold TB, Niers T, Vandooren B, Veys EM, Richel D, Tak PP, Crow MK, Baeten D. Exposure to nuclear antigens contributes to the induction of humoral autoimmunity during TNF alpha blockade. Ann. Rheum. Dis. 68: 1022-1029 (2009).

• Cantz T, Sharma AD, Jochheim-Richter A, Arseniev L, Klein C, Manns MP, Ott M. Reevaluation of bone marrow-derived cells as a source for hepatocyte regeneration. Cell Transplant. 13: 659-666 (2004).

• Canzler U, Bartsch H, Ulitzsch S, Kurien BT, Dorri Y, Scofield RH, Grossmann K, Lehmann W, Pilarsky C, Denz A, Grutzmann R, Conrad K, Schmitz M, Rieber EP, Distler W, Bachmann MP. Detection of autoantibodies to tumour-associated antigens in sera of patients with systemic autoimmunity using a novel protein microblot array. Scand. J. Immunol. 69: 563-569 (2009). *

• Caradonna L, Amati L, Lella P, Jirillo E, Caccavo D. Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease. Am. J. Gastroenterol. 95: 1495-1502 (2000). *

• Caradonna L, Amati L, Magrone T, Pellegrino NM, Jirillo E, Caccavo D. Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance. J. Endotoxin Res. 6: 205-214 (2000). *

• Caramaschi P, Bambara LM, Pieropan S, Tinazzi I, Volpe A, Biasi D. Anti-TNFalpha blockers, autoantibodies and autoimmune diseases. Joint Bone Spine 76: 333-342 (2009). *

• Caramaschi P, Biasi D, Colombatti M, Pieropan S, Martinelli N, Carletto A, Volpe A, Pacor LM, Bambara LM. Anti-TNFalpha therapy in rheumatoid arthritis and autoimmunity. Rheumatol. Int. 26: 209-214 (2006). *

• Carbone J, Sarmiento E, Micheloud D, Rodriguez-Mahou M, Rodriguez-Molina JJ, Cobo R, Fernandez-Cruz E. Systemic autoimmune disease in patients with uveitis. Arch. Soc. Esp. Oftalmol. 81: 193-198 (2006).

• Carl PL, Temple BR, Cohen PL. Most nuclear systemic autoantigens are extremely disordered proteins: implications for the etiology of systemic autoimmunity. Arthritis Res. Ther. 7: R1360-R1374 (2005). *

• Carlberg C, Dunlop TW. The impact of chromatin organization of vitamin D target genes. Anticancer Res. 26: 2637-2645 (2006).

• Caroselli C, Plocco M, Prattic X00f2 F, Bruno C, Antonaglia C, Rota F, Curreli I, Caroselli A, Bruno G. Ulcerative colitis masked by giant urticaria. Int. J. Immunopathol. Pharmacol. 20: 181-184 (2007).

• Carpo M, Scarlato M, Bardella M, Terrani C, Peracchi M, Allaria S, Nobile-Orazio E, Bresolin N. Painful sensory neuropathy and dysimmunity: is there a relation? J. Peripher. Nerv. Syst. 9: 121 (2004).

• Carroccio A, Giannitrapani L, Soresi M, Not T, Iacono G, Di Rosa C, Panfili E, Notarbartolo A, Montalto G. Guinea pig transglutaminase immunolinked assay does not predict coeliac disease in patients with chronic liver disease. Gut 49: 506-511 (2001). *

• Carroll DG, Cavanagh LE. Drug-induced lupus associated with synthetic conjugated estrogens. Ann. Pharmacother. 41: 702-706 (2007).

• Carter RH. B cells in health and disease. Mayo Clin. Proc. 81: 377-384 (2006). *

• Caruso R, Sarra M, Stolfi C, Rizzo A, Fina D, Fantini MC, Pallone F, Macdonald TT, Monteleone G. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut. Gastroenterology 136: 2270-2279 (2009). *

• Casellas Jorda F. TNF-alpha inhibitors in inflamatory bowel disease. Med. Clin. (Barc.) 123: 627-634 (2004).

• Cassani F, Bianchi FB, Lenzi M, Volta U, Pisi E. Immunomorphological characterisation of antinuclear antibodies in chronic liver disease. J. Clin. Pathol. 38: 801-805 (1985). *

• Cassatella MA, da Silva GP, Tinazzi I, Facchetti F, Scapini P, Calzetti F, Tamassia N, Wei P, Nardelli B, Roschke V, Vecchi A, Mantovani A, Bambara LM, Edwards SW, Carletto A. Soluble TNF-like cytokine (TL1A) production by immune complexes stimulated monocytes in rheumatoid arthritis. J. Immunol. 178: 7325-7333 (2007). *

• Cassio D, Macias RI, Grosse B, Marin JJ, Monte MJ. Expression, localization, and inducibility by bile acids of hepatobiliary transporters in the new polarized rat hepatic cell lines, Can 3-1 and Can 10. Cell Tissue Res. 330: 447-460 (2007). *

• Castellino F, Rosina F, Bansi DS, Bauducci M, Touscoz GA, Giorda L, Borghesio E, Bessone MP, Astegiano M, Musso A, et al. Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease: do they recognize different subsets of a heterogeneous disease? Eur. J. Gastroenterol. Hepatol. 7: 859-864 (1995).

• Castellino G, Govoni M, Prandini N, Limpido G, Bernardi S, Campione D, Lanza F, Trotta F. Thrombocytosis in systemic lupus erythematosus: a possible clue to autosplenectomy? J. Rheumatol. 34: 1497-1501 (2007).

• Cavazzana I, Bobbio-Pallavicini F, Bazzani C, Bravi E, Zingarelli S, Ceribelli A, Caporali R, Cattaneo R, Franceschini F, Montecucco C. TNFalpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunological effects. Reumatismo 58: 275-282 (2006).

• Cavinato RA, Casiraghi F, Azzollini N, Mister M, Pezzotta A, Cassis P, Cugini D, Perico N, Remuzzi G, Noris M. Role of thymic- and graft-dependent mechanisms in tolerance induction to rat kidney transplant by donor PBMC infusion. Kidney Int. 71: 1132-1141 (2007). *

• Cesinaro AM, Nannini N, Migaldi M, Pepe P, Maiorana A. Psoriasis vs allergic contact dermatitis in palms and soles: a quantitative histologic and immunohistochemical study. APMIS 117: 629-634 (2009).

• Cezard JP, Nouaili N, Talbotec C, Hugot JP, Gobert JG, Schmitz J, Mougenot JF, Alberti C, Goulet O. A prospective study of the efficacy and tolerance of a chimeric antibody to tumor necrosis factors (remicade) in severe pediatric Crohn disease. J. Pediatr. Gastroenterol. Nutr. 36: 632-636 (2003). *

• Chan KL, Wong KF, Luk JM. Role of LPS/CD14/TLR4-mediated inflammation in necrotizing enterocolitis: pathogenesis and therapeutic implications. World J. Gastroenterol. 15: 4745-4752 (2009). *

• Chan SL, Voskens CJ, Lin W, Schindler DG, Azimzadeh A, Wang LX, Taylor RJ, Strome SE, Schulze DH. Epitope mapping of a chimeric CD137 mAb: a necessary step for assessing the biologic relevance of non-human primate models. J. Mol. Recognit. 22: 242-249 (2009). *

• Chang HK, Bang KT, Lee BH, Kim JH, Bae KW, Kim MJ, Kim SK. Concurrence of Sjogren's syndrome in a patient with Chlamydia-induced reactive arthritis; an unusual finding. Korean J. Intern. Med. 21: 116-119 (2006).

• Charniot JC, Genereau T, Mouthon L. Celiprolol-induced lupus-like syndrome. Acta Cardiol. 61: 661-663 (2006).

• Charrie A, Chikh K, Peix JL, Berger N, Decaussin M, Veber S, Bienvenu J, Lifante JC, Fabien N. Calcium-sensing receptor autoantibodies in primary hyperparathyroidism. Clin. Chim. Acta 406: 94-97 (2009).

• Chavakis E, Hain A, Vinci M, Carmona G, Bianchi ME, Vajkoczy P, Zeiher AM, Chavakis T, Dimmeler S. High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells. Circ. Res. 100: 204-212 (2007). *

• Chazouilleres O. A case of autoimmune hepatitis. Gastroenterol. Clin. Biol. 33: F36-F43 (2009).

• Chen CH, Chen HA, Wang HP, Liao HT, Chou CT, Huang de F. Pulmonary arterial hypertension in autoimmune diseases: an analysis of 19 cases from a medical center in northern Taiwan. J. Microbiol. Immunol. Infect. 39: 162-168 (2006). *

• Chen CS, Roberton D, Hammerton ME. Juvenile arthritis-associated uveitis: visual outcomes and prognosis. Can. J. Ophthalmol. 39: 614-620 (2004).

• Chen JL, Chen YC, Yang SH, Ko YF, Chen SY. Immunological alterations in lupus-prone autoimmune (NZB/NZW) F1 mice by mycelia Chinese medicinal fungus Cordyceps sinensis-induced redistributions of peripheral mononuclear T lymphocytes. Clin. Exp. Med. 9: 277-284 (2009). *

• Chen M, Dittmann A, Kuhn A, Ruzicka T, Mikecz AV. Recruitment of topoisomerase I (Scl-70) to nucleoplasmic proteasomes in response to xenobiotics suggests a role for altered antigen processing in scleroderma. Arthritis Rheum. 52: 877-884 (2005). *

• Chen M, von Mikecz A. Proteasomal processing of nuclear autoantigens in systemic autoimmunity. Autoimmun. Rev. 4: 117-122 (2005).

• Chen M, von Mikecz A. Xenobiotic-induced recruitment of autoantigens to nuclear proteasomes suggests a role for altered antigen processing in scleroderma. Ann. N. Y. Acad. Sci. 1051: 382-389 (2005). *

• Chen WS, Lin KC, Chen CH, Liao HT, Wang HP, Li WY, Lee HT, Tsai CY, Chou CT. Autoantibody and biopsy grading are associated with expression of ICAM-1, MMP-3, and TRAIL in salivary gland mononuclear cells of Chinese patients with Sjogren's syndrome. J. Rheumatol. 36: 989-996 (2009).

• Chen YF, Morel L. Genetics of T cell defects in lupus. Cell. Mol. Immunol. 2: 403-409 (2005). *

• Chen Z, Marsden PA, Gorczynski RM. Role of a distal enhancer in the transcriptional responsiveness of the human CD200 gene to interferon-gamma and tumor necrosis factor-alpha. Mol. Immunol. 46: 1951-1963 (2009). *

• Cheng W, Gilliam AC, Castrovinci A, Pazirandeh M. Anti-thyroid autoantibody-associated interface dermatitis in individuals with undifferentiated connective tissue disease - an unrecognized subset of autoimmune disease? J. Rheumatol. 34: 81-88 (2007).

• Cheung B, Yan J, Smith SA, Nguyen T, Lee M, Kavallaris M, Norris MD, Haber M, Marshall GM. Growth inhibitory retinoid effects after recruitment of retinoid X receptor beta to the retinoic acid receptor beta promoter. Int. J. Cancer 105: 856-867 (2003). *

• Chevailler A, Saint-Andre JP, Preel JL, Boyer J, Joubaud F, Hurez D. Clinico-immunological profile of hepatic and extrahepatic diseases accompanied by anti-mitochondrial antibodies. Ann. Med. Interne. (Paris) 139: 19-23 (1988).

• Chianelli M, Mather SJ, Grossman A, Sobnak R, Fritzberg A, Britton KE, Signore A. (99m)Tc-interleukin-2 scintigraphy in normal subjects and in patients with autoimmune thyroid diseases: a feasibility study. Eur. J. Nucl. Med. Mol. Imaging 35: 2286-2293 (2008). *

• Chiappini E, Taccetti G, Campana S, Turchini S, Marianelli L. Anti-Pseudomonas aeruginosa antibodies, circulating immune complexes, and anticytoplasm antibodies of neutrophils in patients with cystic fibrosis with and without Pseudomonas aeruginosa colonization. Pediatr. Med. Chir. 23: 27-30 (2001).

• Chien RN, Sheen IS, Chen TJ, Liaw YF. A clinicopathological study in primary biliary cirrhosis. J. Formos. Med. Assoc. 91 Suppl. 2: S117-S121 (1992).

• Chikamatsu K, Sakakura K, Matsuoka T, Endo S, Takahashi G, Matsuzaki Z, Masuyama K. Analysis of T-helper responses and FOXP3 gene expression in patients with Japanese cedar pollinosis. Am. J. Rhinol. 22: 582-588 (2008).

• Chikazawa H, Nishiya K, Matsumori A, Hashimoto K. Immunoglobulin isotypes of anti-myeloperoxidase and anti-lactoferrin antibodies in patients with collagen diseases. J. Clin. Immunol. 20: 279-286 (2000). *

• Chin J. Intestinal microflora: negotiating health outcomes with the warring community within us. Asia Pac. J. Clin. Nutr. 13: S24-S25 (2004).

• Chinen T, Kobayashi T, Ogata H, Takaesu G, Takaki H, Hashimoto M, Yagita H, Nawata H, Yoshimura A. Suppressor of cytokine signaling-1 regulates inflammatory bowel disease in which both IFN-gamma and IL-4 are involved. Gastroenterology 130: 373-388 (2006). *

• Cho DH, Choi MS, Kim DH, Kim do Y, Shim SG, Lee JH, Koh KC, Paik SW, Yoo BC, Rhee JC. A prospective study on the prevalence and clinical significance of autoantibodies in patients with suspected nonalcholic fatty liver disease. Korean J. Hepatol. 11: 261-267 (2005).

• Cho ML, Heo YJ, Park MK, Oh HJ, Park JS, Woo YJ, Ju JH, Park SH, Kim HY, Min JK. Grape seed proanthocyanidin extract (GSPE) attenuates collagen-induced arthritis. Immunol. Lett. 124: 102-110 (2009).

• Choi EW, Shin IS, Bhang DH, Lee DH, Bae BK, Kang MS, Kim DY, Hwang CY, Lee CW, Youn HY. Hormonal change and cytokine mRNA expression in peripheral blood mononuclear cells during the development of canine autoimmune thyroiditis. Clin. Exp. Immunol. 146: 101-108 (2006). *

• Choi EW, Shin IS, Youn HY, Kim DY, Lee H, Chae YJ, Lee CW. Gene therapy using non-viral peptide vector in a canine systemic lupus erythematosus model. Vet. Immunol. Immunopathol. 103: 223-233 (2005). *

• Choi HK, Merkel PA, Tervaert JW, Black RM, McCluskey RT, Niles JL. Alternating antineutrophil cytoplasmic antibody specificity: drug-induced vasculitis in a patient with Wegener's granulomatosis. Arthritis Rheum. 42: 384-388 (1999). *

• Choi KH, Lee EB, Yoo CD, Baek HJ, Kang SW, Shin KC, Lee YJ, Kim HA, Jeon JH, Kim CW, Shin DM, Kim IG, Son YW. Clinical significance of anti-filaggrin antibody recognizing uncitrullinated filaggrin in rheumatoid arthritis. Exp. Mol. Med. 37: 546-552 (2005). *

• Choi M, Rolle S, Rane M, Haller H, Luft FC, Kettritz R. Extracellular signal-regulated kinase inhibition by statins inhibits neutrophil activation by ANCA. Kidney Int. 63: 96-106 (2003). *

• Chon CY, Park JY. Primary biliary cirrhosis. Korean J. Hepatol. 12: 364-372 (2006).

• Chou KT, Lee YC, Chen CW, Shih JF, Tung SM, Yang YT, Perng RP. Lupus erythematosus (LE) cells in ascites: initial diagnosis of systemic lupus erythematosus by cytological examination: a case report. Clin. Rheumatol. 26: 1931-1933 (2007). *

• Chou MJ, Lee SL, Chen TY, Tsay GJ. Specificity of antinuclear antibodies in primary biliary cirrhosis. Ann. Rheum. Dis. 54: 148-151 (1995). *

• Chowdhary VR, Grande JP, Luthra HS, David CS. Characterization of haemorrhagic pulmonary capillaritis: another manifestation of pristane-induced lupus. Rheumatology (Oxford) 46: 1405-1410 (2007). *

• Chretien-Leprince P, Ballot E, Andre C, Olsson NO, Fabien N, Escande A, Oksman F, Dubuquoi S, Jego S, Goetz J, Chevailler A, Sanmarco M, Humbel RL, Johanet C. Diagnostic value of anti-F-actin antibodies in a French multicenter study. Ann. N. Y. Acad. Sci. 1050: 266-273 (2005). *

• Christensen SR, Kashgarian M, Alexopoulou L, Flavell RA, Akira S, Shlomchik MJ. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J. Exp. Med. 202: 321-331 (2005). *

• Christensen T. Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses. Rev. Med. Virol. 15: 179-211 (2005). *

• Christiansen FT, Zhang WJ, Griffiths M, Mallal SA, Dawkins RL. Major histocompatibility complex (MHC) complement deficiency, ancestral haplotypes and systemic lupus erythematosus (SLE): C4 deficiency explains some but not all of the influence of the MHC. J. Rheumatol. 18: 1350-1358 (1991).

• Cimaz R, Cazalis MA, Raynaud C, Gerloni V, Zulian F, Biggioggero M, Martini G, Pontikaki I, Fantini F, Mougin B, Miossec P. IL-1 and TNF gene polymorphisms in patients with juvenile idiopathic arthritis treated with TNF inhibitors. Ann. Rheum. Dis. 66: 900-904 (2007). *

• Cirillo N, Gombos F, Lanza A. Pemphigus vulgaris immunoglobulin G can recognize a 130 000 MW antigen other than desmoglein 3 on peripheral blood mononuclear cell surface. Immunology 121: 377-382 (2007). *

• Civilibal M, Canpolat N, Yurt A, Kurugoglu S, Erdamar S, Bagci O, Sever L, Kasapcopur O, Caliskan S, Arisoy N. A child with primary Sjogren syndrome and a review of the literature. Clin. Pediatr. (Phila.) 46: 738-742 (2007).

• Claise C, Johanet C, Bouhnik Y, Kapel N, Homberg JC, Poupon R. Antineutrophil cytoplasmic autoantibodies in autoimmune liver and inflammatory bowel diseases. Liver 16: 28-34 (1996).

• Classen M, Gotze H, Richter HJ, Bender S. Primary sclerosing cholangitis in children. J. Pediatr. Gastroenterol. Nutr. 6: 197-202 (1987).

• Cleland LG, Bell DA. The occurrence of systemic lupus erythematosus in two kindreds in association with selective IgA deficiency. J. Rheumatol. 5: 288-293 (1978).

• Cline AM, Kutteh WH. Is there a role of autoimmunity in implantation failure after in-vitro fertilization? Curr. Opin. Obstet. Gynecol. 21: 291-295 (2009).

• Cojocaru M, Cojocaru IM, Iacob SA. Prevalence of anti-neutrophil cytoplasmic antibodies in patients with chronic hepatitis C infection associated mixed cryoglobulinemia. Rom. J. Intern. Med. 44: 427-431 (2006).

• Coll J, Palazon J, Yazbeck H, Gutierrez J, Aubo C, Benito P, Jagiello P, Maldyk H, Marrugat J, Anglada J, et al. Antibodies to human immunodeficiency virus (HIV-1) in autoimmune diseases: primary Sjogren's syndrome, systemic lupus erythematosus, rheumatoid arthritis and autoimmune thyroid diseases. Clin. Rheumatol. 14: 451-457 (1995).

• Colombato LA, Alvarez F, Cote J, Huet PM. Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis? Gastroenterology 107: 1839-1843 (1994).

• Colombel JF, Reumaux D, Duthilleul P, Noel LH, Gower-Rousseau C, Paris JC, Cortot A. Antineutrophil cytoplasmic autoantibodies in inflammatory bowel diseases. Gastroenterol. Clin. Biol. 16: 656-660 (1992).

• Colucci G, Schaffner F, Paronetto F. In situ characterization of the cell-surface antigens of the mononuclear cell infiltrate and bile duct epithelium in primary biliary cirrhosis. Clin. Immunol. Immunopathol. 41: 35-42 (1986).

• Comby E, Tanaff P, Mariotte D, Costentin-Pignol V, Marcelli C, Ballet JJ. Evolution of antinuclear antibodies and clinical patterns in patients with active rheumatoid arthritis with longterm infliximab therapy. J. Rheumatol. 33: 24-30 (2006).

• Comte C, Guillot B, Durand L, Picot E, Dereure O. Interstitial granulomatous dermatitis with arthritis: four cases. Ann. Dermatol. Venereol. 135: 38-43 (2008).

• Comte D, Lamy O, Schwab M. A rare cause of cervical adenopathy. Schweiz. Rundsch. Med. Prax. 96: 1821-1824 (2007).

• Conrad K, Ittenson A, Reinhold D, Fischer R, Roggenbuck D, Buttner T, Bosselmann HP, Steinbach J, Schossler W. High sensitive detection of double-stranded DNA autoantibodies by a modified Crithidia luciliae immunofluorescence test. Ann. N. Y. Acad. Sci. 1173: 180-185 (2009). *

• Constantin T, Kalovics T, Ponyi A, Nagy E, Sallai K, Szabo L, Garami M, Muller J, Gergely P, Danko K, Fekete G, Kalmanchey R. Prevalence of antiphospholipid and antinuclear antibodies in children with epilepsy. Med. Sci. Monit. 15: CR164-CR169 (2009).

• Cooper GS, Makris SL, Nietert PJ, Jinot J. Evidence of autoimmune-related effects of trichloroethylene exposure from studies in mice and humans. Environ. Health Perspect. 117: 696-702 (2009). *

• Cooper GS, Parks CG, Schur PS, Fraser PA. Occupational and environmental associations with antinuclear antibodies in a general population sample. J. Toxicol. Environ. Health A. 69: 2063-2069 (2006).

• Cooper T, Savige J, Nassis L, Paspaliaris B, Neeson P, Neil J, Knight KR, Daskalakis M, Doery JC. Clinical associations and characterisation of antineutrophil cytoplasmic antibodies directed against bactericidal/permeability-increasing protein and azurocidin. Rheumatol. Int. 19: 129-136 (2000). *

• Copple SS, Martins TB, Masterson C, Joly E, Hill HR. Comparison of three multiplex immunoassays for detection of antibodies to extractable nuclear antibodies using clinically defined sera. Ann. N. Y. Acad. Sci. 1109: 464-472 (2007). *

• Coppo P, Veyradier A, Monge M; , pour le Reseau d'etude des microangiopathies thrombotiques. Acquired idiopathic thrombotic thrombocytopenic purpura: arguments for an autoimmune disease. Presse. Med. 35: 1876-1886 (2006).

• Cordiali-Fei P, Ardigo M, Mastroianni A, Giuliani A, D' Agosto G, Bordignon V, Trento E, Vento A, Berardesca E. Serum cytokines and biohumoral immunological characterization of psoriatic patients in long term etanercept treatment. Int. J. Immunopathol. Pharmacol. 21: 643-650 (2008).

• Corpechot C, Abenavoli L, Rabahi N, Chretien Y, Andreani T, Johanet C, Chazouilleres O, Poupon R. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. Hepatology 48: 871-877 (2008). *

• Corporaal S, Bijl M, Kallenberg CG. Familial occurrence of autoimmune diseases and autoantibodies in a Caucasian population of patients with systemic lupus erythematosus. Clin. Rheumatol. 21: 108-113 (2002).

• Costello P, FitzGerald O. Disease mechanisms in psoriasis and psoriatic arthritis. Curr. Rheumatol. Rep. 3: 419-427 (2001).

• Cotler SJ, Kanji K, Keshavarzian A, Jensen DM, Jakate S. Prevalence and significance of autoantibodies in patients with non-alcoholic steatohepatitis. J. Clin. Gastroenterol. 38: 801-804 (2004).

• Couderc AL, Costello R, Bagneres D, Rossi P, Vitton V, Demoux AL, Bonin-Guillaume S, Frances Y, Granel B. Is pure red cell aplasia a new extra digestive manifestation of celiac disease? Rev. Med. Interne. 27: 336-339 (2006).

• Courvalin JC, Lassoued K, Bartnik E, Blobel G, Wozniak RW. The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore. J. Clin. Invest. 86: 279-285 (1990). *

• Courvalin JC, Lassoued K, Worman HJ, Blobel G. Identification and characterization of autoantibodies against the nuclear envelope lamin B receptor from patients with primary biliary cirrhosis. J. Exp. Med. 172: 961-967 (1990). *

• Courvalin JC, Worman HJ. Nuclear envelope protein autoantibodies in primary biliary cirrhosis. Semin. Liver Dis. 17: 79-90 (1997).

• Craig D, Robins G, Howdle PD. Advances in celiac disease. Curr. Opin. Gastroenterol. 23: 142-148 (2007).

• Crispin-Acuna JC, Remes-Troche JM, Uribe M. Abnormal hepatic biochemistries and clinical liver disease in patients with primary Sjogren's syndrome. Ann. Hepatol. 6: 150-155 (2007). *

• Cristea A, Badea T, Bodizs G, Olinic N. Antineutrophil cytoplasmic autoantibodies (ANCA) - markers in diagnosis and monitoring systemic vasculitides. Rom. J. Intern. Med. 33: 37-46 (1995).

• Crow AR, Brinc D, Lazarus AH. New insight into the mechanism of action of IVIg: the role of dendritic cells. J. Thromb. Haemost. 7 Suppl. 1: 245-248 (2009).

• Crow AR, Lazarus AH. The mechanisms of action of intravenous immunoglobulin and polyclonal anti-D immunoglobulin in the amelioration of immune thrombocytopenic purpura: what do we really know? Transfus. Med. Rev. 22: 103-116 (2008).

• Csepregi A, Szodoray P, Zeher M. Do autoantibodies predict autoimmune liver disease in primary Sjogren's syndrome? Data of 180 patients upon a 5 year follow-up. Scand. J. Immunol. 56: 623-629 (2002). *

• Csepregi A, Treiber G, Rocken C, Malfertheiner P. Acute exacerbation of autoimmune hepatitis induced by Twinrix. World J. Gastroenterol. 11: 4114-4116 (2005). *

• Cui GM, Liu G, Liu W, Kan B, Mao YQ, Wei YQ. Experimental study of pristane-induced murine lupus model. Sichuan Da Xue Xue Bao Yi Xue Ban 37: 309-312 (2006).

• Cullen S, Chapman R. Chapter 19. Sclerosing cholangitis: primary and secondary. In "Liver Immunology: Principles and Practice" (eds. Gershwin ME, Vierling JM, Manns MP), Humana Press Inc., Totowa, NJ, p. 249-261 (2007). *

• Culton DA, Nicholas MW, Bunch DO, Zhen QL, Kepler TB, Dooley MA, Mohan C, Nachman PH, Clarke SH. Similar CD19 dysregulation in two autoantibody-associated autoimmune diseases suggests a shared mechanism of B-cell tolerance loss. J. Clin. Immunol. 27: 53-68 (2007). *

• Cuzzocrea S, Di Paola R, Mazzon E, Genovese T, Muia C, Caputi AP. WY 14643, a potent exogenous PPAR-alpha ligand, reduces intestinal injury associated with splanchnic artery occlusion shock. Shock 22: 340-346 (2004). *

• Cuzzocrea S, Pisano B, Dugo L, Ianaro A, Patel NS, Di Paola R, Genovese T, Chatterjee PK, Di Rosa M, Caputi AP, Thiemermann C. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut. Br. J. Pharmacol. 140: 366-376 (2003). *

• Czaja AJ. The autoimmune hepatitis/hepatitis C overlap syndrome: does it exist? Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 42-43. October 15-16 (2003). *

• Czaja AJ. Autoimmune liver disease. Curr. Opin. Gastroenterol. 16: 262-270 (2000).

• Czaja AJ. Autoimmune liver disease. Curr. Opin. Gastroenterol. 17: 268-275 (2001).

• Czaja AJ. Extrahepatic immunologic features of chronic viral hepatitis. Dig. Dis. 15: 125-144 (1997).

• Czaja AJ. Autoimmune liver disease and rheumatic manifestations. Curr. Opin. Rheumatol. 19: 74-80 (2007).

• Czaja AJ. Behavior and significance of autoantibodies in type 1 autoimmune hepatitis. J. Hepatol. 30: 394-401 (1999). *

• Czaja AJ. Autoantibodies in autoimmune liver disease. Adv. Clin. Chem. 40: 127-164 (2005).

• Czaja AJ. Round table: classification of autoimmune liver diseases and diagnostic criteria. Subgroups of autoimmune hepatitis are irrelevant. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 58-59 (2004). *

• Czaja AJ. Autoimmune hepatitis: clinical and laboratory diagnosis. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 52-54 (2004). *

• Czaja AJ. Variant forms of autoimmune hepatitis. Curr. Gastroenterol. Rep. 1: 63-70 (1999).

• Czaja AJ. Autoimmune liver disease. Curr. Opin. Gastroenterol. 23: 255-262 (2007).

• Czaja AJ. Autoimmune hepatitis - approach to diagnosis. MedGenMed. 8: 55 (2006). *

• Czaja AJ. Rapidity of treatment response and outcome in type 1 autoimmune hepatitis. J. Hepatol. 51: 161-167 (2009).

• Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Genetic predispositions for immunological features in chronic liver diseases other than autoimmune hepatitis. J. Hepatol. 24: 52-59 (1996). *

• Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Host- and disease-specific factors affecting steatosis in chronic hepatitis C. J. Hepatol. 29: 198-206 (1998). *

• Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Immunologic features and HLA associations in chronic viral hepatitis. Gastroenterology 108: 157-164 (1995). *

• Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Genetic predispositions for the immunological features of chronic active hepatitis. Hepatology 18: 816-822 (1993).

• Czaja AJ, Carpenter HA, Santrach PJ, Moore SB, Taswell HF, Homburger HA. Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United States. J. Hepatol. 18: 342-352 (1993).

• Czaja AJ, Cassani F, Cataleta M, Valentini P, Bianchi FB. Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis. Dig. Dis. Sci. 42: 1688-1696 (1997). *

• Czaja AJ, Cassani F, Cataleta M, Valentini P, Bianchi FB. Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology 24: 1068-1073 (1996). *

• Czaja AJ, Davis GL, Ludwig J, Baggenstoss AH, Taswell HF. Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology. Gastroenterology 85: 713-717 (1983).

• Czaja AJ, Donaldson PT, Lohse AW. Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis. Am. J. Gastroenterol. 97: 413-419 (2002). *

• Czaja AJ, Magrin S, Fabiano C, Fiorentino G, Diquattro O, Craxi A, Pagliaro L. Hepatitis C virus infection as a determinant of behavior in type 1 autoimmune hepatitis. Dig. Dis. Sci. 40: 33-40 (1995).

• Czaja AJ, Manns MP. The validity and importance of subtypes in autoimmune hepatitis: a point of view. Am. J. Gastroenterol. 90: 1206-1211 (1995).

• Czaja AJ, Ming C, Shirai M, Nishioka M. Frequency and significance of antibodies to histones in autoimmune hepatitis. J. Hepatol. 23: 32-38 (1995). *

• Czaja AJ, Morshed SA, Parveen S, Nishioka M. Antibodies to single-stranded and double-stranded DNA in antinuclear antibody-positive type 1-autoimmune hepatitis. Hepatology 26: 567-572 (1997). *

• Czaja AJ, Muratori P, Muratori L, Carpenter HA, Bianchi FB. Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis. Liver Int. 24: 322-329 (2004). *

• Czaja AJ, Nishioka M, Morshed SA, Hachiya T. Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis. Gastroenterology 107: 200-207 (1994).

• Czaja AJ, Norman GL. Autoantibodies in the diagnosis and management of liver disease. J. Clin. Gastroenterol. 37: 315-329 (2003).

• Czaja AJ, Pfeifer KD, Decker RH, Vallari AS. Frequency and significance of antibodies to asialoglycoprotein receptor in type 1 autoimmune hepatitis. Dig. Dis. Sci. 41: 1733-1740 (1996).

• Czaja AJ, Souto EO, Bittencourt PL, Cancado EL, Porta G, Goldberg AC, Donaldson PT. Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States. J. Hepatol. 37: 302-308 (2002). *

• Czompoly T, Simon D, Czirjak L, Nemeth P. Anti-topoisomerase I autoantibodies in systemic sclerosis. Autoimmun. Rev. 8: 692-696 (2009).

• D'Alessandria C, Malviya G, Viscido A, Aratari A, Maccioni F, Amato A, Scopinaro F, Caprilli R, Signore A. Use of a (99m)Tc labeled anti-TNFalpha monoclonal antibody in Crohn's disease: in vitro and in vivo studies. Q. J. Nucl. Med. Mol. Imaging 51: 334-342 (2007).

• da Rosa Utiyama SR, da Silva Kotze LM, Nisihara RM, Carvalho RF, de Carvalho EG, de Sena MG, de Messias Reason IJ. Spectrum of autoantibodies in celiac patients and relatives. Dig. Dis. Sci. 46: 2624-2630 (2001). *

• da Rosa Utiyama SR, Nisihara RM, Nass FR, Oliveira NP, Fiedler PT, de Messias-Reason IT. Autoantibodies in patients with Down syndrome: early senescence of the immune system or precocious markers for immunological diseases? J. Paediatr. Child. Health 44: 182-186 (2008). *

• Dai J, Peng L, Fan K, Wang H, Wei R, Ji G, Cai J, Lu B, Li B, Zhang D, Kang Y, Tan M, Qian W, Guo Y. Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells. Oncogene 28: 3412-3422 (2009). *

• Dai SM, Matsuno H, Nakamura H, Nishioka K, Yudoh K. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis. Arthritis Rheum. 50: 432-443 (2004). *

• Dalekos GN, Manoussakis MN, Goussia AC, Tsianos EV, Moutsopoulos HM. Soluble interleukin-2 receptors, antineutrophil cytoplasmic antibodies, and other autoantibodies in patients with ulcerative colitis. Gut 34: 658-664 (1993). *

• Dalekos GN, Zachou K, Liaskos C, Gatselis N. Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview. Eur. J. Intern. Med. 13: 293-303 (2002).

• Damoiseaux JG, Bouten B, Linders AM, Austen J, Roozendaal C, Russel MG, Forget PP, Tervaert JW. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: high prevalence in patients with celiac disease. J. Clin. Immunol. 22: 281-288 (2002). *

• Danner S, Sordet C, Terzic J, Donato L, Velten M, Fischbach M, Sibilia J. Epidemiology of juvenile idiopathic arthritis in Alsace, France. J. Rheumatol. 33: 1377-1381 (2006).

• Das J, Ren G, Zhang L, Roberts AI, Zhao X, Bothwell AL, Van Kaer L, Shi Y, Das G. Transforming growth factor beta is dispensable for the molecular orchestration of Th17 cell differentiation. J. Exp. Med. 206: 2407-2416 (2009). *

• Das KM. Immunopathogenesis of primary sclerosing cholangitis: possible role of a shared colonic and biliary epithelial antigen. J. Gastroenterol. Hepatol. 19: S290-S294 (2004). *

• Dassopoulos T. Diagnostic methodologies: serology, endoscopy, and radiology. Curr. Gastroenterol. Rep. 3: 491-499 (2001).

• Davalos M, Roman R, Bustios C, Zumaeta E, Yabar A. Autoimmune hepatitis: clinical forms and related factors to their response to treatment. Rev. Gastroenterol. Peru 24: 305-313 (2004).

• Davies JK, Yuk D, Nadler LM, Guinan EC. Induction of alloanergy in human donor T cells without loss of pathogen or tumor immunity. Transplantation 86: 854-864 (2008).

• Davis ID, Skak K, Smyth MJ, Kristjansen PE, Miller DM, Sivakumar PV. Interleukin-21 signaling: functions in cancer and autoimmunity. Clin. Cancer Res. 13: 6926-6932 (2007). *

• Davis MK, Andres JM, Jolley CD, Novak DA, Haafiz AB, Gonzalez-Peralta RP. Antibodies to Escherichia coli outer membrane porin C in the absence of anti-Saccharomyces cerevisiae antibodies and anti-neutrophil cytoplasmic antibodies are an unreliable marker of Crohn disease and ulcerative colitis. J. Pediatr. Gastroenterol. Nutr. 45: 409-413 (2007). *

• Dayal VS, Ellman M, Sweiss N. Autoimmune inner ear disease: clinical and laboratory findings and treatment outcome. J. Otolaryngol. Head Neck Surg. 37: 591-596 (2009).

• De Decker M, Bacher K, Thierens H, Slegers G, Dierckx RA, De Vos F. In vitro and in vivo evaluation of direct rhenium-188-labeled anti-CD52 monoclonal antibody alemtuzumab for radioimmunotherapy of B-cell chronic lymphocytic leukemia. Nucl. Med. Biol. 35: 599-604 (2008).

• De Jager PL, Simon KC, Munger KL, Rioux JD, Hafler DA, Ascherio A. Integrating risk factors. HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis. Neurology 70: 1113-1118 (2008).

• de Oliveira JP, Levy A, Morel P, Guibal F. Efficacy of infliximab for severe recalcitrant psoriasis after 6 weeks of treatment. J. Dermatol. 35: 575-580 (2008).

• Dearling JL, Park EJ, Dunning P, Baker A, Fahey F, Treves ST, Soriano SG, Shimaoka M, Packard AB, Peer D. Detection of intestinal inflammation by MicroPET imaging using a (64)Cu-labeled anti-beta(7) integrin antibody. Inflamm. Bowel Dis. Feb 23 [Epub ahead of print] (2010).

• Decker P, Briand JP, de Murcia G, Pero RW, Isenberg DA, Muller S. Zinc is an essential cofactor for recognition of the DNA binding domain of poly(ADP-ribose) polymerase by antibodies in autoimmune rheumatic and bowel diseases. Arthritis Rheum. 41: 918-926 (1998). *

• Dellavance A, Viana VS, Leon EP, Bonfa ES, Andrade LE, Leser PG. The clinical spectrum of antinuclear antibodies associated with the nuclear dense fine speckled immunofluorescence pattern. J. Rheumatol. 32: 2144-2149 (2005).

• Delorenze GN, Munger KL, Lennette ET, Orentreich N, Vogelman JH, Ascherio A. Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up. Arch. Neurol. 63: 839-844 (2006). *

• Deltenre P, Berson A, Marcellin P, Degott C, Biour M, Pessayre D. Mesalazine (5-aminosalicylic acid) induced chronic hepatitis. Gut 44: 886-888 (1999). *

• Dendrinos KG, Becker JM, Stucchi AF, Saubermann LJ, Lamorte W, Farraye FA. Anti-Saccharomyces cerevisiae antibodies are associated with the development of postoperative fistulas following ileal pouch-anal anastomosis. J. Gastrointest. Surg. 10: 1060-1064 (2006).

• Dentener MA, Francot GJ, Buurman WA. Bactericidal/permeability-increasing protein, a lipopolysaccharide-specific protein on the surface of human peripheral blood monocytes. J. Infect. Dis. 173: 252-255 (1996).

• Deocharan B, Zhou Z, Antar K, Siconolfi-Baez L, Angeletti RH, Hardin J, Putterman C. alpha-Actinin immunization elicits anti-chromatin autoimmunity in nonautoimmune mice. J. Immunol. 179: 1313-1321 (2007). *

• Der G, Love T, Schreck J, Horn M. Primary sclerosing cholangitis: a case presentation. Gastroenterol. Nurs. 28: 13-16 (2005). *

• Desai HG, Gupte PA. Increasing incidence of Crohn's disease in India: is it related to improved sanitation? Indian J. Gastroenterol. 24: 23-24 (2005). *

• Desai SN, White DM, O'Shea KM, Brown ML, Cywin CL, Spero DM, Panzenbeck MJ. An orally active reversible inhibitor of cathepsin S inhibits human trans vivo delayed-type hypersensitivity. Eur. J. Pharmacol. 538: 168-174 (2006). *

• Descamps V, Mahe E, Houhou N, Abramowitz L, Rozenberg F, Ranger-Rogez S, Crickx B. Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection. Br. J. Dermatol. 148: 1032-1034 (2003). *

• Deshmukh US, Bagavant H, Sim D, Pidiyar V, Fu SM. A SmD peptide induces better antibody responses to other proteins within the small nuclear ribonucleoprotein complex than to SmD protein via intermolecular epitope spreading. J. Immunol. 178: 2565-2571 (2007). *

• Deshmukh US, Lewis JE, Gaskin F, Kannapell CC, Waters ST, Lou YH, Tung KS, Fu SM. Immune responses to Ro60 and its peptides in mice. I. The nature of the immunogen and endogenous autoantigen determine the specificities of the induced autoantibodies. J. Exp. Med. 189: 531-540 (1999). *

• Deshmukh US, Ohyama Y, Bagavant H, Guo X, Gaskin F, Fu SM. Inflammatory stimuli accelerate Sjogren's syndrome-like disease in (NZB x NZW)F(1) mice. Arthritis Rheum. 58: 1318-1323 (2008). *

• Desir B, Amre DK, Lu SE, Ohman-Strickland P, Dubinsky M, Fisher R, Seidman EG. Utility of serum antibodies in determining clinical course in pediatric Crohn's disease. Clin. Gastroenterol. Hepatol. 2: 139-146 (2004). *

• Desplat-Jego S, Johanet C, Escande A, Goetz J, Fabien N, Olsson N, Ballot E, Sarles J, Baudon JJ, Grimaud JC, Veyrac M, Chamouard P, Humbel RL. Update on anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases … World J. Gastroenterol. 13: 2312-2318 (2007). *

• Dhamija R, Tan KM, Pittock SJ, Foxx-Orenstein A, Benarroch E, Lennon VA. Serologic profiles aiding the diagnosis of autoimmune gastrointestinal dysmotility. Clin. Gastroenterol. Hepatol. 6: 988-992 (2008).

• Di Comite G, Rossi CM, Marinosci A, Lolmede K, Baldissera E, Aiello P, Mueller RB, Herrmann M, Voll RE, Rovere-Querini P, Sabbadini MG, Corti A, Manfredi AA. Circulating chromogranin A reveals extra-articular involvement in patients with rheumatoid arthritis and curbs TNF-alpha-elicited endothelial activation. J. Leukoc. Biol. 85: 81-87 (2009). *

• Di Sabatino A, Ciccocioppo R, Cupelli F, Cinque B, Millimaggi D, Clarkson MM, Paulli M, Cifone MG, Corazza GR. Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Gut 55: 469-477 (2006). *

• Di Sabatino A, Pickard KM, Rampton D, Kruidenier L, Rovedatti L, Leakey NA, Corazza GR, Monteleone G, Macdonald TT. Blockade of transforming growth factor beta up-regulates T-box transcription factor T-bet, and increases T helper cell type 1 cytokine and matrix metalloproteinase-3 production in the human gut mucosa. Gut 57: 605-612 (2008).

• Dia D, Ba-Fall K, Bouldouyre M, Chevalier B, Debonne JM. DRESS syndrome to allopurinol: a case in Dakar. Dakar Med. 49: 114-115 (2004).

• Diaz-Lopez C, Geli C, Corominas H, Malat N, Diaz-Torner C, Llobet JM, De La Serna AR, Laiz A, Moreno M, Vazquez G. Are there clinical or serological differences between male and female patients with primary Sjogren's syndrome? J. Rheumatol. 31: 1352-1355 (2004). *

• Dieker J, Muller S. Post-translational modifications, subcellular relocation and release in apoptotic microparticles: apoptosis turns nuclear proteins into autoantigens. Folia Histochem. Cytobiol. 47: 343-348 (2009). *

• Dieude P, Guedj M, Wipff J, Avouac J, Fajardy I, Diot E, Granel B, Sibilia J, Cabane J, Mouthon L, Cracowski JL, Carpentier PH, Hachulla E, Meyer O, Kahan A, Boileau C, Allanore Y. Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis. Arthritis Rheum. 60: 225-233 (2009). *

• DiIulio NA, Xu H, Fairchild RL. Diversion of CD4+ T cell development from regulatory T helper to effector T helper cells alters the contact hypersensitivity response. Eur. J. Immunol. 26: 2606-2612 (1996).

• Dinesen L, Travis S. Targeting nanomedicines in the treatment of Crohn's disease: focus on certolizumab pegol (CDP870). Int. J. Nanomedicine 2: 39-47 (2007).

• Ding C. Belimumab, an anti-BLyS human monoclonal antibody for potential treatment of inflammatory autoimmune diseases. Expert Opin. Biol. Ther. 8: 1805-1814 (2008).

• Ding C, Cai Y, Marroquin J, Ildstad ST, Yan J. Plasmacytoid dendritic cells regulate autoreactive B cell activation via soluble factors and in a cell-to-cell contact manner. J. Immunol. 183: 7140-7149 (2009).

• Dinser R, Braun A, Jendro MC, Engel A. Increased titres of anti-nuclear antibodies do not predict the development of associated disease in the absence of initial suggestive signs and symptoms. Scand. J. Rheumatol. 36: 448-451 (2007).

• Ditzel HJ, Rosenkilde MM, Garred P, Wang M, Koefoed K, Pedersen C, Burton DR, Schwartz TW. The CCR5 receptor acts as an alloantigen in CCR5Delta32 homozygous individuals: identification of chemokineand HIV-1-blocking human antibodies. Proc. Natl. Acad. Sci. U.S.A. 95: 5241-5255 (1998). *

• Dizdar O, Ozcakar L, Malas FU, Harputluoglu H, Bulut N, Aksoy S, Ozisik Y, Altundag K. Sonographic and electrodiagnostic evaluations in patients with aromatase inhibitor-related arthralgia. J. Clin. Oncol. 27: 4955-4960 (2009).

• Djilali-Saiah I, Fakhfakh A, Louafi H, Caillat-Zucman S, Debray D, Alvarez F. HLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis. J. Hepatol. 45: 844-850 (2006). *

• Djilali-Saiah I, Renous R, Caillat-Zucman S, Debray D, Alvarez F. Linkage disequilibrium between HLA class II region and autoimmune hepatitis in pediatric patients. J. Hepatol. 40: 904-909 (2004).

• Doetze A, Satoguina J, Burchard G, Rau T, Loliger C, Fleischer B, Hoerauf A. Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by T(h)3/T(r)1-type cytokines IL-10 and transforming growth factor-beta but not by a T(h)1 to T(h)2 shift. Int. Immunol. 12: 623-630 (2000). *

• Doffinger R, Helbert MR, Barcenas-Morales G, Yang K, Dupuis S, Ceron-Gutierrez L, Espitia-Pinzon C, Barnes N, Bothamley G, Casanova JL, Longhurst HJ, Kumararatne DS. Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity. Clin. Infect. Dis. 38: e10-e14 (2004). *

• Dohi T, Fujihashi K, Koga T, Etani Y, Yoshino N, Kawamura YI, McGhee JR. CD4+CD45RBHi interleukin-4 defective T cells elicit antral gastritis and duodenitis. Am. J. Pathol. 165: 1257-1268 (2004). *

• Dominguez MC, Torres M, Tamayo O, Criollo W, Quintana M, Sanchez A, Garcia F. Autoimmune syndrome in the tropical spastic paraparesis/myelopathy associated with human T-lymphotropic virus infections. Biomedica 28: 510-522 (2008).

• Dong YW, Wang XP, Wu K. Suppression of pancreatic carcinoma growth by activating peroxisome proliferator-activated receptor gamma involves angiogenesis inhibition. World J. Gastroenterol. 15: 441-448 (2009). *

• Donn RP, Thomson W, Pepper L, Carthy D, Farhan A, Ryder C, Southwood T, Holt L, Ollier W. Antinuclear antibodies in early onset pauciarticular juvenile chronic arthritis (JCA) are associated with HLA-DQB1*0603: a possible JCA-associated human leucocyte antigen haplotype. Br. J. Rheumatol. 34: 461-465 (1995).

• Dressel A, Kolb AK, Elitok E, Bitsch A, Bogumil T, Kitze B, Tumani H, Weber F. Interferon-beta1b treatment modulates cytokines in patients with primary progressive multiple sclerosis. Acta Neurol. Scand. 114: 368-373 (2006).

• Du F, Lv L, Fu Q, Dai M, Fan W, Teng J, Chen S, Ye P, Shen N, Huang X, Qian J, Bao C. T-614, a novel immunomodulator, attenuates joint inflammation and articular damage in collagen-induced arthritis. Arthritis Res. Ther. 10: R136 (2008). *

• Du H, Chen M, Zhang Y, Zhao MH. Non-DNA-binding antibodies in patients with lupus nephritis could recognize membrane proteins of glomerular sesangial cells. J. Clin. Immunol. 26: 138-144 (2006). *

• Dubel L, Farges O, Courvalin JC, Sebagh M, Johanet C. Persistence of gp210 and multiple nuclear dots antibodies does not correlate with recurrence of primary biliary cirrhosis 6 years after liver transplantation. J. Hepatol. 28: 169-170 (1998). *

• Dubinsky MC, Kugathasan S, Mei L, Picornell Y, Nebel J, Wrobel I, Quiros A, Silber G, Wahbeh G, Katzir L, Vasiliauskas E, Bahar R, Otley A, Mack D, Evans J, Rosh J, Hemker MO, Leleiko N, Crandall W, Langton C, Landers C, Taylor KD, Targan SR, et al. Increased immune reactivity predicts aggressive complicating Crohn's disease in children. Clin. Gastroenterol. Hepatol. 6: 1105-1111 (2008).

• Duchmann R, Schmitt E, Knolle P, Meyer zum Buschenfelde KH, Neurath M. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur. J. Immunol. 26: 934-938 (1996).

• Duclos-Vallee JC, Hadengue A, Ganne-Carrie N, Robin E, Degott C, Erlinger S. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Corticoresistance and effective treatment by cyclosporine A. Dig. Dis. Sci. 40: 1069-1073 (1995).

• Duclos-Vallee JC, Johanet C, Bach JF, Yamamoto AM. Autoantibodies associated with acute rejection after liver transplantation for type-2 autoimmune hepatitis. J. Hepatol. 33: 163-166 (2000). *

• Duerr RH, Neigut DA. Molecularly defined HLA-DR2 alleles in ulcerative colitis and an antineutrophil cytoplasmic antibody-positive subgroup. Gastroenterology 108: 423-427 (1995). *

• Duerr RH, Targan SR, Landers CJ, LaRusso NF, Lindsay KL, Wiesner RH, Shanahan F. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 100: 1385-1391 (1991).

• Dumitriu IE, Bianchi ME, Bacci M, Manfredi AA, Rovere-Querini P. The secretion of HMGB1 is required for the migration of maturing dendritic cells. J. Leukoc. Biol. 81: 84-91 (2007). *

• Dunster K, Lai FP, Sentry JW. Limkain b1, a novel human autoantigen localized to a subset of ABCD3 and PXF marked peroxisomes. Clin. Exp. Immunol. 140: 556-563 (2005). *

• Duparc A, Staumont-Salle D, Broly F, Piette F, Delaporte E. Treatment of chronic lupus erythematosus with sulfasalazine in 18 patients: reappraisal. Presse. Med. 35: 1138-1142 (2006).

• Durand V, Pers JO, Renaudineau Y, Saraux A, Youinou P, Jamin C. Differential effects of anti-Fc gamma RIIIb autoantibodies on polymorphonuclear neutrophil apoptosis and function. J. Leukoc. Biol. 69: 233-240 (2001). *

• Durandy A. Hyper-IgM syndromes: a model for studying the regulation of class switch recombination and somatic hypermutation generation. Biochem. Soc. Trans. 30: 815-818 (2002). *

• Durinovic-Bello I, Jelinek E, Schlosser M, Eiermann T, Boehm BO, Karges W, Marchand L, Polychronakos C. Class III alleles at the insulin VNTR polymorphism are associated with regulatory T-cell responses to proinsulin epitopes in HLA-DR4, DQ8 individuals. Diabetes 54: S18-S24 (2005). *

• Duthie MS, Kahn M, White M, Kapur RP, Kahn SJ. Critical proinflammatory and anti-inflammatory functions of different subsets of CD1d-restricted natural killer T cells during Trypanosoma cruzi infection. Infect. Immun. 73: 181-192 (2005). *

• Duzgun N, Sahin M, Genc Y, Tutkak H. Antinucleosome antibodies and systemic lupus erythematosus. Ann. N. Y. Acad. Sci. 1109: 421-428 (2007). *

• Edwards JR, Sun SG, Locklin R, Shipman CM, Adamopoulos IE, Athanasou NA, Sabokbar A. LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis. Arthritis Rheum. 54: 1451-1462 (2006). *

• Egerod FL, Svendsen JE, Hinley J, Southgate J, Bartels A, Brunner N, Oleksiewicz MB. PPARalpha and PPARgamma coactivation rapidly induces Egr-1 in the nuclei of the dorsal and ventral urinary bladder and kidney pelvis urothelium of rats. Toxicol. Pathol. 37: 947-958 (2009). *

• Eggena M, Cohavy O, Parseghian MH, Hamkalo BA, Clemens D, Targan SR, Gordon LK, Braun J. Identification of histone H1 as a cognate antigen of the ulcerative colitis-associated marker antibody pANCA. J. Autoimmun. 14: 83-97 (2000).

• Eggena M, Targan SR, Iwanczyk L, Vidrich A, Gordon LK, Braun J. Phage display cloning and characterization of an immunogenetic marker (perinuclear anti-neutrophil cytoplasmic antibody) in ulcerative colitis. J. Immunol. 156: 4005-4011 (1996).

• Egger SS, Studer IG, Bravo AE, Krahenbuhl S. Minocycline-induced lupus erythematodes. Schweiz. Rundsch. Med. Prax. 95: 1297-1303 (2006).

• El Khoury G, Laurenceau E, Dugas V, Chevolot Y, Merieux Y, Duclos MC, Souteyrand E, Rigal D, Wallach J, Cloarec JP. Acid deprotection of covalently immobilized peptide probes on glass slides for peptide microarrays. Conf. Proc. IEEE Eng. Med. Biol. Soc. 1: 2242-2246 (2007).

• El-Bostany EA, El-Ghoroury EA, El-Ghafar EA. Anti-beta2-glycoprotein I in childhood immune thrombocytopenic purpura. Blood Coagul. Fibrinolysis 19: 26-31 (2008).

• el-Shabrawi M, Wilkinson ML, Portmann B, Mieli-Vergani G, Chong SK, Williams R, Mowat AP. Primary sclerosing cholangitis in childhood. Gastroenterology 92: 1226-1235 (1987).

• Elezoglou A, Kafasi N, Kaklamanis PH, Theodossiadis PG, Kapsimali V, Choremi E, Vaiopoulos G, Sfikakis PP. Infliximab treatment-induced formation of autoantibodies is common in Behcet's disease. Clin. Exp. Rheumatol. 25: S65-S69 (2007).

• Elfaitouri A, Berg AK, Frisk G, Yin H, Tuvemo T, Blomberg J. Recent enterovirus infection in type 1 diabetes: evidence with a novel IgM method. J. Med. Virol. 79: 1861-1867 (2007).

• Elitsur Y, Lawrence Z, Tolaymat N. The diagnostic accuracy of serologic markers in children with IBD: the West Virginia experience. J. Clin. Gastroenterol. 39: 670-673 (2005).

• Elkayam O, Levartovsky D, Brautbar C, Yaron M, Burke M, Vardinon N, Caspi D. Clinical and immunological study of 7 patients with minocycline-induced autoimmune phenomena. Am. J. Med. 105: 484-487 (1998). *

• Elkayam O, Yaron M, Caspi D. Minocycline-induced autoimmune syndromes: an overview. Semin. Arthritis Rheum. 28: 392-397 (1999).

• Elliott DE, Setiawan T, Metwali A, Blum A, Urban JF Jr, Weinstock JV. Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice. Eur. J. Immunol. 34: 2690 (2004). *

• Ellis RD, Goodlad JR, Limb GA, Powell JJ, Thompson RP, Punchard NA. Activation of nuclear factor kappa B in Crohn's disease. Inflamm. Res. 47: 440-445 (1998). *

• Eloranta ML, Lovgren T, Finke D, Mathsson L, Ronnelid J, Kastner B, Alm GV, Ronnblom L. Regulation of the interferon-alpha production induced by RNA-containing immune complexes in plasmacytoid dendritic cells. Arthritis Rheum. 60: 2418-2427 (2009). *

• Elsbach P. The bactericidal/permeability-increasing protein (BPI) in antibacterial host defense. J. Leukoc. Biol. 64: 14-18 (1998). *

• Elshazly LB, Youssef AM, Mahmoud NH, Ibrahim MM. Study of non-standard auto-antibodies as prognostic markers in auto immune hepatitis in children. Ital. J. Pediatr. 35: 22 (2009). *

• Enarson P, Rattner JB, Ou Y, Miyachi K, Horigome T, Fritzler MJ. Autoantigens of the nuclear pore complex. J. Mol. Med. 82: 423-433 (2004). *

• Ennaifer R, Moussa A, Mouelhi L, Salem M, Bouzaidi S, Debbeche R, Trabelsi S, Najjar T. Cerebral venous sinus thrombosis as presenting feature of ulcerative colitis. Acta Gastroenterol. Belg. 72: 350-353 (2009).

• Enzenauer RJ, West SG. Sarcoidosis in autoimmune disease. Semin. Arthritis Rheum. 22: 1-17 (1992).

• Ersvaer E, Bertelsen LT, Espenes LC, Bredholt T, Boe SO, Iversen BM, Bruserud O, Ulvestad E, Gjertsen BT. Characterization of ribosomal P autoantibodies in relation to cell destruction and autoimmune disease. Scand. J. Immunol. 60: 189-198 (2004). *

• Esters N, Vermeire S, Joossens S, Noman M, Louis E, Belaiche J, De Vos M, Van Gossum A, Pescatore P, Fiasse R, Pelckmans P, Reynaert H, Poulain D, Bossuyt X, Rutgeerts P; Belgian Group of Infliximab Expanded Access Program in Crohn's Disease. Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn's disease. Am. J. Gastroenterol. 97: 1458-1462 (2002). *

• Etxagibel A, Julia MR, Brotons A, Company MM, Dolz C. Drug-induced hepatitis superimposed on the presence of anti-SLA antibody: a case report. J. Med. Case Reports 2: 25 (2008). *

• Etzioni A, Ochs HD. The hyper IgM syndrome - an evolving story. Pediatr. Res. 56: 519-525 (2004). *

• Evans J, Reuben A, Craft J. PBC 95k, a 95-kilodalton nuclear autoantigen in primary biliary cirrhosis. Arthritis Rheum. 34: 731-736 (1991).

• Faber C, Morbach H, Singh SK, Girschick HJ. Differential expression patterns of recombination activating genes in individual mature B cells in juvenile idiopathic arthritis. Ann. Rheum. Dis. 65: 1351-1356 (2006). *

• Fabien N, Desbos A, Bienvenu J, Magdalou J. Autoantibodies directed against the UDP-glucuronosyltransferases in human autoimmune hepatitis. Autoimmun. Rev. 3: 1-9 (2004). *

• Fagoonee S, Caorsi C, Giovarelli M, Stoltenberg M, Silengo L, Altruda F, Camussi G, Tolosano E, Bussolati B. Lack of plasma protein hemopexin dampens mercury-induced autoimmune response in mice. J. Immunol. 181: 1937-1947 (2008). *

• Fagoonee S, De Luca L, De Angelis C, Castelli A, Rizzetto M, Pellicano R. Anti-Saccharomyces cerevisiae as unusual antibodies in autoimmune hepatitis. Minerva Gastroenterol. Dietol. 55: 37-40 (2009).

• Faguer S, Kamar N, Boulestin A, Esposito L, Durand D, Blancher A, Rostaing L. Prevalence of cryoglobulinemia and autoimmunity markers in renal-transplant patients. Clin. Nephrol. 69: 239-243 (2008).

• Fairhurst AM, Wandstrat AE, Wakeland EK. Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease. Adv. Immunol. 92: 1-69 (2006).

• Fathalla BM, Miller L, Brady S, Schaller JG. Cutaneous polyarteritis nodosa in children. J. Am. Acad. Dermatol. 53: 724-728 (2005).

• Feghali-Bostwick C, Medsger TA Jr, Wright TM. Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum. 48: 1956-1963 (2003). *

• Feillet H, Bach JF. Increased incidence of inflammatory bowel disease: the price of the decline of infectious burden? Curr. Opin. Gastroenterol. 20: 560-564 (2004).

• Feist E, Brychcy M, Hausdorf G, Hoyer B, Egerer K, Dorner T, Kuckelkorn U, Burmester GR. Anti-proteasome autoantibodies contribute to anti-nuclear antibody patterns on human larynx carcinoma cells. Ann. Rheum. Dis. 66: 5-11 (2007). *

• Feld J, Heathcote E. Epidemiology of autoimmune liver disease. J. Gastroenterol. Hepatol. 18: 1118-1128 (2003). *

• Felici E, Novarini C, Magni-Manzoni S, Pistorio A, Magnani A, Bozzola E, Buoncompagni A, Martini A, Ravelli A. Course of joint disease in patients with antinuclear antibody-positive juvenile idiopathic arthritis. J. Rheumatol. 32: 1805-1810 (2005).

• Fenniche S, Dhaoui A, Ben Ammar F, Benmously R, Marrak H, Mokhtar I. Acebutolol-induced subacute cutaneous lupus erythematosus. Skin Pharmacol. Physiol. 18: 230-233 (2005).

• Ferec C, Youinou P, Le Goff P, Miossec P, Morin JF, Pennec Y, Morin PP, Le Menn G. Significance of antinuclear anti-histone antibodies. Ann. Med. Interne. (Paris) 135: 427-430 (1984).

• Fernandez D, Bonilla E, Phillips P, Perl A. Signaling abnormalities in systemic lupus erythematosus as potential drug targets. Endocr. Metab. Immune Disord. Drug Targets 6: 305-311 (2006).

• Ferrante M, Henckaerts L, Joossens M, Pierik M, Joossens S, Dotan N, Norman G, Altstock R, Van Steen K, Rutgeerts P, Van Assche G, Vermeire S. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut 56: 1394-1403 (2007). *

• Ferreira AR, Roquete ML, Penna FJ, Toppa NH. Autoimmune hepatitis in children and adolescents: clinical study, diagnosis and therapeutic response. J. Pediatr. (Rio. J.) 78: 309-314 (2002). *

• Fickert P, Trauner M. When lightning strikes twice: the plot thickens for a dual role of the anion exchanger 2 (AE2/SLC4A2) in the pathogenesis and treatment of primary biliary cirrhosis. J. Hepatol. 50: 633-635 (2009). *

• Fiducia M, Lauretta R, Lunghi R, Kyanvash S, Pallotti S. Hashimoto's thyroiditis and autoimmunity parameters: descriptive study. Minerva Med. 98: 95-99 (2007).

• Field J, Alderuccio F, Hertzog P, Toh BH. GM-CSF-induced autoimmune gastritis in interferon alpha receptor deficient mice. J. Autoimmun. 31: 274-280 (2008).

• Field J, Biondo M, Murphy K, Alderuccio F, Toh B. Experimental autoimmune gastritis: mouse models of human organ-specific autoimmune disease. Int. Rev. Immunol. 24: 93-110 (2005).

• Finke D, Randers K, Hoerster R, Hennig H, Zawatzky R, Marion T, Brockmann C, Klempt-Giessing K, Jacobsen K, Kirchner H, Goerg S. Elevated levels of endogenous apoptotic DNA and IFN-alpha in complement C4-deficient mice: implications for induction of systemic lupus erythematosus. Eur. J. Immunol. 37: 1702-1709 (2007). *

• Fiocchi C, Tubbs RR, Youngman KR. Human intestinal mucosal mononuclear cells exhibit lymphokine-activated killer cell activity. Gastroenterology 88: 625-637 (1985).

• Fischer A, Swigris JJ, du Bois RM, Lynch DA, Downey GP, Cosgrove GP, Frankel SK, Fernandez-Perez ER, Gillis JZ, Brown KK. Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia. Respir. Med. 103: 1719-1724 (2009).

• Fiuza C, Bustin M, Talwar S, Tropea M, Gerstenberger E, Shelhamer JH, Suffredini AF. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 101: 2652-2660 (2003). *

• Fleshner P, Ippoliti A, Dubinsky M, Vasiliauskas E, Mei L, Papadakis KA, Rotter JI, Landers C, Targan S. Both preoperative perinuclear antineutrophil cytoplasmic antibody and anti-CBir1 expression in ulcerative colitis patients influence pouchitis development after ileal pouch-anal anastomosis. Clin. Gastroenterol. Hepatol. 6: 561-568 (2008). *

• Fleshner PR, Vasiliauskas EA, Kam LY, Fleshner NE, Gaiennie J, Abreu-Martin MT, Targan SR. High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis. Gut 49: 671-677 (2001). *

• Florey OJ, Johns M, Esho OO, Mason JC, Haskard DO. Anti-endothelial cell antibodies mediate enhanced leukocyte adhesion to cytokine-activated endothelial cells through a novel mechanism requiring cooperation between FcgammaRIIa and CXCR1/2. Blood 109: 3881-3889 (2007). *

• Fodor M, Nagy V, Berta A, Tornai I, Pfliegler G. Hepatitis C virus presumably associated bilateral consecutive anterior ischemic optic neuropathy. Eur. J. Ophthalmol. 18: 313-315 (2008).

• Folco EJ, Rocha VZ, Lopez-Ilasaca M, Libby P. Adiponectin inhibits pro-inflammatory signaling in human macrophages independently of interleukin-10. J. Biol. Chem. 284: 25569-25575 (2009). *

• Folwaczny C, Jochum M, Noehl N, Schnettler D, Loeschke K, Fricke H. p-ANCA target antigens in ulcerative colitis. Z. Gastroenterol. 36: 625-633 (1998).

• Folwaczny C, Noehl N, Endres SP, Heldwein W, Loeschke K, Fricke H. Antinuclear autoantibodies in patients with inflammatory bowel disease. High prevalence in first-degree relatives. Dig. Dis. Sci. 42: 1593-1597 (1997). *

• Folwaczny C, Noehl N, Endres SP, Loeschke K, Fricke H. Antineutrophil and pancreatic autoantibodies in first-degree relatives of patients with inflammatory bowel disease. Scand. J. Gastroenterol. 33: 523-528 (1998). *

• Fong DJ, Hogaboam CM, Matsuno Y, Akira S, Uematsu S, Joshi AD. Toll-like receptor 6 drives interleukin-17A expression during experimental hypersensitivity pneumonitis. Immunology Jan 11 [Epub ahead of print] (2010). *

• Ford TJ, Dillon JF. Minocycline hepatitis. Eur. J. Gastroenterol. Hepatol. 20: 796-799 (2008).

• Fox RI. Sjogren's syndrome. Lancet 366: 321-331 (2005). *

• Fragoso-Loyo H, Cabiedes J, Orozco-Narvaez A, Davila-Maldonado L, Atisha-Fregoso Y, Diamond B, Llorente L, Sanchez-Guerrero J. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis. PLoS ONE 3: e3347 (2008). *

• Franco J, Saeian K. Biliary tract inflammatory disorders: primary sclerosing cholangitis and primary biliary cirrhosis. Curr. Gastroenterol. Rep. 1: 95-101 (1999).

• Fransen JH, Hilbrands LB, Jacobs CW, Adema GJ, Berden JH, Van der Vlag J. Both early and late apoptotic blebs are taken up by DC and induce IL-6 production. Autoimmunity 42: 325-327 (2009).

• Fransen JH, Hilbrands LB, Ruben J, Stoffels M, Adema GJ, van der Vlag J, Berden JH. Mouse dendritic cells matured by ingestion of apoptotic blebs induce T cells to produce interleukin-17. Arthritis Rheum. 60: 2304-2313 (2009). *

• Franssen CF, Hoorntje SJ, Kallenberg CG, Gans RO. The role of perinuclear antineutrophil granulocytes cytoplasmic antibodies in the diagnosis of vasculitis and chronic inflammatory diseases. Ned. Tijdschr. Geneeskd. 140: 2076-2082 (1996).

• Freeman HJ. Inflammatory bowel disease with cytoplasmic-staining antineutrophil cytoplasmic antibody and extensive colitis. Can. J. Gastroenterol. 12: 279-282 (1998). *

• Freeman HJ. Perinuclear antineutrophil cytoplasmic antibodies in collagenous or lymphocytic colitis with or without celiac disease. Can. J. Gastroenterol. 11: 417-420 (1997). *

• Freeman HJ. Atypical perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease. Can. J. Gastroenterol. 11: 689-693 (1997). *

• Freeman HJ, Roeck B, Devine DV, Carter CJ. Atypical perinuclear antineutrophil cytoplasmic antibodies after colectomy in inflammatory bowel disease. Can. J. Gastroenterol. 11: 305-310 (1997). *

• French MA, Bernstein RM. Immunoglobulin G subclass distribution of autoantibodies in systemic sclerosis, primary biliary cirrhosis, and overlap syndromes. Ann. Rheum. Dis. 46: 436-440 (1987). *

• Frenzer A, Fierz W, Rundler E, Hammer B, Binek J. Atypical, cytoplasmic and perinuclear anti-neutrophil cytoplasmic antibodies in patients with inflammatory bowel disease. J. Gastroenterol. Hepatol. 13: 950-954 (1998). *

• Frisoni L, McPhie L, Kang SA, Monestier M, Madaio M, Satoh M, Caricchio R. Lack of chromatin and nuclear fragmentation in vivo impairs the production of lupus anti-nuclear antibodies. J. Immunol. 179: 7959-7966 (2007). *

• Fu HL, Hsu TC, Chang CC, Tsay GJ. Antigenic specificity of anti-neutrophil cytoplasmic antibody. J. Formos. Med. Assoc. 100: 35-39 (2001).

• Fujii T. The mechanisms of antinuclear antibody production and its pathogenicity in systemic autoimmune diseases. Nihon Rinsho Meneki Gakkai Kaishi 29: 57-64 (2006). *

• Fujii T, Takada-Takatori Y, Kawashima K. Basic and clinical aspects of non-neuronal acetylcholine: expression of an independent, non-neuronal cholinergic system in lymphocytes and its clinical significance in immunotherapy. J. Pharmacol. Sci. 106: 186-192 (2008). *

• Fujikura S, Davis PA, Prindiville T, Leung P, Fox RI, Gershwin ME. Sjogren's syndrome and primary biliary cirrhosis: presence of autoantibodies to purified mitochondrial 2-oxo acid dehydrogenases. J. Rheumatol. 17: 1453-1457 (1990).

• Fujiwara K, Fukuda Y, Yokosuka O. Precise histological evaluation of liver biopsy specimen is indispensable for diagnosis and treatment of acute-onset autoimmune hepatitis. J. Gastroenterol. 43: 951-958 (2008). *

• Fuleihan RL. The hyper IgM syndrome. Curr. Allergy Asthma Rep. 1: 445-450 (2001).

• Furrie E, Macfarlane S, Cummings JH, Macfarlane GT. Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response. Gut 53: 91-98 (2004). *

• Fusconi M, Vannini A, Dall'aglio AC, Pappas G, Bianchi FB, Zauli D. Etanercept and infliximab induce the same serological autoimmune modifications in patients with rheumatoid arthritis. Rheumatol. Int. 28: 47-49 (2007). *

• Fuss IJ, Becker C, Yang Z, Groden C, Hornung RL, Heller F, Neurath MF, Strober W, Mannon PJ. Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody. Inflamm. Bowel Dis. 12: 9-15 (2006). *

• Gaipl US, Munoz LE, Grossmayer G, Lauber K, Franz S, Sarter K, Voll RE, Winkler T, Kuhn A, Kalden J, Kern P, Herrmann M. Clearance deficiency and systemic lupus erythematosus (SLE). J. Autoimmun. 28: 114-121 (2007).

• Gait RC, Affleck AG, Leach IH, Varma S. Perinuclear antineutrophilic cytoplasmic antibody-positive polyarteritis nodosa secondary to minocycline treatment for acne vulgaris. J. Am. Acad. Dermatol. 58: S123-S124 (2008).

• Galdeano CM, Perdigon G. The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity. Clin. Vaccine Immunol. 13: 219-226 (2006). *

• Gao L, Tian X, Liu B, Zhang F. The value of antinuclear antibodies in primary biliary cirrhosis. Clin. Exp. Med. 8: 9-15 (2008). *

• Gao X, Hu PJ, He Y, Liao SY, Peng S, Chen MH. Diagnostic role of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Zhonghua Nei Ke Za Zhi 44: 428-430 (2005).

• Garcia-Leiva J, Rios-Vaca A, Torre-Delgadillo A. Antibodies and physiopathogeny of autoimmune hepatitis. Rev. Invest. Clin. 55: 577-582 (2003).

• Gardner RM, Nyland JF, Silva IA, Maria Ventura A, Maria de Souza J, Silbergeld EK. Mercury exposure, serum antinuclear/antinucleolar antibodies, and serum cytokine levels in mining populations in Amazonian Brazil: a cross-sectional study. Environ. Res. Feb 20 [Epub ahead of print] (2010).

• Garg N, Weinstock-Guttman B, Bhasi K, Locke J, Ramanathan M. An association between autoreactive antibodies and anti-interferon-beta antibodies in multiple sclerosis. Mult. Scler. 13: 895-899 (2007). *

• Garg N, Zivadinov R, Ramanathan M, Vasiliu I, Locke J, Watts K, Lema J, Rajeswary J, Munschauer FE, Ambrus J Jr, Weinstock-Guttman B. Clinical and MRI correlates of autoreactive antibodies in multiple sclerosis patients. J. Neuroimmunol. 187: 159-165 (2007).

• Garrouste C, Kamar N, Boulestin A, Esposito L, Lavayssiere L, Durand D, Blancher A, Rostaing L. Prevalence of cryoglobulinemia and autoimmune markers in liver transplant patients. Exp. Clin. Transplant. 6: 184-189 (2008).

• Gatselis NK, Georgiadou SP, Tassopoulos N, Zachou K, Liaskos C, Hatzakis A, Dalekos GN. Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: a pilot study. World J. Gastroenterol. 11: 482-487 (2005). *

• Gattei V, Aldinucci D, Quinn JM, Degan M, Cozzi M, Perin V, Iuliis AD, Juzbasic S, Improta S, Athanasou NA, Ashman LK, Pinto A. Human osteoclasts and preosteoclast cells (FLG 29.1) express functional c-kit receptors and interact with osteoblast and stromal cells via membrane-bound stem cell factor. Cell Growth Differ. 7: 753-763 (1996). *

• Gaudio E, Barbaro B, Alvaro D, Glaser S, Francis H, Ueno Y, Meininger CJ, Franchitto A, Onori P, Marzioni M, Taffetani S, Fava G, Stoica G, Venter J, Reichenbach R, De Morrow S, Summers R, Alpini G. Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanism. Gastroenterology 130: 1270-1282 (2006). *

• Geboes K, De Hertogh G. Indeterminate colitis. Inflamm. Bowel Dis. 9: 324-331 (2003). *

• Geffriaud-Ricouard C, Noel LH, Chauveau D, Houhou S, Grunfeld JP, Lesavre P. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients. Clin. Nephrol. 39: 125-136 (1993).

• Geier A, Martin IV, Dietrich CG, Balasubramaniyan N, Strauch S, Suchy FJ, Gartung C, Trautwein C, Ananthanarayanan M. Hepatocyte nuclear factor 4alpha is a central transactivator of the mouse Ntcp gene. Am. J. Physiol. Gastrointest. Liver Physiol. 295: G226-G233 (2008). *

• Gergely P Jr, Pullmann R, Stancato C, Otvos L Jr, Koncz A, Blazsek A, Poor G, Brown KE, Phillips PE, Perl A. Increased prevalence of transfusion-transmitted virus and cross-reactivity with immunodominant epitopes of the HRES-1/p28 endogenous retroviral autoantigen in patients with systemic lupus erythematosus. Clin. Immunol. 116: 124-134 (2005). *

• Gerl V, Hostmann B, Johnen C, Waka A, Gerl M, Schumann F, Klein R, Radbruch A, Hiepe F. The intracellular 52-kd Ro/SSA autoantigen in keratinocytes is up-regulated by tumor necrosis factor alpha via tumor necrosis factor receptor I. Arthritis Rheum. 52: 531-538 (2005). *

• Germenis AE, Yiannaki EE, Zachou K, Roka V, Barbanis S, Liaskos C, Adam K, Kapsoritakis AN, Potamianos S, Dalekos GN. Prevalence and clinical significance of immunoglobulin A antibodies against tissue transglutaminase in patients with diverse chronic liver diseases. Clin. Diagn. Lab. Immunol. 12: 941-948 (2005). *

• Gershwin ME. Primary biliary cirrhosis: from induction through destruction. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 39-40 (2004). *

• Gerth AJ, Lin L, Neurath MF, Glimcher LH, Peng SL. An innate cell-mediated, murine ulcerative colitis-like syndrome in the absence of nuclear factor of activated T cells. Gastroenterology 126: 1115-1121 (2004). *

• Ghadiminejad I, Baum H. Evidence for the cell-surface localization of antigens cross-reacting with the "mitochondrial antibodies" of primary biliary cirrhosis. Hepatology 7: 743-749 (1987).

• Ghassemi M, Andersen BR, Roebuck KA, Rabbi MF, Plate JM, Novak RM. Mycobacterium avium complex activates nuclear factor kappaB via induction of inflammatory cytokines. Cell. Immunol. 191: 117-123 (1999). *

• Gheorghe L, Iacob S, Gheorghe C, Iacob R, Simionov I, Vadan R, Becheanu G, Parvulescu I, Toader C. Frequency and predictive factors for overlap syndrome between autoimmune hepatitis and primary cholestatic liver disease. Eur. J. Gastroenterol. Hepatol. 16: 585-592 (2004).

• Ghillani P, Rouquette AM, Desgruelles C, Hauguel N, LE Pendeven C, Piette JC, Musset L. Evaluation of the LIAISON ANA screen assay for antinuclear antibody testing in autoimmune diseases. Ann. N. Y. Acad. Sci. 1109: 407-413 (2007). *

• Ghonaim M, Al-Ghamdi A, El-Bana H, Bakr A, Ghoneim E, El-Edel R, Hassona M, Shoeib S, Allam H. Autoantibodies in chronic liver disease. Egypt. J. Immunol. 12: 101-111 (2005).

• Giacomelli R, Passacantando A, Frieri G, Parzanese I, D'Alo S, Vernia P, Pimpo MT, Petrucci C, Caprilli R, Cifone MG, Tonietti G. Circulating soluble factor-inhibiting natural killer (NK) activity of fresh peripheral blood mononuclear cells (PBMC) from inflammatory bowel disease (IBD) patients. Clin. Exp. Immunol. 115: 72-77 (1999). *

• Gigase P, De Clerck LS, Van Cotthem KA, Bridts CH, Stevens WJ, Van Outryve M, Pelckmans PA. Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease with special attention for IgA-class antibodies. Dig. Dis. Sci. 42: 2171-2174 (1997). *

• Gigliozzi A, Alpini G, Svegliati Baroni G, Marucci L, Drudi Metalli V, Glaser SS, Francis H, Grazia Mancino M, Ueno Y, Barbaro B, Benedetti A, Attili AF, Alvaro D. Nerve growth factor modulates the proliferative capacity of the intrahepatic biliary epithelium in experimental cholestasis. Gastroenterology 127: 1198-1209 (2004). *

• Gilbert KM, Griffin JM, Pumford NR. Trichloroethylene activates CD4+ T cells: potential role in an autoimmune response. Drug Metab. Rev. 31: 901-916 (1999).

• Gilburd B, Abu-Shakra M, Shoenfeld Y, Giordano A, Bocci EB, delle Monache F, Gerli R. Autoantibodies profile in the sera of patients with Sjogren's syndrome: the ANA evaluation - a homogeneous, multiplexed system. Clin. Dev. Immunol. 11: 53-56 (2004). *

• Gillespie K, Kodani I, Dickinson DP, Ogbureke KU, Camba AM, Wu M, Looney S, Chu TC, Qin H, Bisch F, Sharawy M, Schuster GS, Hsu SD. Effects of oral consumption of the green tea polyphenol EGCG in a murine model for human Sjogren's syndrome, an autoimmune disease. Life Sci. 83: 581-588 (2008). *

• Giovanella L, Ceriani L, Ghelfo A. Second-generation thyrotropin receptor antibodies assay and quantitative thyroid scintigraphy in autoimmune hyperthyroidism. Horm. Metab. Res. 40: 484-486 (2008).

• Giraud M, Taubert R, Vandiedonck C, Ke X, Levi-Strauss M, Pagani F, Baralle FE, Eymard B, Tranchant C, Gajdos P, Vincent A, Willcox N, Beeson D, Kyewski B, Garchon HJ. An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus. Nature 448: 934-937 (2007). *

• Glaser SS, Demorrow S, Francis H, Ueno Y, Gaudio E, Vaculin S, Venter J, Franchitto A, Onori P, Vaculin B, Marzioni M, Wise CE, Pilanthananond M, Savage J, Pierce L, Mancinelli R, Alpini G. Progesterone stimulates the proliferation of female and male cholangiocytes via autocrine/paracrine mechanisms. Am. J. Physiol. Gastrointest. Liver Physiol. 295: G124-G136 (2008). *

• Gleicher N, Weghofer A, Barad DH. A pilot study of premature ovarian senescence: II. Different genotype and phenotype for genetic and autoimmune etiologies. Fertil. Steril. 91: 1707-1711 (2009).

• Gleicher N, Weghofer A, Oktay K, Barad D. Do etiologies of premature ovarian aging (POA) mimic those of premature ovarian failure (POF)? Hum. Reprod. 24: 2395-2400 (2009).

• Gliddon AE, Dore CJ, Black CM, McHugh N, Moots R, Denton CP, Herrick A, Barnes T, Camilleri J, Chakravarty K, Emery P, Griffiths B, Hopkinson ND, Hickling P, Lanyon P, Laversuch C, Lawson T, Mallya R, Nisar M, Rhys-Dillon C, Sheeran T, Maddison PJ. Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril. Arthritis Rheum. 56: 3837-3846 (2007). *

• Gogas H, Ioannovich J, Dafni U, Stavropoulou-Giokas C, Frangia K, Tsoutsos D, Panagiotou P, Polyzos A, Papadopoulos O, Stratigos A, Markopoulos C, Bafaloukos D, Pectasides D, Fountzilas G, Kirkwood JM. Prognostic significance of autoimmunity during treatment of melanoma with interferon. N. Engl. J. Med. 354: 709-718 (2006). *

• Gogos CA, Nikolopoulou V, Zolota V, Siampi V, Vagenakis A. Autoimmune cholangitis in a patient with celiac disease: a case report and review of the literature. J. Hepatol. 30: 321-324 (1999). *

• Gohlke F, Lohse AW, Dienes HP, Lohr H, Marker-Hermann E, Gerken G, Meyer zum Buschenfelde KH. Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis. J. Hepatol. 24: 699-705 (1996). *

• Goiriz R, Penas P, Delgado-Jimenez Y, Fernandez-Herrera J, Aragues-Montanes M, Fraga J, Garcia-Diez A. Cutaneous lichenoid graft-versus-host disease mimicking lupus erythematosus. Lupus 17: 591-595 (2008). *

• Goldstein MF, Goldstein AL, Dunsky EH, Dvorin DJ, Belecanech GA, Shamir K. Selective IgM immunodeficiency: retrospective analysis of 36 adult patients with review of the literature. Ann. Allergy Asthma Immunol. 97: 717-730 (2006).

• Goldstein NS, Bayati N, Silverman AL, Gordon SC. Minocycline as a cause of drug-induced autoimmune hepatitis. Report of four cases and comparison with autoimmune hepatitis. Am. J. Clin. Pathol. 114: 591-598 (2000). *

• Gomard-Mennesson E, Fabien N, Cordier JF, Ninet J, Tebib J, Rousset H. Clinical significance of anti-histidyl-tRNA synthetase (Jo1) autoantibodies. Ann. N. Y. Acad. Sci. 1109: 414-420 (2007). *

• Gomez-Puerta JA, Martin H, Amigo MC, Aguirre MA, Camps MT, Cuadrado MJ, Hughes GR, Khamashta MA. Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus? Medicine (Baltimore) 84: 225-230 (2005).

• Gonnet-Gracia C, Barnetche T, Richez C, Blanco P, Dehais J, Schaeverbeke T. Anti-nuclear antibodies, anti-DNA and C4 complement evolution in rheumatoid arthritis and ankylosing spondylitis treated with TNF-alpha blockers. Clin. Exp. Rheumatol. 26: 401-407 (2008).

• Gonzalez C, Garcia-Berrocal B, Herraez O, Navajo JA, Gonzalez-Buitrago JM. Anti-nucleosome, anti-chromatin, anti-dsDNA and anti-histone antibody reactivity in systemic lupus erythematosus. Clin. Chem. Lab. Med. 42: 266-272 (2004).

• Gonzalez C, Garcia-Berrocal B, Perez M, Navajo JA, Herraez O, Gonzalez-Buitrago JM. Laboratory screening of connective tissue diseases by a new automated ENA screening assay (EliA Symphony) in clinically defined patients. Clin. Chim. Acta 359: 109-114 (2005). *

• Gonzalez-Rey E, Fernandez-Martin A, Chorny A, Delgado M. Therapeutic action of Ghrelin in a mouse model of colitis. Gastroenterology 130: 1707-1720 (2006). *

• Goodman ZD, McNally PR, Davis DR, Ishak KG. Autoimmune cholangitis: a variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases. Dig. Dis. Sci. 40: 1232-1242 (1995).

• Gopalakrishnan S, Marwaha RK. Juvenile autoimmune thyroiditis. J. Pediatr. Endocrinol. Metab. 20: 961-970 (2007).

• Gordon JN, Sabatino AD, Macdonald TT. The pathophysiologic rationale for biological therapies in inflammatory bowel disease. Curr. Opin. Gastroenterol. 21: 431-437 (2005).

• Gordon LK, Eggena M, Holland GN, Weisz JM, Braun J. pANCA antibodies in patients with anterior uveitis: identification of a marker antibody usually associated with ulcerative colitis. J. Clin. Immunol. 18: 264-271 (1998).

• Gordon LK, Eggena M, Targan SR, Braun J. Definition of ocular antigens in ciliary body and retinal ganglion cells by the marker antibody pANCA. Invest. Ophthalmol. Vis. Sci. 40: 1250-1255 (1999). *

• Gorriz L, Molino R, Arjona D, Estripeaut D. Sjogren syndrome associated with renal tubular acidosis type I. Rev. Med. Panama 25: 30-33 (2000).

• Gouwy M, Struyf S, Verbeke H, Put W, Proost P, Opdenakker G, Van Damme J. CC chemokine ligand-2 synergizes with the nonchemokine G protein-coupled receptor ligand fMLP in monocyte chemotaxis, and it cooperates with the TLR ligand LPS via induction of CXCL8. J. Leukoc. Biol. 86: 671-680 (2009). *

• Graham KL, Thibault DL, Steinman JB, Okeke L, Kao PN, Utz PJ. Granzyme B is dispensable for immunologic tolerance to self in a murine model of systemic lupus erythematosus. Arthritis Rheum. 52: 1684-1693 (2005). *

• Graham RR, Ortmann W, Rodine P, Espe K, Langefeld C, Lange E, Williams A, Beck S, Kyogoku C, Moser K, Gaffney P, Gregersen PK, Criswell LA, Harley JB, Behrens TW. Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE. Eur. J. Hum. Genet. 15: 823-830 (2007). *

• Granito A, Muratori L, Muratori P, Guidi M, Lenzi M, Bianchi FB, Volta U. Anti-Saccharomyces cerevisiae antibodies (ASCA) in coeliac disease. Gut 55: 296 (2006). *

• Granito A, Muratori L, Pappas G, Muratori P, Ferri S, Cassani F, Lenzi M, Bianchi FB. Clinical features of type 1 autoimmune hepatitis in elderly Italian patients. Aliment. Pharmacol. Ther. 21: 1273-1277 (2005). *

• Granito A, Muratori P, Ferri S, Pappas G, Quarneti C, Lenzi M, Bianchi FB, Muratori L. Diagnosis and therapy of autoimmune hepatitis. Mini Rev. Med. Chem. 9: 847-860 (2009).

• Granito A, Muratori P, Muratori L, Pappas G, Cassani F, Worthington J, Ferri S, Quarneti C, Cipriano V, DE Molo C, Lenzi M, Chapman RW, Bianchi FB. Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis. Aliment. Pharmacol. Ther. 26: 831-838 (2007). *

• Granito A, Muratori P, Muratori L, Pappas G, Cassani F, Worthington J, Guidi M, Ferri S, DE Molo C, Lenzi M, Chapman RW, Bianchi FB. Antinuclear antibodies giving the 'multiple nuclear dots' or the 'rim-like/membranous' patterns: diagnostic accuracy for primary biliary cirrhosis. Aliment. Pharmacol. Ther. 24: 1575-1583 (2006). *

• Granito A, Yang WH, Muratori L, Lim MJ, Nakajima A, Ferri S, Pappas G, Quarneti C, Bianchi FB, Bloch DB, Muratori P. PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis. Am. J. Gastroenterol. 105: 125-131 (2010). *

• Granito A, Zauli D, Muratori P, Muratori L, Grassi A, Bortolotti R, Petrolini N, Veronesi L, Gionchetti P, Bianchi FB, Volta U. Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil cytoplasmic antibodies in coeliac disease before and after gluten-free diet. Aliment. Pharmacol. Ther. 21: 881-887 (2005). *

• Grassi A, Corona F, Casellato A, Carnelli V, Bardare M. Prevalence and outcome of juvenile idiopathic arthritis-associated uveitis and relation to articular disease. J. Rheumatol. 34: 1139-1145 (2007).

• Greene CM, Low TB, O'Neill SJ, McElvaney NG. Anti-PGP or anti-elastin autoantibodies are not evident in chronic inflammatory lung disease. Am. J. Respir. Crit. Care Med. 181: 31-35 (2010). *

• Greenwood DL, Sentry JW. Murine experimental autoimmune gastritis models refractive to development of intrinsic factor autoantibodies, cobalamin deficiency and pernicious anemia. Clin. Immunol. 122: 41-52 (2007). *

• Greeve M, Ferrell L, Kim M, Combs C, Roberts J, Ascher N, Wright TL. Cirrhosis of undefined pathogenesis: absence of evidence for unknown viruses or autoimmune processes. Hepatology 17: 593-598 (1993).

• Gregorio GV, Davies ET, Mieli-Vergani G, Vergani D. Significance of extractable nuclear antigens in childhood autoimmune liver disease. Clin. Exp. Immunol. 102: 308-313 (1995). *

• Gregorio GV, McFarlane B, Bracken P, Vergani D, Mieli-Vergani G. Organ and non-organ specific autoantibody titres and IgG levels as markers of disease activity: a longitudinal study in childhood autoimmune liver disease. Autoimmunity 35: 515-519 (2002).

• Gregorio GV, Portmann B, Karani J, Harrison P, Donaldson PT, Vergani D, Mieli-Vergani G. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology 33: 544-553 (2001). *

• Gregorio GV, Portmann B, Mowat AP, Vergani D, Mieli-Vergani G. A 12-year-old girl with antimitochondrial antibody-positive autoimmune hepatitis. J. Hepatol. 27: 751-754 (1997). *

• Greidinger EL, Zang Y, Jaimes K, Hogenmiller S, Nassiri M, Bejarano P, Barber GN, Hoffman RW. A murine model of mixed connective tissue disease induced with U1 small nuclear RNP autoantigen. Arthritis Rheum. 54: 661-669 (2006). *

• Griffin JM, Blossom SJ, Jackson SK, Gilbert KM, Pumford NR. Trichloroethylene accelerates an autoimmune response by Th1 T cell activation in MRL +/+ mice. Immunopharmacology 46: 123-137 (2000).

• Griffin JM, Gilbert KM, Lamps LW, Pumford NR. CD4(+) T-cell activation and induction of autoimmune hepatitis following trichloroethylene treatment in MRL+/+ mice. Toxicol. Sci. 57: 345-352 (2000). *

• Griffiths MM, Remmers EF. Genetic analysis of collagen-induced arthritis in rats: a polygenic model for rheumatoid arthritis predicts a common framework of cross-species inflammatory/autoimmune disease loci. Immunol. Rev. 184: 172-183 (2001). *

• Griga T, Tromm A, Muller KM, May B. Overlap syndrome between autoimmune hepatitis and primary sclerosing cholangitis in two cases. Eur. J. Gastroenterol. Hepatol. 12: 559-564 (2000).

• Grogan PM, Katz JS. Inflammatory myopathies. Curr. Treat. Options Neurol. 6: 155-161 (2004).

• Grose RH, Thompson FM, Cummins AG. Deficiency of 6B11+ invariant NK T-cells in celiac disease. Dig. Dis. Sci. 53: 1846-1851 (2008). *

• Gross WL, Csernok E, Flesch BK. 'Classic' anti-neutrophil cytoplasmic autoantibodies (cANCA), 'Wegener's autoantigen' and their immunopathogenic role in Wegener's granulomatosis. J. Autoimmun. 6: 171-184 (1993).

• Grossmayer GE, Munoz LE, Gaipl US, Franz S, Sheriff A, Voll RE, Kalden JR, Herrmann M. Removal of dying cells and systemic lupus erythematosus. Mod. Rheumatol. 15: 383-390 (2005).

• Grover A, Taylor J, Troudt J, Keyser A, Sommersted K, Schenkel A, Izzo AA. Mycobacterial infection induces the secretion of high-mobility group box 1 protein. Cell. Microbiol. 10: 1390-1404 (2008). *

• Gu BJ, Wiley JS. Rapid ATP-induced release of matrix metalloproteinase 9 is mediated by the P2X7 receptor. Blood 107: 4946-4953 (2006). *

• Gubbels MR, Jorgensen TN, Metzger TE, Menze K, Steele H, Flannery SA, Rozzo SJ, Kotzin BL. Effects of MHC and gender on lupus-like autoimmunity in Nba2 congenic mice. J. Immunol. 175: 6190-6196 (2005). *

• Gudjonsdottir AH, Nilsson S, Ek J, Kristiansson B, Ascher H. The risk of celiac disease in 107 families with at least two affected siblings. J. Pediatr. Gastroenterol. Nutr. 38: 338-342 (2004). *

• Guejes L, Zurgil N, Stambler I, Deutsch M, Gilburd B, Shoenfeld Y. The influence of different cultivating conditions on polymorphonuclear leukocyte apoptotic process in vitro, II: ultrastructural characteristics of PMN populations incubated with proteinase 3 anti-neutrophil autoantibodies. Ultrastruct. Pathol. 29: 37-51 (2005).

• Guggenbuhl P, Jean S, Jego P, Grosbois B, Chales G, Semana G, Lancien G, Veillard E, Pawlotsky Y, Perdriger A. Primary Sjogren's syndrome: role of the HLA-DRB1*0301-*1501 heterozygotes. J. Rheumatol. 25: 900-905 (1998).

• Guldner HH, Szostecki C, Grotzinger T, Will H. IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis. J. Immunol. 149: 4067-4073 (1992).

• Gulez N, Karaca NE, Aksu G, Kutukculer N. Increased percentages of autoantibodies in immunoglobulin A-deficient children do not correlate with clinical manifestations. Autoimmunity 42: 74-79 (2009).

• Gullo C, Au M, Feng G, Teoh G. The biology of Ku and its potential oncogenic role in cancer. Biochim. Biophys. Acta 1765: 223-234 (2006). *

• Gundling F, Rohrbach H, Schepp W. Cholestatic hepatitis in situs inversus abdominalis. Schweiz. Rundsch. Med. Prax. 96: 1029-1033 (2007).

• Gunnarsson I, Kanerud L, Pettersson E, Lundberg I, Lindblad S, Ringertz B. Predisposing factors in sulphasalazine-induced systemic lupus erythematosus. Br. J. Rheumatol. 36: 1089-1094 (1997).

• Gunther C, Hertl M, Meurer M. Diagnostic use of autoantibodies. Hautarzt. 58: 1063-1075 (2007).

• Guo XH, Zhao MH, Gao Y, Wang SF, Gao Y. Antineutrophil cytoplasmic antibody associated vasculitis induced by antithyroid agents. Zhonghua Yi Xue Za Zhi 83: 932-935 (2003).

• Gupta R, Agarwal SR, Jain M, Malhotra V, Sarin SK. Autoimmune hepatitis in the Indian subcontinent: 7 years experience. J. Gastroenterol. Hepatol. 16: 1144-1148 (2001). *

• Gupta RC, Seibold JR, Krishnan MR, Steigerwald JC. Precipitating autoantibodies to mitochondrial proteins in progressive systemic sclerosis. Clin. Exp. Immunol. 58: 68-76 (1984). *

• Gupta RC, Tan EM. Isolation of circulating immune complexes by conglutinin and separation of antigen from dissociated complexes by immobilized protein A. Clin. Exp. Immunol. 46: 9-19 (1981). *

• Gur H, Shen G, Sutjita M, Terrberry J, Alosachie I, Barka N, Lin HC, Peter JB, Meroni PL, Kaplan M, et al. Autoantibody profile of primary sclerosing cholangitis. Pathobiology 63: 76-82 (1995).

• Gurian LE, Rogoff TM, Ware AJ, Jordan RE, Combes B, Gilliam JN. The immunologic diagnosis of chronic active "autoimmune" hepatitis: distinction from systemic lupus erythematosus. Hepatology 5: 397-402 (1985).

• Guth A, Detanico T, Smith D, Tung K, Bonorino C, Wysocki Lj. Spontaneous autoimmunity in mice that carry an IghV partial transgene: a required arginine in VHCDR3. Lupus 18: 299-308 (2009). *

• Haagsma EB, Mulder AH, Gouw AS, Horst G, Meerman L, Slooff MJ, Kallenberg CG. Neutrophil cytoplasmic autoantibodies after liver transplantation in patients with primary sclerosing cholangitis. J. Hepatol. 19: 8-14 (1993).

• Haake H, Koneke J, Amann K, Vom Dahl J, Janssen U. Development of systemic lupus erythematosus with focal proliferative lupus nephritis during anti-TNF-alpha therapy for psoriatic arthritis. Med. Klin. (Munich) 102: 852-857 (2007).

• Habeeb MA, Rajalingam R, Dhar A, Kumar A, Sharma MP, Mehra NK. HLA association and occurrence of autoantibodies in Asian-Indian patients with ulcerative colitis. Am. J. Gastroenterol. 92: 772-776 (1997).

• Haberhauer G, Wandner G, Machacek E, Broll H. CRST syndrome and primary biliary cirrhosis. Z. Rheumatol. 46: 341-343 (1987).

• Häggblom JO, Jokilammi-Siltanen AB, Peuravuori H, Nevalainen TJ. Time-resolved fluoroimmunoassay for bactericidal/permeability-increasing protein. Mediators Inflamm. 5: 47-50 (1996). *

• Hagiwara K, Murai H, Ochi H, Osoegawa M, Shigeto H, Ohyagi Y, Kira JI. Upper motor neuron syndrome associated with subclinical Sjogren's syndrome. Intern. Med. 47: 1047-1051 (2008). *

• Hahm D, Anderer U. Establishment of HEp-2 cell preparation for automated analysis of ANA fluorescence pattern. Cytometry A. 69A: 178-181 (2006). *

• Halbwachs-Mecarelli L, Nusbaum P, Noel LH, Reumaux D, Erlinger S, Grunfeld JP, Lesavre P. Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin. Exp. Immunol. 90: 79-84 (1992). *

• Halcomb KE, Musuka S, Gutierrez T, Wright HL, Satterthwaite AB. Btk regulates localization, in vivo activation, and class switching of anti-DNA B cells. Mol. Immunol. 46: 233-241 (2009). *

• Hall S, Czaja AJ, Kaufman DK, Markowitz H, Ginsburg WW. How lupoid is lupoid hepatitis? J. Rheumatol. 13: 95-98 (1986).

• Hamaguchi Y. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis. J. Dermatol. 37: 42-53 (2010).

• Hamaguchi Y, Hasegawa M, Fujimoto M, Matsushita T, Komura K, Kaji K, Kondo M, Nishijima C, Hayakawa I, Ogawa F, Kuwana M, Takehara K, Sato S. The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis. Br. J. Dermatol. 158: 487-495 (2008). *

• Hamilton MI, Bradley NJ, Srai SK, Thrasivoulou C, Pounder RE, Wakefield AJ. Autoimmunity in ulcerative colitis: tropomyosin is not the major antigenic determinant of the Das monoclonal antibody, 7E12H12. Clin. Exp. Immunol. 99: 404-411 (1995). *

• Hamnik SE, Hacein-Bey L, Biller J, Gruener G, Jay W. Neuromyelitis optica (NMO) antibody positivity in patients with transverse myelitis and no visual manifestations. Semin. Ophthalmol. 23: 191-200 (2008).

• Han B, Bojalil R, Amezcua-Guerra LM, Springall R, Valderrama-Carvajal H, Wu J, Luo H. DcR3 as a diagnostic parameter and risk factor for systemic lupus erythematosus. Int. Immunol. 20: 1067-1075 (2008).

• Han PD, Cohen RD. Managing immunogenic responses to infliximab: treatment implications for patients with Crohn's disease. Drugs 64: 1767-1777 (2004).

• Han S, Tredger M, Gregorio GV, Mieli-Vergani G, Vergani D. Anti-liver cytosolic antigen type 1 (LC1) antibodies in childhood autoimmune liver disease. Hepatology 21: 58-62 (1995).

• Han Y, Zhang W, Chen J, Zhou H, Wang L. Clinical and pathological study of autoimmune hepatopathy. Zhonghua Gan Zang Bing Za Zhi 9: 82S-84S (2001).

• Hanauer SB. New biologicals for inflammatory bowel disease. Gastroenterology & Hepatology Annual Review Vol. 1, June 2006, p. 67-71 (2006). *

• Hanauer SB. Review article: safety of infliximab in clinical trials. Aliment. Pharmacol. Ther. 13 Suppl. 4: 16-22 (1999). *

• Hanauer SB. Update on the etiology, pathogenesis and diagnosis of ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 1: 26-31 (2004). *

• Hannestad K, Scott H. The MHC haplotype H2b converts two pure nonlupus mouse strains to producers of antinuclear antibodies. J. Immunol. 183: 3542-3550 (2009).

• Hanriot D, Bello G, Ropars A, Seguin-Devaux C, Poitevin G, Grosjean S, Latger-Cannard V, Devaux Y, Zannad F, Regnault V, Lacolley P, Mertes PM, Hess K, Longrois D. C-reactive protein induces pro- and anti-inflammatory effects, including activation of the liver X receptor alpha, on human monocytes. Thromb. Haemost. 99: 558-569 (2008). *

• Hansen JE, Tse CM, Chan G, Heinze ER, Nishimura RN, Weisbart RH. Intranuclear protein transduction through a nucleoside salvage pathway. J. Biol. Chem. 282: 20790-20793 (2007). *

• Hansson M, Djerbi M, Rabbani H, Mellstedt H, Gharibdoost F, Hassan M, Depierre JW, Abedi-Valugerdi M. Exposure to mercuric chloride during the induction phase and after the onset of collagen-induced arthritis enhances immune/autoimmune responses and exacerbates the disease in DBA/1 mice. Immunology 114: 428-437 (2005). *

• Hansson-Hamlin H, Lilliehook I, Trowald-Wigh G. Subgroups of canine antinuclear antibodies in relation to laboratory and clinical findings in immune-mediated disease. Vet. Clin. Pathol. 35: 397-404 (2006).

• Hansson-Hamlin H, Ronnelid J. Detection of antinuclear antibodies by the Inno-Lia ANA update test in canine systemic rheumatic disease. Vet. Clin. Pathol. Nov 3 [Epub ahead of print] (2009).

• Harada K, Ohira S, Isse K, Ozaki S, Zen Y, Sato Y, Nakanuma Y. Lipopolysaccharide activates nuclear factor-kappaB through Toll-like receptors and related molecules in cultured biliary epithelial cells. Lab. Invest. 83: 1657-1667 (2003). *

• Harada K, Ozaki S, Gershwin ME, Nakanuma Y. Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis. Hepatology 26: 1399-1405 (1997). *

• Harada M, Kumemura H, Fujita A, Yanagimoto C, Harada R, Hashimoto O, Sakamoto M, Yoshida H, Okamura T, Sata M. A human T-cell lymphotropic virus type-1 (HTLV-1) carrier complicated with various autoimmune diseases including primary biliary cirrhosis. Hepatol. Res. 31: 116-119 (2005) (2005).

• Hardarson S, Labrecque DR, Mitros FA, Neil GA, Goeken JA. Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases. High prevalence in ulcerative colitis, primary sclerosing cholangitis, and autoimmune hepatitis. Am. J. Clin. Pathol. 99: 277-281 (1993).

• Haringman JJ, Gerlag DM, Smeets TJ, Baeten D, van den Bosch F, Bresnihan B, Breedveld FC, Dinant HJ, Legay F, Gram H, Loetscher P, Schmouder R, Woodworth T, Tak PP. A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis. Arthritis Rheum. 54: 2387-2392 (2006). *

• Harley JB, Harley IT, Guthridge JM, James JA. The curiously suspicious: a role for Epstein-Barr virus in lupus. Lupus 15: 768-777 (2006).

• Harley JB, James JA. Epstein-Barr virus infection induces lupus autoimmunity. Bull. Hosp. Jt. Dis. 64: 45-50 (2006).

• Harper L, Radford D, Plant T, Drayson M, Adu D, Savage CO. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients. Arthritis Rheum. 44: 921-930 (2001). *

• Hartleb M, Nowak A, Gabriel A. Benign form of idiopathic biliary ductopenia in adult woman. Wiad. Lek. 57: 171-173 (2004).

• Hartman C, Eliakim R, Shamir R. Perinuclear antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies: serologic markers in inflammatory bowel disease. Isr. Med. Assoc. J. 6: 221-226 (2004). *

• Hartung K, Seelig HP. Laboratory diagnostics of systemic autoimmune diseases. Part 1. Collagenoses. Z. Rheumatol. 65: 709-724 (2006).

• Haruta I, Hashimoto E, Shibata N, Kato Y, Kobayashi M, Shiratori K. Lipoteichoic acid may affect the pathogenesis of PBC-like bile duct damage and might be involved in systemic multifocal epithelial inflammations in chronic colitis-harboring TCRalpha-/-xAIM-/- mice. Autoimmunity 40: 372-379 (2007). *

• Haruta I, Kikuchi K, Hashimoto E, Nakamura M, Miyakawa H, Hirota K, Shibata N, Kato H, Arimura Y, Kato Y, Uchiyama T, Nagamune H, Kobayashi M, Miyake Y, Shiratori K, Yagi J. Long-term bacterial exposure can trigger nonsuppurative destructive cholangitis associated with multifocal epithelial inflammation. Lab. Invest. Feb 8 [Epub ahead of print] (2010). *

• Hasegawa M, Sato S, Takehara K. Augmented production of transforming growth factor-beta by cultured peripheral blood mononuclear cells from patients with systemic sclerosis. Arch. Dermatol. Res. 296: 89-93 (2004). *

• Haselmayer P, Tenzer S, Kwon BS, Jung G, Schild H, Radsak MP. Herpes virus entry mediator synergizes with Toll-like receptor mediated neutrophil inflammatory responses. Immunology 119: 404-411 (2006). *

• Hashimoto E, Taniai M, Yatsuji S, Tokushige K, Shiratori K, Yamamoto M, Fuchinoue S. Long-term clinical outcome of living-donor liver transplantation for primary biliary cirrhosis. Hepatol. Res. 37 Suppl. 3: S455-S461 (2007). *

• Hashimoto K, Inoue T, Higashi T, Takei SI, Awata T, Katayama S, Takagi R, Okada H, Matsushita S. Dopamine D1-like receptor antagonist, SCH23390, exhibits a preventive effect on diabetes mellitus that occurs naturally in NOD mice. Biochem. Biophys. Res. Commun. 383: 460-463 (2009). *

• Hashimoto T, Akiyama K, Kobayashi N, Mori A. Comparison of IL-17 production by helper T cells among atopic and nonatopic asthmatics and control subjects. Int. Arch. Allergy Immunol. 137 Suppl. 1: 51-54 (2005).

• Hatano T, Fukuda M, Shiotsuki H, Miwa H, Urabe T, Mizuno Y. Chronic inflammatory demyelinating polyneuropathy followed by systemic lupus erythematosus and Sjogren syndrome: a case report. Rinsho Shinkeigaku 46: 203-209 (2006).

• Hattar K, Oppermann S, Ankele C, Weissmann N, Schermuly RT, Bohle RM, Moritz R, Krogel B, Seeger W, Grimminger F, Sibelius U, Grandel U. c-ANCA induce neutrophil-mediated lung injury - a model of acute Wegener's granulomatosis. Eur. Respir. J. Dec 23 [Epub ahead of print] (2009).

• Haugen F, Drevon CA. Activation of nuclear factor-kappaB by high molecular weight and globular adiponectin. Endocrinology 148: 5478-5486 (2007). *

• Havarinasab S, Hultman P. Alteration of the spontaneous systemic autoimmune disease in (NZB x NZW)F1 mice by treatment with thimerosal (ethyl mercury). Toxicol. Appl. Pharmacol. 214: 43-54 (2006). *

• Havarinasab S, Pollard KM, Hultman P. Gold- and silver-induced murine autoimmunity - requirement for cytokines and CD28 in murine heavy metal-induced autoimmunity. Clin. Exp. Immunol. 155: 567-576 (2009). *

• Hay JE, Czaja AJ, Rakela J, Ludwig J. The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients. Hepatology 9: 193-197 (1989).

• Hayakawa T, Jin CX, B H Ko S, Kitagawa M, Ishiguro H. Lactoferrin in gastrointestinal disease. Intern. Med. 48: 1251-1254 (2009). *

• Hayashi T, Matsumoto I, Muraki Y, Takahashi R, Chino Y, Goto D, Ito S, Tsutsumi A, Sumida T. Clinical characteristics of anti-glucose-6-phosphate isomerase antibody-positive Japanese patients with rheumatoid arthritis. Mod. Rheumatol. 15: 258-263 (2005).

• Hayashi Y, Haneji N, Hamano H, Yanagi K. Transfer of Sjogren's syndrome-like autoimmune lesions into SCID mice and prevention of lesions by anti-CD4 and anti-T cell receptor antibody treatment. Eur. J. Immunol. 24: 2826-2831 (1994).

• Hayashi Y, Ishimaru N, Arakaki R, Tsukumo S, Fukui H, Kishihara K, Shiota H, Yasutomo K, Hayashi Y. Effective treatment of a mouse model of Sjogren's syndrome with eyedrop administration of anti-CD4 monoclonal antibody. Arthritis Rheum. 50: 2903-2910 (2004). *

• Hayashida K, Kume N, Minami M, Inui-Hayashida A, Mukai E, Toyohara M, Kita T. Peroxisome proliferator-activated receptor alpha ligands activate transcription of lectin-like oxidized low density lipoprotein receptor-1 gene through GC box motif. Biochem. Biophys. Res. Commun. 323: 1116-1123 (2004). *

• Hazzan R, Mukamel M, Yacobovich J, Yaniv I, Tamary H. Risk factors for future development of systemic lupus erythematosus in children with idiopathic thrombocytopenic purpura. Pediatr. Blood Cancer 47: 657-659 (2006).

• Heathcote EJ. Autoimmune cholangitis. Clin. Liver Dis. 2: 303-311, viii-ix (1998).

• Heathcote J. Overlap syndromes - outlier syndromes and changing diagnoses. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 39-41. October 15-16 (2003). *

• Hedegaard CJ, Chen N, Sellebjerg F, Sřrensen PS, Leslie RG, Bendtzen K, Nielsen CH. Autoantibodies to myelin basic protein (MBP) in healthy individuals and in patients with multiple sclerosis: a role in regulating cytokine responses to MBP. Immunology 128: e451-e461 (2009). *

• Heidari Y, Bygrave AE, Rigby RJ, Rose KL, Walport MJ, Cook HT, Vyse TJ, Botto M. Identification of chromosome intervals from 129 and C57BL/6 mouse strains linked to the development of systemic lupus erythematosus. Genes Immun. 7: 592-599 (2006). *

• Heim MH. Autoimmune hepatitis. Ther. Umsch. 61: 499-504 (2004).

• Hellmich B, Csernok E, Trabandt A, Gross WL, Ernst M. Granulocyte-macrophage colony-stimulating factor (GM-CSF) but not granulocyte colony-stimulating factor (G-CSF) induces plasma membrane expression of proteinase 3 (PR3) on neutrophils in vitro. Clin. Exp. Immunol. 120: 392-398 (2000). *

• Hendricks AA, Hutcheon DF, Maddrey WC, Farmer ER, Provost TT. Cutaneous immunoglobulin deposition in primary biliary cirrhosis. Arch. Dermatol. 118: 634-637 (1982).

• Hendrickx BW, Punt CJ, Boerman OC, Postema EJ, Oosterwijk E, Mavridu A, Corstens FH, Oyen WJ. Targeting of biliary cancer with radiolabeled chimeric monoclonal antibody CG250. Cancer Biother. Radiopharm. 21: 263-268 (2006).

• Heneghan MA, Portmann BC, Norris SM, Williams R, Muiesan P, Rela M, Heaton ND, O'Grady JG. Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults. Hepatology 34: 464-470 (2001). *

• Henry T, Mohan C. Systemic lupus erythematosus - recent clues from congenic strains. Arch. Immunol. Ther. Exp. (Warsz.) 53: 207-212 (2005).

• Herber D, Brown TP, Liang S, Young DA, Collins M, Dunussi-Joannopoulos K. IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression. J. Immunol. 178: 3822-3830 (2007). *

• Herkel J, Modrow JP, Bamberger S, Kanzler S, Rotter V, Cohen IR, Lohse AW. Prevalence of autoantibodies to the p53 protein in autoimmune hepatitis. Autoimmunity 35: 493-496 (2002).

• Herlands RA, William J, Hershberg U, Shlomchik MJ. Anti-chromatin antibodies drive in vivo antigen-specific activation and somatic hypermutation of rheumatoid factor B cells at extrafollicular sites. Eur. J. Immunol. 37: 3339-3351 (2007). *

• Hermann R, Lipponen K, Kiviniemi M, Kakko T, Veijola R, Simell O, Knip M, Ilonen J. Lymphoid tyrosine phosphatase (LYP/PTPN22) Arg620Trp variant regulates insulin autoimmunity and progression to type 1 diabetes. Diabetologia 49: 1198-1208 (2006). *

• Hernandez HM, Kovarik P, Whitington PF, Alonso EM. Autoimmune hepatitis as a late complication of liver transplantation. J. Pediatr. Gastroenterol. Nutr. 32: 131-136 (2001). *

• Hertervig E, Wieslander J, Johansson C, Wiik A, Nilsson A. Anti-neutrophil cytoplasmic antibodies in chronic inflammatory bowel disease. Prevalence and diagnostic role. Scand. J. Gastroenterol. 30: 693-698 (1995).

• Herve M, Isnardi I, Ng YS, Bussel JB, Ochs HD, Cunningham-Rundles C, Meffre E. CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance. J. Exp. Med. 204: 1583-1593 (2007). *

• Hess C, Sadallah S, Schifferli JA. Induction of neutrophil responsiveness to myeloperoxidase antibodies by their exposure to supernatant of degranulated autologous neutrophils. Blood 96: 2822-2827 (2000). *

• Heteren JT, Knaap MS, Poll The BW, Kuijpers TW. Plasmacytoid dendritic cells and interferon-alpha in Aicardi-Goutieres syndrome. Neuropediatrics 38: 269-275 (2007).

• Heyman SN, Spectre G, Aamar S, Rubinger D, Pappo O, Ackerman Z. Autoimmune cholangiopathy associated with systemic lupus erythematosus. Liver 22: 102-106 (2002).

• Hibi T, Ohara M, Watanabe M, Kanai T, Takaishi H, Hayashi A, Hosoda Y, Ogata H, Iwao Y, Aiso S, et al. Interleukin 2 and interferon-gamma augment anticolon antibody dependent cellular cytotoxicity in ulcerative colitis. Gut 34: 788-793 (1993). *

• Higashi N, Kawana S. Atopic eczema complicated by systemic lupus erythematosus. Eur. J. Dermatol. 15: 500-502 (2005).

• Hilario MO, Len CA, Roja SC, Terreri MT, Almeida G, Andrade LE. Frequency of antinuclear antibodies in healthy children and adolescents. Clin. Pediatr. (Phila.) 43: 637-642 (2004).

• Hill JA, Bell DA, Brintnell W, Yue D, Wehrli B, Jevnikar AM, Lee DM, Hueber W, Robinson WH, Cairns E. Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice. J. Exp. Med. 205: 967-979 (2008). *

• Himoto T, Nakai S, Kinekawa F, Yoneyama H, Deguchi A, Kurokochi K, Masaki T, Senda S, Haba R, Watanabe S, Nishioka M, Kuriyama S. Clinical characteristics of patients with hepatitis C virus-related chronic liver disease seropositive for anticentromere antibody. Dig. Dis. Sci. 54: 360-368 (2009). *

• Hirai Y, Iyoda M, Shibata T, Ashikaga E, Hosaka N, Suzuki H, Nagai H, Mukai M, Honda H, Kuroki A, Kitazawa K, Akizawa T. Lupus nephritis associated with positive MPO-ANCA in a patient with underlying autoimmune hemolytic anemia. Clin. Exp. Nephrol. 12: 393-397 (2008).

• Hirakata M. Autoantibodies and their clinical significance in idiopathic inflammatory myopathies; polymyositis/dermatomyositis and related conditions. Nihon Rinsho Meneki Gakkai Kaishi 30: 444-454 (2007).

• Hiramitsu T, Yasuda T, Ito H, Shimizu M, Julovi SM, Kakinuma T, Akiyoshi M, Yoshida M, Nakamura T. Intercellular adhesion molecule-1 mediates the inhibitory effects of hyaluronan on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts via down-regulation of NF-kappaB and p38. Rheumatology (Oxford) 45: 824-832 (2006). *

• Hirano F, Tanada H, Makino Y, Okamoto K, Hiramoto M, Handa H, Makino I. Induction of the transcription factor AP-1 in cultured human colon adenocarcinoma cells following exposure to bile acids. Carcinogenesis 17: 427-433 (1996). *

• Hirano T, Fukushima H, Sasaki Y, Yoshikawa N, Yoshida M, Oka K. Bacterial superantigen TSST-1 attenuates suppressive efficacy of glucocorticoids and calcineurin inhibitors against blastogenesis of peripheral blood mononuclear cells from patients with antineutrophil cytoplasmic antibody-associated vasculitis and … Int. Immunopharmacol. 6: 924-934 (2006).

• Hirayama K, Ishizu T, Shimohata H, Miyamoto Y, Kakita T, Nagai M, Ogawa Y, Fujita S, Hirayama A, Yamagata K, Kobayashi M, Koyama A. Analysis of T-cell receptor usage in myeloperoxidase-antineutrophil cytoplasmic antibody-associated renal vasculitis. Clin. Exp. Nephrol. Oct 7 [Epub ahead of print] (2009).

• Hirschfield GM, Al-Harthi N, Heathcote EJ. Review: current status of therapy in autoimmune liver disease. Ther. Adv. Gastroenterol. 2: 11-28 (2009). *

• Hisamatsu T, Suzuki M, Podolsky DK. Interferon-gamma augments CARD4/NOD1 gene and protein expression through interferon regulatory factor-1 in intestinal epithelial cells. J. Biol. Chem. 278: 32962-32968 (2003). *

• Hitchon CA, Peschken CA. Sm antibodies increase risk of death in systemic lupus erythematosus. Lupus 16: 186-194 (2007). *

• Hochman JA. Autoimmune hemolytic anemia associated with Crohn's disease. Inflamm. Bowel Dis. 8: 98-100 (2002). *

• Hoentjen F, Sartor RB, Ozaki M, Jobin C. STAT3 regulates NF-kappaB recruitment to the IL-12p40 promoter in dendritic cells. Blood 105: 689-696 (2005). *

• Hof D, Cheung K, de Rooij DJ, van den Hoogen FH, Pruijn GJ, van Venrooij WJ, Raats JM. Autoantibodies specific for apoptotic U1-70K are superior serological markers for mixed connective tissue disease. Arthritis Res. Ther. 7: R302-R309 (2005). *

• Hoffman M, Burke M, Fried M, Turner D, Yosipov Y, Yust I. Primary biliary cirrhosis associated with antiphospholipid syndrome. Isr. J. Med. Sci. 33: 681-686 (1997).

• Hoffmann M, Hayer S, Steiner G. Immmunopathogenesis of rheumatoid arthritis; induction of arthritogenic autoimmune responses by proinflammatory stimuli. Ann. N. Y. Acad. Sci. 1173: 391-400 (2009). *

• Hoffmann U, Heilmann K, Hayford C, Stallmach A, Wahnschaffe U, Zeitz M, Gunthert U, Wittig BM. CD44v7 ligation downregulates the inflammatory immune response in Crohn's disease patients by apoptosis induction in mononuclear cells from the lamina propria. Cell Death Differ. 14: 1542-1551 (2007).

• Hohler T, Grossmann S, Stradmann-Bellinghausen B, Kaluza W, Reuss E, de Vlam K, Veys E, Marker-Hermann E. Differential association of polymorphisms in the TNFalpha region with psoriatic arthritis but not psoriasis. Ann. Rheum. Dis. 61: 213-218 (2002). *

• Hoie O, Aamodt G, Vermeire S, Bernklev T, Odes S, Wolters FL, Riis L, Politi P, Tsianos EV, Butron M, Stockbrugger RW, Munkholm P, Vatn M, Moum B, on behalf of the European Collaborative study group of Inflammatory Bowel Disease (EC-IBD). Serological markers are associated with disease course in ulcerative colitis. A study in an unselected population-based cohort followed for 10 years. Journal of Crohn's and Colitis 2: 114-122 (2008).

• Holstein A, Burmeister J, Plaschke A, Rosemeier D, Widjaja A, Egberts EH. Autoantibody profiles in microscopic colitis. J. Gastroenterol. Hepatol. 21: 1016-1020 (2006). *

• Homberg JC, Abuaf N, Bernard O, Islam S, Alvarez F, Khalil SH, Poupon R, Darnis F, Levy VG, Grippon P, et al. Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis. Hepatology 7: 1333-1339 (1987).

• Homma S, Sagawa Y, Ito M, Ohno T, Toda G. Cancer immunotherapy using dendritic/tumour-fusion vaccine induces elevation of serum anti-nuclear antibody with better clinical responses. Clin. Exp. Immunol. 144: 41-47 (2006). *

• Hong S, Lee J, Chi H, Lee C, Nah S, Kim Y, Oh J, Moon H, Yoo B. Systemic lupus erythematosus complicated by acquired von Willebrand's syndrome. Lupus 17: 846-848 (2008). *

• Honma F, Shio K, Monoe K, Kanno Y, Takahashi A, Yokokawa J, Kobayashi H, Watanabe H, Irisawa A, Ohira H. Primary biliary cirrhosis complicated by polymyositis and pulmonary hypertension. Intern. Med. 47: 667-669 (2008). *

• Hopf U, Moller B, Lobeck H, Klein R, Berg PA. Immunoserologic differentiation of chronic cholestatic hepatitis. Significance of antimitochondrial antibodies and hepatic membrane antibodies. Dtsch. Med. Wochenschr. 110: 1924-1929 (1985).

• Hopf U, Riecken EO, Zeitz M, Eckhardt R, Lobeck H, Malchus R, Moller B. Immunologic parameters in pericholangitis and primary sclerosing cholangitis with and without ulcerative colitis. Dtsch. Med. Wochenschr. 108: 1515-1521 (1983).

• Hopf U, Stemerowicz R, Knigge O, Khadar R, Konig V, Lobeck H, Neuhaus P. Primary sclerosing cholangitis (PSC) - humoral immune phenomena, pathogenetic aspects and therapeutic possibilities. Z. Gastroenterol. 31 Suppl. 2: 106-110 (1993).

• Hoppe B, Haupl T, Egerer K, Gruber R, Kiesewetter H, Salama A, Burmester GR, Dorner T. Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis. Ann. Rheum. Dis. 68: 898-903 (2009).

• Horvath IF, Szodoray P, Zeher M. Primary Sjogren's syndrome in men: clinical and immunological characteristic based on a large cohort of Hungarian patients. Clin. Rheumatol. 27: 1479-1483 (2008). *

• Hosseinpour F, Moore R, Negishi M, Sueyoshi T. Serine-202 regulates the nuclear translocation of constitutive active/androstane receptor CAR. Mol. Pharmacol. 69: 1095-1102 (2006). *

• Hounoki H, Sugiyama E, Mohamed SG, Shinoda K, Taki H, Abdel-Aziz HO, Maruyama M, Kobayashi M, Miyahara T. Activation of peroxisome proliferator-activated receptor gamma inhibits TNF-alpha-mediated osteoclast differentiation in human peripheral monocytes in part via suppression of monocyte chemoattractant protein-1 expression. Bone 42: 765-774 (2008). *

• Howe R, Dillon S, Rogers L, McCarter M, Kelly C, Gonzalez R, Madinger N, Wilson CC. Evidence for dendritic cell-dependent CD4(+) T helper-1 type responses to commensal bacteria in normal human intestinal lamina propria. Clin. Immunol. 131: 317-332 (2009). *

• Hsiao HW, Liu WH, Wang CJ, Lo YH, Wu YH, Jiang ST, Lai MZ. Deltex1 is a target of the rranscription factor NFAT that promotes T cell anergy. Immunity 31: 72-83 (2009).

• Hsieh JC, Nakajima S, Galligan MA, Jurutka PW, Haussler CA, Whitfield GK, Haussler MR. Receptor mediated genomic action of the 1,25(OH)2D3 hormone: expression of the human vitamin D receptor in E. coli. J. Steroid Biochem. Mol. Biol. 53: 583-594 (1995).

• Hsieh SC, Yu HS, Cheng SH, Li KJ, Lu MC, Wu CH, Tsai CY, Yu CL. Anti-myeloperoxidase antibodies enhance phagocytosis, IL-8 production, and glucose uptake of polymorphonuclear neutrophils rather than anti-proteinase 3 antibodies leading to activation-induced cell death of the neutrophils. Clin. Rheumatol. 26: 216-224 (2007). *

• Huang J, Karakucuk V, Levitsky LL, Rhoads DB. Expression of HNF4alpha variants in pancreatic islets and Ins-1 beta cells. Diabetes Metab. Res. Rev. 24: 533-543 (2008).

• Huang MC, Liao JJ, Bonasera S, Longo DL, Goetzl EJ. Nuclear factor-kappaB-dependent reversal of aging-induced alterations in T cell cytokines. FASEB J. 22: 2142-2150 (2008). *

• Huang WC, Lien SH, Chang DM, Lu JJ, Cheng SN. Monozygotic twins concordant for idiopathic thrombocytopenic purpura and discordant for systemic lupus erythematosus and lupus nephritis. Eur. J. Pediatr. 166: 497-500 (2007). *

• Huang X, Shen N, Bao C, Gu Y, Wu L, Chen S. Interferon-induced protein IFIT4 is associated with systemic lupus erythematosus and promotes differentiation of monocytes into DC-like cells. Arthritis Res. Ther. 10: R91 (2008). *

• Hubball A, Martin JE, Lang B, De Giorgio R, Knowles CH. The role of humoral autoimmunity in gastrointestinal neuromuscular diseases. Prog. Neurobiol. 87: 10-20 (2009).

• Hughes RA. Arthritis precipitated by isotretinoin treatment for acne vulgaris. J. Rheumatol. 20: 1241-1242 (1993).

• Huguet S, Labas V, Duclos-Vallee JC, Bruneel A, Vinh J, Samuel D, Johanet C, Ballot E. Heterogeneous nuclear ribonucleoprotein A2/B1 identified as an autoantigen in autoimmune hepatitis by proteome analysis. Proteomics 4: 1341-1345 (2004). *

• Hui T, Landers C, Vasiliauskas E, Abreu M, Dubinsky M, Papadakis KA, Price J, Lin YC, Huiying Y, Targan S, Fleshner P. Serologic responses in indeterminate colitis patients before ileal pouch-anal anastomosis may determine those at risk for continuous pouch inflammation. Dis. Colon Rectum 48: 1254-1262 (2005). *

• Huic D, Vukovic J, Senecic-Cala I, Dodig D. Splenic atrophy as complication of ulcerative colitis diagnosed by antigranulocyte antibodies labeled with tc-99m-pertechnetate. Croat. Med. J. 44: 767-769 (2003).

• Hundemer M, Schmidt S, Condomines M, Lupu A, Hose D, Moos M, Cremer F, Kleist C, Terness P, Belle S, Ho AD, Goldschmidt H, Klein B, Christensen O. Identification of a new HLA-A2-restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myeloma. Exp. Hematol. 34: 486-496 (2006). *

• Hunnangkul S, Nitsch D, Rhodes B, Chadha S, Roberton CA, Pessôa-Lopes P, Norsworthy PJ, Fernando MM, Charles P, Mackworth-Young C, Isenberg DA, Whittaker JC, Vyse TJ. Familial clustering of non-nuclear autoantibodies and C3 and C4 complement components in systemic lupus erythematosus. Arthritis Rheum. 58: 1116-1124 (2008). *

• Hunt JR, Martin CB, Martin BK. Transcriptional regulation of the murine C5a receptor gene: NF-Y is required for basal and LPS induced expression in macrophages and endothelial cells. Mol. Immunol. 42: 1405-1415 (2005). *

• Ichikawa T, Nakao K, Hamasaki K, Ohkubo K, Toriyama K, Eguchi K. An autopsy case of acute pancreatitis with a high serum IgG4 complicated by amyloidosis and rheumatoid arthritis. World J. Gastroenterol. 11: 2032-2034 (2005). *

• Ierardi E, Della Valle N, Cosimo Nacchiero M, De Francesco V, Stoppino G, Panella C. Onset of liver damage after a single administration of infliximab in a patient with refractory ulcerative colitis. Clin. Drug Investig. 26: 673-676 (2006).

• Ihenetu K, Espinosa R, de Leon R, Planas G, Perez-Pinero A, Waldbeser L. Digoxin and digoxin-like immunoreactive factors (DLIF) modulate the release of pro-inflammatory cytokines. Inflamm. Res. 57: 519-523 (2008). *

• Ikarashi Y, Matsumoto Y, Omata S, Fujiwara M. Recipient-derived T cells participate in autoimmune-like hepatic lesions induced by graft-versus-host reaction. Autoimmunity 20: 121-127 (1995).

• Ikeda H, Sasaki M, Ishikawa A, Sato Y, Harada K, Zen Y, Kazumori H, Nakanuma Y. Interaction of Toll-like receptors with bacterial components induces expression of CDX2 and MUC2 in rat biliary epithelium in vivo and in culture. Lab. Invest. 87: 559-571 (2007). *

• Ikeda Y, Toda G, Hashimoto N, Aotsuka S, Yokohari R, Maruyama T, Oka H. Anticalmodulin autoantibody in liver diseases: a new antibody against a cytoskeleton-related protein. Hepatology 7: 285-293 (1987).

• Iking-Konert C, Vogl T, Prior B, Wagner C, Sander O, Bleck E, Ostendorf B, Schneider M, Andrassy K, Hansch GM. T lymphocytes in patients with primary vasculitis: expansion of CD8+ T cells with the propensity to activate polymorphonuclear neutrophils. Rheumatology (Oxford) 47: 609-616 (2008). *

• Iltanen S, Tervo L, Halttunen T, Wei B, Braun J, Rantala I, Honkanen T, Kronenberg M, Cheroutre H, Turovskaya O, Autio V, Ashorn M. Elevated serum anti-I2 and anti-OmpW antibody levels in children with IBD. Inflamm. Bowel Dis. 12: 389-394 (2006). *

• Imazio M, Brucato A, Doria A, Brambilla G, Ghirardello A, Romito A, Natale G, Palmieri G, Trinchero R, Adler Y. Antinuclear antibodies in recurrent idiopathic pericarditis: prevalence and clinical significance. Int. J. Cardiol. 136: 289-293 (2009).

• Incaprera M, Rindi L, Bazzichi A, Garzelli C. Potential role of the Epstein-Barr virus in systemic lupus erythematosus autoimmunity. Clin. Exp. Rheumatol. 16: 289-294 (1998).

• Inestrosa NC, Godoy JA, Quintanilla RA, Koenig CS, Bronfman M. Peroxisome proliferator-activated receptor gamma is expressed in hippocampal neurons and its activation prevents beta-amyloid neurodegeneration: role of Wnt signaling. Exp. Cell Res. 304: 91-104 (2005). *

• Innocencio RM, Romaldini JH, Ward LS. Thyroid autoantibodies in autoimmune diseases. Medicina (B. Aires) 64: 227-230 (2004).

• Invernizzi P, Crosignani A, Battezzati PM, Covini G, De Valle G, Larghi A, Zuin M, Podda M. Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis. Hepatology 25: 1090-1095 (1997). *

• Invernizzi P, Lleo A, Podda M. Interpreting serological tests in diagnosing autoimmune liver diseases. Semin. Liver Dis. 27: 161-172 (2007).

• Invernizzi P, Podda M, Battezzati PM, Crosignani A, Zuin M, Hitchman E, Maggioni M, Meroni PL, Penner E, Wesierska-Gadek J. Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis. J. Hepatol. 34: 366-372 (2001). *

• Invernizzi P, Selmi C, Ranftler C, Podda M, Wesierska-Gadek J. Antinuclear antibodies in primary biliary cirrhosis. Semin. Liver Dis. 25: 298-310 (2005).

• Irie J, Wu Y, Sass DA, Ridgway WM. Genetic control of anti-Sm autoantibody production in NOD congenic mice narrowed to the Idd9.3 region. Immunogenetics 58: 9-14 (2006). *

• Ishibashi H, Komori A, Shimoda S, Gershwin ME. Guidelines for therapy of autoimmune liver disease. Semin. Liver Dis. 27: 214-226 (2007). *

• Ishihara Y. Autoantibodies. Rinsho Byori 53: 562-569 (2005).

• Ishikawa H, Takeda K, Okamoto A, Matsuo SI, Isobe KI. Induction of autoimmunity in a bleomycin-induced murine model of experimental systemic sclerosis: an important role for CD4(+) T cells. J. Invest. Dermatol. 129: 1688-1695 (2009). *

• Ishikawa T, Kakumu S, Wakita T, Takayanagi M, Yoshioka K. In vitro production of antimitochondrial antibody by peripheral blood mononuclear cells in patients with primary biliary cirrhosis. J. Clin. Lab. Immunol. 35: 17-25 (1991).

• Israeli E, Grotto I, Gilburd B, Balicer RD, Goldin E, Wiik A, Shoenfeld Y. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut 54: 1232-1236 (2005). *

• Ito A, Umeda M, Koike T, Naruse S, Fujita N. A case of dermatomyositis associated with chronic idiopathic myelofibrosis. Rinsho Shinkeigaku 46: 210-213 (2006).

• Itoh S, Ichida T, Yoshida T, Hayakawa A, Uchida M, Tashiro-Itoh T, Matsuda Y, Ishihara K, Asakura H. Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis. J. Gastroenterol. Hepatol. 13: 257-265 (1998).

• Itoh S, Nagasaka T, Suzuki K, Satake H, Ota T, Naganawa S. Lymphoplasmacytic sclerosing cholangitis: assessment of clinical, CT, and pathological findings. Clin. Radiol. 64: 1104-1114 (2009). *

• Ittiprasert W, Kantachuvesiri S, Pavasuthipaisit K, Verasertniyom O, Chaomthum L, Totemchokchyakarn K, Kitiyanant Y. Complete deficiencies of complement C4A and C4B including 2-bp insertion in codon 1213 are genetic risk factors of systemic lupus erythematosus in Thai populations. J. Autoimmun. 25: 77-84 (2005).

• Izumi H, Nobukawa B, Takahashi K, Kumasaka T, Miyamoto H, Yamazaki A, Sonobe S, Uekusa T, Suda K. Multilocular thymic cyst associated with follicular hyperplasia: clinicopathologic study of 4 resected cases. Hum. Pathol. 36: 841-844 (2005).

• Izumi Y, Tanaka S, Hidaka Y, Shimaoka Y, Tatsumi KI, Takano T, Kaneko A, Oku K, Amino N. Relation between post-partum liver dysfunction and anti-cytochrome 2D6 antibodies. Am. J. Reprod. Immunol. 50: 355-362 (2003). *

• Jaaskelainen T, Itkonen A, Maenpaa PH. Retinoid-X-receptor-alpha-independent binding of vitamin D receptor to its response element from human osteocalcin gene. Eur. J. Biochem. 228: 222-228 (1995).

• Jackola DR, Basu S, Liebeler CL, Willaert R, Luah SS, Oetting W, King RA, Blumenthal MN. CD14 promoter polymorphisms in atopic families: implications for modulated allergen-specific immunoglobulin E and G1 responses. Int. Arch. Allergy Immunol. 139: 217-224 (2006).

• Jacobsen S, Halberg P, Ullman S, Van Venrooij WJ, Hoier-Madsen M, Wiik A, Petersen J. Clinical features and serum antinuclear antibodies in 230 Danish patients with systemic sclerosis. Br. J. Rheumatol. 37: 39-45 (1998). *

• Jager M, Bachmann R, Scharfstadt A, Krauspe R. Ovine cord blood accommodates multipotent mesenchymal progenitor cells. In Vivo 20: 205-214 (2006).

• Jangpatarapongsa K, Chootong P, Sattabongkot J, Chotivanich K, Sirichaisinthop J, Tungpradabkul S, Hisaeda H, Troye-Blomberg M, Cui L, Udomsangpetch R. Plasmodium vivax parasites alter the balance of myeloid and plasmacytoid dendritic cells and the induction of regulatory T cells. Eur. J. Immunol. 38: 2697-2705 (2008). *

• Janjumratsang P, Phainupong D, Chanjanakijskul S, Roongphibulsopit P. Positive direct immunofluorescence and autoantibody profiles in psoriasis patients. J. Dermatol. 35: 508-513 (2008).

• Janka C, Selmi C, Gershwin ME, Will H, Sternsdorf T. Small ubiquitin-related modifiers: a novel and independent class of autoantigens in primary biliary cirrhosis. Hepatology 41: 609-616 (2005). *

• Jansson A, Renner ED, Ramser J, Mayer A, Haban M, Meindl A, Grote V, Diebold J, Jansson V, Schneider K, Belohradsky BH. Classification of non-bacterial osteitis: retrospective study of clinical, immunological and genetic aspects in 89 patients. Rheumatology (Oxford) 46: 154-160 (2007). *

• Januchowski R, Prokop J, Jagodzinski PP. Role of epigenetic DNA alterations in the pathogenesis of systemic lupus erythematosus. J. Appl. Genet. 45: 237-248 (2004). *

• Jaroszewicz J, Pelszynska MJ, Kalinowska A, Wierzbicka I, Flisiak R, Prokopowicz D. Analysis of prognostic factors in patients with autoimmune hepatitis. Pol. Arch. Med. Wewn. 115: 329-335 (2006).

• Jaskowski TD, Konnick EQ, Ashwood ER, Litwin CM, Hill HR. Prevalence of IgG autoantibody against F-actin in patients suspected of having autoimmune or acute viral hepatitis. J. Clin. Lab. Anal. 21: 249-253 (2007).

• Jaskowski TD, Litwin CM, Hill HR. Analysis of serum antibodies in patients suspected of having inflammatory bowel disease. Clin. Vaccine Immunol. 13: 655-660 (2006). *

• Jearn LH, Kim DA, Kim TY. Limitations of antinuclear antibody tests (HEp-2) are overcome with the autoimmune target test (IT-1) in systemic lupus erythematosus. J. Rheumatol. 36: 1833-1834 (2009).

• Jennings P, Chan A, Schwartzberg P, Wakeland EK, Yuan D. Antigen-specific responses and ANA production in B6.Sle1b mice: a role for SAP. J. Autoimmun. 31: 345-353 (2008).

• Jensen M, Klehr M, Vogel A, Schmitz S, Tawadros S, Muhlenhoff M, Pluck A, Fischer T, Schomacker K, Schultze JL, Berthold F. One step generation of fully chimeric antibodies using Cgamma1- and Ckappa mutant mice. J. Immunother. 30: 338-349 (2007).

• Jeudy G, Dutronc Y, Galliot-Repkat C, Dupuis J, Jolimoy G, Lambert D, Collet E. Infliximab-induced skin reaction with visceral manifestations and high levels of anti-DNA antibodies. Ann. Dermatol. Venereol. 134: 268-271 (2007).

• Jiang C, Deshmukh US, Gaskin F, Bagavant H, Hanson J, David CS, Fu SM. Differential responses to Smith D autoantigen by mice with HLA-DR and HLA-DQ transgenes: dominant responses by HLA-DR3 transgenic mice with diversification of autoantibodies to small nuclear ribonucleoprotein, double-stranded DNA, and nuclear antigens. J. Immunol. 184: 1085-1091 (2010).

• Jiang W, Pisetsky DS. The induction of HMGB1 release from RAW 264.7 cells by transfected DNA. Mol. Immunol. 45: 2038-2044 (2008). *

• Jiang W, Pisetsky DS. Mechanisms of disease: the role of high-mobility group protein 1 in the pathogenesis of inflammatory arthritis. Nat. Clin. Pract. Rheumatol. 3: 52-58 (2007). *

• Jiang XH, Zhong RQ, Yu SQ, Hu Y, Li WW, Kong XT. Construction and expression of a humanized M2 autoantigen trimer and its application in the diagnosis of primary biliary cirrhosis. World J. Gastroenterol. 9: 1352-1355 (2003). *

• Jin O, Zhang H, Gu Z, Zhao S, Xu T, Zhou K, Jiang B, Wang J, Zeng X, Sun L. A pilot study of the therapeutic efficacy and mechanism of artesunate in the MRL/lpr murine model of systemic lupus erythematosus. Cell. Mol. Immunol. 6: 461-467 (2009). *

• Johnson PA, Alexander HD, McMillan SA, Maxwell AP. Up-regulation of the endothelial cell adhesion molecule intercellular adhesion molecule-1 (ICAM-1) by autoantibodies in autoimmune vasculitis. Clin. Exp. Immunol. 108: 234-242 (1997). *

• Johnson S, Hulton SA, Brundler MA, Moss C, Huissoon A, Taylor CM. End-stage renal failure in adolescence with Sjogren's syndrome autoantibodies SSA and SSB. Pediatr. Nephrol. 22: 1793-1797 (2007).

• Johnson SR, Schentag CT, Gladman DD. Autoantibodies in biological agent naive patients with psoriatic arthritis. Ann. Rheum. Dis. 64: 770-772 (2005). *

• Jones DA, Yawalkar N, Suh KY, Sadat S, Rich B, Kupper TS. Identification of autoantigens in psoriatic plaques using expression cloning. J. Invest. Dermatol. 123: 93-100 (2004). *

• Jones DE. Autoantigens in primary biliary cirrhosis. J. Clin. Pathol. 53: 813-821 (2000). *

• Jones DE, Palmer JM, Yeaman SJ, Kirby JA, Bassendine MF. Breakdown of tolerance to pyruvate dehydrogenase complex in experimental autoimmune cholangitis: a mouse model of primary biliary cirrhosis. Hepatology 30: 65-70 (1999). *

• Jonsson G, Sjoholm AG, Truedsson L, Bengtsson AA, Braconier JH, Sturfelt G. Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency. Rheumatology (Oxford) 46: 1133-1139 (2007). *

• Joossens S, Colombel JF, Landers C, Poulain D, Geboes K, Bossuyt X, Targan S, Rutgeerts PJ, Reinisch W. Anti-outer membrane of porin C and anti-I2 antibodies in indeterminate colitis. Gut 55: 1667-1669 (2006). *

• Joossens S, Reinisch W, Vermeire S, Sendid B, Poulain D, Peeters M, Geboes K, Bossuyt X, Vandewalle P, Oberhuber G, Vogelsang H, Rutgeerts P, Colombel JF. The value of serologic markers in indeterminate colitis: a prospective follow-up study. Gastroenterology 122: 1242-1247 (2002). *

• Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegard D, van den Berg WB. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis. Arthritis Res. 1: 81-91 (1999). *

• Jorgensen TN, Alfaro J, Enriquez HL, Jiang C, Loo WM, Atencio S, Bupp MR, Mailloux CM, Metzger T, Flannery S, Rozzo SJ, Kotzin BL, Rosemblatt M, Bono MR, Erickson LD. Development of murine lupus involves the combined genetic contribution of the SLAM and FcgammaR intervals within the Nba2 autoimmune susceptibility locus. J. Immunol. 184: 775-786 (2010).

• Jorgensen TN, Roper E, Thurman JM, Marrack P, Kotzin BL. Type I interferon signaling is involved in the spontaneous development of lupus-like disease in B6.Nba2 and (B6.Nba2 x NZW)F(1) mice. Genes Immun. 8: 653-662 (2007). *

• Joshi S, Cauch-Dudek K, Wanless IR, Lindor KD, Jorgensen R, Batts K, Heathcote EJ. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid. Hepatology 35: 409-413 (2002). *

• Ju Y, Hou N, Meng J, Wang X, Zhang X, Zhao D, Liu Y, Zhu F, Zhang L, Sun W, Liang X, Gao L, Ma C. T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B. J. Hepatol. Jan 6 [Epub ahead of print] (2010).

• Jung EJ, Hur M, Kim YL, Lee GH, Kim J, Kim I, Lee M, Han HK, Kim MS, Hwang S, Kim S, Woo AM, Yoon Y, Park HJ, Won J. Oral administration of 1, 4-aryl-2-mercaptoimidazole (KRM-III) inhibits T cell proliferation and reduces clinical severity in murine experimental autoimmune encephalomyelitis model. J. Pharmacol. Exp. Ther. 331: 1005-1013 (2009). *

• Jung YO, Cho ML, Kang CM, Jhun JY, Park JS, Oh HJ, Min JK, Park SH, Kim HY. Toll-like receptor 2 and 4 combination engagement upregulate IL-15 synergistically in human rheumatoid synovial fibroblasts. Immunol. Lett. 109: 21-27 (2007).

• Junta CM, Sandrin-Garcia P, Fachin-Saltoratto AL, Mello SS, Oliveira RD, Rassi DM, Giuliatti S, Sakamoto-Hojo ET, Louzada-Junior P, Donadi EA, Passos GA. Differential gene expression of peripheral blood mononuclear cells from rheumatoid arthritis patients may discriminate immunogenetic, pathogenic and treatment features. Immunology 127: 365-372 (2009). *

• Jyonouchi H, Geng L, Cushing-Ruby A, Quraishi H. Impact of innate immunity in a subset of children with autism spectrum disorders: a case control study. J. Neuroinflammation 5: 52 (2008).

• Kaditis AG, Perrault J, Sandborn WJ, Landers CJ, Zinsmeister AR, Targan SR. Antineutrophil cytoplasmic antibody subtypes in children and adolescents after ileal pouch-anal anastomosis for ulcerative colitis. J. Pediatr. Gastroenterol. Nutr. 26: 386-392 (1998). *

• Kafkala C, Choi J, Zafirakis P, Baltatzis S, Livir-Rallatos C, Rojas B, Foster CS. Mooren ulcer: an immunopathologic study. Cornea 25: 667-673 (2006).

• Kagalwalla AF, Altraif I, Shamsan L, Omojola M, Khan H, Kagalwalla YA. Primary sclerosing cholangitis in Arab children: report of four cases and literature review. J. Pediatr. Gastroenterol. Nutr. 24: 146-152 (1997). *

• Kai Y, Takahashi I, Ishikawa H, Hiroi T, Mizushima T, Matsuda C, Kishi D, Hamada H, Tamagawa H, Ito T, Yoshizaki K, Kishimoto T, Matsuda H, Kiyono H. Colitis in mice lacking the common cytokine receptor gamma chain is mediated by IL-6-producing CD4+ T cells. Gastroenterology 128: 922-934 (2005). *

• Kaijzel EL, Bayley JP, van Krugten MV, Smith L, van de Linde P, Bakker AM, Breedveld FC, Huizinga TW, Verweij CL. Allele-specific quantification of tumor necrosis factor alpha (TNF) transcription and the role of promoter polymorphisms in rheumatoid arthritis patients and healthy individuals. Genes Immun. 2: 135-144 (2001). *

• Kain R, Matsui K, Exner M, Binder S, Schaffner G, Sommer EM, Kerjaschki D. A novel class of autoantigens of anti-neutrophil cytoplasmic antibodies in necrotizing and crescentic glomerulonephritis: the lysosomal membrane glycoprotein h-lamp-2 in neutrophil granulocytes and a related membrane protein in glomerular endothelial … J. Exp. Med. 181: 585-597 (1995). *

• Kaji K, Fujimoto M, Hasegawa M, Kondo M, Saito Y, Komura K, Matsushita T, Orito H, Hamaguchi Y, Yanaba K, Itoh M, Asano Y, Seishima M, Ogawa F, Sato S, Takehara K. Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. Rheumatology (Oxford) 46: 25-28 (2007). *

• Kalaaji M, Sturfelt G, Mjelle JE, Nossent H, Rekvig OP. Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis. Arthritis Rheum. 54: 914-926 (2006). *

• Kalergis AM, Iruretagoyena MI, Barrientos MJ, Gonzalez PA, Herrada AA, Leiva ED, Gutierrez MA, Riedel CA, Bueno SM, Jacobelli SH. Modulation of nuclear factor-kappaB activity can influence the susceptibility to systemic lupus erythematosus. Immunology 128: e306-e314 (2008). *

• Kallenberg CG. Laboratory findings in the vasculitides. Baillieres Clin. Rheumatol. 11: 395-421 (1997).

• Kallenberg CG, Mulder AH, Tervaert JW. Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders. Am. J. Med. 93: 675-682 (1992).

• Kalluri M, Sahn SA, Oddis CV, Gharib SL, Christopher-Stine L, Danoff SK, Casciola-Rosen L, Hong G, Dellaripa PF, Highland KB. Clinical profile of anti-PL-12 autoantibody: cohort study and review of the literature. Chest 135: 1550-1556 (2009).

• Kalunian K, Joan TM. New directions in the treatment of systemic lupus erythematosus. Curr. Med. Res. Opin. May 11 [Epub ahead of print] (2009).

• Kaluza W, Reuss E, Grossmann S, Hug R, Schopf RE, Galle PR, Maerker-Hermann E, Hoehler T. Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphism. J. Invest. Dermatol. 114: 1180-1183 (2000). *

• Kameda H, Pandey JP, Kaburaki J, Inoko H, Kuwana M. Immunoglobulin allotype gene polymorphisms in systemic sclerosis: interactive effect of MHC class II and KM genes on anticentromere antibody production. Ann. Rheum. Dis. 57: 366-370 (1998). *

• Kanai T, Nemoto Y, Kamada N, Totsuka T, Hisamatsu T, Watanabe M, Hibi T. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease. Curr. Opin. Gastroenterol. 25: 306-313 (2009). *

• Kanazawa S, Ota S, Sekine C, Tada T, Otsuka T, Okamoto T, Sonderstrup G, Peterlin BM. Aberrant MHC class II expression in mouse joints leads to arthritis with extraarticular manifestations similar to rheumatoid arthritis. Proc. Natl. Acad. Sci. U.S.A. 103: 14465-14470 (2006). *

• Kaneko F, Yokomori H, Tahara K, Takeshita T, Takeuchi H, Yoshida H, Hoshi K, Kondo H, Ohbu M, Sato T, Hibi T. Autoimmune hepatitis associated with pulmonary arterial hypertension. Intern. Med. 47: 1971-1976 (2008). *

• Kang HK, Ecklund D, Liu M, Datta SK. Apigenin, a nonmutagenic dietary flavonoid suppresses lupus by inhibiting autoantigen presentation for expansion of autoreactive Th1 and Th17 cells. Arthritis Res. Ther. 11: R59 (2009). *

• Kang SY, Lee WI. Clinical significance of dense fine speckled pattern in anti-nuclear antibody test using indirect immunofluorescence method. Korean J. Lab. Med. 29: 145-151 (2009).

• Kano T, Shimizu M, Kanda T. Differences in individual efficacy of two Sairei-to preparations (Sojyutu-Sairei-to and Byakujyutu-Sairei-to) on recurrent spontaneous abortions of autoimmune etiologies evaluated by antinuclear antibody and anticardiolipin antibody titers. Am. J. Chin. Med. 38: 27-36 (2010).

• Kanski JJ. Care of children with anterior uveitis. Trans. Ophthalmol. Soc. U.K. 101: 387-390 (1981).

• Kapetanovic MC, Larsson L, Truedsson L, Sturfelt G, Saxne T, Geborek P. Predictors of infusion reactions during infliximab treatment in patients with arthritis. Arthritis Res. Ther. 8: R131 (2006). *

• Kaplan MM, Bianchi DW. Primary biliary cirrhosis: for want of an X chromosome? Lancet 363: 505-506 (2004). *

• Kaplan MM, Gandolfo JV, Quaroni EG. An enzyme-linked immunosorbent assay (ELISA) for detecting antimitochondrial antibody. Hepatology 4: 727-730 (1984).

• Karamehic J, Subasic D, Gavrankapetanovic F, Zecevic L, Eminovic I, Memic S, Seric N, Drace Z. The incidence of antinuclear antibodies (ANA) detected by indirect immunofluorescence assay (IFA) method. Med. Arh. 61: 16-19 (2007).

• Karanikas G, Schuetz M, Kontur S, Duan H, Kommata S, Schoen R, Antoni A, Kletter K, Dudczak R, Willheim M. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid 18: 7-12 (2008).

• Karim S, Majithia V. Devic's Syndrome as Initial Presentation of Systemic Lupus Erythematosus. Am. J. Med. Sci. 338: 245-247 (2009).

• Karttunnen R, Breese EJ, Walker-Smith JA, MacDonald TT. Decreased mucosal interleukin-4 (IL-4) production in gut inflammation. J. Clin. Pathol. 47: 1015-1018 (1994). *

• Kasagi S, Kawano S, Nakazawa T, Sugino H, Koshiba M, Ichinose K, Ida H, Eguchi K, Kumagai S. A case of periodic-fever-syndrome-like disorder with lipodystrophy, myositis, and autoimmune abnormalities. Mod. Rheumatol. 18: 203-207 (2008). *

• Kasashima S, Zen Y, Kawashima A, Endo M, Matsumoto Y, Kasashima F. A new clinicopathological entity of IgG4-related inflammatory abdominal aortic aneurysm. J. Vasc. Surg. 49: 1264-1271 (2009).

• Kaserer K, Exner M, Mosberger I, Penner E, Wrba F. Characterization of the inflammatory infiltrate in autoimmune cholangitis. A morphological and immunhistochemical study. Virchows Arch. 432: 217-222 (1998). *

• Kashima A, Tajiri A, Yamashita A, Asada Y, Setoyama M. Two Japanese cases of lichen planus pigmentosus-inversus. Int. J. Dermatol. 46: 740-742 (2007). *

• Kataaha PK, Mortazavi-Milani SM, Russell G, Holborow EJ. Anti-intermediate filament antibodies, antikeratin antibody, and antiperinuclear factor in rheumatoid arthritis and infectious mononucleosis. Ann. Rheum. Dis. 44: 446-449 (1985).

• Kato T, Miyakawa H, Ishibashi M. Frequency and significance of anti-glutathione S-transferase autoantibody (anti-GST A1-1) in autoimmune hepatitis. J. Autoimmun. 22: 211-216 (2004).

• Katsuma Y, Swierenga SH, Khettry U, Marceau N, French SW. Changes in the cytokeratin intermediate filament cytoskeleton associated with Mallory body formation in mouse and human liver. Hepatology 7: 1215-1223 (1987).

• Kawa S, Hamano H. Clinical features of autoimmune pancreatitis. J. Gastroenterol. 42 Suppl. 18: 9-14 (2007). *

• Kawaguchi N, Miyakawa H, Abe K, Kitazawa E, Fujikawa H, Kikuchi K, Kako M, Shibata M, Shibuya A, Onozuka Y, Yoshida N, Ueno Y. Western blot analysis of anti-M2 antibodies in anti-mitochondrial antibody-negative primary biliary cirrhosis. Rinsho Byori 45: 1079-1084 (1997).

• Kawakami A, Osaka M, Aikawa M, Uematsu S, Akira S, Libby P, Shimokado K, Sacks FM, Yoshida M. Toll-like receptor 2 mediates apolipoprotein CIII-induced monocyte activation. Circ. Res. 103: 1402-1409 (2008). *

• Kawaoka T, Oka M, Takashima M, Ueno T, Yamamoto K, Yahara N, Yoshino S, Hazama S. Adoptive immunotherapy for pancreatic cancer: cytotoxic T lymphocytes stimulated by the MUC1-expressing human pancreatic cancer cell line YPK-1. Oncol. Rep. 20: 155-163 (2008). *

• Kaya S, Demirci M, Sesli Cetin E, Cicioglu Aridogan B, Sahin M, Tas T, Korkmaz M. Investigation of the presence of autoantibodies in patients with toxocariasis. Mikrobiyol. Bul. 43: 661-666 (2009).

• Ke CZ, Chen Y, Gong ZJ, Meng ZJ, Liu L, Ren ZJ, Zhou ZH. Dynamic changes of HBV DNA in serum and peripheral blood mononuclear cells of chronic hepatitis patients after lamivudine treatment. World J. Gastroenterol. 12: 4061-4063 (2006). *

• Keenan RA, De Riva A, Corleis B, Hepburn L, Licence S, Winkler TH, Martensson IL. Censoring of autoreactive B cell development by the pre-B cell receptor. Science 321: 696-699 (2008). *

• Keitel V, Reinehr R, Haussinger D, Kubitz R. Bile acids activate endothelial NO synthase in sinusendothelial cells of the liver via the G-protein coupled receptor TGR5. Falk Symposium 155. XIII FALK LIVER WEEK (Part I) XIX International Bile Acid Meeting. Bile Acids: Biological Actions and Clinical Relevance, October 6 - 7, 2006 Freiburg (Germany), p. 54 (2006). *

• Kemppainen T, Tammi R, Tammi M, Agren U, Julkunen R, Bohm J, Uusitupa M, Kosma VM. Elevated expression of hyaluronan and its CD44 receptor in the duodenal mucosa of coeliac patients. Histopathology 46: 64-72 (2005).

• Kessel A, Elias G, Pavlotzky E, Zuckerman E, Rosner I, Toubi E. Anti-C-reactive protein antibodies in chronic hepatitis C infection: correlation with severity and autoimmunity. Hum. Immunol. 68: 844-848 (2007).

• Kessenbrock K, Raijmakers R, Fritzler MJ, Mahler M. Synthetic peptides: the future of patient management in systemic rheumatic diseases? Curr. Med. Chem. 14: 2831-2838 (2007).

• Kettritz R, Jennette JC, Falk RJ. Crosslinking of ANCA-antigens stimulates superoxide release by human neutrophils. J. Am. Soc. Nephrol. 8: 386-394 (1997). *

• Khan K, Schwarzenberg SJ, Sharp H, Greenwood D, Weisdorf-Schindele S. Role of serology and routine laboratory tests in childhood inflammatory bowel disease. Inflamm. Bowel Dis. 8: 325-329 (2002). *

• Khan WA, Habib S, Khan WA, Alam K, Moinuddin. Enhanced binding of circulating SLE autoantibodies to catecholestrogen-copper-modified DNA. Mol. Cell. Biochem. 315: 143-150 (2008). *

• Kido J, Kido R, Suryono, Kataoka M, Fagerhol MK, Nagata T. Calprotectin release from human neutrophils is induced by Porphyromonas gingivalis lipopolysaccharide via the CD-14-Toll-like receptor-nuclear factor kappaB pathway. J. Periodontal Res. 38: 557-563 (2003). *

• Kido M, Watanabe N, Okazaki T, Akamatsu T, Tanaka J, Saga K, Nishio A, Honjo T, Chiba T. Fatal autoimmune hepatitis induced by concurrent loss of naturally arising regulatory T cells and PD-1-mediated signaling. Gastroenterology 135: 1333-1343 (2008). *

• Kilby AE, Krawitt EL, Albertini RJ, Chastenay BF, John A. Suppressor T-cell deficiency in primary sclerosing cholangitis. Case and family study. Dig. Dis. Sci. 36: 1213-1216 (1991). *

• Kilic ZM, Tunc B, Ayaz S, Filik L, Aktas S, Parlak E, Ulker A. Antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies in inflammatory bowel diseases. Turk. J. Gastroenterol. 15: 238-242 (2004). *

• Kim BG, Kim YS, Kim JS, Jung HC, Song IS. Diagnostic role of anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic antibodies in patients with inflammatory bowel disease. Dis. Colon Rectum 45: 1062-1069 (2002).

• Kim HA, Chung JW, Park HJ, Joe DY, Yim HE, Park HS, Suh CH. An antinuclear antibody-negative patient with lupus nephritis. Korean J. Intern. Med. 24: 76-79 (2009). *

• Kim HR, Park MK, Cho ML, Yoon CH, Lee SH, Park SH, Leng L, Bucala R, Kang I, Choe J, Kim HY. Macrophage migration inhibitory factor upregulates angiogenic factors and correlates with clinical measures in rheumatoid arthritis. J. Rheumatol. 34: 927-936 (2007).

• Kim JE, Kim KS, Seo JK. Diagnostic role of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in pediatric inflammatory bowel disease. Korean J. Gastroenterol. 42: 297-302 (2003).

• Kim JH, Kim BH, Kim YW, Park JC, Jung YH, Lee BO, Han YS, Dong SH, Kim HJ, Chang YW, Lee JI, Chang R. Autoimmune cholangitis in a patient with thymoma. J. Gastroenterol. Hepatol. 19: 1324-1327 (2004). *

• Kim JM, Ihm CH, Sin DH, Ihm MK, Sim SC. Detection of anti-ENA and anti-dsDNA antibodies using line immunoassay in systemic autoimmune diseases. Korean J. Lab. Med. 28: 353-361 (2008).

• Kim KW, Cho ML, Park MK, Yoon CH, Park SH, Lee SH, Kim HY. Increased interleukin-17 production via a phosphoinositide 3-kinase/Akt and nuclear factor kappaB-dependent pathway in patients with rheumatoid arthritis. Arthritis Res. Ther. 7: R139-R148 (2005). *

• Kim W, Fan YY, Smith R, Patil B, Jayaprakasha GK, McMurray DN, Chapkin RS. Dietary curcumin and limonin suppress CD4 T-cell proliferation and Interleukin-2 production in mice. J. Nutr. 139: 1042-1048 (2009). *

• Kim YG, Lee CK, Nah SS, Mun SH, Yoo B, Moon HB. Human CD4+CD25+ regulatory T cells inhibit the differentiation of osteoclasts from peripheral blood mononuclear cells. Biochem. Biophys. Res. Commun. 357: 1046-1052 (2007). *

• Kim YK, Kim JS, Jeong SH, Park KS, Kim SE, Park SH. Cerebral glucose metabolism in Fisher syndrome. J. Neurol. Neurosurg. Psychiatry 80: 512-517 (2009).

• Kimura K, Nagaki M, Takai S, Satake S, Moriwaki H. Pivotal role of nuclear factor kappaB signaling in anti-CD40-induced liver injury in mice. Hepatology 40: 1180-1189 (2004). *

• Kimura M, Tatsumi KI, Tada H, Ikemoto M, Fukuda Y, Kaneko A, Kato M, Hidaka Y, Amino N. Enzyme immunoassay for autoantibodies to human liver-type arginase and its clinical application. Clin. Chem. 46: 112-117 (2000). *

• Kimura M, Tatsumi KI, Tada H, Izumi Y, Kaneko A, Kato M, Masuzawa M, Ikemoto M, Yabusaki Y, Hidaka Y, Amino N. Anti-CYP2D6 antibodies detected by quantitative radioligand assay and relation to antibodies to liver-specific arginase in patients with autoimmune hepatitis. Clin. Chim. Acta 316: 155-164 (2002). *

• Kinoshita H, Omagari K, Whittingham S, Kato Y, Ishibashi H, Sugi K, Yano M, Kohno S, Nakanuma Y, Penner E, Wesierska-Gadek J, Reynoso-Paz S, Gershwin ME, Anderson J, Jois JA, Mackay IR. Autoimmune cholangitis and primary biliary cirrhosis - an autoimmune enigma. Liver 19: 122-128 (1999).

• Kirino Y, Takeno M, Murakami S, Kobayashi M, Kobayashi H, Miura K, Ideguchi H, Ohno S, Ueda A, Ishigatsubo Y. Tumor necrosis factor alpha acceleration of inflammatory responses by down-regulating heme oxygenase 1 in human peripheral monocytes. Arthritis Rheum. 56: 464-475 (2007). *

• Kiriyama K, Usui T, Takemura T, Ikeda K, Kishida H, Izumoto T, Kanayama Y, Hirota S. A case of rapid-onset antimitochondrial antibody-positive autoimmune hepatitis possibly triggered by a urinary tract infection. Nippon Shokakibyo Gakkai Zasshi 107: 270-277 (2010).

• Kirman I, Nielsen OH. Increased numbers of interleukin-15-expressing cells in active ulcerative colitis. Am. J. Gastroenterol. 91: 1789-1794 (1996).

• Kiss E, Shoenfeld Y. Are anti-ribosomal P protein antibodies relevant in systemic lupus erythematosus? Clin. Rev. Allergy Immunol. 32: 37-46 (2007).

• Kita H, Lian ZX, Van de Water J, He XS, Matsumura S, Kaplan M, Luketic V, Coppel RL, Ansari AA, Gershwin ME. Identification of HLA-A2-restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells. J. Exp. Med. 195: 113-123 (2002). *

• Kita R, Kita-Sasai Y, Hanaoka I, Kimura T, Kokuryu H, Takamatsu S, Osaki Y, Tomono N, Hachiya T, Shimizu T. Beneficial effect of bezafibrate on primary sclerosing cholangitis (three case reports). Am. J. Gastroenterol. 97: 1849-1851 (2002). *

• Kitahara T, Hiromura K, Maezawa A, Ono K, Narabara N, Yano S, Naruse T, Takenouchi K, Yasumoto Y. Case of propylthiouracil-induced vasculitis associated with anti-neutrophil cytoplasmic antibody (ANCA); review of literature. Clin. Nephrol. 47: 336-340 (1997).

• Kitami N, Komada T, Ishii H, Shimizu H, Adachi H, Yamaguchi Y, Kitamura T, Oide H, Miyazaki A, Ishikawa M, et al. Immunological study of anti-M2 in antimitochondrial antibody-negative primary biliary cirrhosis. Intern. Med. 34: 496-501 (1995). *

• Kitareewan S, Blumen S, Sekula D, Bissonnette RP, Lamph WW, Cui Q, Gallagher R, Dmitrovsky E. G0S2 is an all-trans-retinoic acid target gene. Int. J. Oncol. 33: 397-404 (2008). *

• Kizaki T, Izawa T, Sakurai T, Haga S, Taniguchi N, Tajiri H, Watanabe K, Day NK, Toba K, Ohno H. beta2-Adrenergic receptor regulates Toll-like receptor-4-induced nuclear factor-kappaB activation through beta-arrestin 2. Immunology 124: 348-356 (2008). *

• Klapman JB, Ene-Stroescu D, Becker MA, Hanauer SB. A lupus-like syndrome associated with infliximab therapy. Inflamm. Bowel Dis. 9: 176-178 (2003). *

• Klebl FH, Bataille F, Bertea CR, Herfarth H, Hofstadter F, Scholmerich J, Rogler G. Association of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies with Vienna classification subtypes of Crohn's disease. Inflamm. Bowel Dis. 9: 302-307 (2003). *

• Klein R, Eisenburg J, Weber P, Seibold F, Berg PA. Significance and specificity of antibodies to neutrophils detected by western blotting for the serological diagnosis of primary sclerosing cholangitis. Hepatology 14: 1147-1152 (1991).

• Klein R, Huizenga JR, Gips CH, Berg PA. Antimitochondrial antibody profiles in patients with primary biliary cirrhosis before orthotopic liver transplantation and titres of antimitochondrial antibody-subtypes after transplantation. J. Hepatol. 20: 181-189 (1994).

• Kloppel G, Seifert G, Lindner H, Dammermann R, Sack HJ, Berg PA. Histopathological features in mixed types of chronic aggressive hepatitis and primary biliary cirrhosis. Correlations of liver histology with mitochondrial antibodies of different specificity. Virchows Arch. A. Pathol. Anat. Histol. 373: 143-160 (1977).

• Kobashi H, Yamamoto K, Yoshioka T, Tomita M, Tsuji T. Nonsuppurative cholangitis is induced in neonatally thymectomized mice: a possible animal model for primary biliary cirrhosis. Hepatology 19: 1424-1430 (1994).

• Kobayashi H, Kimura S, Aoki N, Sato K, Celis E, Katagiri M. Existence of MHC class I-restricted alloreactive CD4+ T cells reacting with peptide transporter-deficient cells. Immunogenetics 53: 626-633 (2001).

• Kobayashi K, Shibata T, Sugisaki T. Aggravation of rat nephrotoxic serum nephritis by anti-myeloperoxidase antibodies. Kidney Int. 47: 454-463 (1995).

• Kobayashi S, Ito A, Okuzaki D, Onda H, Yabuta N, Nagamori I, Suzuki K, Hashimoto H, Nojima H. Expression profiling of PBMC-based diagnostic gene markers isolated from vasculitis patients. DNA Res. 15: 253-265 (2008). *

• Kocher M, Siegel ME, Edberg JC, Kimberly RP. Cross-linking of Fc gamma receptor IIa and Fc gamma receptor IIIb induces different proadhesive phenotypes on human neutrophils. J. Immunol. 159: 3940-3948 (1997).

• Kochi Y, Yamada R, Suzuki A, Harley JB, Shirasawa S, Sawada T, Bae SC, Tokuhiro S, Chang X, Sekine A, Takahashi A, Tsunoda T, Ohnishi Y, Kaufman KM, Kang CP, Kang C, Otsubo S, Yumura W, Mimori A, Koike T, Nakamura Y, Sasazuki T, Yamamoto K. A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat. Genet. 37: 478-485 (2005). *

• Koelsch K, Zheng NY, Zhang Q, Duty A, Helms C, Mathias MD, Jared M, Smith K, Capra JD, Wilson PC. Mature B cells class switched to IgD are autoreactive in healthy individuals. J. Clin. Invest. 117: 1558-1565 (2007). *

• Koga Y, Matsuzaki A, Suminoe A, Hattori H, Hara T. Neutrophil-derived TNF-related apoptosis-inducing ligand (TRAIL): a novel mechanism of antitumor effect by neutrophils. Cancer Res. 64: 1037-1043 (2004). *

• Kogawa H, Migita K, Ito M, Takii Y, Daikoku M, Nakao M, Miyashita T, Kimura H, Ezaki H, Nakamura M, Yatsuhashi H, Eguchi K, Ishibashi H. Idiopathic portal hypertension associated with systemic sclerosis and Sjogren's syndrome. Clin. Rheumatol. 24: 544-547 (2005). *

• Koh WH, Dunphy J, Whyte J, Dixey J, McHugh NJ. Characterisation of anticytoplasmic antibodies and their clinical associations. Ann. Rheum. Dis. 54: 269-273 (1995). *

• Kojima K, Nagayama R, Hirama S, Maeda T, Takikawa H, Miyake K, Yamanaka M, Shiga J. Epstein-Barr virus infection resembling autoimmune hepatitis with lactate dehydrogenase and alkaline phosphatase anomaly. J. Gastroenterol. 34: 706-712 (1999).

• Kolbus N, Fleischer U, Mader M, Felgenhauer K, Beuche W. Detection of T cells reactive to intestinal alkaline phosphatase, an autoantigen in acute bacterial infections, and discrimination between autoantigen-specific CD5+ and CD5- B cells. Clin. Exp. Immunol. 108: 19-25 (1997). *

• Komohara Y, Harada M, Ishihara Y, Suekane S, Noguchi M, Yamada A, Matsuoka K, Itoh K. HLA-G as a target molecule in specific immunotherapy against renal cell carcinoma. Oncol. Rep. 18: 1463-1468 (2007). *

• Kondo M, Murakawa Y, Harashima N, Kobayashi S, Yamaguchi S, Harada M. Roles of proinflammatory cytokines and the Fas/Fas ligand interaction in the pathogenesis of inflammatory myopathies. Immunology 128: e589-e599 (2009).

• Kondo Y, Kobayashi K, Ueno Y, Shiina M, Niitsuma H, Kanno N, Kobayashi T, Shimosegawa T. Mechanism of T cell hyporesponsiveness to HBcAg is associated with regulatory T cells in chronic hepatitis B. World J. Gastroenterol. 12: 4310-4317 (2006). *

• Kong JS, Yoo SA, Kim HS, Kim HA, Yea K, Ryu SH, Chung YJ, Cho CS, Kim WU. Inhibition of synovial hyperplasia, rheumatoid T cell activation, and experimental arthritis in mice by sulforaphane, a naturally occurring isothiocyanate. Arthritis Rheum. 62: 159-170 (2009). *

• Konikoff F, Isenberg DA, Kooperman O, Kennedy RC, Rauch J, Theodor E, Shoenfeld Y. Common lupus anti-DNA antibody idiotypes in chronic liver diseases. Clin. Immunol. Immunopathol. 43: 265-272 (1987).

• Konikoff F, Shoenfeld Y, Isenberg DA, Barrison I, Sobe T, Theodor E, Slor H. Anti-Rnp antibodies in chronic liver diseases. Clin. Exp. Rheumatol. 5: 359-361 (1987).

• Kontzias A, Efthimiou P. Adult-onset Still's disease: pathogenesis, clinical manifestations and therapeutic advances. Drugs 68: 319-337 (2008).

• Kooy A, de Heide LJ, Engelkens HJ, Mulder AH, van Hagen M, Schalm SW. Hepatitis in a patient with SLE: is it autoimmune hepatitis? Neth. J. Med. 48: 128-132 (1996).

• Koppang EO, Bjerkas I, Haugarvoll E, Chan EK, Szabo NJ, Ono N, Akikusa B, Jirillo E, Poppe TT, Sveier H, Torud B, Satoh M. Vaccination-induced systemic autoimmunity in farmed atlantic salmon. J. Immunol. 181: 4807-4814 (2008). *

• Korkmaz B, Jaillet J, Jourdan ML, Gauthier A, Gauthier F, Attucci S. Catalytic activity and inhibition of Wegener's antigen proteinase 3 on the cell surface of human polymorphonuclear neutrophils. J. Biol. Chem. 284: 19896-19902 (2009). *

• Kosboth M, Chin-Loy A, Lyons R, Wesson SK, Reeves WH. Malar rash caused by metal allergy in a patient with systemic lupus erythematosus. Nat. Clin. Pract. Rheumatol. 3: 240-245 (2007). *

• Koskinas J, Raptis I, Manika Z, Hadziyannis S. Overlapping syndrome of autoimmune hepatitis and primary sclerosing cholangitis associated with pyoderma gangrenosum and ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 11: 1421-1424 (1999).

• Kossa K, Coulthart A, Ives CT, Pusey CD, Hodgson HJ. Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 7: 783-789 (1995).

• Kotter I, Neuscheler D, Gunaydin I, Wernet D, Klein R. Is there a predisposition for the development of autoimmune diseases in patients with fibromyalgia? Retrospective analysis with long term follow-up. Rheumatol. Int. 27: 1031-1039 (2007). *

• Koutroubakis IE, Petinaki E, Mouzas IA, Vlachonikolis IG, Anagnostopoulou E, Castanas E, Maniatis AN, Kouroumalis EA. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease. Am. J. Gastroenterol. 96: 449-454 (2001). *

• Kovvali G, Das KM. Molecular mimicry may contribute to pathogenesis of ulcerative colitis. FEBS Lett. 579: 2261-2266 (2005). *

• Kraehenbuhl JP, Corbett M. Keeping the gut microflora at bay. Science 303: 1624-1625 (2004). *

• Krischock L, Horsfield C, D'Cruz D, Rigden SP. Drug-induced lupus and antiphospholipid syndrome associated with cysteamine therapy. Nephrol. Dial. Transplant. 24: 1997-1999 (2009).

• Kristjansdottir H, Saevarsdottir S, Grondal G, Alarcon-Riquelme ME, Erlendsson K, Valdimarsson H, Steinsson K. Association of three systemic lupus erythematosus susceptibility factors, PD-1.3A, C4AQ0, and low levels of mannan-binding lectin, with autoimmune manifestations in icelandic multicase systemic lupus erythematosus families. Arthritis Rheum. 58: 3865-3872 (2008). *

• Krug A. Nucleic acid recognition receptors in autoimmunity. Handb. Exp. Pharmacol. 183: 129-151 (2008).

• Krulik M, Zylberait D, Vittecoq D, Audebert AA, Debray J. Primary biliary cirrhosis associated with acute disseminated lupus erythematosus. Nouv. Presse. Med. 9: 31-34 (1980).

• Krzesiek E, Pytrus T, Kosmowska A, Iwanczak B. Carbonyl groups content in serum proteins as an indicator of disease activity in children with inflammatory bowel diseases and its dependence on the other markers of inflammatory process. Pol. Merkur. Lekarski. 25: 455-459 (2008).

• Kubo T, Uchida Y, Watanabe Y, Abe M, Nakamura A, Ono M, Akira S, Takai T. Augmented TLR9-induced Btk activation in PIR-B-deficient B-1 cells provokes excessive autoantibody production and autoimmunity. J. Exp. Med. 206: 1971-1982 (2009). *

• Kubota K, Wada T, Kato S, Mozaki Y, Yoneda M, Fujita K, Takahashi H, Inamori M, Abe Y, Kobayashi N, Kirikoshi H, Saito S, Inayama Y, Nakajima A. Highly active state of autoimmune pancreatitis with Mikulicz disease. Pancreas 39: e6-e10 (2010).

• Kuczkowski J, Kozlowski J, Narozny W. Acute autoimmune sensorineural hearing loss in pregnant women with Lesniowski-Crohn disease. Otolaryngol. Pol. 60: 583-585 (2006).

• Kudo T, Nagata S, Aoyagi Y, Suzuki R, Matsuda H, Ohtsuka Y, Shimizu T, Okumura K, Yamashiro Y. Polarized production of T-helper cell type 1 cells in Peyer's patches in Crohn's disease. Digestion 70: 214-225 (2004).

• Kugathasan S. Pediatric inflammatory bowel disease: clinical and therapeutic aspects. Curr. Opin. Gastroenterol. 17: 350-355 (2001).

• Kuipers JG, Ehrfeld H, Hammer M, Zeidler H, Schmidt RE. Coincidence of a primary sclerosing cholangitis with an undifferentiated autoimmune disease. Immun. Infekt. 20: 64-65 (1992).

• Kuisma J, Jarvinen H, Kahri A, Farkkila M. Factors associated with disease activity of pouchitis after surgery for ulcerative colitis. Scand. J. Gastroenterol. 39: 544-548 (2004). *

• Kumpfel T, Hoffmann LA, Pellkofer H, Pollmann W, Feneberg W, Hohlfeld R, Lohse P. Multiple sclerosis and the TNFRSF1A R92Q mutation: clinical characteristics of 21 cases. Neurology 71: 1812-1820 (2008).

• Kunishige JH, Hymes SR, Madkan V, Wyatt AJ, Uptmore D, Lazar AJ, Giralt S, Rady P, Tyring S. Epidermodysplasia verruciformis in the setting of graft-versus-host disease. J. Am. Acad. Dermatol. 57: S78-S80 (2007).

• Kurien BT. Affinity purification of autoantibodies from an antigen strip excised from a nitrocellulose protein blot. Methods Mol. Biol. 536: 201-211 (2009).

• Kurien BT, Scofield RH. Autoantibody determination in the diagnosis of systemic lupus erythematosus. Scand. J. Immunol. 64: 227-235 (2006). *

• Kurien BT, Scofield RH. Multiple nuclear dot antinuclear antibody in patients without primary biliary cirrhosis. Indian J. Biochem. Biophys. 35: 41-47 (1998).

• Kurki P, Gripenberg M, Teppo AM, Salaspuro M. Profiles of antinuclear antibodies in chronic active hepatitis, primary biliary cirrhosis and alcoholic liver disease. Liver 4: 134-138 (1984).

• Kuroda Y, Ono N, Akaogi J, Nacionales DC, Yamasaki Y, Barker TT, Reeves WH, Satoh M. Induction of lupus-related specific autoantibodies by non-specific inflammation caused by an intraperitoneal injection of n-hexadecane in BALB/c mice. Toxicology 218: 186-196 (2006). *

• Kurtovic J, Riordan S. Clinical aspects of primary biliary cirrhosis. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 31-32. October 15-16 (2003). *

• Kurtovic J, Segal I. Recent advances in biological therapy for inflammatory bowel disease. Trop. Gastroenterol. 25: 9-14 (2004).

• Kusugami K, Matsuura T, West GA, Youngman KR, Rachmilewitz D, Fiocchi C. Loss of interleukin-2-producing intestinal CD4+ T cells in inflammatory bowel disease. Gastroenterology 101: 1594-1605 (1991).

• Kutukculer N, Yuksel SE, Aksu G, Alper S. Autoantibodies other than antineutrophil cytoplasmic antibodies are not positive in patients with psoriasis vulgaris. J. Dermatol. 32: 179-185 (2005).

• Kuwabara N, Itoh Y, Igarshi T, Fukunaga Y. Autoantibodies to lens epithelium-derived growth factor/transcription co-activator P75 (LEDGF/P75) in children with chronic nonspecific complaints and with positive antinuclear antibodies. Autoimmunity 42: 492-496 (2009).

• Kuwana M, Inoko H, Kameda H, Nojima T, Sato S, Nakamura K, Ogasawara T, Hirakata M, Ohosone Y, Kaburaki J, Okano Y, Mimori T. Association of human leukocyte antigen class II genes with autoantibody profiles, but not with disease susceptibility in Japanese patients with systemic sclerosis. Intern. Med. 38: 336-344 (1999). *

• Kuwana M, Okano Y, Kaburaki J, Inoko H. HLA class II genes associated with anticentromere antibody in Japanese patients with systemic sclerosis (scleroderma). Ann. Rheum. Dis. 54: 983-987 (1995). *

• Kuwana T, Sato Y, Saka M, Kondo Y, Miyata M, Obara K, Nishimaki T, Kasukawa R. Anti-cathepsin G antibodies in the sera of patients with ulcerative colitis. J. Gastroenterol. 35: 682-689 (2000). *

• Kuyucu S, Argin A, Kuyucu N, Ozen S. Systemic lupus erythematosus presenting with pseudotumor cerebri: a rare association. Turk. J. Pediatr. 49: 98-101 (2007).

• Kwon YD, Lee HS, Park CH, Jeen YT, Chun HJ, Lee SW, Choi JH, Kim CD, Ryu HS, Hyun JH. A case of auto-immune hepatitis associated with primary Sjogren's syndrome. Taehan Kan Hakhoe Chi 9: 25-30 (2003).

• Laadhar L, Zitouni M, Kallel-Sellami M, Bouguerra R, Chaabouni H, Makni S. Spectrum of autoantibodies in Tunisian adult type 1 diabetes mellitus. Ann. N. Y. Acad. Sci. 1107: 356-362 (2007). *

• Laan M, Linden. IL-17 as a potential target for modulating airway neutrophilia. Curr. Pharm. Des. 8: 1855-1861 (2002).

• Lacerda MA, Ludwig J, Dickson ER, Jorgensen RA, Lindor KD. Antimitochondrial antibody-negative primary biliary cirrhosis. Am. J. Gastroenterol. 90: 247-249 (1995).

• Lacotte S, Dumortier H, Decossas M, Briand JP, Muller S. Identification of new pathogenic players in lupus: autoantibody-secreting cells are present in nephritic kidneys of (NZBxNZW)F1 mice. J. Immunol. Feb 24 [Epub ahead of print] (2010).

• Ladefoged K, Andersen P, Jorgensen J. Autoantibodies and serum immunoglobulins in chronic liver diseases. Acta Med. Scand. 205: 103-109 (1979).

• Lambova SN, Kuzmanova SI. Raynaud's phenomenon in common rheumatic diseases. Folia Med. (Plovdiv.) 48: 22-28 (2006).

• Lamproye A, Belaiche J, Louis E, Salmon J, Mahieu P. Antineutrophil cytoplasmic antibodies (ANCA) in inflammatory diseases of the digestive tract. Acta Gastroenterol. Belg. 57: 171-176 (1994).

• Lan CC, Yu HS, Wu CS, Kuo HY, Chai CY, Chen GS. FK506 inhibits tumour necrosis factor-alpha secretion in human keratinocytes via regulation of nuclear factor-kappaB. Br. J. Dermatol. 153: 725-732 (2005). *

• Landers CJ, Cohavy O, Misra R, Yang H, Lin YC, Braun J, Targan SR. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology 123: 689-699 (2002). *

• Landry Y, Gies JP. Drugs and their molecular targets: an updated overview. Fundam. Clin. Pharmacol. 22: 1-18 (2008). *

• Lang B, Dale RC, Vincent A. New autoantibody mediated disorders of the central nervous system. Curr. Opin. Neurol. 16: 351-357 (2003).

• Langan RC, Gotsch PB, Krafczyk MA, Skillinge DD. Ulcerative colitis: diagnosis and treatment. Am. Fam. Physician 76: 1323-1330 (2007). *

• Lange A. Genetic factors predicting IFN-gamma generation potential in patients with sarcoidosis and after haematopoietic stem cell transplantation. Int. J. Immunogenet. 35: 385-388 (2008). *

• Langguth DM, Morris S, Clifford L, Wilson RJ, Neil J, Hogan PG, Wong RC. Specific testing for "isolated" anti-52 kDa SSA/Ro antibodies during standard anti-extractable nuclear antigen testing is of limited clinical value. J. Clin. Pathol. 60: 670-673 (2007). *

• Lankford S, Petty C, Lavoy A, Reckling S, Tompkins W, Dean GA. Cloning of feline FOXP3 and detection of expression in CD4+CD25+ regulatory T cells. Vet. Immunol. Immunopathol. 122: 159-166 (2008). *

• Lartigue A, Colliou N, Calbo S, Francois A, Jacquot S, Arnoult C, Tron F, Gilbert D, Musette P. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus. J. Immunol. 183: 6207-6216 (2009).

• Lartigue A, Courville P, Auquit I, Francois A, Arnoult C, Tron F, Gilbert D, Musette P. Role of TLR9 in anti-nucleosome and anti-DNA antibody production in lpr mutation-induced murine lupus. J. Immunol. 177: 1349-1354 (2006). *

• Lassoued K, Guilly MN, Andre C, Paintrand M, Dhumeaux D, Danon F, Brouet JC, Courvalin JC. Autoantibodies to 200 kD polypeptide(s) of the nuclear envelope: a new serologic marker of primary biliary cirrhosis. Clin. Exp. Immunol. 74: 283-288 (1988). *

• Launay D, Hachulla E, Hatron PY, Jais X, Simonneau G, Humbert M. Pulmonary arterial hypertension: a rare complication of primary Sjogren syndrome: report of 9 new cases and review of the literature. Medicine (Baltimore) 86: 299-315 (2007).

• Lawind MF, Alyasky A, Elwan NM, Mourad H, Al-Bendary A. Alpha-fodrin autoantibodies are reliable diagnostic markers for juvenile and adult Sjogren's syndrome. Egypt. J. Immunol. 11: 75-81 (2004).

• Lawson TM, Amos N, Bulgen D, Williams BD. Minocycline-induced lupus: clinical features and response to rechallenge. Rheumatology (Oxford) 40: 329-335 (2001). *

• Lazaridou E, Apalla Z, Sotiraki S, Ziakas NG, Fotiadou C, Ioannides D. Clinical and laboratory study of rosacea in northern Greece. J. Eur. Acad. Dermatol. Venereol. Sep 8 [Epub ahead of print] (2009).

• Lazaro D. Elderly-onset systemic lupus erythematosus: prevalence, clinical course and treatment. Drugs Aging 24: 701-715 (2007).

• Lazurova I, Benhatchi K, Rovensky J, Kozakova D, Wagnerova H, Tajtakova M, Shoenfeld Y, Macejova Z. Autoimmune thyroid disease and autoimmune rheumatic disorders: a two-sided analysis. Ann. N. Y. Acad. Sci. 1173: 211-216 (2009). *

• Lebwohl M, Bagel J, Gelfand JM, Gladman D, Gordon KB, Hsu S, Kalb RE, Kimball AB, Korman NJ, Krueger GG, Mease P, Morison WL, Paller A, Pariser DM, Ritchlin C, Strober B, Van Voorhees A, Weinstein GD, Young M, Horn L. From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasis. J. Am. Acad. Dermatol. 58: 94-105 (2008).

• Lee HY, Youn SW, Kim JY, Park KW, Hwang CI, Park WY, Oh BH, Park YB, Walsh K, Seo JS, Kim HS. FOXO3a turns the tumor necrosis factor receptor signaling towards apoptosis through reciprocal regulation of c-Jun N-terminal kinase and NF-kappaB. Arterioscler. Thromb. Vasc. Biol. 28: 112-120 (2008).

• Lee J, Chang KH, Park CS, Lee CH, Song CH, Park YN, Park C, Lee SK. A case of autoimmune cholangitis associated with Sjogren's syndrome and arthropathy. J. Korean Med. Sci. 13: 85-88 (1998). *

• Lee JH, Cheon JH, Kim ES, Chung MJ, Kang W, Kim DH, Ha YJ, Park JJ, Kim TI, Kim WH. The prevalence and clinical significance of perinuclear anti-neutrophil cytoplasmic antibody in Korean patients with ulcerative colitis. Dig. Dis. Sci. Jun 9 [Epub ahead of print] (2009). *

• Lee JY, Chang HK, Kim SK. Successful etanercept therapy for refractory sacroiliitis in a patient with ankylosing spondylitis and mixed connective tissue disease. Yonsei Med. J. 49: 159-162 (2008). *

• Lee KS, Buck M, Houglum K, Chojkier M. Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-Myb expression. J. Clin. Invest. 96: 2461-2468 (1995). *

• Lee SM, Dunnavant FD, Jang H, Zunt J, Levin MC. Autoantibodies that recognize functional domains of hnRNPA1 implicate molecular mimicry in the pathogenesis of neurological disease. Neurosci. Lett. 401: 188-193 (2006). *

• Lee SM, Morcos Y, Jang H, Stuart JM, Levin MC. HTLV-1 induced molecular mimicry in neurological disease. Curr. Top. Microbiol. Immunol. 296: 125-136 (2005).

• Lee WM, Shelton LL, Galbraith RM. Antibodies to hepatocyte membrane antigens in chronic liver disease: detection by immunofluorescence after Bouin's fixation. J. Histochem. Cytochem. 31: 1246-1249 (1983).

• Lee-Kirsch MA, Chowdhury D, Harvey S, Gong M, Senenko L, Engel K, Pfeiffer C, Hollis T, Gahr M, Perrino FW, Lieberman J, Hubner N. A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus. J. Mol. Med. 85: 531-537 (2007). *

• Lee-Kirsch MA, Gong M, Schulz H, Ruschendorf F, Stein A, Pfeiffer C, Ballarini A, Gahr M, Hubner N, Linne M. Familial chilblain lupus, a monogenic form of cutaneous lupus erythematosus, maps to chromosome 3p. Am. J. Hum. Genet. 79: 731-737 (2006). *

• Leibovitch I, Amital H, Levy Y, Langevitz P, Shoenfeld Y. Isotretinoin-induced adult onset Still's disease. Clin. Exp. Rheumatol. 18: 616-618 (2000).

• Leid RW, Ballieux BE, van der Heijden I, Kleyburg-van der Keur C, Hagen EC, van Es LA, van der Woude FJ, Daha MR. Cleavage and inactivation of human C1 inhibitor by the human leukocyte proteinase, proteinase 3. Eur. J. Immunol. 23: 2939-2944 (1993).

• Leitenberger JJ, Cayce RL, Haley RW, Adams-Huet B, Bergstresser PR, Jacobe HT. Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases. Arch. Dermatol. 145: 545-550 (2009). *

• Lemann M. Treatment of chronic inflammatory bowel diseases. Bull. Acad. Natl. Med. 191: 1125-1141 (2007).

• Lenzi M, Bellentani S, Saccoccio G, Muratori P, Masutti F, Muratori L, Cassani F, Bianchi FB, Tiribelli C. Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort. Gut 45: 435-441 (1999). *

• Lesavre P. Antineutrophil cytoplasmic autoantibodies antigen specificity. Am. J. Kidney Dis. 18: 159-163 (1991).

• Lesavre P, Noel LH. Causes and mechanisms of vasculitides. Rev. Prat. 50: 255-260 (2000).

• Leuschner F, Katus HA, Kaya Z. Autoimmune myocarditis: past, present and future. J. Autoimmun. 33: 282-289 (2009).

• Leuschner M, Holtmeier J, Ackermann H, Leuschner U. The influence of sulindac on patients with primary biliary cirrhosis that responds incompletely to ursodeoxycholic acid: a pilot study. Eur. J. Gastroenterol. Hepatol. 14: 1369-1376 (2002).

• Leuschner U. Primary biliary cirrhosis - presentation and diagnosis. Clin. Liver Dis. 7: 741-758 (2003).

• Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, Ascherio A. Multiple sclerosis and Epstein-Barr virus. JAMA 289: 1533-1536 (2003). *

• Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, Ascherio A. Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA 293: 2496-2500 (2005). *

• Levin MC, Lee SM, Kalume F, Morcos Y, Dohan FC Jr, Hasty KA, Callaway JC, Zunt J, Desiderio D, Stuart JM. Autoimmunity due to molecular mimicry as a cause of neurological disease. Nat. Med. 8: 509-513 (2002). *

• Levy C, Lindor KD. Treatment options for primary biliary cirrhosis and primary sclerosing cholangitis. Curr. Treat. Options Gastroenterol. 6: 93-103 (2003).

• Levy O, Elsbach P. Bactericidal/permeability-increasing protein in host defense and its efficacy in the treatment of bacterial sepsis. Curr. Infect. Dis. Rep. 3: 407-412 (2001).

• Levy RM, Mollen KP, Prince JM, Kaczorowski DJ, Vallabhaneni R, Liu S, Tracey KJ, Lotze MT, Hackam DJ, Fink MP, Vodovotz Y, Billiar TR. Systemic inflammation and remote organ injury following trauma require HMGB1. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293: R1538-R1544 (2007). *

• Levy Y, Segal N, Weintrob N, Danon YL. Chronic urticaria: association with thyroid autoimmunity. Arch. Dis. Child. 88: 517-519 (2003). *

• Li CP, Hwang SJ, Chan CY, Lee FY, Huang YS, Chang FY, Lee SD. Clinical evaluation of primary biliary cirrhosis in Chinese patients without serum anti-mitochondrial antibody. Zhonghua Yi Xue Za Zhi (Taipei) 59: 334-340 (1997).

• Li CP, Tong MJ, Hwang SJ, Luo JC, Co RL, Tsay SH, Chang FY, Lee SD. Autoimmune cholangitis with features of autoimmune hepatitis: successful treatment with immunosuppressive agents and ursodeoxycholic acid. J. Gastroenterol. Hepatol. 15: 95-98 (2000). *

• Li DH, Winslow MM, Cao TM, Chen AH, Davis CR, Mellins ED, Utz PJ, Crabtree GR, Parnes JR. Modulation of peripheral B cell tolerance by CD72 in a murine model. Arthritis Rheum. 58: 3192-3204 (2008). *

• Li J, Stein TD, Johnson JA. Genetic dissection of systemic autoimmune disease in nrf2 deficient mice. Physiol. Genomics 18: 261-272 (2004). *

• Li L, Chen M, Huang DY, Nishioka M. Frequency and significance of antibodies to chromatin in autoimmune hepatitis type I. J. Gastroenterol. Hepatol. 15: 1176-1182 (2000). *

• Li T, Wong VK, Yi XQ, Wong YF, Zhou H, Liu L. Matrine induces cell anergy in human Jurkat T cells through modulation of mitogen-activated protein kinases and nuclear factor of activated T-cells signaling with concomitant up-regulation of anergy-associated genes expression. Biol. Pharm. Bull. 33: 40-46 (2010). *

• Li XY, Xiao JH, Feng X, Qin L, Voorhees JJ. Retinoid X receptor-specific ligands synergistically upregulate 1, 25-dihydroxyvitamin D3-dependent transcription in epidermal keratinocytes in vitro and in vivo. J. Invest. Dermatol. 108: 506-512 (1997). *

• Li Z, Yang S, Lin H, Huang J, Watkins PA, Moser AB, Desimone C, Song XY, Diehl AM. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 37: 343-350 (2003). *

• Li1 CS, Zhang Q, Lim MK, Sheen DH, Shim SC, Kim JY, Lee SS, Yun KJ, Moon HB, Chung HT, Chae SC. Association of FOXJ1 polymorphisms with systemic lupus erythematosus and rheumatoid arthritis in Korean population. Exp. Mol. Med. 39: 805-811 (2007). *

• Liao CH, Huang JL. Juvenile ankylosing spondylitis with uveitis. Asian Pac. J. Allergy Immunol. 21: 69-71 (2003).

• Liao CH, Yao TC, Chung HT, See LC, Kuo ML, Huang JL. Polymorphisms in the promoter region of RANTES and the regulatory region of monocyte chemoattractant protein-1 among Chinese children with systemic lupus erythematosus. J. Rheumatol. 31: 2062-2067 (2004). *

• Liberman AC, Druker J, Refojo D, Arzt E. Molecular mechanisms of action of some immunosuppressive drugs. Medicina (B. Aires) 68: 455-464 (2008).

• Lim YS, Oh HB, Choi SE, Kwon OJ, Heo YS, Lee HC, Suh DJ. Susceptibility to type 1 autoimmune hepatitis is associated with shared amino acid sequences at positions 70-74 of the HLA-DRB1 molecule. J. Hepatol. 48: 133-139 (2008). *

• Lima CS, Paula EV, Takahashi T, Saad ST, Lorand-Metze I, Costa FF. Causes of incidental neutropenia in adulthood. Ann. Hematol. 85: 705-709 (2006). *

• Lin CF, Wan SW, Chen MC, Lin SC, Cheng CC, Chiu SC, Hsiao YL, Lei HY, Liu HS, Yeh TM, Lin YS. Liver injury caused by antibodies against dengue virus nonstructural protein 1 in a murine model. Lab. Invest. 88: 1079-1089 (2008). *

• Lin F, Noyer CM, Ye Q, Courvalin JC, Worman HJ. Autoantibodies from patients with primary biliary cirrhosis recognize a region within the nucleoplasmic domain of inner nuclear membrane protein LBR. Hepatology 23: 57-61 (1996). *

• Lin LF, Huang PT, Ho KS, Tung JN. Autoimmune chronic pancreatitis. J. Chin. Med. Assoc. 71: 14-22 (2008).

• Lin SC, Shyur SD, Huang LH, Wu JY, Chuo HT, Lee HC. Neonatal lupus erythematosus with cholestatic hepatitis. J. Microbiol. Immunol. Infect. 37: 131-134 (2004). *

• Lin SC, Shyur SD, Wu JY, Huang LH, Yi-Chun. Facial telangiectasia-an unusual complication of neonatal lupus erythematosus: report of one case. Acta Paediatr. Taiwan 45: 246-248 (2004).

• Lin YJ, Chen RH, Wan L, Sheu JC, Huang CM, Lin CW, Chen SY, Lai CH, Lan YC, Hsueh KC, Tsai CH, Lin TH, Huang YM, Chao K, Chen DY, Tsai FJ. Association of TNF-alpha gene polymorphisms with systemic lupus erythematosus in Taiwanese patients. Lupus 18: 974-979 (2009). *

• Lin YJ, Wan L, Sheu JJ, Huang CM, Lin CW, Lan YC, Lai CH, Hung CH, Tsai Y, Tsai CH, Lin WY, Liu HP, Lin TH, Huang YM, Tsai FJ. G/T polymorphism in the interleukin-2 exon 1 region among Han Chinese systemic lupus erythematosus patients in Taiwan. Clin. Immunol. 129: 36-39 (2008). *

• Lindgren S, Floren CH, Lindhagen T, Starck M, Stewenius J, Nassberger L. Low prevalence of anti-neutrophil cytoplasmic antibodies in ulcerative colitis patients with long-term remission. Eur. J. Gastroenterol. Hepatol. 7: 563-568 (1995).

• Lindqvist AK, Nakken B, Sundler M, Kjellen P, Jonsson R, Holmdahl R, Skarstein K. Influence on spontaneous tissue inflammation by the major histocompatibility complex region in the nonobese diabetic mouse. Scand. J. Immunol. 61: 119-127 (2005). *

• Linskens RK, Mallant-Hent RC, Groothuismink ZM, Bakker-Jonges LE, van de Merwe JP, Hooijkaas H, von Blomberg BM, Meuwissen SG. Evaluation of serological markers to differentiate between ulcerative colitis and Crohn's disease: pANCA, ASCA and agglutinating antibodies to anaerobic coccoid rods. Eur. J. Gastroenterol. Hepatol. 14: 1013-1018 (2002).

• Linskens RK, Mallant-Hent RC, Murillo LS, von Blomberg BME, Alizadeh BZ, Pena AS. Genetic and serological markers to identify phenotypic subgroups in a Dutch Crohn’s disease population. Dig. Liver Dis. 36: 29-34 (2004). *

• Lisa A, Monti D, Franceschi C, Scovassi AI. Autoantibodies to poly(ADP-ribose) polymerase in centenarians: a reappraisal of Grabar's hypothesis. Gerontology 55: 427-429 (2009).

• Lisi S, Sisto M, Lofrumento D, Frassanito MA, Caprio S, Romano ML, Mitolo V, D'Amore M. Regulation of mRNA caspase-8 levels by anti-nuclear autoantibodies. Clin. Exp. Med. Dec 24 [Epub ahead of print] (2009). *

• Liu B, Shi XH, Zhang FC, Zhang W, Gao LX. Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis. Liver Int. 28: 233-239 (2008). *

• Liu C, Chen X, Jin Y, Qu R, Jiang PF, Wen GM, Tang ZH. Effects of calcitonin gene-related peptide on apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clin. Exp. Dermatol. 32: 650-653 (2007). *

• Liu HY, Wang LX, Liu YF, Pietro I, Xu DX, Zhong RQ, Gong ST. Frequencies of autoantibodies specific for primary biliary cirrhosis in a general adult population group. Zhonghua Gan Zang Bing Za Zhi 16: 922-925 (2008).

• Liu K, Li QZ, Yu Y, Liang C, Subramanian S, Zeng Z, Wang HW, Xie C, Zhou XJ, Mohan C, Wakeland EK. Sle3 and Sle5 can independently couple with Sle1 to mediate severe lupus nephritis. Genes Immun. 8: 634-645 (2007). *

• Liu K, Mori S, Takahashi HK, Tomono Y, Wake H, Kanke T, Sato Y, Hiraga N, Adachi N, Yoshino T, Nishibori M. Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats. FASEB J. 21: 3904-3916 (2007). *

• Liu W, Feng W, Wang F, Li W, Gao C, Zhou B, Ma M. Osteoprotegerin/RANK/RANKL axis in cardiac remodeling due to immuno-inflammatory myocardial disease. Exp. Mol. Pathol. 84: 213-217 (2008).

• Llorente MJ, Jimenez J, Gonzalez C, Alarcon I, Alsina M, Casas LM, Benedito JE, Luis Araquistain J, Farre V, Gonzalez-Buitrago JM; Biochemistry Commission for Immunological Diseases of the Spanish Society of Clinical Chemistry. Effectiveness of different methods for anti-Sm antibody identification. A multicentre study. Clin. Chem. Lab. Med. 43: 748-752 (2005). *

• Lo SK, Fleming KA, Chapman RW. Prevalence of anti-neutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique. Gut 33: 1370-1375 (1992). *

• lofin I, Levine B, Badlani N, Klein GR, Jaffe WL. Psoriatic arthritis and arthroplasty: a review of the literature. Bull. N.Y.U. Hosp. Jt. Dis. 66: 41-48 (2008).

• Lohr H, Fleischer B, Gerken G, Meyer zum Buschenfelde KH, Manns M. Infiltrating T-cells in primary biliary cirrhosis recognize mitochondrial epitopes. Z. Gastroenterol. 31 Suppl. 2: 99-103 (1993).

• Lohr H, Treichel U, Poralla T, Manns M, Meyer zum Buschenfelde KH. Liver-infiltrating T helper cells in autoimmune chronic active hepatitis stimulate the production of autoantibodies against the human asialoglycoprotein receptor in vitro. Clin. Exp. Immunol. 88: 45-49 (1992). *

• Lohr HF, Schlaak JF, Lohse AW, Bocher WO, Arenz M, Gerken G, Meyer Zum Buschenfelde KH. Autoreactive CD4+ LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis. Hepatology 24: 1416-1421 (1996). *

• Loiseau P, Lepage V, Djelal F, Busson M, Tamouza R, Raffoux C, Menkes CJ, Meyer O, Charron D, Goldberg D. HLA class I and class II are both associated with the genetic predisposition to primary Sjogren syndrome. Hum. Immunol. 62: 725-731 (2001).

• Lombardi G, Annese V, Piepoli A, Bovio P, Latiano A, Napolitano G, Perri F, Conoscitore P, Andriulli A. Antineutrophil cytoplasmic antibodies in inflammatory bowel disease: clinical role and review of the literature. Dis. Colon Rectum 43: 999-1007 (2000).

• Longhi MS, Ma Y, Bogdanos DP, Cheeseman P, Mieli-Vergani G, Vergani D. Impairment of CD4+CD25+ regulatory T-cells in autoimmune liver disease. J. Hepatol. 41: 31-37 (2004). *

• Longhi MS, Ma Y, Mieli-Vergani G, Vergani D. Aetiopathogenesis of autoimmune hepatitis. J. Autoimmun. Sep 17 [Epub ahead of print] (2009).

• Looney RJ, Anolik J, Sanz I. Treatment of SLE with anti-CD20 monoclonal antibody. Curr. Dir. Autoimmun. 8: 193-205 (2005).

• Lopate G, Pestronk A, Al-Lozi M, Lynch T, Florence J, Miller T, Levine T, Rampy T, Beson B, Ramneantu I. Peripheral neuropathy in an outpatient cohort of patients with Sjogren's syndrome. Muscle Nerve 33: 672-676 (2006).

• Lopez Serrano P, Santander C, Fernandez Rodriguez C. Prevalence of perinuclear antineutrophil cytoplasmic antibodies (pANCA) in inflammatory bowel disease. Med. Clin. (Barc.) 123: 119 (2004).

• Lopez-Hoyos M, Rodriguez-Valverde V, Martinez-Taboada V. Performance of antinuclear antibody connective tissue disease screen. Ann. N. Y. Acad. Sci. 1109: 322-329 (2007). *

• Lopez-Moratalla N, Ruiz E, Lopez-Zabalza MJ, Santiago E. A common structural motif in immunopotentiating peptides with sequences present in human autoantigens. Elicitation of a response mediated by monocytes and Th1 cells. Biochim. Biophys. Acta 1317: 183-191 (1996).

• Loria P, Lonardo A, Leonardi F, Fontana C, Carulli L, Verrone AM, Borsatti A, Bertolotti M, Cassani F, Bagni A, Muratori P, Ganazzi D, Bianchi FB, Carulli N. Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates. Dig. Dis. Sci. 48: 2173-2181 (2003). *

• Lortholary A, Cary-Ten Have Dallinga M, El Kouri C, Morineau N, Ramee JF. Paclitaxel-induced lupus. Presse. Med. 36: 1207-1208 (2007).

• Loser K, Hansen W, Apelt J, Balkow S, Buer J, Beissert S. In vitro-generated regulatory T cells induced by Foxp3-retrovirus infection control murine contact allergy and systemic autoimmunity. Gene Ther. 12: 1294-1304 (2005).

• Louis M, Rauch J, Armstrong M, Fitzcharles MA. Induction of autoantibodies during prolonged treatment with infliximab. J. Rheumatol. 30: 2557-2562 (2003).

• Louzir B, Othmani S, Ben Abdelhafidh N; Groupe d'Etude du Lupus Erythematuex Systemique en Tunisie. Systemic lupus erythematosus in Tunisia. A multicentric study. About 295 cases. Rev. Med. Interne. 24: 768-774 (2003).

• Lovgren T, Eloranta ML, Kastner B, Wahren-Herlenius M, Alm GV, Ronnblom L. Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjogren's syndrome autoantigen-associated RNA. Arthritis Rheum. 54: 1917-1927 (2006). *

• Lozano A, Vildosola H, Takano J, Vargas G, Uribe R, Moreno C. Clinical and immunological profile in 22 patients with primary biliary cirrhosis. Rev. Gastroenterol. Peru. 20: 14-24 (2000).

• Lozano F, Pares A, Borche L, Plana M, Gallart T, Rodes J, Vives J. Autoantibodies against nuclear envelope-associated proteins in primary biliary cirrhosis. Hepatology 8: 930-938 (1988).

• Lu JJ, Chen DY, Hsieh CW, Lan JL, Lin FJ, Lin SH. Association of Epstein-Barr virus infection with systemic lupus erythematosus in Taiwan. Lupus 16: 168-175 (2007). *

• Luckschander N, Allenspach K, Hall J, Seibold F, Grone A, Doherr MG, Gaschen F. Perinuclear antineutrophilic cytoplasmic antibody and response to treatment in diarrheic dogs with food responsive disease or inflammatory bowel disease. J. Vet. Intern. Med. 20: 221-227 (2006).

• Luckschander N, Hall JA, Gaschen F, Forster U, Wenzlow N, Hermann P, Allenspach K, Dobbelaere D, Burgener IA, Welle M. Activation of nuclear factor-kappaB in dogs with chronic enteropathies. Vet. Immunol. Immunopathol. 133: 228-236 (2010).

• Ludwig D, Stahl M, Ibrahim ET, Wenzel BE, Drabicki D, Wecke A, Fellermann K, Stange EF. Enhanced intestinal expression of heat shock protein 70 in patients with inflammatory bowel diseases. Dig. Dis. Sci. 44: 1440-1447 (1999). *

• Luettig B, Boeker KH, Schoessler W, Will H, Loges S, Schmidt E, Worman HJ, Gershwin ME, Manns MP. The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis. J. Hepatol. 28: 824-828 (1998). *

• Luhder F, Huang Y, Dennehy KM, Guntermann C, Muller I, Winkler E, Kerkau T, Ikemizu S, Davis SJ, Hanke T, Hunig T. Topological requirements and signaling properties of T cell-activating, anti-CD28 antibody superagonists. J. Exp. Med. 197: 955-966 (2003). *

• Ma Q, Battelli L, Hubbs AF. Multiorgan autoimmune inflammation, enhanced lymphoproliferation, and impaired homeostasis of reactive oxygen species in mice lacking the antioxidant-activated transcription factor Nrf2. Am. J. Pathol. 168: 1960-1974 (2006). *

• Ma Y, Bogdanos DP, Hussain MJ, Underhill J, Bansal S, Longhi MS, Cheeseman P, Mieli-Vergani G, Vergani D. Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type-2. Gastroenterology 130: 868-882 (2006). *

• Ma Z, Chen F, Madaio MP, Cohen PL, Eisenberg RA. Modulation of autoimmunity by TLR9 in the chronic graft-vs-host model of systemic lupus erythematosus. J. Immunol. 177: 7444-7450 (2006). *

• MacDermott RP, Schloemann SR, Bertovich MJ, Nash GS, Peters M, Stenson WF. Inhibition of antibody secretion by 5-aminosalicylic acid. Gastroenterology 96: 442-448 (1989).

• Machado SH, von Muhlen CA, Brenol JC, Bisotto L, Xavier RM. The prevalence of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. J. Pediatr. (Rio J.) 81: 491-494 (2005).

• Mackay IR. Historical reflections on autoimmune hepatitis. World J. Gastroenterol. 14: 3292-3300 (2008). *

• Mackay IR. Foreword. Contemporary liver immunology and immunopathology: obstacles and opportunities. In "Liver Immunology: Principles and Practice" (eds. Gershwin ME, Vierling JM, Manns MP), Humana Press Inc., Totowa, NJ, p. 1-14 (2007). *

• Mackay IR, Whittingham S, Fida S, Myers M, Ikuno N, Gershwin ME, Rowley MJ. The peculiar autoimmunity of primary biliary cirrhosis. Immunol. Rev. 174: 226-237 (2000). *

• Maczynska I, Millo B, Ratajczak-Stefanska V, Maleszka R, Szych Z, Kurpisz M, Giedrys-Kalemba S. Proinflammatory cytokine (IL-1beta, IL-6, IL-12, IL-18 and TNF-alpha) levels in sera of patients with subacute cutaneous lupus erythematosus (SCLE). Immunol. Lett. 102: 79-82 (2006).

• Madi L, Cohen S, Ochayin A, Bar-Yehuda S, Barer F, Fishman P. Overexpression of A3 adenosine receptor in peripheral blood mononuclear cells in rheumatoid arthritis: involvement of nuclear factor-kB in mediating receptor level. J. Rheumatol. 34: 20-26 (2007).

• Maeda S, Hikiba Y, Sakamoto K, Nakagawa H, Hirata Y, Hayakawa Y, Yanai A, Ogura K, Karin M, Omata M. Ikappa B kinasebeta/nuclear factor-kappaB activation controls the development of liver metastasis by way of interleukin-6 expression. Hepatology 50: 1851-1860 (2009).

• Maeda S, Hikiba Y, Shibata W, Ohmae T, Yanai A, Ogura K, Yamada S, Omata M. Essential roles of high-mobility group box 1 in the development of murine colitis and colitis-associated cancer. Biochem. Biophys. Res. Commun. 360: 394-400 (2007). *

• Maeda Y, Yamaguchi T, Hijikata Y, Tanaka M, Hirase C, Takai S, Morita Y, Kanamaru A. Partial restoration of immunoglobulin production by cytokines in common variable immunodeficiency. Clin. Lab. 53: 469-475 (2007).

• Maek-A-Nantawat W, Buranapraditkun S, Klaewsongkram J, Ruxrungthum K. Increased interleukin-17 production both in helper T cell subset Th17 and CD4-negative T cells in human immunodeficiency virus infection. Viral Immunol. 20: 66-75 (2007).

• Maek-A-Nantawat W, Silachamroon U. Presence of autoimmune antibody in Chikungunya infection. Case Report Med. 2009: 840183 (2009). *

• Maggiore G, Riva S, Sciveres M. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood. Minerva Gastroenterol. Dietol. 55: 53-70 (2009).

• Maggiore G, Sciveres M. Autoimmune hepatitis: a childhood disease. Current Pediatric Reviews 1: 73-90 (2005). *

• Magnusson SE, Pejler G, Kleinau S, Abrink M. Mast cell chymase contributes to the antibody response and the severity of autoimmune arthritis. FASEB J. 23: 875-882 (2009). *

• Mahadevan U, Sandborn WJ. Evolving medical therapies for Crohn's disease. Curr. Gastroenterol. Rep. 3: 471-476 (2001).

• Mahesh SP, Li Z, Buggage R, Mor F, Cohen IR, Chew EY, Nussenblatt RB. Alpha tropomyosin as a self-antigen in patients with Behcet's disease. Clin. Exp. Immunol. 140: 368-375 (2005). *

• Maiuri L, Auricchio S, Coletta S, De Marco G, Picarelli A, Di Tola M, Quaratino S, Londei M. Blockage of T-cell costimulation inhibits T-cell action in celiac disease. Gastroenterology 115: 564-572 (1998). *

• Makaritsis KP, Gatselis NK, Ioannou M, Petinaki E, Dalekos GN. Polyclonal hypergammaglobulinemia and high smooth-muscle autoantibody titers with specificity against filamentous actin: consider visceral leishmaniasis, not just autoimmune hepatitis. Int. J. Infect. Dis. 13: e157-e160 (2009).

• Makol A, Grover M, Guggenheim C, Hassouna H. Etanercept and venous thromboembolism: a case series. J. Med. Case Reports 4: 12 (2010). *

• Malaguarnera M, Guccione N, Musumeci S, Brogna A, Motta M, Di Fazio I. Intravenous immunoglobulin plus interferon-alpha in autoimmune hepatitis C. BioDrugs 18: 63-70 (2004).

• Malleson PN, Fung MY, Petty RE, Mackinnon MJ, Schroeder ML. Autoantibodies in chronic arthritis of childhood: relations with each other and with histocompatibility antigens. Ann. Rheum. Dis. 51: 1301-1306 (1992). *

• Malviya G, Conti F, Chianelli M, Scopinaro F, Dierckx RA, Signore A. Molecular imaging of rheumatoid arthritis by radiolabelled monoclonal antibodies: new imaging strategies to guide molecular therapies. Eur. J. Nucl. Med. Mol. Imaging Sep 24 [Epub ahead of print] (2009).

• Malviya G, D'Alessandria C, Bonanno E, Vexler V, Massari R, Trotta C, Scopinaro F, Dierckx R, Signore A. Radiolabeled humanized anti-CD3 monoclonal antibody visilizumab for imaging human T-lymphocytes. J. Nucl. Med. 50: 1683-1691 (2009). *

• Mameli G, Astone V, Arru G, Marconi S, Lovato L, Serra C, Sotgiu S, Bonetti B, Dolei A. Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERV-W endogenous retrovirus, but not Human herpesvirus 6. J. Gen. Virol. 88: 264-274 (2007). *

• Mancini S, Amorotti E, Vecchio S, Ponz de Leon M, Roncucci L. Infliximab-related hepatitis: discussion of a case and review of the literature. Intern. Emerg. Med. Jan 27 [Epub ahead of print] (2010).

• Mandel M, Gurevich M, Pauzner R, Kaminski N, Achiron A. Autoimmunity gene expression portrait: specific signature that intersects or differentiates between multiple sclerosis and systemic lupus erythematosus. Clin. Exp. Immunol. 138: 164-170 (2004). *

• Manderson AP, Carlucci F, Lachmann PJ, Lazarus RA, Festenstein RJ, Cook HT, Walport MJ, Botto M. The in vivo expression of actin/salt-resistant hyperactive DNase I inhibits the development of anti-ssDNA and anti-histone autoantibodies in a murine model of systemic lupus erythematosus. Arthritis Res. Ther. 8: R68 (2006). *

• Manger K, Repp R, Spriewald BM, Rascu A, Geiger A, Wassmuth R, Westerdaal NA, Wentz B, Manger B, Kalden JR, van de Winkel JG. Fcgamma receptor IIa polymorphism in Caucasian patients with systemic lupus erythematosus: association with clinical symptoms. Arthritis Rheum. 41: 1181-1189 (1998). *

• Mannon PJ, Fuss IJ, Mayer L, Elson CO, Sandborn WJ, Present D, Dolin B, Goodman N, Groden C, Hornung RL, Quezado M, Neurath MF, Salfeld J, Veldman GM, Schwertschlag U, Strober W; Anti-IL-12 Crohn's Disease Study Group. Anti-interleukin-12 antibody for active Crohn's disease. N. Engl. J. Med. 351: 2069-2079 (2004). *

• Manns M, Meyer zum Buschenfelde KH, Arnold W. The diagnostic value of immunologic findings in the differentiation of chronic liver diseases. Leber. Magen. Darm. 18: 290-292, 295, 298 (1988).

• Manns MP. Round table: classification of autoimmune liver diseases and diagnostic criteria. Subgroups of autoimmune hepatitis are important. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 56-57 (2004). *

• Manns MP, Nakamura RM. Autoimmune liver diseases. Clin. Lab. Med. 8: 281-301 (1988).

• Manns MP, Vogel A. Autoimmune hepatitis, from mechanisms to therapy. Hepatology 43: S132-S144 (2006). *

• Manolios N, Dunckley H, Chivers T, Brooks P, Englert H. Immunogenetic analysis of 5 families with multicase occurrence of scleroderma and/or related variants. J. Rheumatol. 22: 85-92 (1995).

• Manson JJ, Rahman A. Systemic lupus erythematosus. Orphanet J. Rare Dis. 1: 6 (2006). *

• Mansoor F, Ali A, Ali R. Binding of circulating SLE autoantibodies to oxygen free radical damaged chromatin. Autoimmunity 38: 431-438 (2005).

• Mantel I, Ramchand KV, Holder GE, Ohbayashi M, Morohoshi K, Patel N, Toda M, Fitzke FW, Bird AC, Ono SJ. Macular and retinal dysfunction of unknown origin in adults with normal fundi: evidence for an autoimmune pathophysiology. Exp. Mol. Pathol. 84: 90-101 (2008). *

• Manuel Lucena J, Montes Cano M, Luis Caro J, Respaldiza N, Alvarez A, Sanchez-Roman J, Nunez-Roldán A, Wichmann I. Comparison of two ELISA assays for anti-sp100 determination. Ann. N. Y. Acad. Sci. 1109: 203-211 (2007). *

• Marasini B, Gagetta M, Rossi V, Ferrari P. Rheumatic disorders and primary biliary cirrhosis: an appraisal of 170 Italian patients. Ann. Rheum. Dis. 60: 1046-1049 (2001). *

• Marchini B, Dolcher MP, Sabbatini A, Klein G, Migliorini P. Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases. J. Autoimmun. 7: 179-191 (1994).

• Marcinkiewicz M, Gryc E, Kreczko S. The role of selected serologic markers in the diagnosis of autoimmune hepatitis. Przegl. Lek. 55: 614-618 (1998).

• Maret M, Ruffie C, Periquet B, Campo AM, Menevret M, Phelep A, Dziewiszek K, Druilhe A, Pretolani M. Liposomal retinoic acids modulate asthma manifestations in mice. J. Nutr. 137: 2730-2736 (2007). *

• Marfatia YS, Ghiya RA, Chaudhary D. Dermatomyositis in a human immunodeficiency virus infected person. Indian J. Dermatol. Venereol. Leprol. 74: 241-243 (2008).

• Marie I, Levesque H, Tranvouez JL, Francois A, Riachi G, Cailleux N, Courtois H. Autoimmune hepatitis and systemic sclerosis: a new overlap syndrome? Rheumatology (Oxford) 40: 102-106 (2001). *

• Marin GG, Cardiel MH, Cornejo H, Viveros ME. Prevalence of antinuclear antibodies in 3 groups of healthy individuals: blood donors, hospital personnel, and relatives of patients with autoimmune diseases. J. Clin. Rheumatol. 15: 325-329 (2009).

• Marini M, Bamias G, Rivera-Nieves J, Moskaluk CA, Hoang SB, Ross WG, Pizarro TT, Cominelli F. TNF-alpha neutralization ameliorates the severity of murine Crohn's-like ileitis by abrogation of intestinal epithelial cell apoptosis. Proc. Natl. Acad. Sci. U.S.A. 100: 8366-8371 (2003). *

• Marks MA, Gravitt PE, Burk RR, Studentsov Y, Farzadegan H, Klein SL. Progesterone and 17beta-estradiol enhance regulatory responses to HPV 16 VLP in peripheral blood mononuclear cells from healthy women. Clin. Vaccine Immunol. Feb 3 [Epub ahead of print] (2010). *

• Marshak-Rothstein A, Busconi L, Rifkin IR, Viglianti GA. The stimulation of Toll-like receptors by nuclear antigens: a link between apoptosis and autoimmunity. Rheum. Dis. Clin. North Am. 30: 559-574, ix (2004).

• Marshall AC, Toh BH, Alderuccio F. Tumor necrosis factor alpha is not implicated in the genesis of experimental autoimmune gastritis. J. Autoimmun. 22: 1-11 (2004). *

• Marshall-Heyman H, Engel G, Ljungdahl S, Shoshan MC, Svensson C, Wasylyk B, Linder S. Tumorigenic and metastatic properties of two ras-oncogene transfected rat fibrosarcoma cell lines defective in c-jun. Oncogene 9: 3655-3663 (1994).

• Marta S, Ewa NM, Miroslaw S, Marek S, Krzysztof L, Jan Z. The diagnostic problems in patient with ascites, elevated Ca 125 level and autoantibodies against nuclear antigens and smooth muscle antigens mimicking advanced ovarian carcinoma - case study. Ginekol. Pol. 79: 375-377 (2008).

• Martinez P, Aggio M, Rozenfeld P. High incidence of autoantibodies in Fabry disease patients. J. Inherit. Metab. Dis. 30: 365-369 (2007). *

• Martins EB, Chapman RW. Sclerosing cholangitis. Curr. Opin. Gastroenterol. 17: 458-462 (2001).

• Martinsson K, Hultman P. The role of Fc-receptors in murine mercury-induced systemic autoimmunity. Clin. Exp. Immunol. 144: 309-318 (2006). *

• Martinuc Porobic J, Avcin T, Bozic B, Kuhar M, Cucnik S, Zupancic M, Prosenc K, Kveder T, Rozman B. Anti-phospholipid antibodies following vaccination with recombinant hepatitis B vaccine. Clin. Exp. Immunol. 142: 377-380 (2005). *

• Marttila J, Huttunen S, Vaarala O, Suzuki K, Elliott JF, Narvanen A, Knip M, Simell O, Ilonen J. T-cell reactivity to insulin peptide A1-12 in children with recently diagnosed type 1 diabetes or multiple beta-cell autoantibodies. J. Autoimmun. 31: 142-148 (2008).

• Marzano A, Vezzoli P, Crosti C. Drug-induced lupus: an update on its dermatologic aspects. Lupus 18: 935-940 (2009). *

• Marzo-Ortega H, Baxter K, Strauss RM, Drysdale S, Griffiths B, Misbah SA, Gough A, Cunliffe WJ, Emery P. Is minocycline therapy in acne associated with antineutrophil cytoplasmic antibody positivity? A cross-sectional study. Br. J. Dermatol. 156: 1005-1009 (2007). *

• Masaki Y, Dong L, Kurose N, Kitagawa K, Morikawa Y, Yamamoto M, Takahashi H, Shinomura Y, Imai K, Saeki T, Azumi A, Nakada S, Sugiyama E, Matsui S, Origuchi T, Nishiyama S, Nishimori I, Nojima T, Yamada K, Kawano M, Zen Y, Kaneko M, Miyazaki K, et al. Proposal for a new clinical entity, IgG4-positive multi-organ lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann. Rheum. Dis. 68: 1310-1315 (2009).

• Masamune A, Kikuta K, Watanabe T, Satoh K, Hirota M, Hamada S, Shimosegawa T. Fibrinogen induces cytokine and collagen production in pancreatic stellate cells. Gut 58: 550-559 (2009).

• Maser EA, Present DH. Pouch-ouch. Curr. Opin. Gastroenterol. 24: 70-74 (2008). *

• Mason A, Nair S. Primary biliary cirrhosis: new thoughts on pathophysiology and treatment. Curr. Gastroenterol. Rep. 4: 45-51 (2002).

• Mason AL, Xu L, Guo L, Munoz S, Jaspan JB, Bryer-Ash M, Cao Y, Sander DM, Shoenfeld Y, Ahmed A, Van de Water J, Gershwin ME, Garry RF. Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet 351: 1620-1624 (1998). *

• Mason J, Bossingham D. The clinical characterisation of systemic lupus erythematosus in a Far North Queensland Indigenous kindred. Lupus 18: 144-148 (2009). *

• Masson-Bessiere C, Sebbag M, Girbal-Neuhauser E, Nogueira L, Vincent C, Senshu T, Serre G. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J. Immunol. 166: 4177-4184 (2001). *

• Masuda J, Omagari K, Matsuo I, Kinoshita H, Sakimura K, Hazama H, Ohba K, Isomoto H, Murase K, Murata I, Kohno S. Changes in titers of antimitochondrial and antinuclear antibodies during the course of primary biliary cirrhosis. J. Gastroenterol. Hepatol. 16: 239-243 (2001). *

• Masumoto T, Ninomiya T, Michitaka K, Horiike N, Yamamoto K, Akbar SM, Abe M, Onji M. Three patients with autoimmune cholangiopathy treated with prednisolone. J. Gastroenterol. 33: 909-913 (1998). *

• Mathsson L, Ahlin E, Sjowall C, Skogh T, Ronnelid J. Cytokine induction by circulating immune complexes and signs of in-vivo complement activation in systemic lupus erythematosus are associated with the occurrence of anti-Sjogren's syndrome A antibodies. Clin. Exp. Immunol. 147: 513-520 (2007). *

• Mathsson L, Lampa J, Mullazehi M, Ronnelid J. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells. Arthritis Res. Ther. 8: R64 (2006). *

• Matos M, Capozzolo N, Golindano C, Gonzalez JC, Guirola E, Ramirez R, Machado I. Humoral immunologic changes in inflammatory colonic diseases. G. E. N. 47: 129-135 (1993).

• Matsubayashi H, Tomita H, Sugiura T, Sasaki K, Inui T, Takizawa K, Yamaguchi Y, Ono H. Autoimmune pancreatitis without a response to steroid therapy: a case which met criteria after withdrawal of steroid. Intern. Med. 48: 2087-2091 (2009). *

• Matsumoto K, Inoue H, Tsuda M, Nakano T, Komori M, Fukuyama S, Nakanishi Y. Different profiles of IL-10+IFN-gamma-IL-4-CD4+ T cells in the peripheral blood in atopic and non-atopic asthmatics. Respiration 75: 281-287 (2008). *

• Matsumoto S, Hashimoto K, Yamada M, Satoh T, Hirato J, Mori M. Liver X receptor-alpha positively regulates proopiomelanocortin (POMC) gene expression at the transcriptional level in the pituitary. Mol. Endocrinol. 23: 47-60 (2009). *

• Matsuo I, Ikuno N, Omagari K, Kinoshita H, Oka M, Yamaguchi H, Kohno S, Mackay IR. Autoimmune reactivity of sera to hepatocyte plasma membrane in type 1 autoimmune hepatitis. J. Gastroenterol. 35: 226-234 (2000).

• Matsuoka K, Inoue N, Sato T, Okamoto S, Hisamatsu T, Kishi Y, Sakuraba A, Hitotsumatsu O, Ogata H, Koganei K, Fukushima T, Kanai T, Watanabe M, Ishii H, Hibi T. T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn's disease. Gut 53: 1303-1308 (2004). *

• Matsushita M, Takemura T, Imai Y, Takimoto K, Kuchide M, Kajikawa H, Kojima Y, Shimamoto F, Yamauchi H, Matsuyama K, Yoshikawa T. A case of probable autoimmune hepatitis from which the persistence of hepatitis A IgM antibody, and the improvement was pathologically obtained by ursodeoxycholic acid medication. Nippon Shokakibyo Gakkai Zasshi 105: 1367-1374 (2008).

• Mattalia A, Luttig B, Rosina F, Leung PS, Van de Water J, Bauducci M, Ciancio A, Boker KH, Worman H, Cooper RL, Manns M, Ansari A, Rizzetto M, Gershwin ME. Persistence of autoantibodies against recombinant mitochondrial and nuclear pore proteins after orthotopic liver transplantation for primary biliary cirrhosis. J. Autoimmun. 10: 491-497 (1997). *

• Maunder RG, Greenberg GR, Hunter JJ, Lancee WJ, Steinhart AH, Silverberg MS. Psychobiological subtypes of ulcerative colitis: pANCA status moderates the relationship between disease activity and psychological distress. Am. J. Gastroenterol. 101: 2546-2551 (2006). *

• Mayanja-Kizza H, Wu M, Aung H, Liu S, Luzze H, Hirsch C, Toossi Z. The interaction of monocyte chemoattractant protein-1 and tumour necrosis factor-alpha in Mycobacterium tuberculosis-induced HIV-1 replication at sites of active tuberculosis. Scand. J. Immunol. 69: 516-520 (2009). *

• Mayet W, Schwarting A, Barreiros AP, Schlaak J, Neurath M. Anti-PR-3 antibodies induce endothelial IL-8 release. Eur. J. Clin. Invest. 29: 973-979 (1999).

• Mayo I, Arribas J, Villoslada P, Alvarez DoForno R, Rodriguez-Vilarino S, Montalban X, De Sagarra MR, Castano JG. The proteasome is a major autoantigen in multiple sclerosis. Brain 125: 2658-2667 (2002). *

• Mazurak VC, Lien V, Field CJ, Goruk SD, Pramuk K, Clandinin MT. Long-chain polyunsaturated fat supplementation in children with low docosahexaenoic acid intakes alters immune phenotypes compared with placebo. J. Pediatr. Gastroenterol. Nutr. 46: 570-579 (2008). *

• McClain MT, Heinlen LD, Dennis GJ, Roebuck J, Harley JB, James JA. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat. Med. 11: 85-89 (2005). *

• McClain MT, Poole BD, Bruner BF, Kaufman KM, Harley JB, James JA. An altered immune response to Epstein-Barr nuclear antigen 1 in pediatric systemic lupus erythematosus. Arthritis Rheum. 54: 360-368 (2005). *

• McClain MT, Rapp EC, Harley JB, James JA. Infectious mononucleosis patients temporarily recognize a unique, cross-reactive epitope of Epstein-Barr virus nuclear antigen-1. J. Med. Virol. 70: 253-257 (2003). *

• McDonnell DP, Mangelsdorf DJ, Pike JW, Haussler MR, O'Malley BW. Molecular cloning of complementary DNA encoding the avian receptor for vitamin D. Science 235: 1214-1217 (1987).

• McFarlane IG. Autoimmune liver diseases. Scand. J. Clin. Lab. Invest. 235: 53-60 (2001).

• McFarlane IG. Autoimmune markers and their role in the pathogenesis of PSC. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 70. October 15-16 (2003). *

• McGhee JL, Kickingbird LM, Jarvis JN. Clinical utility of antinuclear antibody tests in children. BMC Pediatr. 4: 13 (2004). *

• McKeon A, Ahlskog JE, Britton JA, Lennon VA, Pittock SJ. Reversible extralimbic paraneoplastic encephalopathies with large abnormalities on magnetic resonance images. Arch. Neurol. 66: 268-271 (2009).

• McKnight K, Jiang Y, Hart Y, Cavey A, Wroe S, Blank M, Shoenfeld Y, Vincent A, Palace J, Lang B. Serum antibodies in epilepsy and seizure-associated disorders. Neurology 65: 1730-1736 (2005).

• McMillan SA, Alderdice JM, McKee CM, Dawson AT, Callender ME, Fulton TT, Haire M. Diversity of autoantibodies in patients with antimitochondrial antibody and their diagnostic value. J. Clin. Pathol. 40: 232-236 (1987). *

• McNair AN, Moloney M, Portmann BC, Williams R, McFarlane IG. Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases. Am. J. Gastroenterol. 93: 777-784 (1998). *

• McNearney TA, Hunnicutt SE, Fischbach M, Friedman AW, Aguilar M, Ahn CW, Reveille JD, Lisse JR, Baethge BA, Goel N, Mayes MD. Perceived functioning has ethnic-specific associations in systemic sclerosis: another dimension of personalized medicine. J. Rheumatol. 36: 2724-2732 (2009).

• Mecklenbrauker I, Kalled SL, Leitges M, Mackay F, Tarakhovsky A. Regulation of B-cell survival by BAFF-dependent PKCdelta-mediated nuclear signalling. Nature 431: 456-461 (2004). *

• Mehendiratta V, Mitroo P, Bombonati A, Navarro VJ, Rossi S, Rubin R, Herrine SK. Serologic markers do not predict histologic severity or response to treatment in patients with autoimmune hepatitis. Clin. Gastroenterol. Hepatol. 7: 98-103 (2009).

• Meliconi R, Miglio F, Stancari MV, Baraldini M, Stefanini GF, Gasbarrini G. Hepatocyte membrane-bound IgG and circulating liver-specific autoantibodies in chronic liver disease: relation to hepatitis B virus serum markers and liver histology. Hepatology 3: 155-161 (1983).

• Meliconi R, Stancari MV, Garagnani M, Baraldini M, Stefanini GF, Miglio F, Gasbarrini G. Occurrence and significance of IgG liver membrane autoantibodies (LMA) in chronic liver diseases of different aetiology. Clin. Exp. Immunol. 51: 565-571 (1983). *

• Mellbye OJ, Mollnes TE, Steen LS. IgG subclass distribution and complement activation ability of autoantibodies to neutrophil cytoplasmic antigens (ANCA). Clin. Immunol. Immunopathol. 70: 32-39 (1994).

• Melmed GY, Elashoff R, Chen GC, Nastaskin I, Papadakis KA, Vasiliauskas EA, Liu W, Landers C, Ippoliti AF, Targan SR. Predicting a change in diagnosis from ulcerative colitis to Crohn's disease: a nested, case-control study. Clin. Gastroenterol. Hepatol. 5: 602-608 (2007).

• Melmed GY, Fleshner PR, Bardakcioglu O, Ippoliti A, Vasiliauskas EA, Papadakis KA, Dubinsky M, Landers C, Rotter JI, Targan SR. Family history and serology predict Crohn's disease after ileal pouch-anal anastomosis for ulcerative colitis. Dis. Colon Rectum 51: 100-108 (2008). *

• Mendez-Sanchez N, Aguilar-Dominguez C, Chavez-Tapia NC, Uribe M. Hepatic manifestations of Epstein-Barr viral infection. Ann. Hepatol. 4: 205-209 (2005). *

• Mendoza JL, Abreu MT. Biological markers in inflammatory bowel disease: practical consideration for clinicians. Gastroenterol. Clin. Biol. 33S3: S158-S173 (2009).

• Meristoudis G, Liotsou T, Ilias I, Christakopoulou J. Atypical subacute thyroiditis causing fever of unknown origin: the value of gallium-67 imaging. Hell. J. Nucl. Med. 11: 120-121 (2008).

• Merkel PA, Polisson RP, Chang Y, Skates SJ, Niles JL. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann. Intern. Med. 126: 866-873 (1997).

• Meroni PL, Raschi E, Testoni C, Parisio A, Borghi MO. Innate immunity in the antiphospholipid syndrome: role of Toll-like receptors in endothelial cell activation by antiphospholipid antibodies. Autoimmun. Rev. 3: 510-515 (2004).

• Mete N, Gulbahar O, Aydin A, Sin AZ, Kokuludag A, Sebik F. Low B2 levels in chronic idiopathic urticaria. J. Investig. Allergol. Clin. Immunol. 14: 292-299 (2004). *

• Metskula K, Salur L, Mandel M, Uibo R. Demonstration of high prevalence of SS-A antibodies in a general population: association with HLA-DR and enterovirus antibodies. Immunol. Lett. 106: 14-18 (2006).

• Meyer O. Evaluating inflammatory joint disease: how and when can autoantibodies help? Joint Bone Spine 70: 433-447 (2003).

• Meyer zum Buschenfelde KH. Immunology of liver diseases. Schweiz. Med. Wochenschr. 117: 1065-1075 (1987).

• Mezzesimi A, Florio P, Reis FM, D'Aniello G, Sabatini L, Razzi S, Fineschi D, Petraglia F. The detection of anti-beta2-glycoprotein I antibodies is associated with increased risk of pregnancy loss in women with threatened abortion in the first trimester. Eur. J. Obstet. Gynecol. Reprod. Biol. 133: 164-168 (2007).

• Michieletti P, Wanless IR, Katz A, Scheuer PJ, Yeaman SJ, Bassendine MF, Palmer JM, Heathcote EJ. Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis. Gut 35: 260-265 (1994). *

• Mieli-Vergani G, Heller S, Jara P, Vergani D, Chang MH, Fujisawa T, Gonzalez-Peralta RP, Kelly D, Mohan N, Shah U, Murray KF. Autoimmune hepatitis. J. Pediatr. Gastroenterol. Nutr. 49: 158-164 (2009).

• Mieli-Vergani G, Vergani D. Immunological liver diseases in children. Semin. Liver Dis. 18: 271-279 (1998).

• Mieli-Vergani G, Vergani D. Approach to a child with chronic liver disease. J. Gastroenterol. Hepatol. 19: S377-S378 (2004). *

• Mieli-Vergani G, Vergani D. Autoimmune liver disease in children. Ann. Acad. Med. Singapore 32: 239-243 (2003). *

• Mieli-Vergani G, Vergani D. Autoimmune paediatric liver disease. World J. Gastroenterol. 14: 3360-3367 (2008). *

• Mieli-Vergani G, Vergani D. Autoimmune liver disease - therapeutic aspects in children. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 89-91 (2004). *

• Mieli-Vergani G, Vergani D. Autoimmune liver disease. Indian J. Pediatr. 69: 93-98 (2002).

• Mieli-Vergani G, Vergani D. Autoimmune hepatitis in children: what is different from adult AIH? Semin. Liver Dis. 29: 297-306 (2009).

• Mieli-Vergani G, Vergani D. Chapter 21. Unique aspects of autoimmune hepatitis in children. In "Liver Immunology: Principles and Practice" (eds. Gershwin ME, Vierling JM, Manns MP), Humana Press Inc., Totowa, NJ, p. 277-283 (2007). *

• Mieli-Vergani G, Vergani D. Autoimmune liver disease in children. Pedgastro 2005 - Conference Abstracts. Pediatric Oncall [http://www.pediatriconcall.com/fordoctor/Conference_abstracts/autoimmune_liver_disease_in_children.asp] (2006).

• Migita K, Abiru S, Maeda Y, Nakamura M, Komori A, Ito M, Fujiwara S, Yano K, Yatsuhashi H, Eguchi K, Ishibashi H. Elevated serum BAFF levels in patients with autoimmune hepatitis. Hum. Immunol. 68: 586-591 (2007).

• Migliorini P, Baldini C, Rocchi V, Bombardieri S. Anti-Sm and anti-RNP antibodies. Autoimmunity 38: 47-54 (2005).

• Mihailova D, Grigorova R, Vassileva B, Mladenova G, Ivanova N, Stephanov S, Lissitchky K, Dimova E. Autoimmune thyroid disorders in juvenile chronic arthritis and systemic lupus erythematosus. Adv. Exp. Med. Biol. 455: 55-60 (1999).

• Mikata R, Yokosuka O, Imazeki F, Fukai K, Kanda T, Saisho H. Prolonged acute hepatitis A mimicking autoimmune hepatitis. World J. Gastroenterol. 11: 3791-3793 (2005). *

• Milkiewicz P, Buwaneswaran H, Coltescu C, Shums Z, Norman GL, Heathcote EJ. Value of autoantibody analysis in the differential diagnosis of chronic cholestatic liver disease. Clin. Gastroenterol. Hepatol. 7: 1355-1360 (2009).

• Miller PD. Denosumab: anti-RANKL antibody. Curr. Osteoporos. Rep. 7: 18-22 (2009).

• Minden K, Mingels A, Niewerth M, Heiligenhaus A, Ganser G. Juvenile idiopathic arthritis and uveitis: epidemiology including data from a national database. Klin. Monatsbl. Augenheilkd. 224: 469-472 (2007).

• Misdraji J, Thiim M, Graeme-Cook FM. Autoimmune hepatitis with centrilobular necrosis. Am. J. Surg. Pathol. 28: 471-478 (2004).

• Mishima S, Omagari K, Ohba K, Kadokawa Y, Masuda J, Mishima R, Kinoshita H, Hayashida K, Isomoto H, Shikuwa S, Mizuta Y, Kohno S. Clinical implications of antimitochondrial antibodies in type 1 autoimmune hepatitis: a longitudinal study. Hepatogastroenterology 55: 221-227 (2008).

• Misra R, Singh G, Aggarwal P, Aggarwal A. Juvenile onset systemic sclerosis: a single center experience of 23 cases from Asia. Clin. Rheumatol. 26: 1259-1262 (2007).

• Misu N, Zhang M, Mori S, Miyazaki T, Furukawa H, Sasaki T, Nose M, Ono M. Autosomal loci associated with a sex-related difference in the development of autoimmune phenotypes in a lupus model. Eur. J. Immunol. 37: 2787-2796 (2007). *

• Mitoma H, Horiuchi T, Tsukamoto H, Tamimoto Y, Kimoto Y, Uchino A, To K, Harashima SI, Hatta N, Harada M. Mechanisms for cytotoxic effects of anti-tumor necrosis factor agents on transmembrane tumor necrosis factor alpha-expressing cells: comparison among infliximab, etanercept, and adalimumab. Arthritis Rheum. 58: 1248-1257 (2008). *

• Mittler RS, Foell J, McCausland M, Strahotin S, Niu L, Bapat A, Hewes LB. Anti-CD137 antibodies in the treatment of autoimmune disease and cancer. Immunol. Res. 29: 197-208 (2004). *

• Mix H, Weiler-Normann C, Thimme R, Ahlenstiel G, Shin EC, Herkel J, David CS, Lohse AW, Rehermann B. Identification of CD4 T-cell epitopes in soluble liver antigen/liver pancreas autoantigen in autoimmune hepatitis. Gastroenterology 135: 2107-2118 (2008). *

• Miyachi K, Gupta RC, Dickson ER, Tan EM. Precipitating antibodies to mitochondrial antigens in patients with primary biliary cirrhosis. Clin. Exp. Immunol. 39: 599-606 (1980). *

• Miyachi K, Hankins RW, Matsushima H, Kikuchi F, Inomata T, Horigome T, Shibata M, Onozuka Y, Ueno Y, Hashimoto E, Hayashi N, Shibuya A, Amaki S, Miyakawa H. Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study. J. Autoimmun. 20: 247-254 (2003). *

• Miyachi K, Hirano Y, Horigome T, Mimori T, Miyakawa H, Onozuka Y, Shibata M, Hirakata M, Suwa A, Hosaka H, Matsushima S, Komatsu T, Matsushima H, Hankins RW, Fritzler MJ. Autoantibodies from primary biliary cirrhosis patients with anti-p95c antibodies bind to recombinant p97/VCP and inhibit in vitro nuclear envelope assembly. Clin. Exp. Immunol. 136: 568-573 (2004). *

• Miyachi K, Matsushima H, Hankins RW, Hirakata M, Mimori T, Hosaka H, Amagasaki Y, Miyakawa H, Kako M, Shibata M, Onozuka Y, Ueno U. A novel antibody directed against a three-dimensional configuration of a 95-kDa protein in patients with autoimmune hepatic diseases. Scand. J. Immunol. 47: 63-68 (1998). *

• Miyachi K, Miyakawa H, Oda M, Horigome T, Fritzler M. Primary biliary cirrhosis and autoantibodies. Nihon Rinsho Meneki Gakkai Kaishi 31: 47-55 (2008).

• Miyachi K, Shibata M, Onozuka Y, Kikuchi F, Imai N, Horigome T. Primary biliary cirrhosis sera recognize not only gp210 but also proteins of the p62 complex bearing N-acetylglucosamine residues from rat liver nuclear envelope. Anti-p62 complex antibody in PBC. Mol. Biol. Rep. 23: 227-234 (1996).

• Miyake Y, Iwasaki Y, Kobashi H, Yasunaka T, Ikeda F, Takaki A, Okamoto R, Takaguchi K, Ikeda H, Makino Y, Ando M, Sakaguchi K, Yamamoto K. Clinical features of antinuclear antibodies-negative type 1 autoimmune hepatitis. Hepatol. Res. 39: 241-246 (2009). *

• Miyake Y, Iwasaki Y, Kobashi H, Yasunaka T, Ikeda F, Takaki A, Yamamoto K. Autoimmune hepatitis with acute presentation in Japan. Dig. Liver Dis. May 25 [Epub ahead of print] (2009).

• Miyake Y, Iwasaki Y, Kobashi H, Yasunaka T, Ikeda F, Takaki A, Yamamoto K. Clinical features of autoimmune hepatitis diagnosed based on simplified criteria of the International Autoimmune Hepatitis Group. Dig. Liver Dis. Jul 24 [Epub ahead of print] (2009).

• Miyake Y, Iwasaki Y, Takaki A, Kobashi H, Sakaguchi K, Shiratori Y. Clinical features of Japanese elderly patients with type 1 autoimmune hepatitis. Intern. Med. 46: 1945-1950 (2007). *

• Miyake Y, Sakaguchi K, Tanaka H, Nakamura S, Kobayashi Y, Fujioka S, Iwasaki Y, Shiratori Y. Development of hepatocellular carcinoma in a woman with HBV- and HCV-negative autoimmune hepatitis with unsatisfactory response to corticosteroid. Intern. Med. 44: 949-953 (2005). *

• Miyake Y, Yamamoto K. Current status of autoimmune hepatitis in Japan. Acta Med. Okayama 62: 217-226 (2008). *

• Miyawaki S, Asanuma H, Nishiyama S, Yoshinaga Y. Clinical and serological heterogeneity in patients with anticentromere antibodies. J. Rheumatol. 32: 1488-1494 (2005).

• Mizoguchi E, Mizoguchi A, Chiba C, Niles JL, Bhan AK. Antineutrophil cytoplasmic antibodies in T-cell receptor alpha-deficient mice with chronic colitis. Gastroenterology 113: 1828-1835 (1997). *

• Mochida S, Yoshimoto T, Mimura S, Inao M, Matsui A, Ohno A, Koh H, Saitoh E, Nagoshi S, Fujiwara K. Transgenic mice expressing osteopontin in hepatocytes as a model of autoimmune hepatitis. Biochem. Biophys. Res. Commun. 317: 114-120 (2004). *

• Moder KG, Wener MH, Weisman MH, Ishimori ML, Wallace DJ, Buckeridge DL, Homburger HA. Measurement of antinuclear antibodies by multiplex immunoassay: a prospective, multicenter clinical evaluation. J. Rheumatol. 34: 978-986 (2007).

• Mokrowiecka A, Daniel P, Slomka M, Majak P, Malecka-Panas E. Clinical utility of serological markers in inflammatory bowel disease. Hepatogastroenterology 56: 162-166 (2009).

• Mokrowiecka A, Gasiorowska A, Malecka-Panas E. pANCA and ASCA in the diagnosis of different subtypes of inflammatory bowel disease. Hepatogastroenterology 54: 1443-1438 (2007).

• Monaco C, Gregan SM, Navin TJ, Foxwell BM, Davies AH, Feldmann M. Toll-like receptor-2 mediates inflammation and matrix degradation in human atherosclerosis. Circulation 120: 2462-2469 (2009).

• Mongey AB, Hess EV; Medscape. Drug insight: autoimmune effects of medications - what's new? Nat. Clin. Pract. Rheumatol. 4: 136-144 (2008). *

• Monneaux F, Muller S. The spliceosome and its interest for lupus therapy. Rev. Med. Interne. 28: 725-728 (2007).

• Monnet D, Moachon L, Dougados M, Brezin AP. Severe uveitis in an HLA-B27-positive patient with ankylosing spondylitis. Nat. Clin. Pract. Rheumatol. 2: 393-397 (2006). *

• Montcuquet N, Mercier-Letondal P, Perruche S, Duperrier A, Couturier M, Bouchekioua A, Bonyhadi M, Ferrand C, Tiberghien P, Robinet E. Regulatory T-cell expansion and function do not account for the impaired alloreactivity of ex vivo-expanded T cells. Immunology 125: 320-330 (2008). *

• Montes Santiago J, Gambon Deza F, Garcia Garcia MJ, Gonzalez Vazquez L, Hermo Brion JA, Perez Alvarez R. Usefulness of autoantibodies in the study of autoimmune liver diseases and prevalence of autoimmune extrahepatic manifestations. An. Med. Interna. 17: 343-346 (2000).

• Moon H, Noh J, Hur M, Yun Y, Lee CH, Kwon SY. High prevalence of autoantibodies in hepatitis A infection: the impact on laboratory profiles. J. Clin. Pathol. 62: 786-788 (2009).

• Moon UY, Park SJ, Oh ST, Kim WU, Park SH, Lee SH, Cho CS, Kim HY, Lee WK, Lee SK. Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood. Arthritis Res. Ther. 6: R295-R302 (2004). *

• Moore MM, Fabricatorian D, Selby WS. Assessment and relevance of enzyme-linked immunosorbent assay for antibodies to Saccharomyces cerevisiae in Australian patients with inflammatory bowel disease. Intern. Med. J. 32: 349-352 (2002). *

• Mor A, Bingham C 3rd, Barisoni L, Lydon E, Belmont HM. Proliferative lupus nephritis and leukocytoclastic vasculitis during treatment with etanercept. J. Rheumatol. 32: 740-743 (2005).

• Morel S, Georges A, Bordenave L, Corcuff JB. Thyroid and gastric autoimmune diseases. Ann. Endocrinol. (Paris) 70: 55-58 (2009).

• Moreno-Otero R, Civeira MP, Suou T, Kanof ME, James SP, Jones EA. Reduced numbers of CD8+ T cells and B cell-expression of Leu-8 antigen in peripheral blood of patients with primary biliary cirrhosis. Hepatogastroenterology 41: 239-243 (1994).

• Morgan MD, Day CJ, Piper KP, Khan N, Harper L, Moss PA, Savage CO. Patients with Wegener's granulomatosis demonstrate a relative deficiency and functional impairment of T-regulatory cells. Immunology Jan 27 [Epub ahead of print] (2010). *

• Morimoto S, Nakano S, Watanabe T, Tamayama Y, Mitsuo A, Nakiri Y, Suzuki J, Nozawa K, Amano H, Tokano Y, Kobata T, Takasaki Y. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production. Rheumatology (Oxford) 46: 1083-1086 (2007). *

• Moritoki Y, Lian ZX, Wulff H, Yang GX, Chuang YH, Lan RY, Ueno Y, Ansari AA, Coppel RL, Mackay IR, Gershwin ME. AMA production in primary biliary cirrhosis is promoted by the TLR9 ligand CpG and suppressed by potassium channel blockers. Hepatology 45: 314-322 (2007). *

• Moriyama H, Nagata M, Arai T, Okumachi Y, Yamada K, Kotani R, Yasuda H, Hara K, Yokono K. Insulin as a T cell antigen in type 1 diabetes supported by the evidence from the insulin knockout NOD mice. Diabetes Res. Clin. Pract. 77 Suppl. 1: S155-S160 (2007).

• Moroldo MB, Chaudhari M, Shear E, Thompson SD, Glass DN, Giannini EH. Juvenile rheumatoid arthritis affected sibpairs: extent of clinical phenotype concordance. Arthritis Rheum. 50: 1928-1934 (2004). *

• Morrell MR, Patterson GA, Trulock EP, Hachem RR. Acute antibody-mediated rejection after lung transplantation. J. Heart Lung Transplant. 28: 96-100 (2009).

• Morse J, Barst R, Horn E, Cuervo N, Deng Z, Knowles J. Pulmonary hypertension in scleroderma spectrum of disease: lack of bone morphogenetic protein receptor 2 mutations. J. Rheumatol. 29: 2379-2381 (2002).

• Mortensen ES, Fenton KA, Rekvig OP. Lupus nephritis: the central role of nucleosomes revealed. Am. J. Pathol. 172: 275-283 (2008). *

• Moskowitz RW, Lesko M, Hooper M. Open-label study of clarithromycin in patients with undifferentiated connective tissue disease. Semin. Arthritis Rheum. 36: 82-87 (2006). *

• Moss AC, Cheifetz AS, Peppercorn MA. Combined oral and topical mesalazine treatment for extensive ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 3: 290-293 (2006). *

• Mostafa GA, Kitchener N. Serum anti-nuclear antibodies as a marker of autoimmunity in Egyptian autistic children. Pediatr. Neurol. 40: 107-112 (2009).

• Mounach A, Ghazi M, Nouijai A, Ghozlani I, Achemlal L, Bezza A, El Maghraoui A. Drug-induced lupus-like syndrome in ankylosing spondylitis treated with infliximab. Clin. Exp. Rheumatol. 26: 1116-1118 (2008).

• Mow WS, Vasiliauskas EA, Lin YC, Fleshner PR, Papadakis KA, Taylor KD, Landers CJ, Abreu-Martin MT, Rotter JI, Yang H, Targan SR. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology 126: 414-424 (2004). *

• Mudawi HM, Yousif BA. Fulminant hepatic failure in an African setting: etiology, clinical course, and predictors of mortality. Dig. Dis. Sci. 52: 3266-3269 (2007). *

• Mudter J, Weigmann B, Bartsch B, Kiesslich R, Strand D, Galle PR, Lehr HA, Schmidt J, Neurath MF. Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases. Am. J. Gastroenterol. 100: 64-72 (2005). *

• Mueller RB, Skapenko A, Grunke M, Wendler J, Stuhlmuller B, Kalden JR, Schulze-Koops H. Regulation of myeloid cell function and major histocompatibility complex class II expression by tumor necrosis factor. Arthritis Rheum. 52: 451-460 (2005). *

• Mulder AH, Horst G, Haagsma EB, Limburg PC, Kleibeuker JH, Kallenberg CG. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatology 17: 411-417 (1993).

• Mulder L, van Rossum M, Horst G, Limburg P, de Graeff-Meeder ER, Kuis W, Kallenberg C. Antineutrophil cytoplasmic antibodies in juvenile chronic arthritis. J. Rheumatol. 24: 568-575 (1997).

• Muller A, Voswinkel J, Gottschlich S, Csernok E. Human proteinase 3 (PR3) and its binding molecules: implications for inflammatory and PR3-related autoimmune responses. Ann. N. Y. Acad. Sci. 1109: 84-92 (2007). *

• Munoz L, van Bavel C, Franz S, Berden J, Herrmann M, van der Vlag J. Apoptosis in the pathogenesis of systemic lupus erythematosus. Lupus 17: 371-375 (2008). *

• Munoz LE, del Rocio Ayala SR. The clinical laboratory in the diagnosis of autoimmune liver diseases. Rev. Gastroenterol. Mex. 58: 164-169 (1993).

• Murad H, Collet P, Brunner E, Schohn H, Becuwe P, Devignes MD, Dauca M, Domenjoud L. Immunoselection and characterization of a human genomic PPAR binding fragment located within POTE genes. Biochimie 89: 329-336 (2007).

• Muratori L, Cassani F, Pappas G, Guidi M, Mele L, Lorenza V, Lenzi M, Bianchi FB, Muratori P. The hepatitic/cholestatic "overlap" syndrome: an Italian experience. Autoimmunity 35: 565-568 (2002).

• Muratori L, Granito A, Muratori P, Pappas G, Bianchi FB. Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: diagnostic and prognostic value. Clin. Liver Dis. 12: 261-276 (2008).

• Muratori L, Muratori P, Zauli D, Grassi A, Pappas G, Rodrigo L, Cassani F, Lenzi M, Bianchi FB. Antilactoferrin antibodies in autoimmune liver disease. Clin. Exp. Immunol. 124: 470-473 (2001). *

• Muratori P, Granito A, Pappas G, Muratori L, Lenzi M, Bianchi FB. Autoimmune liver disease 2007. Mol. Aspects Med. 29: 96-102 (2007).

• Muratori P, Muratori L, Cassani F, Terlizzi P, Lenzi M, Rodrigo L, Bianchi FB. Anti-multiple nuclear dots (anti-MND) and anti-SP100 antibodies in hepatic and rheumatological disorders. Clin. Exp. Immunol. 127: 172-175 (2002). *

• Muratori P, Muratori L, Ferrari R, Cassani F, Bianchi G, Lenzi M, Rodrigo L, Linares A, Fuentes D, Bianchi FB. Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. Am. J. Gastroenterol. 98: 431-437 (2003). *

• Murdaca G, Colombo BM, Sprecacenere B, Caiti M, Massa G, Picciotto A, Ceppa P, Puppo F. Autoimmune intrahepatic cholangiopathy associated with antiphospholipid antibody syndrome. Eur. J. Gastroenterol. Hepatol. 19: 910-912 (2007).

• Muro Y, Sugiura K, Morita Y, Tomita Y. High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody-positive patients with autoimmune rheumatic disease. Lupus 17: 171-176 (2008). *

• Murtaza I, Adhami VM, Hafeez BB, Saleem M, Mukhtar H. Fisetin, a natural flavonoid, targets chemoresistant human pancreatic cancer AsPC-1 cells through DR3-mediated inhibition of NF-kappaB. Int. J. Cancer 125: 2465-2473 (2009). *

• Musante L, Candiano G, Bruschi M, Santucci L, Carnemolla B, Orecchia P, Giampuzzi M, Zennaro C, Sanna-Cherchi S, Carraro M, Oleggini R, Camussi G, Perfumo F, Ghiggeri GM. Circulating anti-actin and anti-ATP synthase antibodies identify a sub-set of patients with idiopathic nephrotic syndrome. Clin. Exp. Immunol. 141: 491-499 (2005). *

• Musso M, Porretto F, Crescimanno A, Bondi F, Polizzi V, Scalone R, Mariani G. Autologous peripheral blood stem and progenitor (CD34+) cell transplantation for systemic lupus erythematosus complicated by Evans syndrome. Lupus 7: 492-494 (1998).

• Mustafa AS. HLA-promiscuous Th1-cell reactivity of MPT64 (Rv1980c), a major secreted antigen of Mycobacterium tuberculosis, in healthy subjects. Med. Princ. Pract. 18: 385-392 (2009).

• Mutoh S, Osabe M, Inoue K, Moore R, Pedersen L, Perera L, Rebolloso Y, Sueyoshi T, Negishi M. Dephosphorylation of threonine 38 is required for nuclear translocation and subsequent activation of human xenobiotic receptor CAR. J. Biol. Chem. 284: 34785-34792 (2009). *

• Myhre AE, Agren J, Dahle MK, Tamburstuen MV, Lyngstadaas SP, Collins JL, Foster SJ, Thiemermann C, Aasen AO, Wang JE. Liver X receptor is a key regulator of cytokine release in human monocytes. Shock 29: 468-474 (2008). *

• Mzali S, Johanet C, Chretien P, Abuaf N. Antinuclear antibodies in primary biliary cirrhosis. Gastroenterol. Clin. Biol. 13: 690-695 (1989).

• Nachbar F, Korting HC, Hoffmann RM, Kollmann M, Meurer M. Unusual coexistence of systemic lupus erythematosus and primary biliary cirrhosis. Dermatology 188: 313-317 (1994).

• Nagai T, Imamura M, Kamiya Y, Mori M. Graves' disease accompanied by anti-myeloperoxidase antibody-related nephropathy and autoimmune hepatitis. Intern. Med. 43: 516-520 (2004). *

• Nagasaki F, Ueno Y, Kanno N, Okamoto H, Shimosegawa T. A case of acute hepatitis with positive autoantibodies who actually had hepatitis E virus infection. Hepatol. Res. 32: 134-137 (2005).

• Nagasaki F, Ueno Y, Mano Y, Igarashi T, Yahagi K, Niitsuma H, Okamoto H, Shimosegawa T. A patient with clinical features of acute hepatitis E viral infection and autoimmune hepatitis. Tohoku J. Exp. Med. 206: 173-179 (2005). *

• Nagy G, Koncz A, Perl A. T- and B-cell abnormalities in systemic lupus erythematosus. Crit. Rev. Immunol. 25: 123-140 (2005).

• Nagy G, Perl A. The role of nitric oxide in abnormal T cell signal transduction in systemic lupus erythematosus. Clin. Immunol. 118: 145-151 (2006). *

• Najib U, Bajwa ZH, Ostro MG, Sheikh J. A retrospective review of clinical presentation, thyroid autoimmunity, laboratory characteristics, and therapies used in patients with chronic idiopathic urticaria. Ann. Allergy Asthma Immunol. 103: 496-501 (2009).

• Nakahara M, Furuya N, Takagaki K, Sugaya T, Hirota K, Fukamizu A, Kanda T, Fujii H, Sato R. Ileal bile acid-binding protein functionally associated with the farnesoid X receptor or ileal bile acid transporter regulates bile acid activity in the small intestine. J. Biol. Chem. 280: 42283-42289 (2005). *

• Nakajima M, Shimizu H, Miyazaki A, Watanabe S, Kitami N, Sato N. Detection of IgA, IgM, and IgG subclasses of anti-M2 antibody by immunoblotting in autoimmune cholangitis: is autoimmune cholangitis an early stage of primary biliary cirrhosis? J. Gastroenterol. 34: 607-612 (1999). *

• Nakajima S, Umebayashi H, Kurosawa R, Imagawa T, Katakura S, Mori M, Aihara Y, Yokota S, Sogo T, Inui A, Fujisawa T, Hanzawa N. A case of autoimmune hepatitis needed to be differentiated from EBV hepatitis, in that the histology of liver biopsy specimen was useful for diagnosis. Nihon Rinsho Meneki Gakkai Kaishi 28: 154-158 (2005).

• Nakamura H, Eguchi K, Nakamura T, Mizokami A, Shirabe S, Kawakami A, Matsuoka N, Migita K, Kawabe Y, Nagataki S. High prevalence of Sjogren's syndrome in patients with HTLV-I associated myelopathy. Ann. Rheum. Dis. 56: 167-172 (1997). *

• Nakamura H, Wada H, Origuchi T, Kawakami A, Taura N, Aramaki T, Fujikawa K, Iwanaga N, Izumi Y, Aratake K, Ida H, Taguchi T, Irie J, Akiyama M, Mizokami A, Tsutsumi T, Eguchi K. A case of IgG4-related autoimmune disease with multiple organ involvement. Scand. J. Rheumatol. 35: 69-71 (2006). *

• Nakamura K, Yoneda M, Yokohama S, Tamori K, Sato Y, Aso K, Aoshima M, Hasegawa T, Makino I. Efficacy of ursodeoxycholic acid in Japanese patients with type 1 autoimmune hepatitis. J. Gastroenterol. Hepatol. 13: 490-495 (1998).

• Nakamura M. The significance of anti-nuclear envelope (gp210) antibody in primary biliary cirrhosis. Nihon Rinsho Meneki Gakkai Kaishi 28: 117-122 (2005). *

• Nakamura M, Komori A, Ito M, Kondo H, Aiba Y, Migita K, Nagaoka S, Ohata K, Yano K, Abiru S, Daikoku M, Yatsuhashi H, Shimoda S, Ishibashi H. Predictive role of anti-gp210 and anticentromere antibodies in long-term outcome of primary biliary cirrhosis. Hepatol. Res. 37 Suppl. 3: S412-S419 (2007). *

• Nakamura M, Kondo H, Mori T, Komori A, Matsuyama M, Ito M, Takii Y, Koyabu M, Yokoyama T, Migita K, Daikoku M, Abiru S, Yatsuhashi H, Takezaki E, Masaki N, Sugi K, Honda K, Adachi H, Nishi H, Watanabe Y, Nakamura Y, Shimada M, Komatsu T, Saito A, et al. Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology 45: 118-127 (2007). *

• Nakamura M, Nagano H, Sakon M, Yamamoto T, Ota H, Wada H, Damdinsuren B, Noda T, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Nakamori S, Dono K, Monden M. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro. J. Hepatol. 46: 77-88 (2007). *

• Nakamura M, Shimizu-Yoshida Y, Takii Y, Komori A, Yokoyama T, Ueki T, Daikoku M, Yano K, Matsumoto T, Migita K, Yatsuhashi H, Ito M, Masaki N, Adachi H, Watanabe Y, Nakamura Y, Saoshiro T, Sodeyama T, Koga M, Shimoda S, Ishibashi H. Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis. J. Hepatol. 42: 386-392 (2005). *

• Nakamura M, Takii Y, Ito M, Komori A, Yokoyama T, Shimizu-Yoshida Y, Koyabu M, Matsuyama M, Mori T, Kamihira T, Daikoku M, Migita K, Yatsuhashi H, Nozaki N, Shimoda S, Ishibashi H. Increased expression of nuclear envelope gp210 antigen in small bile ducts in primary biliary cirrhosis. J. Autoimmun. 26: 138-145 (2006).

• Nakamura M, Tsutsumi K, Ooka S, Sekine T, Koizuka I, Nishioka K, Kato T. Identification of beta-tubulin isoform V as an autoantigen in allergic rhinitis by a proteomic approach. Microbiol. Immunol. 48: 427-434 (2004).

• Nakamura N, Yoshida M, Umeda M, Huang Y, Kitajima S, Inoue Y, Ishikawa I, Iwai T. Extended exposure of lipopolysaccharide fraction from Porphyromonas gingivalis facilitates mononuclear cell adhesion to vascular endothelium via Toll-like receptor-2 dependent mechanism. Atherosclerosis 196: 59-67 (2008).

• Nakamura RM, Chisari FV, Edgington TS. Laboratory tests for diagnosis of autoimmune diseases. Prog. Clin. Pathol. 6: 177-203 (1975).

• Nakamura T, Kawagoe Y, Ueda Y, Koide H. Antineutrophil cytoplasmic autoantibody-associated rapidly progressive glomerulonephritis in a patient with primary biliary cirrhosis. Am. J. Med. Sci. 328: 176-179 (2004).

• Nakamura T, Suzuki Y, Koide H. Granulocyte and monocyte adsorption apheresis in a patient with antiglomerular basement membrane glomerulonephritis and active ulcerative colitis. Am. J. Med. Sci. 325: 296-398 (2003).

• Nakano T, Goto S, Lai CY, Hsu LW, Kao YH, Lin YC, Kawamoto S, Chiang KC, Ohmori N, Goto T, Sato S, Jawan B, Cheng YF, Ono K, Chen CL. Experimental and clinical significance of antinuclear antibodies in liver transplantation. Transplantation 83: 1122-1125 (2007).

• Nakano T, Goto S, Lai CY, Hsu LW, Ono K, Kawamoto S, Lin YC, Kao YH, Chiang KC, Ohmori N, Goto T, Sato S, Tu CH, Jawan B, Cheng YF, Chen CL. Impact of vaccine therapy using nuclear histone H1 on allograft survival in experimental organ transplantation. Transpl. Immunol. 17: 147-152 (2007).

• Nakano T, Goto S, Lai CY, Hsu LW, Takaoka Y, Kawamoto S, Chiang KC, Shimada Y, Ohmori N, Goto T, Sato S, Ono K, Cheng YF, Chen CL. Immunological aspects and therapeutic significance of an autoantibody against histone H1 in a rat model of concanavalin A-induced hepatitis. Immunology Jun 26 [Epub ahead of print] (2009). *

• Nakano T, Goto S, Lai CY, Hsu LW, Wong JL, Kawamoto S, Chiang KC, Ohmori N, Goto T, Sato S, Yang CH, Wang CC, Jawan B, Cheng YF, Ono K, Chen CL. Involvement of autoimmunity against nuclear histone H1 in liver transplantation tolerance. Transpl. Immunol. 19: 87-92 (2008).

• Nakano T, Ishibashi H, Matsui M, Yasutake T, Ishii Y, Dohmen K, Nagasawa K, Niho Y. A case of primary biliary cirrhosis with negative anti-mitochondrial antibody anteceded by rheumatoid arthritis. Fukuoka Igaku Zasshi 83: 144-148 (1992).

• Nakano T, Lai CY, Goto S, Hsu LW, Lin YC, Kao YH, Kawamoto S, Chiang KC, Ohmori N, Goto T, Sato S, Ono K, Jawan B, Cheng YF, Chen CL. Role of antinuclear antibodies in experimental and clinical liver transplantation. Transplant. Proc. 38: 3605-3606 (2006). *

• Nakao T, Fukushima T, Shimizu T, Nanmoku T, Fujiyama S, Nakajima R, Fukushima F, Noguchi M, Sumazaki R. Transient myelofibrosis with autoimmune pancytopenia: a case report. Eur. J. Pediatr. 168: 1003-1006 (2009).

• Nakauchi H. Isolation and clonal characterization of hematopoietic and liver stem cells. Cornea 23: S2-S7 (2004).

• Nakayama S, Mukae H, Morisaki T, Sakamoto N, Ohba K, Abe K, Takeshima F, Mizuta Y, Ida H, Ozono Y, Kohno S. Sarcoidosis accompanied by systemic lupus erythematosus and autoimmune hepatitis. Intern. Med. 46: 1657-1661 (2007). *

• Nancey S, Blanvillain E, Parmentier B, Flourie B, Bayet C, Bienvenu J, Fabien N. Infliximab treatment does not induce organ-specific or nonorgan-specific autoantibodies other than antinuclear and anti-double-stranded DNA autoantibodies in Crohn's disease. Inflamm. Bowel Dis. 11: 986-991 (2005). *

• Narain S, Richards HB, Satoh M, Sarmiento M, Davidson R, Shuster J, Sobel E, Hahn P, Reeves WH. Diagnostic accuracy for lupus and other systemic autoimmune diseases in the community setting. Arch. Intern. Med. 164: 2435-2441 (2004). *

• Narbutt J, Lesiak A, Kwiecien A, Sysa-Jedrzejowska A, Kuydowicz J. Scleroderma-like lesions in the course of autoimmune hepatitis. Case report. Przegl. Lek. 62: 314-316 (2005).

• Nardi N, Brito-Zeron P, Ramos-Casals M, Aguilo S, Cervera R, Ingelmo M, Font J. Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sjogren's syndrome. Prevalence and clinical significance in 335 patients. Clin. Rheumatol. 25: 341-346 (2006). *

• Narkewicz MR, Dell Olio D, Karpen SJ, Murray KF, Schwarz K, Yazigi N, Zhang S, Belle SH, Squires RH; Pediatric Acute Liver Failure Study Group. Pattern of diagnostic evaluation for the causes of pediatric acute liver failure: an opportunity for quality improvement. J. Pediatr. 155: 801-806.e1 (2009).

• Nasr SH, Markowitz GS, Reddy BS, Maesaka J, Swidler MA, D'Agati VD. Dysproteinemia, proteinuria, and glomerulonephritis. Kidney Int. 69: 772-775 (2006).

• Navaneethan U, Shen B. Laboratory tests for patients with ileal pouch-anal anastomosis: clinical utility in predicting, diagnosing, and monitoring pouch disorders. Am. J. Gastroenterol. 104: 2606-2615 (2009). *

• Neurath MF, Fuss I, Pasparakis M, Alexopoulou L, Haralambous S, Meyer zum Buschenfelde KH, Strober W, Kollias G. Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. Eur. J. Immunol. 27: 1743-1750 (1997).

• Nguyen C, Cornelius J, Singson E, Killedar S, Cha S, Peck AB. Role of complement and B lymphocytes in Sjogren's syndrome-like autoimmune exocrinopathy of NOD.B10-H2(b) mice. Mol. Immunol. 43: 1332-1329 (2006). *

• Nguyen CQ, Gao JH, Kim H, Saban DR, Cornelius JG, Peck AB. IL-4-STAT6 signal transduction-dependent induction of the clinical phase of Sjogren's syndrome-like disease of the nonobese diabetic mouse. J. Immunol. 179: 382-390 (2007). *

• Nickowitz RE, Worman HJ. Autoantibodies from patients with primary biliary cirrhosis recognize a restricted region within the cytoplasmic tail of nuclear pore membrane glycoprotein Gp210. J. Exp. Med. 178: 2237-2242 (1993). *

• Nickowitz RE, Wozniak RW, Schaffner F, Worman HJ. Autoantibodies against integral membrane proteins of the nuclear envelope in patients with primary biliary cirrhosis. Gastroenterology 106: 193-199 (1994).

• Nielsen CH, Hegedus L, Rieneck K, Moeller AC, Leslie RG, Bendtzen K. Production of interleukin (IL)-5 and IL-10 accompanies T helper cell type 1 (Th1) cytokine responses to a major thyroid self-antigen, thyroglobulin, in health and autoimmune thyroid disease. Clin. Exp. Immunol. 147: 287-295 (2007). *

• Nikolaus S, Raedler A, Kuhbacker T, Sfikas N, Folsch UR, Schreiber S. Mechanisms in failure of infliximab for Crohn's disease. Lancet 356: 1475-1479 (2000). *

• Ninova-Bradistilova D, Naumov N, Krustev Z, Ognianov M, Maleev A. Significance of high titers of various autoantibodies in the diagnosis and monitoring of chronic liver diseases. Vutr. Boles. 22: 46-52 (1983).

• Nishikai M. Antinuclear antibodies. Nippon Rinsho 65: 1067-1070 (2007).

• Nishimori I, Miyaji E, Morimoto K, Kohsaki T, Okamoto N, Onishi S. Diminished cellular immune response to carbonic anhydrase II in patients with Sjogren's syndrome and idiopathic chronic pancreatitis. JOP 5: 186-192 (2004). *

• Nishio A, Keeffe EB, Gershwin ME. Immunopathogenesis of primary biliary cirrhosis. Semin. Liver Dis. 22: 291-302 (2002). *

• Nishio A, Van de Water J, Leung PS, Joplin R, Neuberger JM, Lake J, Bjorkland A, Totterman TH, Peters M, Worman HJ, Ansari AA, Coppel RL, Gershwin ME. Comparative studies of antimitochondrial autoantibodies in sera and bile in primary biliary cirrhosis. Hepatology 25: 1085-1089 (1997). *

• Nisihara RM, de Carvalho WB, da Rosa Utiyama SR, Amarante H, Baptista ML. Diagnostic role and clinical association of ASCA and ANCA in Brazilian patients with inflammatory bowel disease. Dig. Dis. Sci. Oct 14 [Epub ahead of print] (2009). *

• Niwa H, Sasaki M, Haratake J, Kasai T, Katayanagi K, Kurumaya H, Masuda S, Minato H, Zen Y, Uchiyama A, Miwa A, Saito K, Sudo Y, Nakanuma Y. Clinicopathological significance of antinuclear antibodies in non-alcoholic steatohepatitis. Hepatol. Res. 37: 923-931 (2007). *

• Nnoruka EN, Obiagboso I, Maduechesi C. Hair loss in children in South-East Nigeria: common and uncommon cases. Int. J. Dermatol. 46 Suppl. 1: 18-22 (2007).

• Nobili V, Marcellini M, Devito R, Comparcola D, Vento S. Co-occurrence of chronic hepatitis B virus infection and autoimmune hepatitis in a young Senegalese girl. Eur. J. Gastroenterol. Hepatol. 18: 927-929 (2006).

• Noel B. Lupus erythematosus and other autoimmune diseases related to statin therapy: a systematic review. J. Eur. Acad. Dermatol. Venereol. 21: 17-24 (2007). *

• Noel LH. Antineutrophil cytoplasm antibodies (ANCA): description and immunopathological role. Ann. Med. Interne (Paris) 151: 178-183 (2000).

• Nomura S, Settle SH, Leys CM, Means AL, Peek RM, Leach SD, Wright CV, Coffey RJ, Goldenring JR. Evidence for repatterning of the gastric fundic epithelium associated with Menetrier's disease and TGFalpha overexpression. Gastroenterology 128: 1292-1305 (2005). *

• O'Connor K, Fulcher D, Phoon RK. Development of anti-glomerular basement membrane disease after remission from perinuclear ANCA-associated glomerulonephritis in a patient with HLA susceptibility. Am. J. Kidney Dis. Sep 4 [Epub ahead of print] (2009).

• Oak JS, Deane JA, Kharas MG, Luo J, Lane TE, Cantley LC, Fruman DA. Sjogren’s syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase. Proc. Natl. Acad. Sci. U.S.A. 103: 16882-16887 (2006). *

• Obermayer-Straub P, Strassburg CP, Manns MP. Autoimmune hepatitis. J. Hepatol. 32: S181-S197 (2000).

• Oertelt S, Rieger R, Selmi C, Invernizzi P, Ansari AA, Coppel RL, Podda M, Leung PS, Gershwin ME. A sensitive bead assay for antimitochondrial antibodies: chipping away at AMA-negative primary biliary cirrhosis. Hepatology 45: 659-665 (2007). *

• Ohana M, Okazaki K, Hajiro K, Uchida K. Antilactoferrin antibodies in autoimmune liver diseases. Am. J. Gastroenterol. 93: 1334-1339 (1998). *

• Ohata M, Yamauchi M, Takeda K, Toda G, Kamimura S, Motomura K, Xiong S, Tsukamoto H. RAR and RXR expression by Kupffer cells. Exp. Mol. Pathol. 68: 13-20 (2000). *

• Ohira H, Takiguchi J, Rai T, Shishido S, Sato Y. Two cases of primary biliary cirrhosis complicated with syringomyelia. Am. J. Gastroenterol. 98: 224-226 (2003). *

• Ohman L, Isaksson S, Lindmark AC, Posserud I, Stotzer PO, Strid H, Sjovall H, Simren M. T-cell activation in patients with irritable bowel syndrome. Am. J. Gastroenterol. 104: 1205-1212 (2009). *

• Ohno CK, Ueda H, Petkovich M. The Drosophila nuclear receptors FTZ-F1 alpha and FTZ-F1 beta compete as monomers for binding to a site in the fushi tarazu gene. Mol. Cell. Biol. 14: 3166-3175 (1994). *

• Ohta S, Bahrun U, Shimazu R, Matsushita H, Fukudome K, Kimoto M. Induction of long-term lipopolysaccharide tolerance by an agonistic monoclonal antibody to the Toll-like receptor 4/MD-2 complex. Clin. Vaccine Immunol. 13: 1131-1136 (2006). *

• Ohtsubo K, Watanabe H, Okada G, Tsuchiyama T, Mouri H, Yamaguchi Y, Motoo Y, Okai T, Amaya K, Kitagawa H, Ohta T, Gabata T, Matsuda K, Ohta H, Sawabu N. A case of pancreatic cancer with formation of a mass mimicking alcoholic or autoimmune pancreatitis in a young man. Possibility of diagnosis by hypermethylation of pure pancreatic juice. JOP 9: 37-45 (2008). *

• Ohtsubo K, Watanabe H, Tsuchiyama T, Mouri H, Yamaguchi Y, Motoo Y, Ohnishi I, Gabata T, Sawabu N. A case of autoimmune pancreatitis associated with retroperitoneal fibrosis. JOP 8: 320-325 (2007). *

• Ohtsuka T. Combinational effect of low-dose oral corticosteroid and mizoribine for ulcerative colitis in a patient with systemic sclerosis. J. Dermatol. 37: 71-74 (2010).

• Oikonomidou O, Vlachoyiannopoulos PG, Kominakis A, Kalofoutis A, Moutsopoulos HM, Moutsatsou P. Glucocorticoid receptor, nuclear factor kappaB, activator protein-1 and C-Jun N-terminal kinase in systemic lupus erythematosus patients. Neuroimmunomodulation 13: 194-204 (2007).

• Okada C, Akbar SM, Horiike N, Onji M. Early development of primary biliary cirrhosis in female C57BL/6 mice because of poly I:C administration. Liver Int. 25: 595-603 (2005). *

• Okamoto M, Ogawa Y, Watanabe A, Sugiura K, Shimomura Y, Aoki N, Nagasaka T, Tomita Y, Muro Y. Autoantibodies to DFS70/LEDGF are increased in alopecia areata patients. J. Autoimmun. 23: 257-266 (2004).

• Okazaki K. Autoimmune pancreatitis: etiology, pathogenesis, clinical findings and treatment. The Japanese experience. JOP 6: S89-S96 (2005). *

• Okazaki K. Clinical relevance of autoimmune-related pancreatitis. Best Pract. Res. Clin. Gastroenterol. 16: 365-378 (2002).

• Okazaki K, Uchida K, Ohana M, Nakase H, Uose S, Inai M, Matsushima Y, Katamura K, Ohmori K, Chiba T. Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology 118: 573-581 (2000). *

• Okazaki T, Otaka Y, Wang J, Hiai H, Takai T, Ravetch JV, Honjo T. Hydronephrosis associated with antiurothelial and antinuclear autoantibodies in BALB/c-Fcgr2b-/-Pdcd1-/- mice. J. Exp. Med. 202: 1643-1648 (2005). *

• Oki K, Yamane K, Koide J, Mandai K, Nakanishi S, Fujikawa R, Kohno N. A case of polyglandular autoimmune syndrome type III complicated with autoimmune hepatitis. Endocr. J. 53: 705-709 (2006). *

• Okiyama N, Sugihara T, Iwakura Y, Yokozeki H, Miyasaka N, Kohsaka H. Therapeutic effects of interleukin-6 blockade in a murine model of polymyositis that does not require interleukin-17A. Arthritis Rheum. 60: 2505-2512 (2009). *

• Olas K, Butterweck H, Teschner W, Schwarz HP, Reipert B. Immunomodulatory properties of human serum immunoglobulin A: anti-inflammatory and pro-inflammatory activities in human monocytes and peripheral blood mononuclear cells. Clin. Exp. Immunol. 140: 478-490 (2005). *

• Olech E, Merrill JT. The prevalence and clinical significance of antiphospholipid antibodies in rheumatoid arthritis. Curr. Rheumatol. Rep. 8: 100-108 (2006).

• Oliveira RR, Gollob KJ, Figueiredo JP, Alcantara LM, Cardoso LS, Aquino CS, Campos RA, Almeida MC, Carvalho EM, Araujo MI. Schistosoma mansoni infection alters co-stimulatory molecule expression and cell activation in asthma. Microbes Infect. 11: 223-229 (2009). *

• Oliver-Minarro D, Sanchez-Ramon S, Rodriguez-Mahou M, Alvarez S, Fernandez-Cruz E. Isolated type 5 antimitochondrial autoantibodies are associated with a history of thrombocytopenia and fetal loss. Fertil. Steril. 87: 976.e17-e18 (2007).

• Olsen NJ, Prather H, Li QZ, Burns DK. Autoantibody profiles in two patients with non-autoimmune muscle disease implicate a role for gliadin autoreactivity. Neuromuscul. Disord. Jan 26 [Epub ahead of print] (2010).

• Omagari K. Autoimmune cholangitis: is it an antimitochondrial antibody negative primary biliary cirrhosis? Acta Medica Nagasakiensia 44: 11-14 (1999). *

• Omagari K, Ikuno N, Matsuo I, Shirono K, Hara K, Feeney SJ, Whittingham S, Mackay IR. Autoimmune cholangitis syndrome with a bias towards primary biliary cirrhosis. Pathology 28: 255-258 (1996).

• Omenetti A, Syn WK, Jung Y, Francis H, Porrello A, Witek RP, Choi SS, Yang L, Mayo MJ, Gershwin ME, Alpini G, Diehl AM. Repair-related activation of hedgehog signaling promotes cholangiocyte chemokine production. Hepatology 50: 518-527 (2009). *

• Omersel J, Jurgec I, Cucnik S, Kveder T, Rozman B, Sodin-Semrl S, Bozic B. Autoimmune and proinflammatory activity of oxidized immunoglobulins. Autoimmun. Rev. 7: 523-529 (2008).

• Ooi CJ, Lim BL, Cheong WK, Ling AE, Ng HS. Antineutrophil cytoplasmic antibodies (ANCAs) in patients with inflammatory bowel disease show no correlation with proteinase 3, lactoferrin, myeloperoxidase, elastase, cathepsin G and lysozyme: a Singapore study. Ann. Acad. Med. Singapore 29: 704-707 (2000).

• Oracki SA, Tsantikos E, Quilici C, Light A, Schmidt T, Lew AM, Martin JE, Smith KG, Hibbs ML, Tarlinton DM. CTLA4Ig alters the course of autoimmune disease development in Lyn-/- mice. J. Immunol. 184: 757-763 (2010).

• Orange JS, Jain A, Ballas ZK, Schneider LC, Geha RS, Bonilla FA. The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation. J. Allergy Clin. Immunol. 113: 725-733 (2004). *

• Orbach H, Shoenfeld Y. Anti-cyclic citrullinated peptide antibodies as a diagnostic test for rheumatoid arthritis. Harefuah. 142: 182-185, 239 (2003).

• Ortega-Hernandez OD, Shoenfeld Y. Infection, vaccination, and autoantibodies in chronic fatigue syndrome, cause or coincidence? Ann. N. Y. Acad. Sci. 1173: 600-609 (2009). *

• Orth T, Gerken G, Meyer Zum Buschenfelde KH, Mayet WJ. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity. Z. Gastroenterol. 35: 113-121 (1997).

• Orth T, Neurath M, Schirmacher P, Galle PR, Mayet WJ. A novel rat model of chronic fibrosing cholangitis induced by local administration of a hapten reagent into the dilated bile duct is associated with increased TNF-alpha production and autoantibodies. J. Hepatol. 33: 862-872 (2000). *

• Osangthamnont C, Manatsathit S, Pongprasopchai S, Viriyataveekul R, Chaihirunkarn S, Leelakusolvong S, Boonyapisit S. Antibodies to neutrophil cytoplasma in patients with ulcerative colitis and their first-degree relatives in Thailand. J. Gastroenterol. Hepatol. 16: 866-871 (2001). *

• Oshima T, Kawasaki T, Ohashi R, Hasegawa G, Jiang S, Umezu H, Aoyagi Y, Iwanari H, Tanaka T, Hamakubo T, Kodama T, Naito M. Downregulated P1 promoter-driven hepatocyte nuclear factor-4alpha expression in human colorectal carcinoma is a new prognostic factor against liver metastasis. Pathol. Int. 57: 82-90 (2007). *

• Otsuka H, Morita N, Yamashita K, Nishitani H. FDG-PET/CT findings of autoimmune pancreatitis associated with idiopathic retroperitoneal fibrosis. Ann. Nucl. Med. 21: 593-596 (2007). *

• Otsuki T, Miura Y, Nishimura Y, Hyodoh F, Takata A, Kusaka M, Katsuyama H, Tomita M, Ueki A, Kishimoto T. Alterations of Fas and Fas-related molecules in patients with silicosis. Exp. Biol. Med. (Maywood) 231: 522-533 (2006). *

• Ou Y, Enarson P, Rattner JB, Barr SG, Fritzler MJ. The nuclear pore complex protein Tpr is a common autoantigen in sera that demonstrate nuclear envelope staining by indirect immunofluorescence. Clin. Exp. Immunol. 136: 379-387 (2004). *

• Oudkerk Pool M, Bouma G, Meuwissen SG, von Blomberg BM, van de Merwe JP, Deville WL, Fonk JC, Pena AS. Serological markers to differentiate between ulcerative colitis and Crohn's disease. J. Clin. Pathol. 48: 346-350 (1995). *

• Oudkerk Pool M, Ellerbroek PM, Ridwan BU, Goldschmeding R, von Blomberg BM, Pena AS, Dolman KM, Bril H, Dekker W, Nauta JJ, et al. Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. Gut 34: 46-50 (1993). *

• Oya H, Sato Y, Yamamoto S, Kobayashi T, Watanabe T, Kokai H, Hatakeyama K. De novo autoimmune hepatitis after living donor liver transplantation in a 25-day-old newborn baby: a case report. Transplant. Proc. 41: 433-434 (2009). *

• Oya Y, Watanabe N, Owada T, Oki M, Hirose K, Suto A, Kagami SI, Nakajima H, Kishimoto T, Iwamoto I, Murphy TL, Murphy KM, Saito Y. Development of autoimmune hepatitis-like disease and production of autoantibodies to nuclear antigens in mice lacking B and T lymphocyte attenuator. Arthritis Rheum. 58: 2498-2510 (2008). *

• Ozen H, Kocak N, Saltik IN, Yuce A, Gurakan F. Autoimmune hepatitis. Indian J. Pediatr. 68: 725-728 (2001).

• Ozes ON, Taylor MW. Reversal of interferon-gamma-resistant phenotype by poly(I:C): possible involvement of ISGF2 (IRF1) in interferon-gamma-mediated induction of the IDO gene. J. Interferon Res. 14: 25-32 (1994).

• Padiath QS, Saigoh K, Schiffman R, Asahara H, Yamada T, Koeppen A, Hogan K, Ptacek LJ, Fu YH. Lamin B1 duplications cause autosomal dominant leukodystrophy. Nat. Genet. 38: 1114-1123 (2006). *

• Page AV, Liles WC. Tumor necrosis factor-alpha inhibitor-induced lupus-like syndrome presenting as fever of unknown origin in a liver transplant recipient: case report and concise review of the literature. Transplant. Proc. 40: 1768-1770 (2008).

• Pakunpanya K, Verasertniyom O, Vanichapuntu M, Pisitkun P, Totemchokchyakarn K, Nantiruj K, Janwityanujit S. Incidence and clinical correlation of anticentromere antibody in Thai patients. Clin. Rheumatol. 25: 325-328 (2006). *

• Pallone F, Del Vecchio Blanco G, Vavassori P, Monteleone I, Fina D, Monteleone G. Genetic and pathogenetic insights into inflammatory bowel disease. Curr. Gastroenterol. Rep. 5: 487-492 (2003).

• Palma BD, Gabriel Jr A, Colugnati FA, Tufik S. Effects of sleep deprivation on the development of autoimmune disease in an experimental model of systemic lupus erythematosus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291: R1527-R1532 (2006). *

• Palucka AK, Blanck JP, Bennett L, Pascual V, Banchereau J. Cross-regulation of TNF and IFN-alpha in autoimmune diseases. Proc. Natl. Acad. Sci. U.S.A. 102: 3372-3377 (2005). *

• Pan HF, Wu GC, Li WP, Li XP, Ye DQ. High mobility group box 1: a potential therapeutic target for systemic lupus erythematosus. Mol. Biol. Rep. Feb 27 [Epub ahead of print] (2009). *

• Pan L, Eckhoff C, Brinckerhoff CE. Suppression of collagenase gene expression by all-trans and 9-cis retinoic acid is ligand dependent and requires both RARs and RXRs. J. Cell. Biochem. 57: 575-589 (1995).

• Panamonta O, Sumethkul V, Radinahmed P, Laopaiboon M, Kirdpon W. Propylthiouracil associated antineutrophil cytoplasmic antibodies (ANCA) in patients with childhood onset Graves' disease. J. Pediatr. Endocrinol. Metab. 21: 539-543 (2008).

• Panani AD, Grigoriadou M, Magira E, Roussos C, Raptis SA. Perinuclear antineutrophil cytoplasmic antibody myeloperoxidase-positive vasculitis in association with ulcerative colitis. Clin. Rheumatol. 25: 35-37 (2006).

• Pando M, Larriba J, Fernandez GC, Fainboim H, Ciocca M, Ramonet M, Badia I, Daruich J, Findor J, Tanno H, Canero-Velasco C, Fainboim L. Pediatric and adult forms of type I autoimmune hepatitis in Argentina: evidence for differential genetic predisposition. Hepatology 30: 1374-1380 (1999). *

• Pankuweit S, Richter A, Ruppert V, Maisch B. Familial predisposition and microbial etiology in dilated cardiomyopathy. Herz. 34: 110-116 (2009).

• Papachristou GI, Demetris AJ, Craig F, Lee KKW, Rabinovitz M. Cholestatic jaundice and bone lesions in an elderly woman. Nat. Clin. Pract. Gastroenterol. Hepatol. 1: 53-57 (2004). *

• Papadimitraki ED, Choulaki C, Koutala E, Bertsias G, Tsatsanis C, Gergianaki I, Raptopoulou A, Kritikos HD, Mamalaki C, Sidiropoulos P, Boumpas DT. Expansion of Toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process. Arthritis Rheum. 54: 3601-3611 (2006). *

• Paparo F, Petrone E, Tosco A, Maglio M, Borrelli M, Salvati VM, Miele E, Greco L, Auricchio S, Troncone R. Clinical, HLA, and small bowel immunohistochemical features of children with positive serum antiendomysium antibodies and architecturally normal small intestinal mucosa. Am. J. Gastroenterol. 100: 2294-2298 (2005). *

• Papp M. Possible pathogenetic role of vascular, immunological and genetic factors in certain gastoenterological disorders. Orv. Hetil. 149: 2269-2276 (2008).

• Papp M, Altorjay I, Dotan N, Palatka K, Foldi I, Tumpek J, Sipka S, Udvardy M, Dinya T, Lakatos L, Kovacs A, Molnar T, Tulassay Z, Miheller P, Norman GL, Szamosi T, Papp J; the Hungarian IBD Study Group, Lakatos PL. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort. Am. J. Gastroenterol. 103: 665-681 (2008). *

• Papp M, Altorjay I, Lakatos P. Relevance of serologic studies in inflammatory bowel diseases. Orv. Hetil. 148: 887-896 (2007).

• Papp M, Altorjay I, Norman GL, Shums Z, Palatka K, Vitalis Z, Foldi I, Lakos G, Tumpek J, Udvardy ML, Harsfalvi J, Fischer S, Lakatos L, Kovacs A, Bene L, Molnar T, Tulassay Z, Miheller P, Veres G, Papp J, Lakatos PL. Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients. Inflamm. Bowel Dis. 13: 984-992 (2007). *

• Papp M, Norman GL, Altorjay I, Lakatos PL. Utility of serological markers in inflammatory bowel diseases: gadget or magic? World J. Gastroenterol. 13: 2028-2036 (2007). *

• Pappworth IY, Kulik L, Haluszczak C, Reuter JW, Holers VM, Marchbank KJ. Increased B cell deletion and significantly reduced auto-antibody titre due to premature expression of human complement receptor 2 (CR2, CD21). Mol. Immunol. 46: 1042-1049 (2009). *

• Park JY, Malik A, Dumoff KL, Gupta PK. Case report and review of lupus erythematosus cells in cytology fluids. Diagn. Cytopathol. 35: 806-809 (2007).

• Park KS, Park JH, Song YW. Inhibitory NKG2A and activating NKG2D and NKG2C natural killer cell receptor genes: susceptibility for rheumatoid arthritis. Tissue Antigens 72: 342-346 (2008). *

• Parker NP, Pearlman AN, Conley DB, Kern RC, Chandra RK. The dilemma of midline destructive lesions: a case series and diagnostic review. Am. J. Otolaryngol. Mar 26 [Epub ahead of print] (2009).

• Parveen S, Morshed SA, Arima K, Nishioka M, Czaja AJ, Chow WC, Ng HS. Antibodies to Ro/La, Cenp-B, and snRNPs antigens in autoimmune hepatitis of North America versus Asia: patterns of immunofluorescence, ELISA reactivities, and HLA association. Dig. Dis. Sci. 43: 1322-1331 (1998). *

• Parveen S, Morshed SA, Nishioka M. High prevalence of antibodies to recombinant CENP-B in primary biliary cirrhosis: nuclear immunofluorescence patterns and ELISA reactivities. J. Gastroenterol. Hepatol. 10: 438-445 (1995).

• Pasha SF, Lunsford TN, Lennon VA. Autoimmune gastrointestinal dysmotility treated successfully with pyridostigmine. Gastroenterology 131: 1592-1596 (2006). *

• Patel RT, Stokes R, Birch D, Ibbotson J, Keighley MR. Influence of total colectomy on serum antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Br. J. Surg. 81: 724-726 (1994).

• Pathmakanthan S, Kay EW, Murray FE. Autoimmune chronic active hepatitis associated with the presence of antiphospholipid antibodies. Eur. J. Gastroenterol. Hepatol. 10: 155-157 (1998).

• Patriarca F, Skert C, Sperotto A, Zaja F, Falleti E, Mestroni R, Kikic F, Calistri E, Fili C, Geromin A, Cerno M, Fanin R. The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recovery. Exp. Hematol. 34: 389-396 (2006). *

• Pattacini L, Boiardi L, Casali B, Salvarani C. Differential effects of anti-TNF-alpha drugs on fibroblast-like synoviocyte apoptosis. Rheumatology (Oxford) 49: 480-489 (2010).

• Paul AK, Miah SR, Mamun AA, Islam S. Thyroid disorders in Khulna district: a community based study. Bangladesh Med. Res. Counc. Bull. 32: 66-71 (2006).

• Pavic S, Simonovic J, Boricic I, Svirtlih N. Autoantibodies characteristic for autoimmune hepatitis found in chronic hepatitis C. Srp. Arh. Celok. Lek. 131: 437-442 (2003).

• Pawar RD, Ramanjaneyulu A, Kulkarni OP, Lech M, Segerer S, Anders HJ. Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus. J. Am. Soc. Nephrol. 18: 1721-1731 (2007). *

• Pawlotsky JM, Andre C, Metreau JM, Beaugrand M, Zafrani ES, Dhumeaux D. Multiple nuclear dots antinuclear antibodies are not specific for primary biliary cirrhosis. Hepatology 16: 127-131 (1992).

• Paz E, Adawi M, Lavi I, Mussel Y, Mader R. Antinuclear antibodies measured by enzyme immunoassay in patients with systemic lupus erythematosus: relation to disease activity. Rheumatol. Int. 27: 941-945 (2007). *

• Peakman M, Bevis L, Mieli-Vergani G, Mowat AP, Vergani D. Double stranded DNA binding in autoimmune chronic active hepatitis and primary sclerosing cholangitis starting in childhood. Autoimmunity 3: 271-280 (1989).

• Pedro AB, Romaldini JH, Americo C, Takei K. Association of circulating antibodies against double-stranded and single-stranded DNA with thyroid autoantibodies in Graves' disease and Hashimoto's thyroiditis patients. Exp. Clin. Endocrinol. Diabetes 114: 35-38 (2006).

• Peelman LJ, Chardon P, Nunes M, Renard C, Geffrotin C, Vaiman M, Van Zeveren A, Coppieters W, van de Weghe A, Bouquet Y, et al. The BAT1 gene in the MHC encodes an evolutionarily conserved putative nuclear RNA helicase of the DEAD family. Genomics 26: 210-218 (1995).

• Peen E, Sundqvist T, Skogh T. Leucocyte activation by anti-lactoferrin antibodies bound to vascular endothelium. Clin. Exp. Immunol. 103: 403-407 (1996). *

• Peeters M, Joossens S, Vermeire S, Vlietinck R, Bossuyt X, Rutgeerts P. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am. J. Gastroenterol. 96: 730-734 (2001). *

• Peitsch WK, Lorentz K, Goebeler M, Goerdt S. Subacute cutaneous lupus erythematosus with bullae associated with porphyria cutanea tarda. J. Dtsch. Dermatol. Ges. 5: 220-222 (2007).

• Peng G, Li S, Wu W, Sun Z, Chen Y, Chen Z. Circulating CD4(+) CD25(+) regulatory T cells correlate with chronic hepatitis B infection. Immunology 123: 57-65 (2008). *

• Penner E, Goldenberg H, Meryn S, Gordon J. A dot-immunobinding assay for antimitochondrial antibodies. Hepatology 6: 381-384 (1986).

• Penner E, Kindas-Mugge I, Hitchman E, Sauermann G. Nuclear antigens recognized by antibodies present in liver disease sera. Clin. Exp. Immunol. 63: 428-433 (1986). *

• Perdriger A, Werner-Leyval S, Rollot-Elamrani K. The genetic basis for systemic lupus erythematosus. Joint Bone Spine 70: 103-108 (2003).

• Perez Garrigues H, Carmona E, Morera C, Sanchez-Cuenca JM. Circulating auto-antibodies in Meniere's disease. Ann. Otolaryngol. Chir. Cervicofac. 112: 225-228 (1995).

• Perl A. Pathogenic mechanisms in systemic lupus erythematosus. Autoimmunity Dec 17 [Epub ahead of print] (2009).

• Perniola R, Congedo M, Rizzo A, Sticchi Damiani A, Faneschi ML, Pizzolante M, Lobreglio G. Innate and adaptive immunity in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Mycoses 51: 228-235 (2008).

• Perniola R, Falorni A, Clemente MG, Forini F, Accogli E, Lobreglio G. Organ-specific and non-organ-specific autoantibodies in children and young adults with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). Eur. J. Endocrinol. 143: 497-503 (2000). *

• Pertovaara M, Jylhava J, Uusitalo H, Pukander J, Helin H, Hurme M. Serum amyloid A and C-reactive protein concentrations are differently associated with markers of autoimmunity in patients with primary Sjogren's syndrome. J. Rheumatol. 36: 2487-2490 (2009).

• Pertovaara M, Kahonen M, Juonala M, Laitinen T, Taittonen L, Lehtimaki T, Viikari JS, Raitakari OT, Hurme M. Autoimmunity and atherosclerosis: the presence of antinuclear antibodies is associated with decreased carotid elasticity in young women. The Cardiovascular Risk in Young Finns Study. Rheumatology (Oxford) 48: 1553-1556 (2009).

• Peterson JD, Worobec SM, Chan LS. An erythrodermic variant of pemphigus foliaceus with puzzling histologic and immunopathologic features. J. Cutan. Med. Surg. 11: 179-184 (2007).

• Petitpain N, Gambier N, Wahl D, Chary-Valckenaere I, Loeuille D, Gillet P; French Network of Pharmacovigilance Centers. Arterial and venous thromboembolic events during anti-TNF therapy: a study of 85 spontaneous reports in the period 2000-2006. Biomed. Mater. Eng. 19: 355-364 (2009).

• Petty RE. Juvenile psoriatic arthritis, or juvenile arthritis with psoriasis? Clin. Exp. Rheumatol. 12 Suppl. 10: S55-S58 (1994).

• Pfau JC, Sentissi JJ, Li S, Calderon-Garciduenas L, Brown JM, Blake DJ. Asbestos-induced autoimmunity in C57BL/6 mice. J. Immunotoxicol. 5: 129-137 (2008).

• Piga M, Serra A, Deiana L, Loi GL, Satta L, Di Liberto M, Mariotti S. Brain perfusion abnormalities in patients with euthyroid autoimmune thyroiditis. Eur. J. Nucl. Med. Mol. Imaging 31: 1639-1644 (2004).

• Pink AE, Fonia A, Allen MH, Smith CH, Barker JN. Antinuclear antibodies associate with loss of response to anti-TNF alpha therapy in psoriasis - a retrospective, observational study. Br. J. Dermatol. Oct 26 [Epub ahead of print] (2009). *

• Pinto LA, Dalgleish AG, Sumar N, Poulton TA. Panel of anti-gp120 monoclonal antibodies reacts with same nuclear proteins in uninfected cells as those recognized by autoantibodies from patients with systemic lupus erythematosus. AIDS Res. Hum. Retroviruses 10: 823-828 (1994).

• Pisetsky DS. The immune response to cell death in SLE. Autoimmun. Rev. 3: 500-504 (2004).

• Pistol G, Matache C, Calugaru A, Stavaru C, Tanaseanu S, Ionescu R, Dumitrache S, Stefanescu M. Roles of CD147 on T lymphocytes activation and MMP-9 secretion in systemic lupus erythematosus. J. Cell. Mol. Med. 11: 339-348 (2007). *

• Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM, Lucchinetti CF, Zephir H, Moder K, Weinshenker BG. Neuromyelitis optica and non organ-specific autoimmunity. Arch. Neurol. 65: 78-83 (2008).

• Plass C, Weichenhan D, Kunze B, Hellwig T, Schneider C, Bautz FA, Grzeschik KH, Traut W, Winking H. A member of the mouse LRR transcript family with homology to the human Sp100 gene. Hereditas 122: 245-256 (1995).

• Plenge RM. Rheumatoid arthritis genetics: 2009 update. Curr. Rheumatol. Rep. 11: 351-356 (2009).

• Ploski R, Dziunycz P, Kostrzewa G, Roszkowski PI, Barcz E, Zabek J, Milewski L, Kaminski P, Malejczyk J. PTPN22/LYP 1858C>T gene polymorphism and susceptibility to endometriosis in a Polish population. J. Reprod. Immunol. 79: 196-200 (2009).

• Pohl JF. Mauriac syndrome in a child with a positive antinuclear antibody screen. Gastroenterol. Res. Pract. 2009: 765318 (2009).

• Polenakovic M, Cukaranovic R, Savic V, Jovanovic I, Stefanovic V. Immunological studies in Balkan Endemic Nephropathy. Prilozi. 28: 13-22 (2007).

• Polese L, De Franchis G, Scarpa M, Sturniolo GC, Ruffolo C, Norberto L, Frego M, D'Amico DF, Angriman I. B1a lymphocytes in ulcerative colitis. Int. J. Colorectal Dis. 22: 1005-1011 (2007). *

• Pollak C, Minar E, Dragosics B, Marosi L. Primary biliary cirrhosis and scleroderma: long-term benign course of a complex autoimmune disease. Leber. Magen. Darm. 15: 85-89 (1985).

• Polman CH, Kappos L, Dahlke F, Graf R, Beckmann K, Bogumil T, Pozzilli C, Thompson AJ. Interferon beta-1b treatment does not induce autoantibodies. Neurology 64: 996-1000 (2005).

• Pontynen N, Miettinen A, Petteri Arstila T, Kampe O, Alimohammadi M, Vaarala O, Peltonen L, Ulmanen I. Aire deficient mice do not develop the same profile of tissue-specific autoantibodies as APECED patients. J. Autoimmun. 27: 96-104 (2006).

• Poole BD, Schneider RI, Guthridge JM, Velte CA, Reichlin M, Harley JB, James JA. Early targets of nuclear RNP humoral autoimmunity in human systemic lupus erythematosus. Arthritis Rheum. 60: 848-859 (2009). *

• Poole BD, Scofield RH, Harley JB, James JA. Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus. Autoimmunity 39: 63-70 (2006).

• Porcel JM, Ordi-Ros J, Esquerda A, Vives M, Madronero AB, Bielsa S, Vilardell-Tarres M, Light RW. Antinuclear antibody testing in pleural fluid for the diagnosis of lupus pleuritis. Lupus 16: 25-27 (2007).

• Poritz LS, Zhang WJ, Thompson J, Boyer M, Clark C, Koltun WA. Impaired IL-4 phosphorylation of STAT6 in EBV transformed B-cells. J. Surg. Res. Jan 27 [Epub ahead of print] (2009).

• Portales P, Fabre S, Vincent T, Desmetz C, Reant B, Noel D, Clot J, Jorgensen C, Corbeau P. Peripheral blood T4 cell surface CCR5 density as a marker of activity in rheumatoid arthritis treated with anti-CD20 monoclonal antibody. Immunology 128: e738-e745 (2009).

• Portincasa P, Vacca M, Moschetta A, Petruzzelli M, Palasciano G, van-Erpecum KJ, van-Berge-Henegouwen GP. Primary sclerosing cholangitis: updates in diagnosis and therapy. World J. Gastroenterol. 11: 7-16 (2005). *

• Pothoulakis C. Review article: anti-inflammatory mechanisms of action of Saccharomyces boulardii. Aliment. Pharmacol. Ther. 30: 826-833 (2009). *

• Poturoglu S, Kaymakoglu S, Gurel Polat N, Ibrisim D, Ahishali E, Akyuz F, Badur S, Demir K, Mungan Z. A new agent for tumour necrosis factor-alpha inhibition: in vitro effects of dipyridamole in Crohn's disease. Scand. J. Clin. Lab. Invest. 69: 696-702 (2009).

• Poulain S, Lacomme S, Battaglia-Hsu SF, du Manoir S, Brochin L, Vignaud JM, Martinet N. Signalling with retinoids in the human lung: validation of new tools for the expression study of retinoid receptors. BMC Cancer 9: 423 (2009). *

• Poulalhon N, Begon E, Lebbe C, Liote F, Lahfa M, Bengoufa D, Morel P, Dubertret L, Bachelez H. A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity. Br. J. Dermatol. 156: 329-336 (2007). *

• Poupon R. Primary biliary cirrhosis: clinical aspects. Falk Symposium 146: GUT-LIVER INTERACTIONS: BASIC AND CLINICAL CONCEPTS, Innsbruck (Austria), March 11-12, 2005, pp. 62-63 (2005). *

• Poupon R, Chazouilleres O, Poupon RE. Chronic cholestatic diseases. J. Hepatol. 32: S129-S140 (2000).

• Poupon R, Poupon RE. Retrovirus infection as a trigger for primary biliary cirrhosis? Lancet 363: 260-261 (2004). *

• Pradhan VD, Badakere SS, Bichile LS, Almeida AF. Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. J. Assoc. Physicians India 52: 533-537 (2004).

• Pradhan VD, Badakere SS, Ghosh K, Almeida A. ANCA: serology in Wegener's granulomatosis. Indian J. Med. Sci. 59: 292-300 (2005). *

• Pradhan VD, Badakere SS, Ghosh K, Pawar AR. Spectrum of anti-neutrophil cytoplasmic antibodies in patients with pulmonary tuberculosis overlaps with that of Wegener's granulomatosis. Indian J. Med. Sci. 58: 283-288 (2004). *

• Pradhan VD, Badakere SS, Iyer YS, Kumar R, Almeida AF. A study of anti-neutrophil cytoplasm antibodies in systemic vasculitis and other related disorders. J. Postgrad. Med. 49: 5-9 (2003). *

• Pratesi F, Tommasi C, Anzilotti C, Chimenti D, Migliorini P. Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti-citrullinated protein antibodies in rheumatoid arthritis. Arthritis Rheum. 54: 733-741 (2006). *

• Pratsidou-Gertsi P, Kanakoudi-Tsakalidou F, Spyropoulou M, Germenis A, Adam K, Taparkou A, Siamopoulou A, Drakou C, Konstantinidis T, Prieur AM, Stavropoulos-Giokas C. Nationwide collaborative study of HLA class II associations with distinct types of juvenile chronic arthritis (JCA) in Greece. Eur. J. Immunogenet. 26: 299-310 (1999). *

• Pratt DS. Cholestasis and cholestatic syndromes. Curr. Opin. Gastroenterol. 21: 270-274 (2005). *

• Pratt EL, Tarantino MD, Wagner D, Hirsch Pescovitz O, Bowyer S, Shapiro AD. Prevalence of elevated antithyroid antibodies and antinuclear antibodies in children with immune thrombocytopenic purpura. Am. J. Hematol. 79: 175-179 (2005). *

• Preda CM, Vermeire S, Rutgeerts P, Joosens S, Diculescu M, Marica C, Ciocarlan M, Mirea V, Oproiu A. Prevalence and significance of perinuclear anti-neutrophil antibodies (pANCA) in Romanian patients with Crohn's disease and ulcerative colitis. Rom. J. Gastroenterol. 14: 357-360 (2005). *

• Primo J, Miralles A, Ferrando J, Albert A, Julve R, Gomez A, Garcia L. Atypical primary biliary cirrhosis or autoimmune cholangitis? Gastroenterol. Hepatol. 22: 505-509 (1999).

• Princen K, Hatse S, Vermeire K, Aquaro S, De Clercq E, Gerlach LO, Rosenkilde M, Schwartz TW, Skerlj R, Bridger G, Schols D. Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist. J. Virol. 78: 12996-13006 (2004). *

• Prinz JC, Kutasi Z, Weisenseel P, Poto L, Battyani Z, Ruzicka T. "Borrelia-associated early-onset morphea": a particular type of scleroderma in childhood and adolescence with high titer antinuclear antibodies? Results of a cohort analysis and presentation of three cases. J. Am. Acad. Dermatol. 60: 248-255 (2009).

• Prokop J, Jagodzinski PP. Identification of retroviral conserved pol sequences in serum of mixed connective tissue disease and systemic sclerosis patients. Biomed. Pharmacother. 58: 61-64 (2004).

• Prost AC, Abuaf N, Rouquette-Gally AM, Homberg JC, Combrisson A. Comparing HEp-2 cell line with rat liver in routine screening test for antinuclear and antinucleolar autoantibodies in autoimmune diseases. Ann. Biol. Clin. (Paris) 45: 610-617 (1987).

• Proujansky R, Fawcett PT, Gibney KM, Treem WR, Hyams JS. Examination of anti-neutrophil cytoplasmic antibodies in childhood inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 17: 193-197 (1993).

• Punnonen J, Aversa G, Cocks BG, McKenzie AN, Menon S, Zurawski G, de Waal Malefyt R, de Vries JE. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. U.S.A. 90: 3730-3734 (1993). *

• Qiao B, Wu J, Chu YW, Wang Y, Wang DP, Wu HS, Xiong SD. Induction of systemic lupus erythematosus-like syndrome in syngeneic mice by immunization with activated lymphocyte-derived DNA. Rheumatology (Oxford) 44: 1108-1114 (2005). *

• Qin X, Tao X, Chen ZJ, Jiang JQ, Xu MH, Li RL, Li TJ, Lin FQ, Li S. Comparison of indirect immunofluorescence assay and ELISA for detecting antinuclear antibodies and anti-double-stranded DNA antibodies. Nan Fang Yi Ke Da Xue Xue Bao 29: 472-475 (2009).

• Qing Y, Zhou JG, Yuan G. Systemic lupus erythematosus presenting as hypoglycaemia with insulin receptor antibodies and insulin autoantibodies. Lupus 18: 457-459 (2009). *

• Qiu DK, Li XM, Wei J, Ye LJ, Peng YS, Ma X. Clinical features of 107 autoimmune hepatitis patients and 30 of them with AIH-primary biliary cirrhosis overlap syndrome. Zhonghua Gan Zang Bing Za Zhi 16: 367-371 (2008).

• Qiu W, Bundell C, Wu JS, Castley A, James I, Hollingsworth P, Christiansen F, Carroll WM, Mastaglia FL, Kermode AG. Low level of systemic autoimmunity in Western Australian multiple sclerosis patients. Mult. Scler. Feb 11 [Epub ahead of print] (2010).

• Quaranta S, Shulman H, Ahmed A, Shoenfeld Y, Peter J, McDonald GB, Van de Water J, Coppel R, Ostlund C, Worman HJ, Rizzetto M, Tsuneyama K, Nakanuma Y, Ansari A, Locatelli F, Paganin S, Rosina F, Manns M, Gershwin ME. Autoantibodies in human chronic graft-versus-host disease after hematopoietic cell transplantation. Clin. Immunol. 91: 106-116 (1999). *

• Quinton JF, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B, Charrier G, Targan SR, Colombel JF, Poulain D. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 42: 788-791 (1998). *

• Quismorio FP Jr, Kaufman RL, Beardmore T, Mongan ES. Reactivity of serum antibodies to the keratin layer of rat esophagus in patients with rheumatoid arthritis. Arthritis Rheum. 58: S69-S74 (2008). *

• Rabelo R, Reyes C, Schifman A, Silva JE. A complex retinoic acid response element in the uncoupling protein gene defines a novel role for retinoids in thermogenesis. Endocrinology 137: 3488-3496 (1996). *

• Radic MZ, Shah K, Zhang W, Lu Q, Lemke G, Hilliard GM. Heterogeneous nuclear ribonucleoprotein p2 is an autoantibody target in mice deficient for mer, axl, and tyro3 receptor tyrosine kinases. J. Immunol. 176: 68-74 (2006). *

• Radice A, Vecchi M, Bianchi MB, Sinico RA. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives. Clin. Exp. Rheumatol. 18: 707-712 (2000).

• Radstake TR, Roelofs MF, Jenniskens YM, Oppers-Walgreen B, van Riel PL, Barrera P, Joosten LA, van den Berg WB. Expression of Toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma. Arthritis Rheum. 50: 3856-3865 (2004). *

• Radstake TR, Vonk MC, Dekkers M, Schijvenaars MM, Treppichio WL, Lafyatis R, Riemekasten G, van den Hoogen F, Coenen MJ. The -2518A>G promoter polymorphism in the CCL2 gene is not associated with systemic sclerosis susceptibility or phenotype: results from a multicenter study of European Caucasian patients. Hum. Immunol. 70: 130-133 (2009).

• Raffeiner B, Dejaco C, Duftner C, Kullich W, Goldberger C, Vega SC, Keller M, Grubeck-Loebenstein B, Schirmer M. Between adaptive and innate immunity: TLR4-mediated perforin production by CD28null T-helper cells in ankylosing spondylitis. Arthritis Res. Ther. 7: R1412-R1420 (2005). *

• Rahman AH, Eisenberg RA. The role of Toll-like receptors in systemic lupus erythematosus. Springer Semin. Immunopathol. 28: 131-143 (2006). *

• Rahman ZS, Tin SK, Buenaventura PN, Ho CH, Yap EP, Yong RY, Koh DR. A novel susceptibility locus on chromosome 2 in the (New Zealand Black x New Zealand White)F1 hybrid mouse model of systemic lupus erythematosus. J. Immunol. 168: 3042-3049 (2002). *

• Rai T, Ohira H, Fukaya E, Abe K, Yokokawa J, Takiguchi J, Shishido S, Sato Y. A case of merged idiopathic portal hypertension in course of mixed connective tissue disease. Hepatol. Res. 30: 51-55 (2004).

• Raile K, Klopocki E, Holder M, Wessel T, Galler A, Deiss D, Muller D, Riebel T, Horn D, Maringa M, Weber J, Ullmann R, Gruters A. Expanded clinical spectrum in hepatocyte nuclear factor 1b-maturity-onset diabetes of the young. J. Clin. Endocrinol. Metab. 94: 2658-2664 (2009). *

• Raina A, Greer JB, Whitcomb DC. Serology in autoimmune pancreatitis. Minerva Gastroenterol. Dietol. 54: 375-387 (2008).

• Rajendran CP, Ledge SG, Rani KP, Madhavan R. Psoriatic arthritis. J. Assoc. Physicians India 51: 1065-1068 (2003).

• Ramachandran J, Chacko A, Peter S, Mathews J, Govil S. Autoimmune pancreatitis - an uncommon type of chronic pancreatitis. Indian J. Gastroenterol. 23: 181-183 (2004). *

• Ramakrishna B, Eapen CE, Kang G, Kurian G, Chandy GM. Familial intrahepatic cholestatic cirrhosis with positive antimitochondrial antibody: familial primary biliary cirrhosis. J. Clin. Gastroenterol. 30: 255-258 (2000).

• Ramos PS, Kelly JA, Gray-McGuire C, Bruner GR, Leiran AN, Meyer CM, Namjou B, Espe KJ, Ortmann WA, Reichlin M, Langefeld CD, James JA, Gaffney PM, Behrens TW, Harley JB, Moser KL. Familial aggregation and linkage analysis of autoantibody traits in pedigrees multiplex for systemic lupus erythematosus. Genes Immun. 7: 417-432 (2006). *

• Ramos-Casals M, Brito-Zeron P, Perez-De-Lis M, Jimenez I, Blanco MJ, Bove A, Soto MJ, Akasbi M, Diaz C, Sentís J, Siso A. Sjogren syndrome or Sjogren disease? The histological and immunological bias caused by the 2002 criteria. Clin. Rev. Allergy Immunol. Jul 4 [Epub ahead of print] (2009). *

• Ramos-Casals M, Jara LJ, Medina F, Rosas J, Calvo-Alen J, Mana J, Anaya JM, Font J; THE HISPAMEC STUDY GROUP. Systemic autoimmune diseases co-existing with chronic hepatitis C virus infection (the HISPAMEC Registry): patterns of clinical and immunological expression in 180 cases. J. Intern. Med. 257: 549-557 (2005). *

• Ramos-Casals M, Munoz S, Medina F, Jara LJ, Rosas J, Calvo-Alen J, Brito-Zeron P, Forns X, Sanchez-Tapias JM. Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (the HISPAMEC registry). J. Rheumatol. 36: 1442-1448 (2009).

• Ramos-Casals M, Sanchez-Tapias JM, Pares A, Forns X, Brito-Zeron P, Nardi N, Vazquez P, Velez D, Arias I, Bove A, Plaza J, Rodes J, Font J. Characterization and differentiation of autoimmune versus viral liver involvement in patients with Sjogren's syndrome. J. Rheumatol. 33: 1593-1599 (2006).

• Ramos-Casals M, Solans R, Rosas J, Camps MT, Gil A, Del Pino-Montes J, Calvo-Alen J, Jimenez-Alonso J, Mico ML, Beltran J, Belenguer R, Pallares L; the GEMESS Study Group. Primary Sjogren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine (Baltimore) 87: 210-219 (2008).

• Randle HW, Millns JL, Schroeter AL, Winkelmann RK. Cutaneous immunofluorescence in primary biliary cirrhosis. JAMA 246: 1679-1681 (1981).

• Rangaswami H, Bulbule A, Kundu GC. Nuclear factor inducing kinase plays crucial role in osteopontin induced MAPK/IKK dependent nuclear factor kB-mediated promatrix metalloproteinase-9 activation. J. Biol. Chem. 279: 38921-38935 (2004). *

• Rangaswami H, Bulbule A, Kundu GC. Nuclear factor inducing kinase: a key regulator in osteopontin-induced MAPK/IkappaB kinase dependent NF-kappaB-mediated promatrix metalloproteinase-9 activation. Glycoconj. J. 23: 221-232 (2006). *

• Rankin EC, Isenberg DA. IgA deficiency and SLE: prevalence in a clinic population and a review of the literature. Lupus 6: 390-394 (1997).

• Raphael SA, Blau EB, Zhang WH, Hsu SH. Analysis of a large kindred with Blau syndrome for HLA, autoimmunity, and sarcoidosis. Am. J. Dis. Child. 147: 842-848 (1993).

• Rastin M, Hatef MR, Tabasi N, Sheikh A, Morad Abbasi J, Mahmoudi M. Sex hormones and peripheral white blood cell subsets in systemic lupus erythematosus patients. Iran J. Immunol. 4: 110-115 (2007).

• Ravel G, Christ M, Horand F, Descotes J. Autoimmunity, environmental exposure and vaccination: is there a link? Toxicology 196: 211-216 (2004). *

• Reese GE, Constantinides VA, Simillis C, Darzi AW, Orchard TR, Fazio VW, Tekkis PP. Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Am. J. Gastroenterol. 101: 2410-2422 (2006). *

• Reeves WH, Lee PY, Weinstein JS, Satoh M, Lu L. Induction of autoimmunity by pristane and other naturally occurring hydrocarbons. Trends Immunol. 30: 455-464 (2009). *

• Reggiani A, Dizioli P, Quattrocchi D, Quinzani M, Marelli A, Bodini P. Intrahepatic cholestasis: clinical and nosological classification. Critical survey of personal experience. Minerva Gastroenterol. Dietol. 43: 71-81 (1997).

• Reiniger N, Lee MM, Coleman FT, Ray C, Golan DE, Pier GB. Resistance to Pseudomonas aeruginosa chronic lung infection requires CFTR modulated IL-1 release and signaling through the IL-1 receptor. Infect. Immun. 75: 1598-1608 (2007). *

• Remmel T, Piirsoo A, Koiveer A, Remmel H, Uibo R, Salupere V. Clinical significance of different antinuclear antibodies patterns in the course of primary biliary cirrhosis. Hepatogastroenterology 43: 1135-1140 (1996).

• Ren H, Zhao H, Wang T, Yang Y, Han Z, Liu B, Wu Z, Tao J, Zhou B, Zhang L, Yang R, Han ZC. Leptin enhances in vitro secretion of IgG antiplatelet antibodies by splenocytes and peripheral blood mononuclear cells from patients with chronic idiopathic thrombocytopenic purpura. Clin. Immunol. 120: 205-211 (2006). *

• Ren J, Jia L, Xu L, Lin X, Pi Z, Xie J. Removal of autoantibodies by 4-mercaptoethylpyridine-based adsorbent. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 877: 1200-1204 (2009).

• Reumaux D, Meziere C, Colombel JF, Duthilleul P, Mueller S. Distinct production of autoantibodies to nuclear components in ulcerative colitis and in Crohn's disease. Clin. Immunol. Immunopathol. 77: 349-357 (1995). *

• Reuter S, Schnekenburger M, Cristofanon S, Buck I, Teiten MH, Daubeuf S, Eifes S, Dicato M, Aggarwal BB, Visvikis A, Diederich M. Tumor necrosis factor alpha induces gamma-glutamyltransferase expression via nuclear factor-kappaB in cooperation with Sp1. Biochem. Pharmacol. 77: 397-411 (2009). *

• Reyes CM, Rudinskaya A, Kloss R, Girardi M, Lazova R. Scleroderma-like illness as a presenting feature of multiple myeloma and amyloidosis. J. Clin. Rheumatol. 14: 161-165 (2008).

• Rhodes G, Carson DA, Valbracht J, Houghten R, Vaughan JH. Human immune responses to synthetic peptides from the Epstein-Barr nuclear antigen. J. Immunol. 134: 211-216 (1985).

• Richardson TA, Morgan E. Hepatic cytochrome P450 gene regulation during endotoxin-induced inflammation in nuclear receptor knockout mice. J. Pharmacol. Exp. Ther. 314: 703-709 (2005). *

• Riches PL, McRorie E, Fraser WD, Determann C, van't Hof R, Ralston SH. Osteoporosis associated with neutralizing autoantibodies against osteoprotegerin. N. Engl. J. Med. 361: 1459-1465 (2009). *

• Richter GH, Mollweide A, Hanewinkel K, Zobywalski C, Burdach S. CD25 blockade protects T cells from activation-induced cell death (AICD) via maintenance of TOSO expression. Scand. J. Immunol. 70: 206-15 (2009). *

• Rieder F, Schleder S, Wolf A, Dirmeier A, Strauch U, Obermeier F, Lopez R, Spector L, Fire E, Yarden J, Rogler G, Dotan N, Klebl F. Association of the novel serologic anti-glycan antibodies anti-laminarin and anti-chitin with complicated Crohn's disease behavior. Inflamm. Bowel Dis. 16: 263-274 (2010).

• Rigon A, Soda P, Zennaro D, Iannello G, Afeltra A. Indirect immunofluorescence in autoimmune diseases: assessment of digital images for diagnostic purpose. Cytometry B. Clin. Cytom. 72: 472-477 (2007).

• Rigopoulou EI, Davies ET, Bogdanos DP, Koukoulis G, Dalekos GN, Vergani D. Primary biliary cirrhosis (PBC) specific antinuclear antibodies (ANA) have prognostic value and a distinct immunoglobulin isotype profile. J. Hepatol. 40 Suppl. 1: 162 (2004).

• Rigopoulou EI, Davies ET, Pares A, Zachou K, Liaskos C, Bogdanos DP, Rodes J, Dalekos GN, Vergani D. Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis. Gut 54: 528-532 (2005). *

• Robak E, Sysa-Jedrzejowska A, Robak T, Smolewski P. Peripheral blood lymphocyte apoptosis and circulating dendritic cells in patients with systemic lupus erythematosus: correlation with immunological status and disease-related symptoms. Clin. Rheumatol. 25: 225-233 (2006).

• Robak E, Sysa-Jedrzejowska A, Wozniacka A. Progress and perspectives in the treatment of systemic lupus erythematosus. Przegl. Lek. 62: 894-899 (2005).

• Roberton DM, Cabral DA, Malleson PN, Petty RE. Juvenile psoriatic arthritis: followup and evaluation of diagnostic criteria. J. Rheumatol. 23: 166-170 (1996).

• Robinson CP, Yamachika S, Bounous DI, Brayer J, Jonsson R, Holmdahl R, Peck AB, Humphreys-Beher MG. A novel NOD-derived murine model of primary Sjogren's syndrome. Arthritis Rheum. 41: 150-156 (1998). *

• Rocklin RE, Maxwell NR, Thistle L, Kaplan MM. In vitro anti-mitochondrial antibody synthesis in patients with primary biliary cirrhosis. Clin. Immunol. Immunopathol. 38: 22-31 (1986).

• Rodrigues CM, Fan G, Ma X, Kren BT, Steer CJ. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J. Clin. Invest. 101: 2790-2799 (1998). *

• Rodriguez-Ayala E, Anderstam B, Suliman ME, Seeberger A, Heimburger O, Lindholm B, Stenvinkel P. Enhanced RAGE-mediated NFkappaB stimulation in inflamed hemodialysis patients. Atherosclerosis 180: 333-340 (2005).

• Rogers NJ, Lees MJ, Gabriel L, Maniati E, Rose SJ, Potter PK, Morley BJ. A defect in Marco expression contributes to systemic lupus erythematosus development via failure to clear apoptotic cells. J. Immunol. 182: 1982-1990 (2009).

• Rogler G, Brand K, Vogl D, Page S, Hofmeister R, Andus T, Knuechel R, Baeuerle PA, Scholmerich J, Gross V. Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology 115: 357-369 (1998). *

• Rojas G, Siegel F, Jorquera J, Ardiles L, Valderrama G, Mezzano S. Antineutrophil cytoplasmic antibodies and nonspecific ulcerative colitis. Rev. Med. Chil. 124: 449-455 (1996).

• Romanelli RG, La Villa G, Almerigogna F, Vizzutti F, Di Pietro E, Fedi V, Gentilini P, Laffi G. Uveitis in autoimmune hepatitis: a case report. World J. Gastroenterol. 12: 1637-1640 (2006). *

• Romano Carratelli C, Mazzola N, Paolillo R, Sorrentino S, Rizzo A. Toll-like receptor-4 (TLR4) mediates human beta-defensin-2 (HBD-2) induction in response to Chlamydia pneumoniae in mononuclear cells. FEMS Immunol. Med. Microbiol. 57: 116-124 (2009). *

• Romas E, Paspaliaris B, d'Apice AJ, Elliott PR. Autoantibodies to neutrophil cytoplasmic (ANCA) and endothelial cell surface antigens (AECA) in chronic inflammatory bowel disease. Aust. N. Z. J. Med. 22: 652-659 (1992).

• Romero Gomez M, Wichmann I, Otero Fernandez MA, Suarez Garcia E, Grande L, Nunez J, Nevado Santos M, Castro Fernandez M. Anti-Sp100 and anti-Gp210 in the diagnosis of primary biliary cirrhosis in patients with autoimmune cholangitis. Gastroenterol. Hepatol. 22: 11-13 (1999).

• Romero-Gomez M, Wichmann I, Crespo J, Pares A, Rodrigo L, Alvarez A, Diago M, Pons-Romero F, Sanchez-Munoz D, Aguilar-Reina J, Andrade RJ, Salmeron J, Sanchez-Pobre P, Rebollo JM, Martin-Vivaldi R, Castellano-Megias V, Nunez-Roldan A, Bruguera M. Serum immunological profile in patients with chronic autoimmune cholestasis. Am. J. Gastroenterol. 99: 2150-2157 (2004). *

• Rossiello L, Palla M, Aiello FS, Baroni A, Satriano RA. Granuloma faciale with extrafacial lesions. Skinmed. 6: 150-151 (2007).

• Rossol M, Pierer M, Arnold S, Keyszer G, Burkhardt H, Baerwald C, Wagner U. Homozygosity for DNASE2 single-nucleotide polymorphisms in the 5' regulatory region is associated with rheumatoid arthritis. Ann. Rheum. Dis. 68: 1498-1503 (2009).

• Routsias JG, Kyriakidis N, Latreille M, Tzioufas AG. RNA recognition motif (RRM) of La/SSB: the bridge for inter-particle spreading of autoimmune response to RNP. Mol. Med. 16: 19-26 (2010). *

• Rovedatti L, Kudo T, Biancheri P, Sarra M, Knowles C, Rampton DS, Corazza GR, Monteleone G, Di Sabatino A, MacDonald TT. Differential regulation of interleukin-17 and interferon-gamma production in inflammatory bowel disease. Gut 58: 1629-1636 (2009). *

• Rozenkov V. Antineutrophil cytoplasmic cntibodies (ANCA): pathophysiological aspects, investigation opportunities and diagnostic role. THE CANBERRA HOSPITAL, AUSTRALIA: PATHOLOGY NEWSLETTER NUMBER 53 p. 4-11 (2000). *

• Rubin RL, Teodorescu M, Beutner EH, Plunkett RW. Complement-fixing properties of antinuclear antibodies distinguish drug-induced lupus from systemic lupus erythematosus. Lupus 13: 249-256 (2004).

• Rubins NE, Friedman JR, Le PP, Zhang L, Brestelli J, Kaestner KH. Transcriptional networks in the liver: hepatocyte nuclear factor 6 function is largely independent of Foxa2. Mol. Cell. Biol. 25: 7069-7077 (2005). *

• Rueda JC, Duarte-Rey C, Casas N. Successful treatment of relapsing autoimmune pancreatitis in primary Sjogren's syndrome with rituximab: report of a case and review of the literature. Rheumatol. Int. 29: 1481-1485 (2009). *

• Ruemmele FM, Targan SR, Levy G, Dubinsky M, Braun J, Seidman EG. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology 115: 822-829 (1998). *

• Rump JA, Roth M, Scholmerich J, Helfesrieder R, Ludemann J, Gross WL, Rautmann A, Peter HH. A new type of ANCA in sera of patients with ulcerative colitis: effects of therapy and disease severity on serum titer. Immun. Infekt. 20: 16-18 (1992).

• Rump JA, Scholmerich J, Gross V, Roth M, Helfesrieder R, Rautmann A, Ludemann J, Gross WL, Peter HH. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. Immunobiology 181: 406-413 (1990).

• Rump JA, Worner I, Roth M, Scholmerich J, Hansch M, Peter HH. p-ANCA of undefined specificity in ulcerative colitis: correlation to disease activity and therapy. Adv. Exp. Med. Biol. 336: 507-513 (1993).

• Rumsey J, Valentine JF, Naser SA. Inhibition of phagosome maturation and survival of Mycobacterium avium subspecies paratuberculosis in polymorphonuclear leukocytes from Crohn's disease patients. Med. Sci. Monit. 12: BR130-BR139 (2006). *

• Ruperto N, Lovell DJ, Cuttica R, Wilkinson N, Woo P, Espada G, Wouters C, Silverman ED, Balogh Z, Henrickson M, Apaz MT, Baildam E, Fasth A, Gerloni V, Lahdenne P, Prieur AM, Ravelli A, Saurenmann RK, Gamir ML, Wulffraat N, Marodi L, Petty RE, et al. A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum. 56: 3096-3106 (2007). *

• Rutherford AE, Pratt DS. Cholestasis and cholestatic syndromes. Curr. Opin. Gastroenterol. 22: 209-214 (2006). *

• Saadah OI, Smith AL, Hardikar W. Long-term outcome of autoimmune hepatitis in children. J. Gastroenterol. Hepatol. 16: 1297-1302 (2001). *

• Saadoun D, Cazals-Hatem D, Denninger MH, Boudaoud L, Pham BN, Mallet V, Condat B, Briere J, Valla D. Association of idiopathic hepatic sinusoidal dilatation with the immunological features of the antiphospholipid syndrome. Gut 53: 1516-1519 (2004). *

• Sabio JM, Vargas-Hitos J, Zamora-Pasadas M, Mediavilla JD, Navarrete N, Ramirez A, Hidalgo-Tenorio C, Jaimez L, Martin J, Jimenez-Alonso J. Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus. J. Rheumatol. 36: 2204-2211 (2009).

• Sack U, Conrad K, Csernok E, Frank I, Hiepe F, Krieger T, Kromminga A, Landenberg PV, Messer G, Witte T, Mierau R. Autoantibody detection by indirect immunofluorescence on HEp-2 cells. Dtsch. Med. Wochenschr. 134: 1278-1282 (2009).

• Sack U, Conrad K, Csernok E, Frank I, Hiepe F, Krieger T, Kromminga A, von Landenberg P, Messer G, Witte T, Mierau R; German EASI (European Autoimmunity Standardization Initiative). Autoantibody detection using indirect immunofluorescence on HEp-2 cells. Ann. N. Y. Acad. Sci. 1173: 166-173 (2009). *

• Saeki K, Hozawa S, Miyata N, Nishizawa T, Soma H, Iwao Y, Kameyama K, Hibi T. IgG4-negative autoimmune pancreatitis with sclerosing cholangitis and colitis: possible association with primary sclerosing cholangitis? Intern. Med. 47: 943-948 (2008). *

• Saeki T, Imai N, Ito T, Yamazaki H, Nishi S. Membranous nephropathy associated with IgG4-related systemic disease and without autoimmune pancreatitis. Clin. Nephrol. 71: 173-178 (2009).

• Saeki T, Saito A, Yamazaki H, Emura I, Imai N, Ueno M, Nishi S, Miyamura S, Gejyo F. Tubulointerstitial nephritis associated with IgG4-related systemic disease. Clin. Exp. Nephrol. 11: 168-173 (2007).

• Sahani DV, Kalva SP, Farrell J, Maher MM, Saini S, Mueller PR, Lauwers GY, Fernandez CD, Warshaw AL, Simeone JF. Autoimmune pancreatitis: imaging features. Radiology 233: 345-352 (2004). *

• Sahin P, Pozsar J, Simon K, ILlyes G, Laszlo F, Topa L. Autoimmune pancreatitis associated with immune-mediated inflammation of the papilla of vater: report on two cases. Pancreas 29: 162-166 (2004).

• Saibeni S, Folli C, de Franchis R, Borsi G, Vecchi M. Diagnostic role and clinical correlates of anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (p-ANCA) in Italian patients with inflammatory bowel diseases. Dig. Liver Dis. 35: 862-868 (2003).

• Saint Marcoux B, De Bandt M; on behalf of the CRI (Club Rhumatismes et Inflammation). Vasculitides induced by TNFalpha antagonists: a study in 39 patients in France. Joint Bone Spine 73: 710-713 (2006). *

• Sairam S, Goel N, Lisse J, McNearney T. Pericardial effusion and cardiomyopathy following arthritis with parvovirus B19 infection: response to intravenous immunoglobulin. J. Clin. Rheumatol. 7: 346-349 (2001).

• Saji N, Taniguchi K, Tadano M, Shimizu H, Kawarai T, Kita Y. A case of brainstem encephalitis following multiple cranial neuropathy in a hepatocellular carcinoma patient - association with cytomegalovirus and varicella-zoster virus infection. Brain Nerve 59: 1273-1279 (2007).

• Sakakibara R, Hirano S, Asahina M, Sawai S, Nemoto Y, Hiraga A, Uchiyama T, Hattori T. Primary Sjogren's syndrome presenting with generalized autonomic failure. Eur. J. Neurol. 11: 635-638 (2004).

• Sakamoto A, Kawasaki T, Kazawa T, Ohashi R, Jiang S, Maejima T, Tanaka T, Iwanari H, Hamakubo T, Sakai J, Kodama T, Naito M. Expression of liver X receptor alpha in rat fetal tissues at different developmental stages. J. Histochem. Cytochem. 55: 641-649 (2007). *

• Sakuma M, Hatsushika K, Koyama K, Katoh R, Ando T, Watanabe Y, Wako M, Kanzaki M, Takano S, Sugiyama H, Hamada Y, Ogawa H, Okumura K, Nakao A. TGF-beta type I receptor kinase inhibitor down-regulates rheumatoid synoviocytes and prevents the arthritis induced by type II collagen antibody. Int. Immunol. 19: 117-126 (2007). *

• Salas JT, Banales JM, Sarvide S, Recalde S, Ferrer A, Uriarte I, Oude Elferink RP, Prieto J, Medina JF. Ae2a,b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis. Gastroenterology 134: 1482-1493 (2008). *

• Salemi S, Picchianti-Diamanti A, Germano V, Donatelli I, Di Martino A, Facchini M, Nisini R, Biselli R, Ferlito C, Podesta E, Cappella A, Milanetti F, Rossi F, Amodeo R, Tabacco F, Di Rosa R, Lagana B, D Amelio R. Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNFalpha blockers: safety and immunogenicity. Clin. Immunol. Oct 20 [Epub ahead of print] (2009). *

• Salo J, Caballeria L, Bruguera M, Pares A, Rodes J. Autoimmune cholangitis or primary biliary cirrhosis without antimitochondrial antibodies? Gastroenterol. Hepatol. 20: 5-10 (1997).

• Salonen EM, Miettinen A, Walle TK, Koskenmies S, Kere J, Julkunen H. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases. Ann. Rheum. Dis. 63: 1250-1254 (2004). *

• Salvi M, Vannucchi G, Sbrozzi F, Del Castello AB, Carnevali A, Fargion S, Beck-Peccoz P. Onset of autoimmune hepatitis during intravenous steroid therapy for thyroid-associated ophthalmopathy in a patient with Hashimoto's thyroiditis: case report. Thyroid 14: 631-634 (2004).

• Sanchez-Munoz D, Castellano-Megias VM, Romero-Gomez M. Expression of bcl-2 in ductular proliferation is related to periportal hepatic stellate cell activation and fibrosis progression in patients with autoimmune cholestasis. Dig. Liver Dis. 39: 262-266 (2007).

• Sanchez-Pobre P, Castellano G, Colina F, Dominguez P, Rodriguez S, Canga F, Herruzo JA. Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis. Atypical primary biliary cirrhosis or autoimmune cholangitis? J. Clin. Gastroenterol. 23: 191-198 (1996).

• Sanchez-Pobre P, Gonzalez C, Paz E, Colina F, Castellano G, Munoz-Yague T, Rodriguez S, Yela C, Alvarez V, Solis-Herruzo J. Chronic hepatitis C and autoimmune cholangitis: a case study and literature review. Dig. Dis. Sci. 47: 1224-1229 (2002). *

• Sanchez-Pobre P, Solis-Herruzo J. Autoimmune cholangitis, nosological location. Rev. Esp. Enferm. Dig. 95: 791-794 (2003).

• Sandborn WJ. Serologic markers in inflammatory bowel disease: state of the art. Rev. Gastroenterol. Disord. 4: 167-174 (2004). *

• Sandborn WJ, Feagan BG, Stoinov S, Honiball PJ, Rutgeerts P, Mason D, Bloomfield R, Schreiber S; the PRECISE 1 Study Investigators. Certolizumab pegol for the treatment of Crohn's disease. N. Engl. J. Med. 357: 228-238 (2007). *

• Sandborn WJ, Hanauer SB. Infliximab in the treatment of Crohn's disease: a user's guide for clinicians. Am. J. Gastroenterol. 97: 2962-2972 (2002). *

• Sandborn WJ, Landers CJ, Tremaine WJ, Targan SR. Association of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitis: results of a pilot study. Mayo Clin. Proc. 71: 431-436 (1996). *

• Sander DM, Szabo S, Gallaher WR, Deas JE, Thompson JJ, Cao Y, Luo-Zhang H, Liu LG, Colmegna I, Koehler J, Espinoza LR, Alexander SS, Hart DJ, Tom DM, Fermin CD, Jaspan JJ, Kulakosky PC, Tenenbaum SA, Wilson RB, Garry RF. Involvement of human intracisternal A-type retroviral particles in autoimmunity. Microsc. Res. Tech. 68: 222-234 (2005).

• Sanderson K, Scotland R, Lee P, Liu D, Groshen S, Snively J, Sian S, Nichol G, Davis T, Keler T, Yellin M, Weber J. Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and montanide ISA 51 for patients with resected stages III and IV melanoma. J. Clin. Oncol. 23: 741-750 (2005). *

• Santaella ML, Cox PR, Colon M, Ramos C, Disdier OM. Rheumatologic manifestations in patients with selected primary immunodeficiencies evaluated at the University Hospital. P. R. Health Sci. J. 24: 191-195 (2005).

• Santiago-Raber ML, Dunand-Sauthier I, Wu T, Li QZ, Uematsu S, Akira S, Reith W, Mohan C, Kotzin BL, Izui S. Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice. J. Autoimmun. Nov 25 [Epub ahead of print] (2009).

• Santoro P, De Andrea M, Migliaretti G, Trapani C, Landolfo S, Gariglio M. High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases. J. Rheumatol. 29: 90-93 (2002). *

• Saradhi M, Krishna B, Mukhopadhyay G, Tyagi RK. Purification of full-length human pregnane and xenobiotic receptor: polyclonal antibody preparation for immunological characterization. Cell Res. 15: 785-795 (2005). *

• Saramaki A, Banwell CM, Campbell MJ, Carlberg C. Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. Nucleic Acids Res. 34: 543-554 (2006). *

• Sarin SK, Monga R, Sandhu BS, Sharma BC, Sakhuja P, Malhotra V. Primary biliary cirrhosis in India. Hepatobiliary Pancreat. Dis. Int. 5: 105-109 (2006). *

• Sarzi-Puttini P, Ardizzone S, Manzionna G, Atzeni F, Colombo E, Antivalle M, Carrabba M, Bianchi-Porro G. Infliximab-induced lupus in Crohn's disease: a case report. Dig. Liver Dis. 35: 814-817 (2003).

• Sasaki M, Allina J, Odin JA, Thung SN, Coppel R, Nakanuma Y, Gershwin ME. Autoimmune cholangitis in the SJL/J mouse is antigen non-specific. Dev. Immunol. 9: 103-111 (2002). *

• Sasaki S, Murase T, Kuno S, Yamamoto T. Changes of complement in recurrent abortion and pregnancy loss with antiphospholipid antibody positive. Nihon Rinsho Meneki Gakkai Kaishi 29: 372-377 (2006).

• Satish Rao BS, Krishnanand BR, Krishan A. Androgen & vitamin D nuclear receptor expression in archival breast tumour samples. Indian J. Med. Res. 123: 73-82 (2006). *

• Sato F, Maruyama S, Hayashi H, Sakamoto I, Yamada S, Uchimura T, Morita Y, Ito Y, Yuzawa Y, Maruyama I, Matsuo S. High mobility group box chromosomal protein 1 in patients with renal diseases. Nephron Clin. Pract. 108: c194-c201 (2008).

• Sato N, Ohira H, Orikasa H, Shinzawa J, Suzuki T, Tojo J, Miyata M, Nishimaki T, Kasukawa R. Primary biliary cirrhosis associated with painless thyroiditis. Intern. Med. 38: 244-248 (1999). *

• Sato T, Kanai T, Watanabe M, Sakuraba A, Okamoto S, Nakai T, Okazawa A, Inoue N, Totsuka T, Yamazaki M, Kroczek RA, Fukushima T, Ishii H, Hibi T. Hyperexpression of inducible costimulator and its contribution on lamina propria T cells in inflammatory bowel disease. Gastroenterology 126: 829-839 (2004). *

• Sato Y, Harada K, Sudo Y, Watanabe K, Nakahama T, Morimoto H, Nakanuma Y. Autoimmune hepatitis associated with bile duct injury resembling chronic non-suppurative destructive cholangitis. Pathol. Int. 52: 478-482 (2002). *

• Saurenmann RK, Levin AV, Feldman BM, Rose JB, Laxer RM, Schneider R, Silverman ED. Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study. Arthritis Rheum. 56: 647-657 (2007). *

• Sauter P, Chehadeh W, Lobert PE, Lazrek M, Goffard A, Soumillon M, Caloone D, Vantyghem MC, Weill J, Fajardy I, Alm G, Lucas B, Hober D. A part of the VP4 capsid protein exhibited by coxsackievirus B4 E2 is the target of antibodies contained in plasma from patients with type 1 diabetes. J. Med. Virol. 80: 866-878 (2008).

• Savage CO, Pottinger BE, Gaskin G, Lockwood CM, Pusey CD, Pearson JD. Vascular damage in Wegener's granulomatosis and microscopic polyarteritis: presence of anti-endothelial cell antibodies and their relation to anti-neutrophil cytoplasm antibodies. Clin. Exp. Immunol. 85: 14-19 (1991). *

• Savarese E, Steinberg C, Pawar RD, Reindl W, Akira S, Anders HJ, Krug A. Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis. Arthritis Rheum. 58: 1107-1115 (2008). *

• Savige JA, Chang L, Horn S, Crowe SM. Anti-nuclear, anti-neutrophil cytoplasmic and anti-glomerular basement membrane antibodies in HIV-infected individuals. Autoimmunity 18: 205-211 (1994).

• Savige JA, Davies DJ, Gatenby PA. Anti-neutrophil cytoplasmic antibodies (ANCA): their detection and significance: report from workshops. Pathology 26: 186-193 (1994). *

• Savige JA, Paspaliaris B, Silvestrini R, Davies D, Nikoloutsopoulos T, Sturgess A, Neil J, Pollock W, Dunster K, Hendle M. A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies. J. Clin. Pathol. 51: 568-575 (1998). *

• Sawada-Hase N, Kiyohara T, Miyagawa J, Ueyama H, Nishibayashi H, Murayama Y, Kashihara T, Nakahara M, Miyazaki Y, Kanayama S, Nezu R, Shinomura Y, Matsuzawa Y. An increased number of CD40-high monocytes in patients with Crohn's disease. Am. J. Gastroenterol. 95: 1516-1523 (2000). *

• Sawalha AH, Jeffries M, Webb R, Lu Q, Gorelik G, Ray D, Osban J, Knowlton N, Johnson K, Richardson B. Defective T-cell ERK signaling induces interferon-regulated gene expression and overexpression of methylation-sensitive genes similar to lupus patients. Genes Immun. 9: 368-378 (2008).

• Sawalha AH, Namjou B, Nath SK, Kilpatrick J, Germundson A, Kelly JA, Hutchings D, James J, Harley J. Genetic linkage of systemic lupus erythematosus with chromosome 11q14 (SLEH1) in African-American families stratified by a nucleolar antinuclear antibody pattern. Genes Immun. 3 Suppl. 1: S31-S34 (2002). *

• Scatena M, Almeida M, Chaisson ML, Fausto N, Nicosia RF, Giachelli CM. NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival. J. Cell Biol. 141: 1083-1093 (1998). *

• Schaeffler A, Gross P, Buettner R, Bollheimer C, Buechler C, Neumeier M, Kopp A, Schoelmerich J, Falk W. Fatty acid-induced induction of Toll-like receptor-4/nuclear factor-kappaB pathway in adipocytes links nutritional signalling with innate immunity. Immunology 126: 233-245 (2009). *

• Schattner A, Kaburaki Y, Kaplan MM, Miller KB. Anti-DNA antibody idiotypes in primary biliary cirrhosis. Cell. Immunol. 104: 37-46 (1987).

• Scheinfeld N. Off-label uses and side effects of infliximab. J. Drugs Dermatol. 3: 273-284 (2004).

• Schlenker T, Apenberg S, Raedsch R, Andrassy K, Plachky J, Kommerell B. Antineutrophil cytoplasmic antibodies in chronic inflammatory bowel diseases. Dtsch. Med. Wochenschr. 117: 1463-1468 (1992).

• Schmidt E, Gutberlet J, Siegmund D, Berg D, Wajant H, Waschke J. Apoptosis is not required for acantholysis in pemphigus vulgaris. Am. J. Physiol. Cell. Physiol. 296: C162-C172 (2009). *

• Schmidt M, Voell M, Rahlff I, Dietlein M, Kobe C, Faust M, Schicha H. Long-term follow-up of antithyroid peroxidase antibodies in patients with chronic autoimmune thyroiditis (Hashimoto's thyroiditis) treated with levothyroxine. Thyroid 18: 755-760 (2008).

• Schneeberger E, Citera G, Heredia M, Maldonado Cocco J. Clinical significance of anti-Ro antibodies in rheumatoid arthritis. Clin. Rheumatol. 27: 517-519 (2008). *

• Schoepfer AM, Schaffer T, Seibold-Schmid B, Muller S, Seibold F. Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patients. Neurogastroenterol. Motil. 20: 1110-1118 (2008).

• Schramm C, Herkel J, Beuers U, Kanzler S, Galle PR, Lohse AW. Pregnancy in autoimmune hepatitis: outcome and risk factors. Am. J. Gastroenterol. 101: 556-560 (2006). *

• Schreiber S, Gehrckens A, Raedler A. Activation of the major omentum-associated lymphoid tissue in Crohn disease. Zentralbl. Chir. 120: 135-144 (1995).

• Schreiber S, Khaliq-Kareemi M, Lawrance IC, Thomsen OO, Hanauer SB, McColm J, Bloomfield R, Sandborn WJ; the PRECISE 2 Study Investigators. Maintenance therapy with certolizumab pegol for Crohn's disease. N. Engl. J. Med. 357: 239-250 (2007). *

• Schreibman I, Regev A. Recurrent primary biliary cirrhosis after liver transplantation - the disease and its management. MedGenMed. 8: 30 (2006). *

• Schultz DR, Tozman EC. Antineutrophil cytoplasmic antibodies: major autoantigens, pathophysiology, and disease associations. Semin. Arthritis Rheum. 25: 143-159 (1995). *

• Schumacher G, Kollberg B, Sandstedt B, Ljungh A, Nassberger L. Circulating granulocyte antibodies in first attacks of colitis. Scand. J. Gastroenterol. 30: 157-163 (1995).

• Sculley TB, Pope JH, Hazelton RA. Correlation between the presence of antibodies to the Epstein-Barr virus nuclear antigen type 2 and antibodies to the rheumatoid arthritis nuclear antigen in patients with rheumatoid arthritis. Arthritis Rheum. 29: 964-970 (1986).

• Sebkova L, Pellicano A, Monteleone G, Grazioli B, Guarnieri G, Imeneo M, Pallone F, Luzza F. Extracellular signal-regulated protein kinase mediates interleukin 17 (IL-17)-induced IL-8 secretion in Helicobacter pylori-infected human gastric epithelial cells. Infect. Immun. 72: 5019-5026 (2004). *

• Sediva A, Lischke R, Simonek J, Tkaczyk J, Vavrova V, Bartosova J, Pohunek P, Bartunkova J, Pafko P. Lung transplantation for cystic fibrosis: immune system and autoimmunity. Med. Sci. Monit. 7: 1219-1223 (2001). *

• Seibold F, Brandwein S, Simpson S, Terhorst C, Elson CO. pANCA represents a cross-reactivity to enteric bacterial antigens. J. Clin. Immunol. 18: 153-160 (1998).

• Seibold F, Slametschka D, Gregor M, Weber P. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 107: 532-536 (1994).

• Seibold F, Weber P, Jenss H, Scheurlen M. Autoimmune hepatitis in inflammatory bowel disease: report of two unusual cases. Z. Gastroenterol. 35: 29-32 (1997).

• Seibold F, Weber P, Klein R, Berg PA, Wiedmann KH. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut 33: 657-662 (1992). *

• Seibold F, Weber P, Schoning A, Mork H, Goppel S, Scheurlen M. Neutrophil antibodies (pANCA) in chronic liver disease and inflammatory bowel disease: do they react with different antigens? Eur. J. Gastroenterol. Hepatol. 8: 1095-1100 (1996).

• Seifert M, Gerth J, Gajda M, Pester F, Pfeifer R, Wolf G. Eosinophilia - a challenging differential diagnosis. Med. Klin. (Munich) 103: 591-597 (2008).

• Seinturier C, Imbert B, Ponard D, Drouet C, Debru JL. Sneddon syndrome with anti-mitochondrial type M5 antibodies. Presse. Med. 34: 1011-1012 (2005).

• Sekigawa I, Yanagida M, Iwabuchi K, Kaneda K, Kaneko H, Takasaki Y, Jung G, Sone S, Tanaka Y, Ogawa H, Takamori K. Protein biomarker analysis by mass spectrometry in patients with rheumatoid arthritis receiving anti-tumor necrosis factor-alpha antibody therapy. Clin. Exp. Rheumatol. 26: 261-267 (2008).

• Sekikawa A, Fukui H, Fujii S, Takeda J, Nanakin A, Hisatsune H, Seno H, Takasawa S, Okamoto H, Fujimori T, Chiba T. REG Ialpha protein may function as a trophic and/or anti-apoptotic factor in the development of gastric cancer. Gastroenterology 128: 642-653 (2005). *

• Sekine H, Graham KL, Zhao S, Elliott MK, Ruiz P, Utz PJ, Gilkeson GS. Role of MHC-linked genes in autoantigen selection and renal disease in a murine model of systemic lupus erythematosus. J. Immunol. 177: 7423-7434 (2006). *

• Sellam J, Miceli-Richard C, Gottenberg JE, Ittah M, Lavie F, Lacabaratz C, Gestermann N, Proust A, Lambotte O, Mariette X. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjogren's syndrome and systemic lupus erythematosus. Ann. Rheum. Dis. 66: 790-797 (2007). *

• Selmi C, Zuin M, Bowlus CL, Gershwin ME. Anti-mitochondrial antibody-negative primary biliary cirrhosis. Clin. Liver Dis. 12: 173-185 (2008).

• Selvam R, Vijaya R, Sivakamasundari P. Characterisation of nuclear pore complex oxalate binding protein from human kidney. Mol. Cell. Biochem. 243: 1-8 (2003). *

• Sema K, Takei M, Uenogawa K, Horikoshi A, Hosokawa Y, Matsuda M, Henmi A, Sawada S. Felty's syndrome with chronic hepatitis and compatible autoimmune hepatitis: a case presentation. Intern. Med. 44: 335-341 (2005). *

• Semmler M, Seeck U, Neustadt B, Schulz M, Dotzlaw H, Neeck G, Eggert M. No effects of adalimumab therapy on the activation of NF-kappaB in lymphocytes from patients with severe rheumatoid arthritis. Clin. Rheumatol. 26: 1499-1504 (2007). *

• Senaldi G, Portmann B, Mowat AP, Mieli-Vergani G, Vergani D. Immunohistochemical features of the portal tract mononuclear cell infiltrate in chronic aggressive hepatitis. Arch. Dis. Child. 67: 1447-1453 (1992). *

• Sengler C, Keitzer R, Pleyer U. Uveitis in conjunction with rheumatological diseases in childhood. Ophthalmologe 102: 463-476 (2005).

• Seo S, Toutounjian R, Conrad A, Blatt L, Tong MJ. Favorable outcomes of autoimmune hepatitis in a community clinic setting. J. Gastroenterol. Hepatol. 23: 1410-1414 (2008). *

• Seow CH, Stempak JM, Xu W, Lan H, Griffiths AM, Greenberg GR, Steinhart AH, Dotan N, Silverberg MS. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype. Am. J. Gastroenterol. 104: 1426-1434 (2009). *

• Serpico R, Pannone G, Santoro A, Mezza E, Piccolo S, Esposito V, Busciolano M, Ciavarella D, Lo Muzio L, Bufo P. Report of a case of discoid lupus erythematosus localised to the oral cavity: immunofluorescence findings. Int. J. Immunopathol. Pharmacol. 20: 655-657 (2007).

• Serra CR, Rodrigues SH, Silva NP, Sztajnbok FR, Andrade LE. Clinical significance of anticardiolipin antibodies in juvenile idiopathic arthritis. Clin. Exp. Rheumatol. 17: 375-380 (1999).

• Servais G, Karmali R, Guillaume MP, Badot V, Duchateau J, Corazza F. Anti DNA antibodies are not restricted to a specific pattern of fluorescence on HEp2 cells. Clin. Chem. Lab. Med. 47: 543-549 (2009). *

• Seve P, Ferry T, Koenig M, Cathebras P, Rousset H, Broussolle C. Lupus-like presentation of parvovirus B19 infection. Semin. Arthritis Rheum. 34: 642-648 (2005). *

• Seyfert-Margolis V, Gisler TD, Asare AL, Wang RS, Dosch HM, Brooks-Worrell B, Eisenbarth GS, Palmer JP, Greenbaum CJ, Gitelman SE, Nepom GT, Bluestone JA, Herold KC. Analysis of T-cell assays to measure autoimmune responses in subjects with type 1 diabetes: results of a blinded controlled study. Diabetes 55: 2588-2594 (2006). *

• Sfar I, Ben Aleya W, Mouelhi L, Aouadi H, Ben Rhomdhane T, Makhlouf M, Ayed-Jendoubi S, Gargaoui H, Najjar T, Ben Abdallah T, Ayed K, Gorgi Y. Lymphoid tyrosine phosphatase R620W variant and inflammatory bowel disease in Tunisia. World J. Gastroenterol. 16: 479-483 (2010). *

• Shaoul R, Lerner A. Associated autoantibodies in celiac disease. Autoimmun. Rev. 6: 559-565 (2007).

• Shen C, Dillissen E, Kasran A, Lin Y, Clydesdale G, Sienaert I, Jonghe SD, Gao LJ, Geboes K, Boon L, Rutgeerts P, Ceuppens JL. Anti-inflammatory activity of a pteridine derivative (4AZA2096) alleviates TNBS-induced colitis in mice. J. Interferon Cytokine Res. 26: 575-582 (2006).

• Shen M, Zhang F, Zhang X. Primary biliary cirrhosis complicated with interstitial lung disease: a prospective study in 178 patients. J. Clin. Gastroenterol. 43: 676-679 (2009).

• Sherer Y, Gorstein A, Fritzler MJ, Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin. Arthritis Rheum. 34: 501-537 (2004). *

• Sherlock S. Primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune cholangitis. Clin. Liver Dis. 4: 97-113 (2000).

• Sherlock S. Ludwig Symposium on biliary disorders. Autoimmune cholangitis: a unique entity? Mayo Clin. Proc. 73: 184-190 (1998). *

• Shetty A, Forbes A. Pharmacogenomics of response to anti-tumor necrosis factor therapy in patients with Crohn's disease. Am. J. Pharmacogenomics 2: 215-221 (2002).

• Shetty S, Ghosh K. Anti-phospholipid antibodies and other immunological causes of recurrent foetal loss - a review of literature of various therapeutic protocols. Am. J. Reprod. Immunol. 62: 9-24 (2009). *

• Shi L, Qiu D, Zhao G, Corthesy B, Lees-Miller S, Reeves WH, Kao PN. Dynamic binding of Ku80, Ku70 and NF90 to the IL-2 promoter in vivo in activated T-cells. Nucleic Acids Res. 35: 2302-2310 (2007). *

• Shi Y, Kaliyaperumal A, Lu L, Southwood S, Sette A, Michaels MA, Datta SK. Promiscuous presentation and recognition of nucleosomal autoepitopes in lupus: role of autoimmune T cell receptor alpha chain. J. Exp. Med. 187: 367-378 (1998). *

• Shibasaki T, Shimada T, Morita T, Sakai O. Immunogenetical penetrance in patients with primary biliary cirrhosis. Jpn. J. Med. 29: 533-536 (1990).

• Shibata M, Morizane T, Tanaka A, Onozuka Y, Uchida T, Gershwin ME, Mitamura K. A case of autoimmune hepatitis with a high titer of antimitochondrial antibody and normal gamma-globulinemia. J. Gastroenterol. Hepatol. 16: 830-835 (2001). *

• Shibata M, Watanabe M, Ueno Y, Sadamoto T, Sato G, Yasushi T, Yamagami T, Tuzimoto S, Enomoto M. Clinicopathological study of proliferating cell nuclear antigen (PCNA) of hepatocytes in primary biliary cirrhosis. J. Gastroenterol. 29: 56-60 (1994).

• Shimakage M, Sasagawa T, Kimura M, Shimakage T, Seto S, Kodama K, Sakamoto H. Expression of Epstein-Barr virus in Langerhans' cell histiocytosis. Hum. Pathol. 35: 862-868 (2004).

• Shimizu K, Kobayashi M, Tahara J, Shiratori K. Cytokines and peroxisome proliferator-activated receptor gamma ligand regulate phagocytosis by pancreatic stellate cells. Gastroenterology 128: 2105-2118 (2005). *

• Shimoda S, Harada K, Niiro H, Taketomi A, Maehara Y, Tsuneyama K, Kikuchi K, Nakanuma Y, Mackay IR, Gershwin ME, Akashi K. CX3CL1 (fractalkine): a signpost for biliary inflammation in primary biliary cirrhosis. Hepatology 51: 567-575 (2010). *

• Shimoda S, Miyakawa H, Nakamura M, Ishibashi H, Kikuchi K, Kita H, Niiro H, Arinobu Y, Ono N, Mackay IR, Gershwin ME, Akashi K. CD4 T-cell autoreactivity to the mitochondrial autoantigen PDC-E2 in AMA-negative primary biliary cirrhosis. J. Autoimmun. 31: 110-115 (2008).

• Shimoda S, Nakamura M, Ishibashi H, Kawano A, Kamihira T, Sakamoto N, Matsushita S, Tanaka A, Worman HJ, Gershwin ME, Harada M. Molecular mimicry of mitochondrial and nuclear autoantigens in primary biliary cirrhosis. Gastroenterology 124: 1915-1925 (2003). *

• Shimoda S, Van de Water J, Ansari A, Nakamura M, Ishibashi H, Coppel RL, Lake J, Keeffe EB, Roche TE, Gershwin ME. Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. J. Clin. Invest. 102: 1831-1840 (1998). *

• Shin HD, Park BL, Kim LH, Lee HS, Kim TY, Bae SC. Common DNase I polymorphism associated with autoantibody production among systemic lupus erythematosus patients. Hum. Mol. Genet. 13: 2343-2350 (2004). *

• Shin JI, Kim KH, Chun JK, Lee TJ, Kim KJ, Kim HS, Kim DS. Prevalence and patterns of anti-nuclear antibodies in Korean children with juvenile idiopathic arthritis according to ILAR criteria. Scand. J. Rheumatol. 37: 348-351 (2008).

• Shin K, Granter SR, Coblyn JS, Gupta S. Progressive arm and leg stiffness in a patient with chronic renal impairment. Nat. Clin. Pract. Rheumatol. 4: 557-562 (2008).

• Shin SH, Ye MK. Th2 responses elicited by nasal epithelial cells exposed to house dust mite extract. Clin. Exp. Otorhinolaryngol. 2: 175-180 (2009).

• Shindo S, Numazawa S, Yoshida T. A physiological role of AMP-activated protein kinase in phenobarbital-mediated constitutive androstane receptor activation and CYP2B induction. Biochem. J. 401: 735-741 (2007). *

• Shinoda M, Tanaka Y, Kuno T, Matsufuji T, Matsufuji S, Murakami Y, Mizutani T. High levels of autoantibodies against drug-metabolizing enzymes in SLA/LP-positive AIH-1 sera. Autoimmunity 37: 473-480 (2004).

• Shirai M, Watanabe S, Nishioka M. Autoantibody specific for transfer ribonucleic acid (tRNA) in patients with autoimmune chronic active hepatitis and primary biliary cirrhosis. Hepatogastroenterology 38: 543-546 (1991).

• Shoenfeld Y, Carp HJ, Molina V, Blank M, Cervera R, Balasch J, Tincani A, Faden D, Lojacono A, Doria A, Konova E, Meroni PL. Autoantibodies and prediction of reproductive failure. Am. J. Reprod. Immunol. 56: 337-344 (2006).

• Shoenfeld Y, Szyper-Kravitz M, Witte T, Doria A, Tsutsumi A, Tatsuya A, Dayer JM, Roux-Lombard P, Fontao L, Kallenberg CG, Bijl M, Matthias T, Fraser A, Zandman-Goddard G, Blank M, Gilburd B, Meroni PL. Autoantibodies against protective molecules - C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus. Ann. N. Y. Acad. Sci. 1108: 227-239 (2007). *

• Si L, Whiteside TL, Van Thiel DH, Rabin BS. Lymphocyte subpopulations at the site of "piecemeal" necrosis in end stage chronic liver diseases and rejecting liver allografts in cyclosporine-treated patients. Lab. Invest. 50: 341-347 (1984).

• Sibilia J, Westhovens R. Safety of T-cell co-stimulation modulation with abatacept in patients with rheumatoid arthritis. Clin. Exp. Rheumatol. 25: S46-S56 (2007).

• Silbergeld EK, Silva IA, Nyland JF. Mercury and autoimmunity: implications for occupational and environmental health. Toxicol. Appl. Pharmacol. 207: S282-S292 (2005). *

• Silva HM, Vieira PM, Costa PL, Pimentel BM, Moro AM, Kalil J, Maranhao AQ, Coelho V, Brigido MM. Novel humanized anti-CD3 antibodies induce a predominantly immunoregulatory profile in human peripheral blood mononuclear cells. Immunol. Lett. 125: 129-136 (2009).

• Silva IA, Nyland JF, Gorman A, Perisse A, Ventura AM, Santos EC, de Souza JM, Burek CL, Rose NR, Silbergeld EK. Mercury exposure, malaria, and serum antinuclear/antinucleolar antibodies in amazon populations in Brazil: a cross-sectional study. Environ. Health 3: 11 (2004). *

• Silveira MG, Lindor KD. Primary sclerosing cholangitis. Can. J. Gastroenterol. 22: 689-698 (2008). *

• Silver KL, Crockford TL, Bouriez-Jones T, Milling S, Lambe T, Cornall RJ. MyD88-dependent autoimmune disease in Lyn-deficient mice. Eur. J. Immunol. 37: 2734-2743 (2007). *

• Silverman GJ, Srikrishnan R, Germar K, Goodyear CS, Andrews KA, Ginzler EM, Tsao BP. Genetic imprinting of autoantibody repertoires in systemic lupus erythematosus patients. Clin. Exp. Immunol. 153: 102-116 (2008). *

• Sim DL, Bagavant H, Scindia YM, Ge Y, Gaskin F, Fu SM, Deshmukh US. Genetic complementation results in augmented autoantibody responses to lupus-associated antigens. J. Immunol. 183: 3505-3511 (2009).

• Sim KT, Venning HE, Barrett S, Gregson RM, Amoaku WM. Extended oligoarthritis and other risk factors for developing JIA-associated uveitis under ILAR classification and its implication for current screening guideline. Ocul. Immunol. Inflamm. 14: 353-357 (2006).

• Simoneau M, Boulanger J, Coulombe G, Renaud MA, Duchesne C, Rivard N. Activation of CDK2 stimulates proteasome-dependent truncation of tyrosine phosphatase SHP-1 in human proliferating intestinal epithelial cells. J. Biol. Chem. 283: 25544-25556 (2008). *

• Singh G, Palaniappan S, Rotimi O, Hamlin PJ. Autoimmune hepatitis triggered by hepatitis A. Gut 56: 304 (2007). *

• Singh S, Singh U, Singh S. Prevalence of autoantibodies in patients of psoriasis. J. Clin. Lab. Anal. 24: 44-48 (2010). *

• Sinico RA, Radice A. The clinical immunology laboratory in diagnosis and monitoring of systemic lupus erythematosus and connective tissue diseases. G. Ital. Nefrol. 22: S21-S26 (2005).

• Sipos W, Pietschmann P, Rauner M. Strategies for novel therapeutic approaches targeting cytokines and signaling pathways of osteoclasto- and osteoblastogenesis in the fight against immune-mediated bone and joint diseases. Curr. Med. Chem. 15: 127-136 (2008).

• Sirotkina OV, Zabotina AM, Taraskina AE, Sivachenko EB, Zueva EE, Kadinskaya MI, Buryachkovskaya LI, Uchitel' IA, Khaspekova SG, Vavilova TV, Shvartsman AL, Mazurov AV. Participation of IIb-IIIa glycoprotein in spontaneous platelet aggregation. Bull. Exp. Biol. Med. 143: 422-425 (2007).

• Sivakamasundari P, Kalaiselvi P, Sakthivel R, Selvam R, Varalakshmi P. Nuclear pore complex oxalate binding protein p62: expression in different kidney disorders. Clin. Chim. Acta 347: 111-119 (2004). *

• Siwiec J, Zaborowski T, Jankowska O, Wojas-Krawczyk K, Krawczyk P, Milanowski J. Evaluation of Th1/Th2 lymphocyte balance and lypopolysaccharide receptor expression in asthma patients. Pneumonol. Alergol. Pol. 77: 123-130 (2009).

• Sjoberg K, Roth EB, Gustavsson L, Jonsson C, Siman H, Henriksson G, Stenberg P, Lindblom A, Svensson P. Autoimmune markers in lymphoid malignancies. Scand. J. Immunol. 67: 509-515 (2008). *

• Sjowall C, Wettero J. Pathogenic implications for autoantibodies against C-reactive protein and other acute phase proteins. Clin. Chim. Acta 378: 13-23 (2007). *

• Skalova S, Minxova L, Slezak R. Hypokalaemic paralysis revealing Sjogren's syndrome in a 16-year old girl. Ghana Med. J. 42: 124-128 (2008). *

• Skarstein K, Wahren M, Zaura E, Hattori M, Jonsson R. Characterization of T cell receptor repertoire and anti-Ro/SSA autoantibodies in relation to sialadenitis of NOD mice. Autoimmunity 22: 9-16 (1995).

• Skogh T, Peen E. Lactoferrin, anti-lactoferrin antibodies and inflammatory disease. Adv. Exp. Med. Biol. 336: 533-538 (1993).

• Skriner K, Hueber W, Suleymanoglu E, Hofler E, Krenn V, Smolen J, Steiner G. AUF1, the regulator of tumor necrosis factor alpha messenger RNA decay, is targeted by autoantibodies of patients with systemic rheumatic diseases. Arthritis Rheum. 58: 511-520 (2008). *

• Smith AJ, Gordon TP, Macardle PJ. Increased expression of the B-cell-regulatory molecule CD72 in primary Sjogren's syndrome. Tissue Antigens 63: 255-259 (2004). *

• Smith DL, Dong X, Du S, Oh M, Singh RR, Voskuhl RR. A female preponderance for chemically induced lupus in SJL/J mice. Clin. Immunol. 122: 101-107 (2007). *

• Smith-Berdan S, Gille D, Weissman IL, Christensen JL. Reversal of autoimmune disease in lupus-prone NZB/NZW mice by nonmyeloablative transplantation of purified allogeneic hematopoietic stem cells. Blood 110: 1370-1378 (2007). *

• Snook JA, Chapman RW, Fleming K, Jewell DP. Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin. Exp. Immunol. 76: 30-33 (1989). *

• Soares Rolim AM, Castro M, Santiago MB. Neonatal antiphospholipid syndrome. Lupus 15: 301-303 (2006).

• Sobajima J, Ozaki S, Osakada F, Uesugi H, Shirakawa H, Yoshida M, Nakao K. Novel autoantigens of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) in ulcerative colitis: non-histone chromosomal proteins, HMG1 and HMG2. Clin. Exp. Immunol. 107: 135-140 (1997). *

• Sobajima J, Ozaki S, Uesugi H, Osakada F, Inoue M, Fukuda Y, Shirakawa H, Yoshida M, Rokuhara A, Imai H, Kiyosawa K, Nakao K. High mobility group (HMG) non-histone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis. Gut 44: 867-873 (1999). *

• Sobajima J, Ozaki S, Uesugi H, Osakada F, Shirakawa H, Yoshida M, Nakao K. Prevalence and characterization of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) directed against HMG1 and HMG2 in ulcerative colitis (UC). Clin. Exp. Immunol. 111: 402-407 (1998). *

• Sokka T, Willoughby J, Yazici Y, Pincus T. Databases of patients with early rheumatoid arthritis in the USA. Clin. Exp. Rheumatol. 21: S146-S153 (2003).

• Solberg IC, Lygren I, Cvancarova M, Jahnsen J, Stray N, Sauar J, Schreiber S, Moum B, Vatn MH, IBSEN Study Group. Predictive value of serologic markers in a population-based Norwegian cohort with inflammatory bowel disease. Inflamm. Bowel Dis. 15: 406-414 (2009).

• Solomon C, Sebag M, White JH, Rhim J, Kremer R. Disruption of vitamin D receptor-retinoid X receptor heterodimer formation following ras transformation of human keratinocytes. J. Biol. Chem. 273: 17573-17578 (1998). *

• Sommershof A, Aichinger H, Engler H, Adenauer H, Catani C, Boneberg EM, Elbert T, Groettrup M, Kolassa IT. Substantial reduction of naive and regulatory T cells following traumatic stress. Brain Behav. Immun. 23: 1117-1124 (2009).

• Son SW, Kim EO, Ryu ES, Kim TJ, Kim JN, Choi JE, Kye YC, Lee KM. Upregulation of Fas and downregulation of CD94/NKG2A inhibitory receptors on circulating natural killer cells in patients with new-onset psoriasis. Br. J. Dermatol. 161: 281-288 (2009). *

• Song MK, Seol YM, Park YE, Kim YS, Lee MK, Lee CH, Jeong YJ. Pulmonary nodular lymphoid hyperplasia associated with Sjogren's syndrome. Korean J. Intern. Med. 22: 192-196 (2007).

• Song P, Gocke C, Wigley FM, Boin F. Resolution of pansclerotic morphea after treatment with antithymocyte globulin. Nat. Rev. Rheumatol. 5: 513-516 (2009).

• Song TJ, Kim MH, Moon SH, Eum JB, Park DH, Lee SS, Seo DW, Lee SK. The combined measurement of total serum IgG and IgG4 may increase diagnostic sensitivity for autoimmune pancreatitis without sacrificing specificity, compared with IgG4 alone. Am. J. Gastroenterol. Dec 14 [Epub ahead of print] (2009). *

• Song YW, Kang EH. Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies. QJM Nov 19 [Epub ahead of print] (2009).

• Sonomoto K, Miyamura T, Watanabe H, Takahama S, Nakamura M, Ando H, Minami R, Yamamoto M, Suematsu E. A case of systemic lupus erythematosus complicated with autoimmune hepatitis and thrombotic thrombocytic purpura. Nihon Rinsho Meneki Gakkai Kaishi 32: 110-115 (2009.

• Sousa JX Jr, Miyamoto D, Zimbres JM, Costa DV, Aoki V. Clinicopathological evaluation of in vivo epidermal nuclear fluorescence. Clin. Exp. Dermatol. 34: 314-318 (2009). *

• Southwood TR, Petty RE, Malleson PN, Delgado EA, Hunt DW, Wood B, Schroeder ML. Psoriatic arthritis in children. Arthritis Rheum. 32: 1007-1013 (1989).

• Soy M, Guldiken S, Arikan E, Altun BU, Tugrul A. Frequency of rheumatic diseases in patients with autoimmune thyroid disease. Rheumatol. Int. 27: 575-577 (2007). *

• Spatz M, Eibl N, Hink S, Wolf HM, Fischer GF, Mayr WR, Schernthaner G, Eibl MM. Impaired primary immune response in type-1 diabetes. Functional impairment at the level of APCs and T-cells. Cell. Immunol. 221: 5-26 (2003). *

• Spencer DM, Veldman GM, Banerjee S, Willis J, Levine AD. Distinct inflammatory mechanisms mediate early versus late colitis in mice. Gastroenterology 122: 94-105 (2002). *

• Spiewak R, Stojek NM, Chmielewska-Badora J. Antinuclear antibodies are not increased in the early phase of Borrelia infection. Ann. Agric. Environ. Med. 11: 145-148 (2004). *

• Spinillo A, Beneventi F, Epis OM, Montanari L, Mammoliti D, Ramoni V, Di Silverio E, Alpini C, Caporali R, Montecucco C. Prevalence of undiagnosed autoimmune rheumatic diseases in the first trimester of pregnancy. Results of a two-steps strategy using a self-administered questionnaire and autoantibody testing. BJOG 115: 51-57 (2008). *

• Spivak J, Landers CJ, Vasiliauskas EA, Abreu MT, Dubinsky MC, Papadakis KA, Ippoliti A, Targan SR, Fleshner PR. Antibodies to I2 predict clinical response to fecal diversion in Crohn's disease. Inflamm. Bowel Dis. 12: 1122-1130 (2006). *

• Squires EJ, Sueyoshi T, Negishi M. Cytoplasmic localization of pregnane X receptor and ligand-dependent nuclear translocation in mouse liver. J. Biol. Chem. 279: 49307-49314 (2004). *

• Srivastava RK, Unterman TG, Shankar S. FOXO transcription factors and VEGF neutralizing antibody enhance antiangiogenic effects of resveratrol. Mol. Cell. Biochem. Dec 14 [Epub ahead of print] (2009). *

• Staal A, van Wijnen AJ, Birkenhager JC, Pols HA, Prahl J, DeLuca H, Gaub MP, Lian JB, Stein GS, van Leeuwen JP, Stein JL. Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes. Mol. Endocrinol. 10: 1444-1456 (1996).

• Stack J, Bowie AG. Characterisation of viral proteins that inhibit Toll-like receptor signal transduction. Methods Mol. Biol. 517: 1-19 (2009).

• Stallmach A, Marth T, Adrian N, Wittig BM, Ecker KW, Schilling M, Zeitz M. Increased expression of interleukin-12 receptor beta(2) on lamina propria mononuclear cells of patients with active Crohn's disease. Int. J. Colorectal Dis. 17: 303-310 (2002). *

• Stanulovic VS, Kyrmizi I, Kruithof-de Julio M, Hoogenkamp M, Vermeulen JL, Ruijter JM, Talianidis I, Hakvoort TB, Lamers WH. Hepatic HNF4alpha deficiency induces periportal expression of glutamine synthetase and other pericentral enzymes. Hepatology 45: 433-444 (2007). *

• Stechemesser E, Klein R, Berg PA. Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis. Hepatology 18: 1-9 (1993).

• Steele IL, Levy C, Lindor KD. Primary sclerosing cholangitis - approach to diagnosis. MedGenMed. 9: 20 (2007). *

• Steiner G. Auto-antibodies and autoreactive T-cells in rheumatoid arthritis: pathogenetic players and diagnostic tools. Clin. Rev. Allergy Immunol. 32: 23-36 (2007).

• Sternsdorf T, Guldner HH, Szostecki C, Grotzinger T, Will H. Two nuclear dot-associated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis. Scand. J. Immunol. 42: 257-268 (1995).

• Sternsdorf T, Jensen K, Will H. Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J. Cell Biol. 139: 1621-1634 (1997). *

• Stjernberg-Salmela S, Ranki A, Karenko L, Siitonen S, Mustonen H, Puolakkainen P, Sarna S, Pettersson T, Repo H. Low TNF-induced NF-kappaB and p38 phosphorylation levels in leucocytes in tumour necrosis factor receptor-associated periodic syndrome. Rheumatology (Oxford) 49: 382-390 (2010).

• Stoll G, Bendszus M. Imaging of inflammation in the peripheral nervous system and CNS by magnetic resonance imaging. Neuroscience 158: 1151-1160 (2009).

• Stoll ML, Zurakowski D, Nigrovic LE, Nichols DP, Sundel RP, Nigrovic PA. Patients with juvenile psoriatic arthritis comprise two distinct populations. Arthritis Rheum. 54: 3564-3572 (2006). *

• Storch WB. Autoimmune hepatitides - update 2004. Cell. Mol. Biol. (Noisy-le-grand) Suppl. 50: OL569-OL580 (2004).

• Strandberg L, Ambrosi A, Espinosa A, Ottosson L, Eloranta ML, Zhou W, Elfving A, Greenfield E, Kuchroo VK, Wahren-Herlenius M. Interferon-alpha induces up-regulation and nuclear translocation of the Ro52 autoantigen as detected by a panel of novel Ro52-specific monoclonal antibodies. J. Clin. Immunol. 28: 220-231 (2007). *

• Strang G, Rickinson AB. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis. Eur. J. Immunol. 17: 1007-1013 (1987).

• Strassburg CP. Molecular characterization of autoantigens in liver diseases. Falk Symposium 135. Immmunological diseases of liver and gut. Prague (Czech Republic). p. 30. September 12 - 13 (2003). *

• Strassburg CP. The role of microsomal antigens in autoimmune hepatitis. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, p. 35 (2004). *

• Strassburg CP. Autoimmune liver diseases. Falk Symposium 146: GUT-LIVER INTERACTIONS: BASIC AND CLINICAL CONCEPTS, Innsbruck (Austria), March 11-12, 2005, pp. 66-70 (2005). *

• Strassburg CP, Alex B, Zindy F, Gerken G, Luttig B, Meyer zum Buschenfelde KH, Brechot C, Manns MP. Identification of cyclin A as a molecular target of antinuclear antibodies (ANA) in hepatic and non-hepatic autoimmune diseases. J. Hepatol. 25: 859-866 (1996).

• Strassburg CP, Jaeckel E, Manns MP. Anti-mitochondrial antibodies and other immunological tests in primary biliary cirrhosis. Eur. J. Gastroenterol. Hepatol. 11: 595-601 (1999).

• Strassburg CP, Manns MP. Autoantibodies and autoantigens in autoimmune hepatitis. Semin. Liver Dis. 22: 339-352 (2002). *

• Strassburg CP, Manns MP. Primary biliary cirrhosis and overlap syndromes. Diagnosis and therapy. Internist (Berl.) 45: 16-26 (2004).

• Strassburg CP, Manns MP. Autoimmune tests in primary biliary cirrhosis. Best Pract. Res. Clin. Gastroenterol. 14: 585-599 (2000). *

• Strassburg CP, Manns MP. Chapter 8. Prevalence and significance of autoantibodies in acute and chronic liver diseases and hepatocellular carcinoma. In "Liver Immunology: Principles and Practice" (eds. Gershwin ME, Vierling JM, Manns MP), Humana Press Inc., Totowa, NJ, p. 95-110 (2007). *

• Stratigos AJ, Antoniou C, Stamathioudaki S, Avgerinou G, Tsega A, Katsambas AD. Discoid lupus erythematosus-like eruption induced by infliximab. Clin. Exp. Dermatol. 29: 150-153 (2004). *

• Stummvoll GH, Fritsch RD, Meyer B, Hoefler E, Aringer M, Smolen JS, Steiner G. Characterization of cellular and humoral autoimmune responses to histone H1 and core histones in human systemic lupus erythematosus. Ann. Rheum. Dis. 68: 110-116 (2009).

• Subramanian S, Yim YS, Liu K, Tus K, Zhou XJ, Wakeland EK. Epistatic suppression of systemic lupus erythematosus: fine mapping of Sles1 to less than 1 mb. J. Immunol. 175: 1062-1072 (2005). *

• Subramaniyam D, Glader P, von Wachenfeldt K, Burneckiene J, Stevens T, Janciauskiene S. C-36 peptide, a degradation product of alpha1-antitrypsin, modulates human monocyte activation through LPS signaling pathways. Int. J. Biochem. Cell. Biol. 38: 563-575 (2006). *

• Suda K, Nishimori I, Takase M, Oi I, Ogawa M. Autoimmune pancreatitis can be classified into early and advanced stages. Pancreas 33: 345-350 (2006).

• Sugi K, Saitoh O, Matsuse R, Tabata K, Uchida K, Kojima K, Nakagawa K, Tanaka S, Teranishi T, Hirata I, Katsu K. Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens. Am. J. Gastroenterol. 94: 1304-1312 (1999). *

• Sugiyama T, Oishi Y, Sueishi M, Matsumura R, Tomioka H, Akikusa B. Diffuse proliferative lupus nephritis in a patient with ulcerative colitis. Ryumachi 36: 651-655 (1996).

• Suleymanoglu E. Molecular phylogenetics and functional evolution of major RNA recognition domains of recently cloned and characterized autoimmune RNA-binding particle. Genomics Proteomics Bioinformatics 1: 310-320 (2003).

• Sun KH, Lin HY, Chen LW, Tai HY, Lin ML, Feng CK, Sung JS, Liu HF, Liu WT. Human foamy virus bel1 sequence in patients with autoimmune rheumatic diseases. Clin. Rheumatol. 25: 694-699 (2006). *

• Sundstrom P, Nystrom L, Jidell E, Hallmans G. EBNA-1 reactivity and HLA DRB1*1501 as statistically independent risk factors for multiple sclerosis: a case-control study. Mult. Scler. 14: 1120-1122 (2008). *

• Suruga K, Mochizuki K, Suzuki R, Goda T, Takase S. Regulation of cellular retinol-binding protein type II gene expression by arachidonic acid analogue and 9-cis retinoic acid in Caco-2 cells. Eur. J. Biochem. 262: 70-78 (1999). *

• Suslu N, Yilmaz T, Gursel B. Utility of anti-HSP 70, TNF-alpha, ESR, antinuclear antibody, and antiphospholipid antibodies in the diagnosis and treatment of sudden sensorineural hearing loss. Laryngoscope 119: 341-346 (2009).

• Suslu N, Yilmaz T, Gursel B. Utility of immunologic parameters in the evaluation of Meniere's disease. Acta Otolaryngol. Jan 13 [Epub ahead of print] (2009).

• Suwa A. Specificities and clinical significance of autoantibodies directed against histones. Nihon Rinsho Meneki Gakkai Kaishi 28: 123-130 (2005).

• Suzuki Y, Kobayashi M, Hosaka T, Someya T, Akuta N, Kobayashi M, Suzuki F, Tsubota A, Saitoh S, Arase Y, Ikeda K, Matsuda M, Sato J, Miyakawa Y, Kumada H. Peripheral CD8+/CD25+ lymphocytes may be implicated in hepatocellular injuries in patients with acute-onset autoimmune hepatitis. J. Gastroenterol. 39: 649-653 (2004). *

• Svacina S. Potential new antidiabetics for the next decade. Vnitr. Lek. 55: 429-433 (2009).

• Svegliati-Baroni G, Ridolfi F, Hannivoort R, Saccomanno S, Homan M, De Minicis S, Jansen PL, Candelaresi C, Benedetti A, Moshage H. Bile acids induce hepatic stellate cell proliferation via activation of the epidermal growth factor receptor. Gastroenterology 128: 1042-1055 (2005). *

• Swale VJ, Perrett CM, Denton CP, Black CM, Rustin MH. Etanercept-induced systemic lupus erythematosus. Clin. Exp. Dermatol. 28: 604-607 (2003). *

• Szamosi S, Marodi L, Czirjak L, Ellenes Z, Szucs G. Juvenile systemic sclerosis: a follow-up study of eight patients. Ann. N. Y. Acad. Sci. 1051: 229-234 (2005). *

• Szanto A, Szodoray P, Kiss E, Kapitany A, Szegedi G, Zeher M. Clinical, serologic, and genetic profiles of patients with associated Sjogren's syndrome and systemic lupus erythematosus. Hum. Immunol. 67: 924-930 (2006).

• Szostecki C, Guldner HH, Netter HJ, Will H. Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. J. Immunol. 145: 4338-4347 (1990).

• Szostecki C, Krippner H, Penner E, Bautz FA. Autoimmune sera recognize a 100 kD nuclear protein antigen (sp-100). Clin. Exp. Immunol. 68: 108-116 (1987). *

• Szostecki C, Will H, Netter HJ, Guldner HH. Autoantibodies to the nuclear Sp100 protein in primary biliary cirrhosis and associated diseases: epitope specificity and immunoglobulin class distribution. Scand. J. Immunol. 36: 555-564 (1992).

• Szucs G, Szekanecz Z, Zilahi E, Kapitany A, Barath S, Szamosi S, Vegvari A, Szabo Z, Szanto S, Czirjak L, Kiss CG. Systemic sclerosis-rheumatoid arthritis overlap syndrome: a unique combination of features suggests a distinct genetic, serological and clinical entity. Rheumatology (Oxford) 46: 989-993 (2007). *

• Tabak F, Ozdemir F, Tabak O, Erer B, Tahan V, Ozaras R. Autoimmune hepatitis induced by the prolonged hepatitis A virus infection. Ann. Hepatol. 7: 177-179 (2008). *

• Tabary O, Corvol H, Boncoeur E, Chadelat K, Fitting C, Cavaillon JM, Clement A, Jacquot J. Adherence of airway neutrophils and inflammatory response is increased in CF airway epithelial cell-neutrophil interactions. Am. J. Physiol. Lung Cell. Mol. Physiol. 290: L588-L596 (2006). *

• Tabe Y. Molecular diagnosis of and molecular targeting therapy for leukemia. Rinsho Byori 57: 137-145 (2009).

• Tagoe C, Shah A, Yee H, Belmont HM. Aplastic anemia in systemic lupus erythematosus: a distinct presentation of acquired aplastic anemia? J. Clin. Rheumatol. 7: 377-383 (2001).

• Takagi M, Tanaka K, Suzuki T, Miki A, Nishizawa M, Abe H. Anti-aquaporin-4 antibody-positive optic neuritis. Acta Ophthalmol. 87: 562-566 (2008).

• Takahashi A, Rai T, Onizawa M, Monoe K, Kanno Y, Saito H, Abe K, Yokokawa J, Irisawa A, Ohira H. Autoimmune hepatitis complicated by late-onset systemic lupus erythematosus. Hepatol. Res. 37: 771-774 (2007). *

• Takahashi HK, Mori S, Wake H, Liu K, Yoshino T, Ohashi K, Tanaka N, Shikata K, Makino H, Nishibori M. Advanced glycation end products subspecies-selectively induce adhesion molecule expression and cytokine production in human peripheral blood mononuclear cells. J. Pharmacol. Exp. Ther. 330: 89-98 (2009). *

• Takahashi M, Nagata R, Ozaki A, Kaneko S, Saiki H, Matsumoto S. A case of anti-AQP4 antibody-positive recurrent myelitis overlapped with autoimmune disorders including incomplete CREST syndrome revealed multiple discontinuous cord lesions. Rinsho Shinkeigaku 49: 115-118 (2009).

• Takahashi N, Fujiu Y. Cytokeratins 16 and 10 bind to retinoic acid covalently in skin tissues of mice. Br. J. Dermatol. Nov 18 [Epub ahead of print] (2009). *

• Takara M, Kouki T, DeGroot LJ. CTLA-4 AT-repeat polymorphism reduces the inhibitory function of CTLA-4 in Graves' disease. Thyroid 13: 1083-1089 (2003).

• Takato H, Yasui M, Ichikawa Y, Fujimura M, Nakao S, Zen Y, Minato H. Nonspecific interstitial pneumonia with abundant IgG4-positive cells infiltration, which was thought as pulmonary involvement of IgG4-related autoimmune disease. Intern. Med. 47: 291-294 (2008). *

• Takegoshi S, Jiang S, Ohashi R, Savchenko AS, Iwanari H, Tanaka T, Hasegawa G, Hamakubo T, Kodama T, Naito M. Protein expression of nuclear receptors in human and murine tissues. Pathol. Int. 59: 61-72 (2009). *

• Takehara K, Sato S. Localized scleroderma is an autoimmune disorder. Rheumatology (Oxford) 44: 274-279 (2005). *

• Takenaka R, Yokota K, Ayada K, Mizuno M, Zhao Y, Fujinami Y, Lin SN, Toyokawa T, Okada H, Shiratori Y, Oguma K. Helicobacter pylori heat-shock protein 60 induces inflammatory responses through the Toll-like receptor-triggered pathway in cultured human gastric epithelial cells. Microbiology 150: 3913-3922 (2004). *

• Takikawa H. Recent status of primary sclerosing cholangitis in Japan. J. Hepatobiliary Pancreat. Surg. 6: 352-355 (1999).

• Takikawa H, Manabe T. Primary sclerosing cholangitis in Japan - analysis of 192 cases. J. Gastroenterol. 32: 134-137 (1997).

• Tallima H, Salah M, Guirguis FR, El Ridi R. Transforming growth factor-beta and Th17 responses in resistance to primary murine Schistosomiasis mansoni. Cytokine 48: 239-245 (2009).

• Talwalkar JA, Keach JC, Angulo P, Lindor KD. Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system. Am. J. Gastroenterol. 97: 1191-1197 (2002). *

• Tampoia M, Mastrandrea V, Cassano N, Vena GA. Anti-NuMA antibodies in a psoriatic patient: considerations about clinical relevance and effect of infliximab treatment. Immunopharmacol. Immunotoxicol. 31: 127-129 (2009).

• Tampoia M, Mastrandrea V, Cassano N, Vena GA. Anti-NuMA antibodies in a psoriatic patient: considerations about clinical relevance and effect of infliximab treatment. Immunopharmacol. Immunotoxicol. 31: 127-129 (2009).

• Tan EM. Pathophysiology of antinuclear antibodies in systemic lupus erythematosus and related diseases. Adv. Dent. Res. 10: 44-46 (1996). *

• Tan LC, Mowat AG, Fazou C, Rostron T, Roskell H, Dunbar PR, Tournay C, Romagne F, Peyrat MA, Houssaint E, Bonneville M, Rickinson AB, McMichael AJ, Callan MF. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes. Arthritis Res. 2: 154-164 (2000). *

• Tan SM, Xu D, Roschke V, Perry JW, Arkfeld DG, Ehresmann GR, Migone TS, Hilbert DM, Stohl W. Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis. Arthritis Rheum. 48: 982-992 (2003). *

• Tanaka K, Shimada M, Sasahara A, Yamamoto H, Naruto T, Tomida Y. Chronic hepatitis associated with Epstein-Barr virus infection in an infant. J. Pediatr. Gastroenterol. Nutr. 5: 467-471 (1986).

• Tanaka M, Nagai T, Tsuneyoshi Y, Sunahara N, Matsuda T, Nakamura T, Tsuyama S, Hasui K, Fitzgerald O, Matsuyama T. Expansion of a unique macrophage subset in rheumatoid arthritis synovial lining layer. Clin. Exp. Immunol. 154: 38-47 (2008). *

• Tanaka S, Masuda M, Nakajima K, Ido N, Ohtsuka T, Nishida M, Utsumi H, Hirano T. P-glycoprotein function in peripheral T lymphocyte subsets of myasthenia gravis patients: clinical implications and influence of glucocorticoid administration. Int. Immunopharmacol. 9: 284-290 (2009).

• Tang HF, Chen XX, Ye HY, Ou BY. Expression of tumor necrosis factor-alpha and nuclear factor-kappaB in childhood ulcerative colitis. Zhonghua Er Ke Za Zhi 41: 743-746 (2003).

• Tang Y, Clayburgh DR, Mittal N, Goretsky T, Dirisina R, Zhang Z, Kron M, Ivancic D, Katzman RB, Grimm G, Lee G, Fryer J, Nusrat A, Turner JR, Barrett TA. Epithelial NFkappaB enhances transmucosal fluid movement by altering tight junction protein composition after T cell activation. Am. J. Pathol. Dec 14 [Epub ahead of print] (2009). *

• Targan SR, Landers C, Vidrich A, Czaja AJ. High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis. Gastroenterology 108: 1159-1166 (1995). *

• Targan SR, Landers CJ, Cobb L, MacDermott RP, Vidrich A. Perinuclear anti-neutrophil cytoplasmic antibodies are spontaneously produced by mucosal B cells of ulcerative colitis patients. J. Immunol. 155: 3262-3267 (1995).

• Targan SR, Landers CJ, Yang H, Lodes MJ, Cong Y, Papadakis KA, Vasiliauskas E, Elson CO, Hershberg RM. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. Gastroenterology 128: 2020-2028 (2005). *

• Tarr T, Muzes G, Pitlik E, Lakos G, Csepany T, Soltesz P, Zeher M, Szegedi G, Kiss E. Is the primary antiphospholipid syndrome a forerunner of SLE? Orv. Hetil. 146: 203-207 (2005).

• Tartakovsky F, Worman HJ. Detection of Gp210 autoantibodies in primary biliary cirrhosis using a recombinant protein containing the predominant autoepitope. Hepatology 21: 495-500 (1995).

• Tassinari OW, Aponte M, Caiazzo RJ Jr, Liu BC. Immunoregulomics: a serum autoantibody-based platform for transcription factor profiling. Methods Mol. Biol. 441: 163-173 (2008). *

• Taylor SL, Dean PJ, Riely CA. Primary autoimmune cholangitis. An alternative to antimitochondrial antibody-negative primary biliary cirrhosis. Am. J. Surg. Pathol. 18: 91-99 (1994).

• Teegen B, Niemann S, Probst C, Schlumberger W, Stocker W, Komorowski L. DNA-bound lactoferrin is the major target for antineutrophil perinuclear cytoplasmic antibodies in ulcerative colitis. Ann. N. Y. Acad. Sci. 1173: 161-165 (2009). *

• Teitelbaum JE, Perez-Atayde AR, Cohen M, Bousvaros A, Jonas MM. Minocycline-related autoimmune hepatitis: case series and literature review. Arch. Pediatr. Adolesc. Med. 152: 1132-1136 (1998).

• Tektonidou MG, Anapliotou M, Vlachoyiannopoulos P, Moutsopoulos HM. Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases. Ann. Rheum. Dis. 63: 1159-1161 (2004). *

• Terjung B, Herzog V, Worman HJ, Gestmann I, Bauer C, Sauerbruch T, Spengler U. Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders colocalize with nuclear lamina proteins. Hepatology 28: 332-340 (1998). *

• Terjung B, Soehne J, Lechtenberg B, Gottwein J, Muennich M, Herzog V, Maehler M, Sauerbruch T, Spengler U. p-ANCA in autoimmune liver disorders recognize human beta-tubulin isotype 5 and cross-react with microbial protein FtsZ. Gut Dec 1 [Epub ahead of print] (2009).

• Terjung B, Spengler U. Atypical p-ANCA in PSC and AIH: a hint toward a "leaky gut"? Clin. Rev. Allergy Immunol. 36: 40-51 (2009). *

• Terjung B, Spengler U. Role of auto-antibodies for the diagnosis of chronic cholestatic liver diseases. Clin. Rev. Allergy Immunol. 28: 115-133 (2005). *

• Terjung B, Spengler U, Sauerbruch T, Worman HJ. "Atypical p-ANCA" in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines. Gastroenterology 119: 310-322 (2000). *

• Terjung B, Worman HJ. Anti-neutrophil antibodies in primary sclerosing cholangitis. Best Pract. Res. Clin. Gastroenterol. 15: 629-642 (2001). *

• Terjung B, Worman HJ, Herzog V, Sauerbruch T, Spengler U. Differentiation of antineutrophil nuclear antibodies in inflammatory bowel and autoimmune liver diseases from antineutrophil cytoplasmic antibodies (p-ANCA) using immunofluorescence microscopy. Clin. Exp. Immunol. 126: 37-46 (2001). *

• Tervaert JW, Van Hoek B, Koek G. Antineutrophil cytoplasmic antibodies in small-duct primary sclerosing cholangitis. Gastroenterology 136: 364 (2009). *

• Teubner A, Tillmann HL, Schuppan D, Gericke G, Manns MP, Stolzel U. Prevalence of circulating autoantibodies in healthy individuals. Med. Klin. (Munich) 97: 645-649 (2002).

• Teufel A, Worns M, Weinmann A, Centner C, Piendl A, Lohse AW, Galle PR, Kanzler S. Genetic association of autoimmune hepatitis and human leucocyte antigen in German patients. World J. Gastroenterol. 12: 5513-5516 (2006). *

• Theiss AL, Obertone TS, Merlin D, Sitaraman SV. Interleukin-6 transcriptionally regulates prohibitin expression in intestinal epithelial cells. J. Biol. Chem. 282: 12804-12812 (2007). *

• Theodoridou A, Settas L. Demyelination in rheumatic diseases. Postgrad. Med. J. 84: 127-132 (2008).

• Theodoridou A, Settas L. Demyelination in rheumatic diseases. J. Neurol. Neurosurg. Psychiatry 77: 290-295 (2006).

• Thewissen M, Linsen L, Geusens P, Raus J, Stinissen P. Impaired activation-induced telomerase activity in PBMC of early but not chronic rheumatoid arthritis patients. Immunol. Lett. 100: 205-210 (2005).

• Thibault DL, Graham KL, Lee LY, Balboni I, Hertzog PJ, Utz PJ. Type I IFN receptor controls B cell expression of nucleic acid sensing Toll-like receptors and autoantibody production in a murine model of lupus. Arthritis Res. Ther. 11: R112 (2009). *

• Thien Huong NT, Pitche P, Minh Hoa T, Laurent R. Persistent pigmented plaques in adult-onset Still's disease. Ann. Dermatol. Venereol. 132: 693-696 (2005).

• Thoelke A, Schmid HP, Figl R, Schadendorf D, Ugurel S. Jo-1 positive paraneoplastic systemic sclerosis in a patient with metastatic melanoma. Eur. J. Dermatol. 16: 428-430 (2006).

• Thurman RG. Sex-related liver injury due to alcohol involves activation of Kupffer cells by endotoxin. Can. J. Gastroenterol. 14 Suppl. D: 129D-135D (2000).

• Tieleman AA, den Broeder AA, van de Logt AE, van Engelen BG. Strong association between myotonic dystrophy type 2 and autoimmune diseases. J. Neurol. Neurosurg. Psychiatry 80: 1293-1295 (2009).

• Toblli JE, Findor J, Sorda J, Bruch Igartua E, Hasenclever K, Collado HD. Latent distal renal tubular acidosis (dRTA) in primary biliary cirrhosis (PBC) and chronic autoimmune hepatitis (CAH). Acta Gastroenterol. Latinoam. 23: 235-238 (1993).

• Toda G, Ikeda Y, Hashimoto N, Yamazaki M, Torii M, Oka H. Liver cell membrane antibody detected by protein A and isolated rabbit liver plasma membrane in sera of patients with chronic liver diseases. Clin. Exp. Immunol. 54: 661-670 (1983). *

• Toh BH, Taylor R, Pollock W. F-actin reactive smooth muscle antibody in subjects with normal liver function. Pathology 41: 572-575 (2009).

• Tojo J, Ohira H, Abe K, Yokokawa J, Takiguchi J, Rai T, Shishido S, Sato Y, Kasukawa R. Autoimmune hepatitis accompanied by systemic lupus erythematosus. Intern. Med. 43: 258-262 (2004). *

• Tojo J, Ohira H, Suzuki T, Takeda I, Shoji I, Kojima T, Takagi T, Kuroda M, Miyata M, Nishimaki T, Ohnami K, Kanno T, Mukai S, Kasukawa R. Clinicolaboratory characteristics of patients with primary biliary cirrhosis associated with CREST symptoms. Hepatol. Res. 22: 187-195 (2002).

• Tojo T, Friou GJ, Spiegelberg HL. Immunoglobulin G subclass of human antinuclear antibodies. Clin. Exp. Immunol. 6: 145-151 (1970). *

• Tonini M, Vicini R, Cervio E, De Ponti F, De Giorgio R, Barbara G, Stanghellini V, Dellabianca A, Sternini C. 5-HT(7) receptors modulate peristalsis and accommodation in the guinea pig ileum. Gastroenterology 129: 1557-1566 (2005). *

• Tonuttia E, Bassetti D, Piazza A, Visentini D, Poletto M, Bassetto F, Caciagli P, Villalta D, Tozzoli R, Bizzaro N. Diagnostic accuracy of ELISA methods as an alternative screening test to indirect immunofluorescence for the detection of antinuclear antibodies. Evaluation of five commercial kits. Autoimmunity 37: 171-176 (2004).

• Toplak N, Kveder T, Trampus-Bakija A, Subelj V, Cucnik S, Avcin T. Autoimmune response following annual influenza vaccination in 92 apparently healthy adults. Autoimmun. Rev. 8: 134-138 (2008).

• Torok HP, Glas J, Gruber R, Brumberger V, Strasser C, Kellner H, Marker-Hermann E, Folwaczny C. Inflammatory bowel disease-specific autoantibodies in HLA-B27-associated spondyloarthropathies: increased prevalence of ASCA and pANCA. Digestion 70: 49-54 (2004).

• Torra IP, Staverosky JA, Ha S, Logan SK, Garabedian MJ. Development of phosphorylation site-specific antibodies to nuclear receptors. Methods Mol. Biol. 505: 221-235 (2009).

• Toyoda M, Yokomori H, Kaneko F, Yoshida H, Hoshi K, Takeuchi H, Tahara K, Takahashi A, Kudo T, Motoori T, Ohbu M, Kondo H, Hibi T. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome concomitant with systemic sclerosis, immune thrombocytopenic purpura. Intern. Med. 48: 2019-2023 (2009). *

• Tran TH, Milea D, Cassoux N, Bodaghi B, Bourgeois P, Lehoang P. Optic neuritis associated with infliximab. J. Fr. Ophtalmol. 28: 201-204 (2005).

• Trauner M, Boyer JL. Cholestatic syndromes. Curr. Opin. Gastroenterol. 20: 220-230 (2004). *

• Trautmann F, Arnold W, Manns M, Stoltenburg-Didinger G, Meyer zum Buschenfelde KH. Antimitochondrial antibodies against the M2-antigen with immune vasculitis and discoid lupus erythematosus without proof of liver disease. Z. Gastroenterol. 20: 659-666 (1982).

• Traynor A, Burt RK. Haematopoietic stem cell transplantation for active systemic lupus erythematosus. Rheumatology (Oxford) 38: 767-772 (1999). *

• Treusch M, Vonthein R, Baur M, Gunaydin I, Koch S, Stubiger N, Eckstein AK, Peter HH, Ness T, Zierhut M, Kotter I. Influence of human recombinant interferon-alpha2a (rhIFN-alpha2a) on altered lymphocyte subpopulations and monocytes in Behcet's disease. Rheumatology (Oxford) 43: 1275-1282 (2004). *

• Treutiger CJ, Mullins GE, Johansson AS, Rouhiainen A, Rauvala HM, Erlandsson-Harris H, Andersson U, Yang H, Tracey KJ, Andersson J, Palmblad JE. High mobility group 1 B-box mediates activation of human endothelium. J. Intern. Med. 254: 375-385 (2003). *

• Triger DR, Gamlen TR, Paraskevas E, Lloyd RS, Wright R. Measles antibodies and autoantibodies in autoimmune disorders. Clin. Exp. Immunol. 24: 407-414 (1976). *

• Triolo G, Accardo-Palumbo A, Dieli F, Ciccia F, Ferrante A, Giardina E, Licata G. Humoral and cell mediated immune response to cow's milk proteins in Behcet's disease. Ann. Rheum. Dis. 61: 459-462 (2002). *

• Trune DR, Kempton JB, Harrison AR, Wobig JL. Glucocorticoid impact on cochlear function and systemic side effects in autoimmune C3.MRL-Fas(lpr) and normal C3H/HeJ mice. Hear. Res. 226: 209-217 (2007). *

• Tsai CY, Huo AP, Chou CT, Wu TH, Tsai YY. Hepatitis, cholangitis, pulmonary hypertension, digital gangrene, and conjunctivitis sicca in a woman with anticentromere antibodies. Eur. J. Intern. Med. 17: 360-362 (2006).

• Tsiakalou V, Tsangaridou E, Polioudaki H, Nifli AP, Koulentaki M, Akoumianaki T, Kouroumalis E, Castanas E, Theodoropoulos PA. Optimized detection of circulating anti-nuclear envelope autoantibodies by immunofluorescence. BMC Immunol. 7: 20 (2006). *

• Tsitsami E, Bozzola E, Magni-Manzoni S, Viola S, Pistorio A, Ruperto N, Martini A, Ravelli A. Positive family history of psoriasis does not affect the clinical expression and course of juvenile idiopathic arthritis patients with oligoarthritis. Arthritis Rheum. 49: 488-493 (2003). *

• Tsopelas C, Penglis S, Ruskiewicz A, Bartholomeusz DL. Scintigraphic imaging of experimental colitis with technetium-99m-infliximab in the rat. Hell. J. Nucl. Med. 9: 85-89 (2006).

• Tsou YK, Yeh CT. Primary biliary cirrhosis in antimitochondrial antibody-negative patients: Chang Gung Memorial Hospital experience. Chang Gung Med. J. 26: 323-329 (2003).

• Tsuji H, Harada A, Mukaida N, Nakanuma Y, Bluethmann H, Kaneko S, Yamakawa K, Nakamura SI, Kobayashi KI, Matsushima K. Tumor necrosis factor receptor p55 is essential for intrahepatic granuloma formation and hepatocellular apoptosis in a murine model of bacterium-induced fulminant hepatitis. Infect. Immun. 65: 1892-1898 (1997). *

• Tsuji H, Murai K, Akagi K, Fujishima M. Familial primary biliary cirrhosis associated with impaired concanavalin A-induced lymphocyte transformation in relatives. Two family studies. Dig. Dis. Sci. 37: 353-360 (1992).

• Tsukamoto H, Horiuchi T. Clinical aspects of the complement system. Rinsho Byori 54: 757-762 (2006).

• Tsung A, Sahai R, Tanaka H, Nakao A, Fink MP, Lotze MT, Yang H, Li J, Tracey KJ, Geller DA, Billiar TR. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J. Exp. Med. 201: 1135-1143 (2005). *

• Tucker RM, Roark CL, Santiago-Raber ML, Izui S, Kotzin BL. Association between nuclear antigens and endogenous retrovirus in the generation of autoantibody responses in murine lupus. Arthritis Rheum. 50: 3626-3636 (2004). *

• Turcu AF, White JA, Kulaga ME, Skluth M, Gruss CB. Calcium channel blocker-associated small bowel angioedema. J. Clin. Gastroenterol. 43: 338-341 (2009).

• Turesson C, Jacobsson LT, Sturfelt G, Matteson EL, Mathsson L, Ronnelid J. Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis. Ann. Rheum. Dis. 66: 59-64 (2007). *

• Turkcapar N, Olmez U, Tutkak H, Duman M. The importance of alpha-fodrin antibodies in the diagnosis of Sjogren's syndrome. Rheumatol. Int. 26: 354-359 (2006). *

• Turkcapar N, Ozyuncu N, Cinar K, Ensari A, Kucuk O, Idilman R, Duman N, Ozden A. A case of systemic lupus erythematosus presenting with protein-losing enteropathy. Turk. J. Gastroenterol. 17: 226-230 (2006). *

• Twaddell WS, Lefkowitch J, Berk PD. Evolution from primary biliary cirrhosis to primary biliary cirrhosis/autoimmune hepatitis overlap syndrome. Semin. Liver Dis. 28: 128-134 (2008).

• Uchida J, Hamaguchi Y, Oliver JA, Ravetch JV, Poe JC, Haas KM, Tedder TF. The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy. J. Exp. Med. 199: 1659-1669 (2004). *

• Uchida K, Okazaki K, Konishi Y, Ohana M, Takakuwa H, Hajiro K, Chiba T. Clinical analysis of autoimmune-related pancreatitis. Am. J. Gastroenterol. 95: 2788-2794 (2000). *

• Uehara A, Sato T, Iwashiro A, Yokota S. PR3-ANCA in Wegener's granulomatosis prime human mononuclear cells for enhanced activation via TLRs and NOD1/2. Diagn. Pathol. 4: 23 (2009). *

• Ueki S, Yamashita K, Aoyagi T, Haga S, Suzuki T, Itoh T, Taniguchi M, Shimamura T, Furukawa H, Ozaki M, Umezawa K, Todo S. Control of allograft rejection by applying a novel nuclear factor-kappaB inhibitor, dehydroxymethylepoxyquinomicin. Transplantation 82: 1720-1727 (2006).

• Ueno Y, Ishii M, Igarashi T, Mano Y, Yahagi K, Kisara N, Kobayashi Y, Niitsuma H, Kobayashi K, Shimosegawa T. Primary biliary cirrhosis with antibody against carbonic anhydrase II associates with distinct immunological backgrounds. Hepatol. Res. 20: 18-27 (2001).

• Ueno Y, Ishii M, Takahashi S, Igarashi T, Toyota T, LaRusso NF. Different susceptibility of mice to immune-mediated cholangitis induced by immunization with carbonic anhydrase II. Lab. Invest. 78: 629-637 (1998).

• Uesugi H, Ozaki S, Sobajima J, Osakada F, Shirakawa H, Yoshida M, Nakao K. Prevalence and characterization of novel pANCA, antibodies to the high mobility group non-histone chromosomal proteins HMG1 and HMG2, in systemic rheumatic diseases. J. Rheumatol. 25: 703-709 (1998).

• Ulvestad E. Modelling autoimmune rheumatic disease: a likelihood rationale. Scand. J. Immunol. 58: 106-111 (2003). *

• Unal I, Ceylan C, Ozdemir F, Turk BG, Kazandi AC, Kandiloglu G. ITP as an initial manifestation of subacute cutaneous lupus erythematosus. J. Dermatol. 32: 727-730 (2005).

• Unoshima M. Therapeutic effect of anti-HMGB1 antibody and anti-RAGE antibody on SIRS/sepsis. Nippon Rinsho 62: 2323-2329 (2004).

• Unsal E, Oren O, Salar K, Makay B, Abaci A, Ozhan B, Bober E. The frequency of autoimmune thyroid disorders in juvenile idiopathic arthritis. Turk. J. Pediatr. 50: 462-465 (2008).

• Uskudar O, Akdogan M, Sasmaz N, Yilmaz S, Tola M, Sahin B. Etiology and portal vein thrombosis in Budd-Chiari syndrome. World J. Gastroenterol. 14: 2858-2862 (2008). *

• Uyar FA, Imeryuz N, Saruhan-Direskeneli G, Ceken H, Ozdogan O, Sahin S, Tozun N. The distribution of HLA-DRB alleles in ulcerative colitis patients in Turkey. Eur. J. Immunogenet. 25: 293-296 (1998).

• Valesini G, Iannuccelli C, Marocchi E, Pascoli L, Scalzi V, Di Franco M. Biological and clinical effects of anti-TNFalpha treatment. Autoimmun. Rev. 7: 35-41 (2007).

• van Beelen AJ, Teunissen MB, Kapsenberg ML, de Jong EC. Interleukin-17 in inflammatory skin disorders. Curr. Opin. Allergy Clin. Immunol. 7: 374-381 (2007). *

• van de Merwe JP. Interstitial cystitis and systemic autoimmune diseases. Nat. Clin. Pract. Urol. 4: 484-491 (2007).

• Van de Water J, Ansari A, Prindiville T, Coppel RL, Ricalton N, Kotzin BL, Liu S, Roche TE, Krams SM, Munoz S, et al. Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis. J. Exp. Med. 181: 723-733 (1995). *

• Van den Bergh K, Hooijkaas H, Blockmans D, Westhovens R, Op De Beeck K, Verschueren P, Dufour D, van de Merwe JP, Fijak M, Klug J, Michiels G, Devogelaere B, De Smedt H, Derua R, Waelkens E, Blanckaert N, Bossuyt X. Heterogeneous nuclear ribonucleoprotein H1, a novel nuclear autoantigen. Clin. Chem. 55: 946-954 (2009). *

• Van den Brande JM, Braat H, van den Brink GR, Versteeg HH, Bauer CA, Hoedemaeker I, van Montfrans C, Hommes DW, Peppelenbosch MP, van Deventer SJ. Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. Gastroenterology 124: 1774-1785 (2003). *

• van der Meij N, Keur I, van Lienden KP, Scheepstra CG, Bos JD. Nephrogenic systemic fibrosis possibly caused by gadolinium-containing contrast agent. Ned. Tijdschr. Geneeskd. 151: 2898-2903 (2007).

• Van Kruiningen HJ, Poulin M, Garmendia AE, Desreumaux P, Colombel JF, DE Hertogh G, Geboes K, Vermeire S, Tsongalis GJ. Search for evidence of recurring or persistent viruses in Crohn's disease. APMIS 115: 962-968 (2007). *

• van Leeuwen DJ, Sood G, Ferrante D, Lazenby AJ, Sellers MJ. A 38-year-old African-American woman with an unusually rapid progression of "Primary Biliary Cirrhosis": a missed opportunity! Semin. Liver Dis. 22: 395-406 (2002).

• Van Tol EA, Verspaget HW, Pena AS, Kraemer CV, Lamers CB. The CD56 adhesion molecule is the major determinant for detecting non-major histocompatibility complex-restricted cytotoxic mononuclear cells from the intestinal lamina propria. Eur. J. Immunol. 22: 23-29 (1992).

• Vanden Heuvel JP. The PPAR resource page. Biochim. Biophys. Acta 1771: 1108-1112 (2007). *

• Vandergheynst F, Ocmant A, Sordet C, Humbel RL, Goetz J, Roufosse F, Cogan E, Sibilia J. Anti-PM/Scl antibodies in connective tissue disease: clinical and biological assessment of 14 patients. Clin. Exp. Rheumatol. 24: 129-133 (2006).

• Vandooren B, Melis L, Veys EM, Tak PP, Baeten D. In vitro spontaneous osteoclastogenesis of human peripheral blood mononuclear cells is not crucially dependent on T lymphocytes. Arthritis Rheum. 60: 1020-1025 (2009). *

• Vantelon JM, Godeau B, Andre C, Bierling P. Screening for autoimmune markers is unnecessary during follow-up of adults with autoimmune thrombocytopenic purpura and no autoimmune markers at onset. Thromb. Haemost. 83: 42-45 (2000).

• Vasiliauskas E. Recent advances in the diagnosis and classification of inflammatory bowel disease. Curr. Gastroenterol. Rep. 5: 493-500 (2003).

• Vasiliauskas EA, Kam LY, Karp LC, Gaiennie J, Yang H, Targan SR. Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics. Gut 47: 487-496 (2000). *

• Vasiliauskas EA, Plevy SE, Landers CJ, Binder SW, Ferguson DM, Yang H, Rotter JI, Vidrich A, Targan SR. Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup. Gastroenterology 110: 1810-1819 (1996). *

• Vasudev M, Zacharisen MC. New-onset rheumatoid arthritis after anthrax vaccination. Ann. Allergy Asthma Immunol. 97: 110-112 (2006).

• Vaughan JH, Nguyen MD, Valbracht JR, Patrick K, Rhodes GH. Epstein-Barr virus-induced autoimmune responses. II. Immunoglobulin G autoantibodies to mimicking and nonmimicking epitopes. Presence in autoimmune disease. J. Clin. Invest. 95: 1316-1327 (1995). *

• Vazquez-Talavera J, Ramirez-Sandoval R, Esparza-Ibarra E, Avalos-Diaz E, Herrera-Esparza R. Autoantibodies against Cajal bodies in systemic lupus erythematosus. Med. Sci. Monit. 10: BR130-BR134 (2004). *

• Veber D, Mutti E, Tacchini L, Gammella E, Tredici G, Scalabrino G. Indirect down-regulation of nuclear NF-kappaB levels by cobalamin in the spinal cord and liver of the rat. J. Neurosci. Res. 86: 1380-1387 (2008).

• Vecchi M, Bianchi MB, Calabresi C, Meucci G, Tatarella M, de Franchis R. Long-term observation of the perinuclear anti-neutrophil cytoplasmic antibody status in ulcerative colitis patients. Scand. J. Gastroenterol. 33: 170-173 (1998). *

• Vecchi M, Bianchi MB, Sinico RA, Radice A, Meucci G, Torgano G, Omodei P, Forzenigo L, Landoni M, Arrigoni M, et al. Antibodies to neutrophil cytoplasm in Italian patients with ulcerative colitis: sensitivity, specificity and recognition of putative antigens. Digestion 55: 34-39 (1994).

• Vecchi M, Sinico A, Bianchi MB, Radice A, Gionchetti P, Campieri M, de Franchis R. Recognition of bactericidal/permeability-increasing protein by perinuclear anti-neutrophil cytoplasmic antibody-positive sera from ulcerative colitis patients: prevalence and clinical significance. Scand. J. Gastroenterol. 33: 1284-1288 (1998). *

• Vega F, Chang CC, Schwartz MR, Preti HA, Younes M, Ewton A, Verm R, Jaffe ES. Atypical NK-cell proliferation of the gastrointestinal tract in a patient with antigliadin antibodies but not celiac disease. Am. J. Surg. Pathol. 30: 539-544 (2006).

• Velu V, Saravanan S, Nandakumar S, Shankar EM, Vengatesan A, Jadhav SS, Kulkarni PS, Thyagarajan SP. Relationship between T-lymphocyte cytokine levels and sero-response to hepatitis B vaccines. World J. Gastroenterol. 14: 3534-3540 (2008). *

• Venables PJ. Mixed connective tissue disease. Lupus 15: 132-137 (2006).

• Vergani D, Longhi MS, Bogdanos DP, Ma Y, Mieli-Vergani G. Autoimmune hepatitis. Semin. Immunopathol. 31: 421-435 (2009). *

• Vergani D, Ma Y, Bogdanos DP, Mieli-Vergani G. Autoreactive T cells: any evidence in autoimmune liver disease? Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 31-32 (2004). *

• Vergani D, Mieli-Vergani G. Autoimmune hepatitis: diagnostic and management challenges. J. Gastroenterol. Hepatol. 19: S388-S390 (2004). *

• Vergani D, Mieli-Vergani G. Mechanisms of autoimmune hepatitis. Pediatr. Transplant. 8: 589-593 (2004). *

• Vergani D, Mieli-Vergani G. Autoimmune hepatitis. Curr. Opin. Gastroenterol. 17: 562-567 (2001).

• Vergani D, Mieli-Vergani G. Autoimmune hepatitis. Minerva Gastroenterol. Dietol. 50: 113-123 (2004).

• Vergani D, Mieli-Vergani G. Autoimmune serology in liver disease: methodology and interpretation. J. Gastroenterol. Hepatol. 19: S287-S289 (2004). *

• Vergani D, Mieli-Vergani G. Autoimmune hepatitis. Ann. Ital. Med. Int. 11: 119-124 (1996).

• Vergani D, Mieli-Vergani G. Aetiopathogenesis of autoimmune hepatitis. World J. Gastroenterol. 14: 3306-3312 (2008). *

• Vergani D, Mieli-Vergani G. Chapter 20. Autoimmune hepatitis. In "Liver Immunology: Principles and Practice" (eds. Gershwin ME, Vierling JM, Manns MP), Humana Press Inc., Totowa, NJ, p. 263-275 (2007). *

• Verhaeghe C, Remouchamps C, Hennuy B, Vanderplasschen A, Chariot A, Tabruyn SP, Oury C, Bours V. Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways. Biochem. Pharmacol. 73: 1982-1994 (2007). *

• Vermeire S, Noman M, Van Assche G, Baert F, Van Steen K, Esters N, Joossens S, Bossuyt X, Rutgeerts P. Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study. Gastroenterology 125: 32-39 (2003). *

• Vermeulen N, Arijs I, Joossens S, Vermeire S, Clerens S, Van den Bergh K, Michiels G, Arckens L, Schuit F, Van Lommel L, Rutgeerts P, Bossuyt X. Anti-alpha-enolase antibodies in patients with inflammatory bowel disease. Clin. Chem. 54: 534-541 (2008). *

• Vernon SD, Reeves WC. Evaluation of autoantibodies to common and neuronal cell antigens in chronic fatigue syndrome. J. Autoimmune Dis. 2: 5 (2005). *

• Viau M, Zouali M. Effect of the B cell superantigen protein A from S. aureus on the early lupus disease of (NZBxNZW) F(1) mice. Mol. Immunol. 42: 849-855 (2005). *

• Vierling JM. Primary biliary cirrhosis and autoimmune cholangiopathy. Clin. Liver Dis. 8: 177-194 (2004).

• Vierling JM. Primary sclerosing cholangitis: is autoimmunity involved in pathogenesis? Falk Symposium 142. GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), pp. 43-44. October 12-13 (2004). *

• Vierling JM. Is primary sclerosing cholangitis an autoimmune disease? Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 67-69. October 15-16 (2003). *

• Vijayalakshmi AM, Jayavardhana A. Bullous systemic lupus erythematosus and lupus nephritis in a 10 year old boy. Indian Pediatr. 44: 861-863 (2007). *

• Vila LM, Molina MJ. Chronic anemia and thrombocytosis as the initial presentation of Still's disease in an elderly patient. Gerontology 53: 289-292 (2007).

• Villadsen LS, Skov L, Dam TN, Dagnaes-Hansen F, Rygaard J, Schuurman J, Parren PW, van de Winkel JG, Baadsgaard O. In situ depletion of CD4(+) T cells in human skin by Zanolimumab. Arch. Dermatol. Res. 298: 449-455 (2007). *

• Vinuesa CG, Cook MC. Genetic analysis of systemic autoimmunity. Novartis Found. Symp. 281: 103-120 (2007).

• Visentini M, Conti V, Cagliuso M, Tinti F, Siciliano G, Trombetta AC, Mitterhofer AP, Fiorilli M, Quinti I. Regression of systemic lupus erythematosus after development of an acquired Toll-like receptor signaling defect and antibody deficiency. Arthritis Rheum. 60: 2767-2771 (2009). *

• Vogel A, Heinrich E, Bahr MJ, Rifai K, Flemming P, Melter M, Klempnauer J, Nashan B, Manns MP, Strassburg CP. Long-term outcome of liver transplantation for autoimmune hepatitis. Clin. Transplant. 18: 62-69 (2004). *

• Vogten AJ, Hadzic N, Shorter RG, Summerskill WH, Taylor WF. Cell-mediated cytotoxicity in chronic active liver disease: a new test system. Gastroenterology 74: 883-889 (1978).

• Voinchet H, Etienne G, Ghiringelli CB, Pellegrin JL, Viallard JF, Parrens M, Longy-Boursier M. Splenic marginal zone lymphoma and autoimmunity: report of six cases. Rev. Med. Interne. Jul 7 [Epub ahead of print] (2009).

• Vollmer J, Tluk S, Schmitz C, Hamm S, Jurk M, Forsbach A, Akira S, Kelly KM, Reeves WH, Bauer S, Krieg AM. Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J. Exp. Med. 202: 1575-1585 (2005). *

• Volpe R. Autoimmune disease. ENCYCLOPEDIA OF LIFE SCIENCES Nature Publishing Group www.els.net (2001). *

• von Euw E, Chodon T, Attar N, Jalil J, Koya RC, Comin-Anduix B, Ribas A. CTLA4 blockade increases Th17 cells in patients with metastatic melanoma. J. Transl. Med. 7: 35 (2009). *

• von Landenberg P, Baumgartner M, Schoelmerich J, Lackner KJ, Klein R. Clinical relevance of antiphospholipid antibodies in primary biliary cirrhosis. Ann. N. Y. Acad. Sci. 1051: 20-28 (2005). *

• von Landenberg P, Doring Y, Modrow S, Lackner KJ. Are antiphospholipid antibodies an essential requirement for an effective immune response to infections? Ann. N. Y. Acad. Sci. 1108: 578-583 (2007). *

• von Landenberg P, Lehmann HW, Modrow S. Human parvovirus B19 infection and antiphospholipid antibodies. Autoimmun. Rev. 6: 278-285 (2007).

• Vos PA, Bast EJ, Derksen RH. Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice. Rheumatology (Oxford) 45: 629-635 (2006). *

• Vossenaar ER, Nijenhuis S, Helsen MM, van der Heijden A, Senshu T, van den Berg WB, van Venrooij WJ, Joosten LA. Citrullination of synovial proteins in murine models of rheumatoid arthritis. Arthritis Rheum. 48: 2489-2500 (2003). *

• Vosters JL, Landek-Salgado MA, Yin H, Swaim WD, Kimura H, Tak PP, Caturegli P, Chiorini JA. Interleukin-12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sjogren's syndrome. Arthritis Rheum. 60: 3633-3641 (2009). *

• Vudattu NK, Kuhlmann-Berenzon S, Khademi M, Seyfert V, Olsson T, Maeurer MJ. Increased numbers of IL-7 receptor molecules on CD4+CD25-CD107a+ T-cells in patients with autoimmune diseases affecting the central nervous system. PLoS One 4: e6534 (2009). *

• Wakamoto S, Fujihara M, Sakagawa H, Takahashi D, Niwa K, Morioka M, Sato S, Kato T, Azuma H, Ikeda H. Endothelial permeability is increased by the supernatant of peripheral blood mononuclear cells stimulated with HLA class II antibody. Transfusion 48: 2060-2068 (2008).

• Wakefield D, Easter J, Robinson P, Graham D, Penny R. Chlamydial antibody crossreactivity with peripheral blood mononuclear cells of patients with ankylosing spondylitis: the role of HLA B27. Clin. Exp. Immunol. 63: 49-57 (1986). *

• Walgenbach-Brunagel G, Burger B, Leman ES, Walgenbach KJ, Tolba R, Heukamp L, Hirner A, Getzenberg RH. The use of a colon cancer associated nuclear antigen CCSA-2 for the blood based detection of colon cancer. J. Cell. Biochem. 104: 286-294 (2008). *

• Walker DJ, Griffiths M, Griffiths ID. Occurrence of autoimmune diseases and autoantibodies in multicase rheumatoid arthritis families. Ann. Rheum. Dis. 45: 323-326 (1986). *

• Walker SE, Ranatunga SK. Rheumatoid arthritis: a review. Mo. Med. 103: 539-544 (2006).

• Wan S, Xia C, Morel L. IL-6 produced by dendritic cells from lupus-prone mice inhibits CD4+CD25+ T cell regulatory functions. J. Immunol. 178: 271-279 (2007). *

• Wanchu A. Antinuclear antibodies: clinical applications. J. Postgrad. Med. 46: 144-148 (2000). *

• Wang G, Ansari GA, Khan MF. Involvement of lipid peroxidation-derived aldehyde-protein adducts in autoimmunity mediated by trichloroethene. J. Toxicol. Environ. Health A. 70: 1977-1985 (2007). *

• Wang G, Cai P, Ansari GA, Khan MF. Oxidative and nitrosative stress in trichloroethene-mediated autoimmune response. Toxicology 229: 186-193 (2007). *

• Wang G, Konig R, Ansari GA, Khan MF. Lipid peroxidation-derived aldehyde-protein adducts contribute to trichloroethene-mediated autoimmunity via activation of CD4(+) T cells. Free Radic. Biol. Med. 44: 1475-1482 (2008).

• Wang GC, Talor MV, Rose NR, Cappola AR, Chiou RB, Weiss C, Walston JD, Fried LP, Caturegli P. Thyroid autoantibodies are associated with a reduced prevalence of frailty in community-dwelling older women. J. Clin. Endocrinol. Metab. Jan 8 [Epub ahead of print] (2010). *

• Wang H, Xu J, Ji X, Yang X, Sun K, Liu X, Shen Y. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus. Cell. Immunol. 235: 117-121 (2005). *

• Wang H, Yang H, Tracey KJ. Extracellular role of HMGB1 in inflammation and sepsis. J. Intern. Med. 255: 320-331 (2004). *

• Wang L, Xiang Z, Ma LL, Chen Z, Gao X, Sun Z, Williams P, Chari RS, Yin DP. Deficiency of protein kinase C-theta facilitates tolerance induction. Transplantation 87: 507-516 (2009).

• Wang M, Sun H, Zhang W, Zhang Y. Functional activation of proline-rich tyrosine kinase2 (PYK2) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. BMC Musculoskelet. Disord. 10: 141 (2009). *

• Wang S, Wolf SE, Evers BM. Differential activation of the Stat signaling pathway in the liver after burn injury. Am. J. Physiol. 273: G1153-G1159 (1997). *

• Wang Y, Becklund BR, Deluca HF. Identification of a highly specific and versatile vitamin D receptor antibody. Arch. Biochem. Biophys. Nov 28 [Epub ahead of print] (2009). *

• Ward JM, Anver MR, Haines DC, Benveniste RE. Chronic active hepatitis in mice caused by Helicobacter hepaticus. Am. J. Pathol. 145: 959-968 (1994). *

• Washington MK. Autoimmune liver disease: overlap and outliers. Mod. Pathol. 20 Suppl. 1: S15-S30 (2007). *

• Watabe D, Kanno H, Yoshida A, Kurose A, Akasaka T, Sawai T. Adhesion of peripheral blood mononuclear cells and CD4+ T cells from patients with psoriasis to cultured endothelial cells via the interaction between lymphocyte function-associated antigen type 1 and intercellular adhesion molecule 1. Br. J. Dermatol. 157: 259-265 (2007). *

• Watanabe S, Deguchi A, Uchida N, Kurokohchi K, Arima K, Nishioka M, Hasui H. Histopathologic comparison of anti-mitochondrial antibody-positive primary biliary cirrhosis and autoimmune cholangiopathy. Hepatol. Res. 19: 41-51 (2001).

• Watanabe Y, Tanaka T, Uchiyama Y, Takeno T, Izumi A, Yamashita H, Kumakura J, Iwanari H, Shu-Ying J, Naito M, Mangelsdorf DJ, Hamakubo T, Kodama T. Establishment of a monoclonal antibody for human LXRalpha: detection of LXRalpha protein expression in human macrophages. Nucl. Recept. 1: 1 (2003). *

• Weindl G, Naglik JR, Kaesler S, Biedermann T, Hube B, Korting HC, Schaller M. Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling. J. Clin. Invest. 117: 3664-3672 (2007). *

• Weir A, Taylor-Robinson SD, Poole S, Pignatelli M, Walters JF, Calam J. Cytoplasmic antineutrophil cytoplasmic antibody-positive vasculitis associated with ulcerative colitis. Am. J. Gastroenterol. 92: 506-508 (1997).

• Weismuller TJ, Wedemeyer J, Kubicka S, Strassburg CP, Manns MP. The challenges in primary sclerosing cholangitis: aetiopathogenesis, autoimmunity, management and malignancy? J. Hepatol. 48: S38-S57 (2008). *

• Wen L, Ma Y, Bogdanos DP, Wong FS, Demaine A, Mieli-Vergani G, Vergani D. Pediatric autoimmune liver diseases: the molecular basis of humoral and cellular immunity. Curr. Mol. Med. 1: 379-389 (2001). *

• Wen Z, Fiocchi C. Inflammatory bowel disease: autoimmune or immune-mediated pathogenesis? Clin. Dev. Immunol. 11: 195-204 (2004). *

• Wen ZH, Quyang Q, Zhang H, Yi ZH, Wang YF. Expression and function of interleukin-18 in mouse dextran sulfate sodium colitis. Sichuan Da Xue Xue Bao Yi Xue Ban 36: 676-678 (2005).

• Wesierska-Gadek J, Hohenauer H, Hitchman E, Penner E. Autoantibodies against constituents of nuclear pore complexes in patients with primary biliary cirrhosis and autoimmune hepatitis. Acta Biochim. Pol. 42: 197-200 (1995).

• Wesierska-Gadek J, Hohenauer H, Hitchman E, Penner E. Autoantibodies from patients with primary biliary cirrhosis preferentially react with the amino-terminal domain of nuclear pore complex glycoprotein gp210. J. Exp. Med. 182: 1159-1162 (1995). *

• Wesierska-Gadek J, Hohenauer H, Hitchman E, Penner E. Anti-gp210 antibodies in sera of patients with primary biliary cirrhosis. Identification of a 64 kD fragment of gp210 as a major epitope. Hum. Antibodies Hybridomas 7: 167-174 (1996).

• Wesierska-Gadek J, Hohenuer H, Hitchman E, Penner E. Autoantibodies against nucleoporin p62 constitute a novel marker of primary biliary cirrhosis. Gastroenterology 110: 840-847 (1996). *

• Wesierska-Gadek J, Klima A, Komina O, Ranftler C, Invernizzi P, Penner E. Characterization of autoantibodies against components of the nuclear pore complexes: high frequency of anti-p62 nucleoporin antibodies. Ann. N. Y. Acad. Sci. 1109: 519-530 (2007). *

• Wesierska-Gadek J, Klima A, Ranftler C, Komina O, Hanover J, Invernizzi P, Penner E. Characterization of the antibodies to p62 nucleoporin in primary biliary cirrhosis using human recombinant antigen. J. Cell. Biochem. 104: 27-37 (2008). *

• Wesierska-Gadek J, Penner E, Battezzati PM, Selmi C, Zuin M, Hitchman E, Worman HJ, Gershwin ME, Podda M, Invernizzi P. Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis. Hepatology 43: 1135-1144 (2006). *

• Wetter DA, Davis MD. Lupus-like syndrome attributable to anti-tumor necrosis factor alpha therapy in 14 patients during an 8-year period at Mayo Clinic. Mayo Clin. Proc. 84: 979-984 (2009).

• Weyman RL, Voigt M. Consecutive occurrence of primary biliary cirrhosis and autoimmune hepatitis: a case report and review of the literature. Am. J. Gastroenterol. 96: 585-587 (2001). *

• Whary MT, Morgan TJ, Dangler CA, Gaudes KJ, Taylor NS, Fox JG. Chronic active hepatitis induced by Helicobacter hepaticus in the A/JCr mouse is associated with a Th1 cell-mediated immune response. Infect. Immun. 66: 3142-3148 (1998). *

• Whiteside TL, Lasky S, Si L, Van Thiel DH. Immunologic analysis of mononuclear cells in liver tissues and blood of patients with primary sclerosing cholangitis. Hepatology 5: 468-474 (1985).

• Whittingham S, Mackay IR, Tait BD. Autoantibodies to small nuclear ribonucleoproteins. A strong association between anti-SS-B(La), HLA-B8, and Sjogren's syndrome. Aust. N. Z. J. Med. 13: 565-570 (1983).

• Wichmann I, Montes-Cano MA, Respaldiza N, Alvarez A, Walter K, Franco E, Sanchez-Roman J, Nunez-Roldan A. Clinical significance of anti-multiple nuclear dots/Sp100 autoantibodies. Scand. J. Gastroenterol. 38: 996-999 (2003). *

• Wicks I, McColl G, D'Amico A, Dougherty L, Tait B. Use of monoclonal antibodies to detect disease associated HLA-DRB1 alleles and the shared epitope in rheumatoid arthritis. Ann. Rheum. Dis. 56: 135-139 (1997). *

• Wielosz E, Majdan M, Zychowska I, Jeleniewicz R. Coexistence of five autoimmune diseases: diagnostic and therapeutic difficulties. Rheumatol. Int. 28: 919-923 (2008). *

• Wiik A, Stummann L, Kjeldsen L, Borregaard N, Ullman S, Jacobsen S, Halberg P. The diversity of perinuclear antineutrophil cytoplasmic antibodies (pANCA) antigens. Clin. Exp. Immunol. 101 Suppl. 1: 15-17 (1995). *

• Wilbe M, Jokinen P, Hermanrud C, Kennedy LJ, Strandberg E, Hansson-Hamlin H, Lohi H, Andersson G. MHC class II polymorphism is associated with a canine SLE-related disease complex. Immunogenetics 61: 557-564 (2009). *

• Wilbe M, Jokinen P, Truve K, Seppala EH, Karlsson EK, Biagi T, Hughes A, Bannasch D, Andersson G, Hansson-Hamlin H, Lohi H, Lindblad-Toh K. Genome-wide association mapping identifies multiple loci for a canine SLE-related disease complex. Nat. Genet. Jan 31 [Epub ahead of print] (2010). *

• Wilkinson R, Lyons AB, Roberts D, Wong MX, Bartley PA, Jackson DE. Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) acts as a regulator of B-cell development, B-cell antigen receptor (BCR)-mediated activation, and autoimmune disease. Blood 100: 184-193 (2002). *

• Williams JM, Kamesh L, Savage CO. Translating basic science into patient therapy for ANCA-associated small vessel vasculitis. Clin. Sci. (Lond.) 108: 101-112 (2005). *

• Williams RO. Collagen-induced arthritis in mice: a major role for tumor necrosis factor-alpha. Methods Mol. Biol. 361: 265-284 (2006).

• Williamson L, Raess NA, Caldelari R, Zakher A, de Bruin A, Posthaus H, Bolli R, Hunziker T, Suter MM, Muller EJ. Pemphigus vulgaris identifies plakoglobin as key suppressor of c-Myc in the skin. EMBO J. 25: 3298-3309 (2006). *

• Winczyk K, Pawlikowski M. Immunohistochemical detection of PPARgamma receptors in the human pituitary adenomas: correlation with PCNA. Folia Histochem. Cytobiol. 43: 137-141 (2005).

• Winfield JB, Jarjour WN. Stress proteins, autoimmunity, and autoimmune disease. Curr. Top. Microbiol. Immunol. 167: 161-189 (1991).

• Winter HS, Landers CJ, Winkelstein A, Vidrich A, Targan SR. Anti-neutrophil cytoplasmic antibodies in children with ulcerative colitis. J. Pediatr. 125: 707-711 (1994).

• Wirth HP, Meyenberger C, Ammann R, Blum HE. Parietal cell antibodies in primary biliary cirrhosis: pathogenetic or diagnostic significance? Schweiz. Med. Wochenschr. 124: 816-820 (1994).

• Wither J, Cai Y, Lim S, McKenzie T, Roslin N, Claudio JO, Cooper GS, Hudson TJ, Paterson AD, Greenwood CM, Gladman D, Pope J, Pineau CA, Smith CD, Hanly JG, Peschken C, Boire G, Investigators C, Fortin PR. Reduced proportions of NKT cells are present in the relatives of lupus patients and are associated with autoimmunity. Arthritis Res. Ther. 10: R108 (2008). *

• Wiwi CA, Gupte M, Waxman DJ. Sexually dimorphic P450 gene expression in liver-specific hepatocyte nuclear factor 4alpha-deficient mice. Mol. Endocrinol. 18: 1975-1987 (2004). *

• Wohrer S, Troch M, Zwerina J, Schett G, Skrabs C, Gaiger A, Jaeger U, Zielinski C, Raderer M. Influence of rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone on serologic parameters and clinical course in lymphoma patients with autoimmune diseases. Ann. Oncol. 18: 647-651 (2007). *

• Wolf AM, Wolf D, Rumpold H, Moschen AR, Kaser A, Obrist P, Fuchs D, Brandacher G, Winkler C, Geboes K, Rutgeerts P, Tilg H. Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease. Clin. Immunol. 113: 47-55 (2004). *

• Woo YL, Sterling JC, Crawford RA, van der Burg SH, Coleman N, Stanley MA. FOXP3 immunohistochemistry on formalin-fixed paraffin embedded tissue: poor correlation between different antibodies. J. Clin. Pathol. 61: 969-971 (2008).

• Worda M, Sgonc R, Dietrich H, Niederegger H, Sundick RS, Gershwin ME, Wick G. In vivo analysis of the apoptosis-inducing effect of anti-endothelial cell antibodies in systemic sclerosis by the chorionallantoic membrane assay. Arthritis Rheum. 48: 2605-2614 (2003). *

• Worman HJ. Nuclear envelope protein autoantigens in primary biliary cirrhosis. Hepatol. Res. 37 Suppl. 3: S406-S411 (2007). *

• Worman HJ, Courvalin JC. Antinuclear antibodies specific for primary biliary cirrhosis. Autoimmun. Rev. 2: 211-217 (2003).

• Wu CH, Xu XY, Lu HY, Yu YY, Wang GQ. Clinical and pathological analysis of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Beijing Da Xue Xue Bao 36: 609-611 (2004).

• Wu CH, Xu XY, Tian GS, Yu YY. Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus. Zhonghua Yi Xue Za Zhi 86: 390-393 (2006).

• Wu KC, Mahida YR, Priddle JD, Jewell DP. Effect of human intestinal macrophages on immunoglobulin production by human intestinal mononuclear cells isolated from patients with inflammatory bowel disease. Clin. Exp. Immunol. 79: 35-40 (1990). *

• Wu Q, Koike Y, Nishina M, Toyoda M, Suzuki D, Endoh M. A case with membranous lupus nephritis developing after a twenty-year remission of membranoproliferative glomerulonephritis. Intern. Med. 45: 531-536 (2006). *

• Wu XY, Gao JL, Ren MY. Expression profiles and function of Toll-like receptors in human corneal epithelia. Chin. Med. J. (Engl.) 120: 893-897 (2007). *

• Wu YL, Hauptmann G, Viguier M, Yu CY. Molecular basis of complete complement C4 deficiency in two North-African families with systemic lupus erythematosus. Genes Immun. 10: 433-445 (2009).

• Wu YY, Hsu TC, Chen TY, Liu TC, Liu GY, Lee YJ, Tsay GJ. Proteinase 3 and dihydrolipoamide dehydrogenase (E3) are major autoantigens in hepatitis C virus (HCV) infection. Clin. Exp. Immunol. 128: 347-352 (2002). *

• Xenellis J, Nikolopoulos TP, Stavroulaki P, Marangoudakis P, Androulakis M, Tsangaroulakis M, Ferekidis E. Simultaneous and sequential bilateral sudden sensorineural hearing loss: are they different from unilateral sudden sensorineural hearing loss? ORL J. Otorhinolaryngol. Relat. Spec. 69: 306-310 (2007).

• Xiang Q, Wen L, Liu MH, Zhang Y, Qu JF, Tian J. Endotoxin tolerance of RAW264.7 correlates with p38-dependent up-regulation of scavenger receptor-A. J. Int. Med. Res. 37: 491-502 (2009).

• Xie HF, Feng H, Zeng HY, Li J, Shi W, Yi M, Wu B. Establishment of systemic lupus erythematosus-like murine model with Sm mimotope. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 29: 191-195 (2007).

• Xie S, Li L, Chang S, Sharma R, Kaliyaperumal A, Datta SK, Mohan C. Genetic origin of lupus in NZB/SWR hybrids: lessons from an intercross study. Arthritis Rheum. 52: 659-667 (2005). *

• Xin G, Zhao MH, Wang HY. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in Chinese patients with clinically suspected vasculitis. Clin. Diagn. Lab. Immunol. 11: 559-562 (2004). *

• Xu BY, Huang D, Pirskanen R, Lefvert AK. beta2-adrenergic receptor gene polymorphisms in myasthenia gravis (MG). Clin. Exp. Immunol. 119: 156-160 (2000). *

• Xu Q. Role of heat shock proteins in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 22: 1547-1559 (2002). *

• Xu X, Hsu HC, Chen J, Grizzle WE, Chatham WW, Stockard CR, Wu Q, Yang PA, Holers VM, Mountz JD. Increased expression of activation-induced cytidine deaminase is associated with anti-CCP and rheumatoid factor in rheumatoid arthritis. Scand. J. Immunol. 70: 309-16 (2009). *

• Xu Z, Duan B, Croker BP, Morel L. STAT4 deficiency reduces autoantibody production and glomerulonephritis in a mouse model of lupus. Clin. Immunol. 120: 189-198 (2006). *

• Xue Q, Luan X, Gu Y, Wu H, Zhang G, Yu G, Zhu H, Wang M, Dong W, Geng YJ, Zhang X. The negative co-signaling molecule B7-H4 is expressed by human BMSC and mediates its T cell modulatory activity. Stem Cells Dev. Sep 29 [Epub ahead of print] (2009).

• Yachha SK, Srivastava A, Chetri K, Saraswat VA, Krishnani N. Autoimmune liver disease in children. J. Gastroenterol. Hepatol. 16: 674-677 (2001). *

• Yacyshyn BR, Lazarovits A, Tsai V, Matejko K. Crohn's disease, ulcerative colitis, and normal intestinal lymphocytes express integrins in dissimilar patterns. Gastroenterology 107: 1364-1371 (1994).

• Yacyshyn BR, Schievella A, Sewell KL, Tami JA. Gene polymorphisms and serological markers of patients with active Crohn's disease in a clinical trial of antisense to ICAM-1*. Clin. Exp. Immunol. 141: 141-147 (2005). *

• Yago T, Nanke Y, Kawamoto M, Furuya T, Kobashigawa T, Kamatani N, Kotake S. IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats. Arthritis Res. Ther. 9: R96 (2007). *

• Yamada S, Oikawa Y, Sakai G, Atsumi Y, Maruyama T, Shimada A. Expression levels of CXC chemokine receptors 3 are associated with clinical phenotype of type 1 diabetes. Ann. N. Y. Acad. Sci. 1079: 186-189 (2006). *

• Yamada T, Handa Y, Kamikawa T, Machino H, Suzuki K, Miyata K. A case of systemic lupus erythematosus associated with thrombotic thrombocytopenic purpura and hemophagocytic syndrome. Nihon Rinsho Meneki Gakkai Kaishi 29: 384-388 (2006).

• Yamamoto K, Terada R, Okamoto R, Hiasa Y, Abe M, Onji M, Tsuji T. A scoring system for primary biliary cirrhosis and its application for variant forms of autoimmune liver disease. J. Gastroenterol. 38: 52-59 (2003). *

• Yamamoto M, Harada S, Ohara M, Suzuki C, Naishiro Y, Yamamoto H, Takahashi H, Imai K. Clinical and pathological differences between Mikulicz's disease and Sjogren's syndrome. Rheumatology (Oxford) 44: 227-234 (2005). *

• Yamamoto M, Nojima M, Ohara M, Suzuki C, Naishiro Y, Itoh Y, Yamamoto H, Takahashi H, Kitajima Y, Endo T, Imai K. A case of systemic lupus erythematosus with postpartum hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome and concomitant high phosphatidylserine-dependent anti-prothrombin antibody levels. Mod. Rheumatol. 14: 402-405 (2004).

• Yamamoto M, Takahashi H, Naishiro Y, Isshiki H, Ohara M, Suzuki C, Yamamoto H, Kokai Y, Himi T, Imai K, Shinomura Y. Mikulicz's disease and systemic IgG4-related plasmacytic syndrome (SIPS). Nihon Rinsho Meneki Gakkai Kaishi 31: 1-8 (2008). *

• Yamamoto M, Taniguchi H, Ohara M, Suzuki C, Naishiro Y, Ozeki I, Yamamoto H, Takahashi H, Imai K. Beneficial effect of glucocorticosteroids for esophageal varices due to idiopathic portal hypertension following systemic lupus erythematosus. Nihon Rinsho Meneki Gakkai Kaishi 27: 40-47 (2004).

• Yamamoto T, Yokozeki H, Nishioka K. Psoriasis arthropathy and HLA-B51: report of 5 cases. J. Dermatol. 32: 606-610 (2005).

• Yamamoto-Furusho JK, Takahashi-Monroy T, Vergara-Fernandez O, Reyes E, Uscanga L. Perinuclear anti-neutrophil cytoplasmic antibodies (p-ANCA) in chronic ulcerative colitis: experience in a Mexican institution. World J. Gastroenterol. 12: 3406-3409 (2006). *

• Yamamoto-Furusho JK, Uscanga-Dominguez L, Lopez-Martinez A, Granados J. Association of the HLA-DRB1*0701 allele with perinuclear anti-neutrophil cytoplasmatic antibodies in Mexican patients with severe ulcerative colitis. World J. Gastroenterol. 12: 1617-1620 (2006). *

• Yamasaki Y, Narain S, Hernandez L, Barker T, Ikeda K, Segal MS, Richards HB, Chan EK, Reeves WH, Satoh M. Autoantibodies against the replication protein A complex in systemic lupus erythematosus and other autoimmune diseases. Arthritis Res. Ther. 8: R111 (2006). *

• Yamasaki Y, Narain S, Yoshida H, Hernandez L, Barker T, Hahn PC, Sobel ES, Segal MS, Richards HB, Chan EK, Reeves WH, Satoh M. Autoantibodies to RNA helicase A: a new serologic marker of early lupus. Arthritis Rheum. 56: 596-604 (2007). *

• Yamashiki M, Kosaka Y, Nishioka J, Tameda Y, Takase K, Watanabe S, Kaito M, Nishimura A, Suzuki H, Nomoto M. Flow cytometric analysis of IL-6 receptors on peripheral lymphocytes in patients with primary biliary cirrhosis. J. Clin. Lab. Anal. 12: 83-87 (1998). *

• Yamauchi K, Yamaguchi N, Furukawa T, Takatsu K, Nakanishi T, Sasaki M, Isono E, Tokushige K, Komatsu T, Shiratori K. A novel IgM class autoantibody to a hepatocyte-related 190 kDa molecule in patients with type 1 autoimmune hepatitis. Hepatology 40: 687-692 (2004). *

• Yamawaki H, Hirohata S, Miyoshi T, Takahashi K, Ogawa H, Shinohata R, Dmircan K, Kusachi S, Yamamoto K, Ninomiya Y. Hyaluronan receptors involved in cytokine induction in monocytes. Glycobiology 19: 83-92 (2009).

• Yamazaki M, Kitamura R, Kusano S, Eda H, Sato S, Okawa-Takatsuji M, Aotsuka S, Yanagi K. Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein-Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjogren's syndrome patients… Clin. Exp. Immunol. 139: 558-568 (2005). *

• Yan H, Zhu WG, Li S, Fan FY, Sun PY, Zhu JH. Pioglitazone inhibits dendritic cell adhesion and transmigration through down-regulation of dendritic cell-specific intercellular adhesion molecule-3 grabbing nonintegrin. Zhonghua Yi Xue Za Zhi 88: 835-839 (2008).

• Yan HP, Zhuang H, Liu YM, Feng X, Tan YF, Liu Y, Zhang X, Zhao CH. Immunological characteristics of primary biliary cirrhosis patients. Zhonghua Gan Zang Bing Za Zhi 13: 12-16 (2005).

• Yang CW, Hung CC, Wu MS, Tian YC, Chang CT, Pan MJ, Vandewalle A. Toll-like receptor 2 mediates early inflammation by leptospiral outer membrane proteins in proximal tubule cells. Kidney Int. 69: 815-822 (2006). *

• Yang H, Wang H, Czura CJ, Tracey KJ. HMGB1 as a cytokine and therapeutic target. J. Endotoxin Res. 8: 469-472 (2002). *

• Yang J, Pospisil R, Ray S, Milton J, Mage RG. Investigations of a rabbit (Oryctolagus cuniculus) model of systemic lupus erythematosus (SLE), BAFF and its receptors. PLoS One 4: e8494 (2009). *

• Yang K, Wen J, Liu X, Kijlstra A, Chen L, Chi W, Zhou H, Huang X, Yang P. Inhibitory effect of rapamycin and dexamethasone on production of IL-17 and IFN-gamma in Vogt-Koyanagi-Harada patients. Br. J. Ophthalmol. 93: 249-253 (2009).

• Yang L, Zhou Z, DU T, Tan S, Zhnag Y, Jin P. Detection of carboxypeptidase H specific T cells in peripheral blood of latent autoimmune diabetic patients with carboxypeptidase antibody positivity by ELISPOT assay. Zhong Nan Da Xue Xue Bao Yi Xue Ban 34: 1011-1016 (2009).

• Yang P. Comparative evaluation of unfixed and fixed human neutrophils for determination of antineutrophil cytoplasmic antibodies by indirect immunofluorescence. J. Clin. Pathol. 50: 677-680 (1997). *

• Yang P, Danielsson D, Jarnerot G. Escherichia coli and Proteus mirabilis inhibit the perinuclear but not the circulating antineutrophil cytoplasmic antibody reaction. Scand. J. Gastroenterol. 33: 529-534 (1998).

• Yang P, Jarnerot G, Danielsson D, Tysk C, Lindberg E. p-ANCA in monozygotic twins with inflammatory bowel disease. Gut 36: 887-890 (1995). *

• Yang Q, Shao XM, Cao Y, Chen C, Cheng GQ, Shi YY, Zhou LJ. Neonatal lupus erythematosus: analysis of 8 cases. Zhonghua Er Ke Za Zhi 46: 18-21 (2008).

• Yang WH, Yu JH, Nakajima A, Neuberg D, Lindor K, Bloch DB. Do antinuclear antibodies in primary biliary cirrhosis patients identify increased risk for liver failure? Clin. Gastroenterol. Hepatol. 2: 1116-1122 (2004). *

• Yang XY, Lu XY, Xu DH, Lu QH, Wang QH, Wu HX. Clinical significance of CD(4)(+)CD(25)(+) T cells in peripheral blood of patients in systemic lupus erythematosus. Zhonghua Nei Ke Za Zhi 44: 570-572 (2005).

• Yao H, Michitaka K, Tokumoto Y, Murata Y, Mashiba T, Abe M, Hiasa Y, Horiike N, Onji M. Recurrence of autoimmune hepatitis after liver transplantation without elevation of alanine aminotransferase. World J. Gastroenterol. 13: 1618-1621 (2007). *

• Yasuda M, Amano H, Yamanaka M, Tamura A, Ishikawa O. Coincidental association of mycosis fungoides and occupational systemic sclerosis? J. Dermatol. 35: 21-24 (2008).

• Yasuda N, Thomas P, Ellis H, Herbst F, Nicholls J, Ciclitira P. Perinuclear anti-neutrophil cytoplasmic antibodies in ulcerative colitis after restorative proctocolectomy do not correlate with the presence of pouchitis. Scand. J. Gastroenterol. 33: 509-513 (1998). *

• Yasuda Y, Nakano S, Akiguchi I, Tanaka M, Kameyama M. Polymyositis associated with asymptomatic primary biliary cirrhosis. Eur. Neurol. 33: 51-53 (1993).

• Yatsuji S, Hashimoto E, Kaneda H, Taniai M, Tokushige K, Shiratori K. Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful? J. Gastroenterol. 40: 1130-1138 (2005). *

• Ye H, Gao Y, Guo XH, Zhao MH. Clinical features and outcomes of hyperthyroidism patients positive in propylthiouracil-induced antineutrophil cytoplasmic antibody. Zhonghua Yi Xue Za Zhi 85: 3323-3327 (2005).

• Ye Q, Worman HJ. Primary structure analysis and lamin B and DNA binding of human LBR, an integral protein of the nuclear envelope inner membrane. J. Biol. Chem. 269: 11306-11311 (1994). *

• Yeh SH, Ni YH, Jeng YM, Chen HL, Wu JF, Chang MH. Emerging importance of autoimmune hepatitis in children in Taiwan, an endemic area for viral hepatitis. Pediatr. Neonatol. 50: 65-69 (2009).

• Yeon SI, Youn JH, Lim MH, Lee HJ, Kim YM, Choi JE, Lee JM, Shin JS. Development of monoclonal antibodies against human IRF-5 and their use in identifying the binding of IRF-5 to nuclear import proteins karyopherin-alpha1 and -beta1. Yonsei Med. J. 49: 1023-1031 (2008). *

• Yilmaz M, Camci C, Sari I, Okan V, Sevinc A, Onat AM, Buyukhatipoglu H. Histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto's disease) mimicking systemic lupus erythematosus: a review of two cases. Lupus 15: 384-387 (2006).

• Yilmaz M, Kendirli SG, Altintas DU, Karakoc GB, Inal A, Kilic M. Juvenile idiopathic arthritis profile in Turkish children. Pediatr. Int. 50: 154-158 (2008). *

• Yokogawa N, Vivino FB. Hydralazine-induced autoimmune disease: comparison to idiopathic lupus and ANCA-positive vasculitis. Mod. Rheumatol. 19: 338-347 (2009). *

• Yongchaitrakul T, Manokawinchoke J, Pavasant P. Osteoprotegerin induces osteopontin via syndecan-1 and phosphoinositol 3-kinase/Akt in human periodontal ligament cells. J. Periodontal Res. 44: 776-783 (2009).

• Yoshida M. Antineutrophil cytoplasmic antibody (ANCA). Rinsho Byori 51: 644-648 (2003).

• Yoshida O, Abe M, Furukawa S, Murata Y, Hamada M, Hiasa Y, Matsuura B, Akbar F, Michitaka K, Onji M. A familial case of autoimmune hepatitis. Intern. Med. 48: 315-319 (2009). *

• You X, Liu W, Zhang X, Zhang FC. Patterns of anti-nuclear antibodies in patients with primary biliary cirrhosis and primary Sjogren syndrome. Zhonghua Yi Xue Za Zhi 88: 168-170 (2008).

• You Y, Wang Z, Deng G, Hao F. Lack of association between Fc receptor-like 3 gene polymorphisms and systemic lupus erythematosus in Chinese population. J. Dermatol. Sci. 52: 118-122 (2008).

• Youd ME, Luus L, Corley RB. IgM monomers accelerate disease manifestations in autoimmune-prone Fas-deficient mice. J. Autoimmun. 23: 333-343 (2004).

• Young A, Koduri G. Extra-articular manifestations and complications of rheumatoid arthritis. Best Pract. Res. Clin. Rheumatol. 21: 907-927 (2007).

• Yueh MF, Huang YH, Hiller A, Chen S, Nguyen N, Tukey RH. Involvement of the xenobiotic response element (XRE) in Ah receptor-mediated induction of human UDP-glucuronosyltransferase 1A1. J. Biol. Chem. 278: 15001-15006 (2003). *

• Yukawa S, Tahara K, Hayashi H, Tsuji S, Shoji A, Tsuboi N. A case of lupus cystitis in a 74-year-old woman. Nihon Rinsho Meneki Gakkai Kaishi 31: 183-189 (2008).

• Zachou K, Rigopoulou E, Dalekos GN. Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease. J. Autoimmune Dis. 1: 2 (2004). *

• Zaletel K, Krhin B, Gaberscek S, Hojker S. Thyroid autoantibody production is influenced by exon 1 and promoter CTLA-4 polymorphisms in patients with Hashimoto's thyroiditis. Int. J. Immunogenet. 33: 87-91 (2006). *

• Zandman-Goddard G, Shoenfeld Y. HIV and autoimmunity. Autoimmun. Rev. 1: 329-337 (2002).

• Zangani M, Carlsen H, Kielland A, Os A, Hauglin H, Blomhoff R, Munthe LA, Bogen B. Tracking early autoimmune disease by bioluminescent imaging of NF-kappaB activation reveals pathology in multiple organ systems. Am. J. Pathol. 174: 1358-1367 (2009). *

• Zanini GM, De Moura Carvalho LJ, Brahimi K, De Souza-Passos LF, Guimaraes SJ, Da Silva Machado E, Bianco-Junior C, Riccio EK, De Sousa MA, Alecrim MD, Leite N, Druilhe P, Daniel-Ribeiro CT. Sera of patients with systemic lupus erythematosus react with plasmodial antigens and can inhibit the in vitro growth of Plasmodium falciparum. Autoimmunity 42: 545-552 (2009).

• Zauli D, Crespi C, Miserocchi F, Musiani M, Bianchi FB, Pisi E. Comparison of various cell types as substrates for the detection of antiactin antibodies in chronic liver disease. Diagn. Clin. Immunol. 5: 184-187 (1987).

• Zauli D, Ghetti S, Grassi A, Descovich C, Cassani F, Ballardini G, Muratori L, Bianchi FB. Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis. Hepatology 25: 1105-1107 (1997). *

• Zauli D, Schrumpf E, Crespi C, Cassani F, Fausa O, Aadland E. An autoantibody profile in primary sclerosing cholangitis. J. Hepatol. 5: 14-18 (1987).

• Zen Y, Notsumata K, Tanaka N, Nakanuma Y. Hepatic centrilobular zonal necrosis with positive antinuclear antibody: a unique subtype or early disease of autoimmune hepatitis? Hum. Pathol. 38: 1669-1675 (2007).

• Zeng Z, Han YK, Zhang XF, Geng H. Clinical features of 35 cases of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome. Zhonghua Gan Zang Bing Za Zhi 13: 3-5 (2005).

• Zentilin P, Seriolo B, Dulbecco P, Caratto E, Iiritano E, Fasciolo D, Bilardi C, Mansi C, Testa E, Savarino V. Eradication of Helicobacter pylori may reduce disease severity in rheumatoid arthritis. Aliment. Pharmacol. Ther. 16: 1291-1299 (2002). *

• Zepeda-Gomez S, Montano-Loza A, Zapata-Colindres JC, Paz F, Olivera-Martinez M, Lopez-Reyes A, Granados J, Vargas-Alarcon G. HLA-DR allele frequencies in Mexican mestizos with autoimmune liver diseases including overlap syndromes. Immunol. Invest. 38: 276-283 (2009).

• Zhang CL, Shu MG, Qi HW, Li LW. Inhibition of tumor angiogenesis by HMGB1 A box peptide. Med. Hypotheses 70: 343-345 (2008).

• Zhang FK, Jia JD, Wang BE. Clinical evaluation of serum antimitochondrial antibody-negative primary biliary cirrhosis. Hepatobiliary Pancreat. Dis. Int. 3: 288-291 (2004). *

• Zhang H, Yan JH, Li YP, Cai Y. Growth inhibition and differentiation of retinoblastoma cells induced by all trans retinoic acid. Zhonghua Yan Ke Za Zhi 44: 549-553 (2008).

• Zhang MC, Misu N, Furukawa H, Watanabe Y, Terada M, Komori H, Miyazaki T, Nose M, Ono M. An epistatic effect of the female-specific loci on the development of autoimmune vasculitis and anti-nuclear autoantibody in murine lupus. Ann. Rheum. Dis. 65: 495-500 (2006). *

• Zhang Y, McCormick LL, Gilliam AC. Latency-associated peptide prevents skin fibrosis in murine sclerodermatous graft-versus-host disease, a model for human scleroderma. J. Invest. Dermatol. 121: 713-719 (2003). *

• Zhao Y, Yan HP, Tan YF, Feng X, Liu Y, Cui D, Ma DM, Li WH, Zhang HP. The significance of anti-soluble liver antigen/liver-pancreas in diagnosing and typing autoimmune hepatitis. Zhonghua Gan Zang Bing Za Zhi 15: 283-286 (2007).

• Zhao Y, Yokota K, Ayada K, Yamamoto Y, Okada T, Shen L, Oguma K. Helicobacter pylori heat-shock protein 60 induces interleukin-8 via a Toll-like receptor (TLR)2 and mitogen-activated protein (MAP) kinase pathway in human monocytes. J. Med. Microbiol. 56: 154-164 (2007). *

• Zheng L, Sinniah R, I-Hong Hsu S. Renal cell apoptosis and proliferation may be linked to nuclear factor-kappaB activation and expression of inducible nitric oxide synthase in patients with lupus nephritis. Hum. Pathol. 37: 637-647 (2006).

• Zholudev A, Zurakowski D, Young W, Leichtner A, Bousvaros A. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Am. J. Gastroenterol. 99: 2235-2241 (2004). *

• Zhong X, Lau S, Bai C, Degauque N, Holodick NE, Steven SJ, Tumang J, Gao W, Rothstein TL. A novel subpopulation of B-1 cells is enriched with autoreactivity in normal and lupus-prone mice. Arthritis Rheum. 60: 3734-3743 (2009). *

• Zhou JS, Gill HS. Immunostimulatory probiotic Lactobacillus rhamnosus HN001 and Bifidobacterium lactis HN019 do not induce pathological inflammation in mouse model of experimental autoimmune thyroiditis. Int. J. Food Microbiol. 103: 97-104 (2005). *

• Zhou M, Wu R, Dong W, Jacob A, Wang P. Endotoxin downregulates peroxisome proliferator-activated receptor-gamma via the increase in TNF-alpha release. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294: R84-R92 (2008). *

• Zhou Y, Huang D, Farver C, Hoffman GS. Relative importance of CCR5 and antineutrophil cytoplasmic antibodies in patients with Wegener's granulomatosis. J. Rheumatol. 30: 1541-1547 (2003).

• Zhu GJ, Chen S, Mao Q, Wang YM. Clinical and pathological characterization of the overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis. Zhonghua Gan Zang Bing Za Zhi 13: 6-8 (2005).

• Zhu P, Li XY, Wang HK, Jia JF, Zheng ZH, Ding J, Fan CM. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis. Clin. Immunol. 122: 75-84 (2007). *

• Zhu XM, Yao YM, Liang HP, Xu S, Dong N, Yu Y, Sheng ZY. The effect of high mobility group box-1 protein on splenic dendritic cell maturation in rats. J. Interferon Cytokine Res. 29: 677-686 (2009).

• Zhuang H, Kosboth M, Lee P, Rice A, Driscoll DJ, Zori R, Narain S, Lyons R, Satoh M, Sobel E, Reeves WH. Lupus-like disease and high interferon levels corresponding to trisomy of the type I interferon cluster on chromosome 9p. Arthritis Rheum. 54: 1573-1579 (2006). *

• Zierold C, DeLuca HF. Additional protein factors play a role in the formation of VDR/RXR complexes on vitamin D response elements. J. Cell. Biochem. 71: 515-523 (1998). *

• Zimmer J, Bausinger H, Andres E, Donato L, Hanau D, Hentges F, Moretta A, de la Salle H. Phenotypic studies of natural killer cell subsets in human transporter associated with antigen processing deficiency. PLoS ONE 2: e1033 (2007). *

• Zophel K, Gruning T, Roggenbuck D, Wunderlich G, Kotzerke J. On specificity of 2nd generation TSH receptor autoantibody measurements. Clin. Lab. 54: 243-249 (2008).

• Zophel K, Roggenbuck D, Landenberg PV, Wunderlich G, Gruning T, Kotzerke J, Lackner KJ, Rees Smith B. TSH receptor antibody (TRAb) assays based on the human monoclonal autoantibody M22 are more sensitive than bovine TSH based assays. Horm. Metab. Res. 42: 65-69 (2010).

• Zuchner D, Sternsdorf T, Szostecki C, Heathcote EJ, Cauch-Dudek K, Will H. Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis. Hepatology 26: 1123-1130 (1997). *

Number of references = 2168

www psc-literature.org